,symbol,name,description__profile,ceo__profile,industry__profile,price__profile,currency__profile,mktCap__profile,image__profile,volAvg__profile,pe__quote,change__quote,volume__quote,ebitda__income_statement,netIncome__income_statement,annual_earnings,quaterly_earnings,eps__income_statement,epsdiluted__income_statement,totalAssets__balance_sheet_statement,totalCurrentAssets__balance_sheet_statement,cashAndShortTermInvestments__balance_sheet_statement,totalLiabilities__balance_sheet_statement,netReceivables__balance_sheet_statement,longTermInvestments__balance_sheet_statement,totalCurrentLiabilities__balance_sheet_statement,cashAndCashEquivalents__balance_sheet_statement,freeCashFlow__cash_flow_statement,growthEBITDA__income_statement_growth,growthNetIncome__income_statement_growth,growthEPS__income_statement_growth,dividend__historical-price-full/stock_dividend,date__historical-price-full/stock_dividend,derived__netIncomeMargin,derived__debtRatio
0,CCNC,Code Chain New Continent Limited Common Stock,"Code Chain New Continent Limited, through its subsidiaries, focuses on research, development, and application of Internet of Things (IoT) and electronic token digital door signs. It creates digital door signs which is the digitalization of a physical store by means of animation and other technical services; and offers electronic tokens, that are used for purchasing virtual real estate properties. The company also offers Wuge Manor, a game that combines Internet of Things and e-commerce based on code chain platform that provides players with access to vendors and business owners in approximately 100 cities in China. Code Chain New Continent Limited is based in Chengdu, China.",Mr. Wei  Xu,Electronic Gaming & Multimedia,3.015,USD,0,https://images.financialmodelingprep.com/symbol/CCNC.png,27372,0,0.215,31337,-423443,-424652,"[{'period': '2022', 'revenue': 153.3, 'unit': 'K', 'net_profit': -424.65}, {'period': '2021', 'revenue': 25.03, 'unit': 'M', 'net_profit': -15.82}, {'period': '2020', 'revenue': 11.85, 'unit': 'M', 'net_profit': 2.51}, {'period': '2019', 'revenue': 19.58, 'unit': 'M', 'net_profit': -16.83}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -102.48}, {'period': ""Q2 '23"", 'revenue': 206.8, 'unit': 'K', 'net_profit': -155.5}, {'period': ""Q1 '23"", 'revenue': 75.37, 'unit': 'K', 'net_profit': -20.62}, {'period': ""Q4 '22"", 'revenue': -7.46, 'unit': 'M', 'net_profit': 19.02}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.09}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.37}]",-0.28,-0.28,3800908,1609921,389108,333784,194520,0,333784,389108,-886211,0.9710893352601512,0.9731637578145613,0.9765494137353434,__nan__,__nan__,__nan__,0.08781691111702783
1,CCNE,CNB Financial Corporation Common Stock,"CNB Financial Corporation operates as the bank holding company for CNB Bank that provides a range of banking products and services for individual, business, governmental, and institutional customers. The company accepts checking, savings, and time deposit accounts; and offers real estate, commercial, industrial, residential, and consumer loans, as well as various other specialized financial services. It also provides wealth and asset management services, including the administration of trusts and estates, retirement plans, and other employee benefit plans, as well as a range of wealth management services. In addition, the company invests in debt and equity securities; sells nonproprietary annuities and other insurance products; and small balance unsecured loans and secured loans primarily collateralized by automobiles and equipment. As of February 8, 2022, the company operated a private banking division; three loan production office; one drive-up office; and 45 full-service offices in Pennsylvania, Ohio, New York, and Virginia. CNB Financial Corporation was founded in 1865 and is headquartered in Clearfield, Pennsylvania.",Mr. Michael D. Peduzzi CPA,Banks - Regional,21.15,USD,443734043,https://images.financialmodelingprep.com/symbol/CCNE.png,85186,9.04,-0.22,74009,0,54575000,"[{'period': '2024', 'revenue': 325.47, 'unit': 'M', 'net_profit': 54.58}, {'period': '2023', 'revenue': 218.14, 'unit': 'M', 'net_profit': 58.02}, {'period': '2022', 'revenue': 219.62, 'unit': 'M', 'net_profit': 63.19}, {'period': '2021', 'revenue': 189.38, 'unit': 'M', 'net_profit': 57.71}]","[{'period': ""Q4 '24"", 'revenue': 58.04, 'unit': 'M', 'net_profit': 15.06}, {'period': ""Q3 '24"", 'revenue': 56.08, 'unit': 'M', 'net_profit': 13.95}, {'period': ""Q2 '24"", 'revenue': 89.52, 'unit': 'M', 'net_profit': 12.96}, {'period': ""Q1 '24"", 'revenue': 86.86, 'unit': 'M', 'net_profit': 12.6}, {'period': ""Q4 '23"", 'revenue': 88.34, 'unit': 'M', 'net_profit': 13.98}, {'period': ""Q3 '23"", 'revenue': 53.89, 'unit': 'M', 'net_profit': 13.73}]",2.84,2.83,6192010000,5093916000,532317000,5581315000,4561599000,0,0,443035000,71512000,-1.0,-0.059376077214753534,0.10937499999999992,"[0.18, 0.27]","['2025-02-28', '1994-08-31']",__nan__,0.9013737057918189
2,CCNEP,CNB Financial Corporation Depositary Shares each representing a 1/40th ownership interest in a share of 7.125% Series A Fixed-Rate Non-Cumulative Perpetual Preferred Stock,"CNB Financial Corporation operates as the bank holding company for CNB Bank that provides a range of banking products and services for individual, business, governmental, and institutional customers. The company accepts checking, savings, and time deposit accounts; and offers real estate, commercial, industrial, residential, and consumer loans, as well as various other specialized financial services. It also provides wealth and asset management services, including the administration of trusts and estates, retirement plans, and other employee benefit plans, as well as a range of wealth management services. In addition, the company invests in debt and equity securities; sells nonproprietary annuities and other insurance products; and small balance unsecured loans and secured loans primarily collateralized by automobiles and equipment. As of February 8, 2022, the company operated a private banking division; three loan production office; one drive-up office; and 45 full-service offices in Pennsylvania, Ohio, New York, and Virginia. CNB Financial Corporation was founded in 1865 and is headquartered in Clearfield, Pennsylvania.",Mr. Michael D. Peduzzi CPA,Banks - Regional,23.4887,USD,492800748,https://images.financialmodelingprep.com/symbol/CCNEP.png,2793,7.29,-0.2713,2921,0,54575000,"[{'period': '2024', 'revenue': 325.47, 'unit': 'M', 'net_profit': 54.58}, {'period': '2023', 'revenue': 218.14, 'unit': 'M', 'net_profit': 58.02}, {'period': '2022', 'revenue': 219.62, 'unit': 'M', 'net_profit': 63.19}, {'period': '2021', 'revenue': 189.38, 'unit': 'M', 'net_profit': 57.71}]","[{'period': ""Q4 '24"", 'revenue': 58.04, 'unit': 'M', 'net_profit': 15.06}, {'period': ""Q3 '24"", 'revenue': 56.08, 'unit': 'M', 'net_profit': 13.95}, {'period': ""Q2 '24"", 'revenue': 89.52, 'unit': 'M', 'net_profit': 12.96}, {'period': ""Q1 '24"", 'revenue': 86.86, 'unit': 'M', 'net_profit': 12.6}, {'period': ""Q4 '23"", 'revenue': 88.34, 'unit': 'M', 'net_profit': 13.98}, {'period': ""Q3 '23"", 'revenue': 53.89, 'unit': 'M', 'net_profit': 13.73}]",2.84,2.83,6192010000,5093916000,532317000,5581315000,4561599000,0,0,443035000,71512000,-1.0,-0.059376077214753534,0.10937499999999992,"[0.44531, 0.475]","['2025-02-14', '2020-11-16']",__nan__,0.9013737057918189
3,CCOI,Cogent Communications Holdings Inc.,"Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, Europe, Asia, South America, Australia, and Africa. The company offers on-net Internet access and private network services to law firms, financial services firms, and advertising and marketing firms, as well as heath care providers, educational institutions and other professional services businesses, other Internet service providers, telephone companies, cable television companies, Web hosting companies, media service providers, mobile phone operators, content delivery network companies, and commercial content and application service providers. It also provides Internet access and private network services to customers that are not located in buildings directly connected to its network; and on-net services to customers located in buildings that are physically connected to its network. In addition, the company offers off-net services to corporate customers using other carriers' circuits to provide the last mile portion of the link from the customers' premises to the network. Further, it operates data centers that allow its customers to collocate their equipment and access the network. The company operates 54 data centers and provides facilities to 3,035 buildings and on-net services to 1,817 to multi-tenant office buildings. It serves primarily to small and medium-sized businesses, communications service providers, and other bandwidth-intensive organizations. Cogent Communications Holdings, Inc. was founded in 1999 and is headquartered in Washington, the District of Columbia.",Mr. David  Schaeffer Ph.D.,Telecommunications Services,51.5,USD,2540288640,https://images.financialmodelingprep.com/symbol/CCOI.png,486881,-12.03,-1.6,455641,169605000,-204074000,"[{'period': '2024', 'revenue': 783.81, 'unit': 'M', 'net_profit': -204.07}, {'period': '2023', 'revenue': 0.94092, 'unit': 'B', 'net_profit': 1.27}, {'period': '2022', 'revenue': 599.6, 'unit': 'M', 'net_profit': 5.15}, {'period': '2021', 'revenue': 589.8, 'unit': 'M', 'net_profit': 48.19}]","[{'period': ""Q4 '24"", 'revenue': 252.29, 'unit': 'M', 'net_profit': -43.32}, {'period': ""Q3 '24"", 'revenue': 257.2, 'unit': 'M', 'net_profit': -63.11}, {'period': ""Q2 '24"", 'revenue': 260.44, 'unit': 'M', 'net_profit': -32.34}, {'period': ""Q1 '24"", 'revenue': 266.17, 'unit': 'M', 'net_profit': -65.31}, {'period': ""Q4 '23"", 'revenue': 272.1, 'unit': 'M', 'net_profit': 200.15}, {'period': ""Q3 '23"", 'revenue': 275.43, 'unit': 'M', 'net_profit': -56.72}]",-4.3,-4.3,3173102000,53090000,15336000,2950254000,3123000,0,82465000,15336000,-8645000,-0.8911720412789731,-1.1602539889951713,-1.1599702380952381,"[1.005, 0.1]","['2025-03-13', '2012-08-20']",__nan__,0.9297696701839399
4,CCRC,China Customer Relations Centers Inc. Ordinary Shares,"China Customer Relations Centers, Inc. is a business process outsourcing service provider company, which focuses on the voice-based customer care services including inbound and outbound. The company is headquartered in Taian, Shandong and currently employs 11,101 full-time employees. The firm's customers are the provincial subsidiaries of various telecommunications carriers in the PRC. The company also provides outsourcing services to its clients whereby they can lease its employees to work at their offices. The firm operates its business through contractual arrangements between its subsidiary, wholly foreign owned enterprise (WFOE) and its variable interest entity, Shandong Taiying Technology Co., Ltd (Taiying). Its line of services includes Inbound Customer Care Service and Outbound Customer Care Service. The firm's inbound customer support service offers answering service hotlines in China, round the clock.",Mr. Gary Wang,Information Technology Services,6.5,USD,0,https://images.financialmodelingprep.com/symbol/CCRC.png,51535,4.793510324483776,0.01999998,147697,32177280,24860799,"[{'period': '2020', 'revenue': 240.32, 'unit': 'M', 'net_profit': 24.86}, {'period': '2019', 'revenue': 173.41, 'unit': 'M', 'net_profit': 13.06}, {'period': '2018', 'revenue': 141.43, 'unit': 'M', 'net_profit': 16.09}, {'period': '2017', 'revenue': 88.97, 'unit': 'M', 'net_profit': 8.77}]","[{'period': ""Q2 '20"", 'revenue': 48.86, 'unit': 'M', 'net_profit': 5.15}, {'period': ""Q4 '19"", 'revenue': 100.13, 'unit': 'M', 'net_profit': 8.07}, {'period': ""Q2 '19"", 'revenue': 73.27, 'unit': 'M', 'net_profit': 4.99}, {'period': ""Q4 '18"", 'revenue': 75.4, 'unit': 'M', 'net_profit': 5.08}, {'period': ""Q2 '18"", 'revenue': 66.04, 'unit': 'M', 'net_profit': 11.01}, {'period': ""Q4 '17"", 'revenue': 54.23, 'unit': 'M', 'net_profit': 4.73}]",1.36,1.36,143957860,114870576,43669538,48442062,64763837,3678171,40805723,43669538,18715270,0.7242617708497107,0.9041651316137166,0.9154929577464791,__nan__,__nan__,__nan__,0.33650168181160794
5,CCRN,Cross Country Healthcare Inc. Common Stock $0.0001 Par Value,"Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.",Mr. John A. Martins,Medical - Care Facilities,14.13,USD,463260528,https://images.financialmodelingprep.com/symbol/CCRN.png,417495,-32.11,-0.13,128728,3990000,-14556000,"[{'period': '2024', 'revenue': 1340.0, 'unit': 'M', 'net_profit': -14.56}, {'period': '2023', 'revenue': 2020.0, 'unit': 'M', 'net_profit': 72.63}, {'period': '2022', 'revenue': 2810.0, 'unit': 'M', 'net_profit': 188.46}, {'period': '2021', 'revenue': 1680.0, 'unit': 'M', 'net_profit': 132.0}]","[{'period': ""Q4 '24"", 'revenue': 309.94, 'unit': 'M', 'net_profit': -3.75}, {'period': ""Q3 '24"", 'revenue': 315.12, 'unit': 'M', 'net_profit': 2.56}, {'period': ""Q2 '24"", 'revenue': 339.77, 'unit': 'M', 'net_profit': -16.05}, {'period': ""Q1 '24"", 'revenue': 379.17, 'unit': 'M', 'net_profit': 2.69}, {'period': ""Q4 '23"", 'revenue': 414.04, 'unit': 'M', 'net_profit': 9.04}, {'period': ""Q3 '23"", 'revenue': 442.29, 'unit': 'M', 'net_profit': 12.81}]",-0.44,-0.44,589251000,335000000,81633000,170292000,223238000,0,120402000,81633000,111402000,-0.9691498820891483,-1.200410293125525,-1.21256038647343,__nan__,__nan__,__nan__,0.28899738820977816
6,CCXI,ChemoCentryx Inc. Common Stock,"ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.",Dr. Thomas Schall,Biotechnology,51.99,USD,0,https://images.financialmodelingprep.com/symbol/CCXI.png,2020634,-25.930174563591024,0.0,656224,-131311000,-129060000,"[{'period': '2021', 'revenue': 32.22, 'unit': 'M', 'net_profit': -129.06}, {'period': '2020', 'revenue': 64.89, 'unit': 'M', 'net_profit': -55.36}, {'period': '2019', 'revenue': 35.95, 'unit': 'M', 'net_profit': -55.49}, {'period': '2018', 'revenue': 42.88, 'unit': 'M', 'net_profit': -37.97}]","[{'period': ""Q2 '22"", 'revenue': 11.76, 'unit': 'M', 'net_profit': -32.24}, {'period': ""Q1 '22"", 'revenue': 5.46, 'unit': 'M', 'net_profit': -39.2}, {'period': ""Q4 '21"", 'revenue': 2.61, 'unit': 'M', 'net_profit': -35.78}, {'period': ""Q3 '21"", 'revenue': 17.69, 'unit': 'M', 'net_profit': -22.31}, {'period': ""Q2 '21"", 'revenue': 1.7, 'unit': 'M', 'net_profit': -39.21}, {'period': ""Q1 '21"", 'revenue': 10.22, 'unit': 'M', 'net_profit': -29.71}]",-1.96,-1.96,425652000,269177000,264492000,139532000,411000,97856000,63017000,49978000,-94641000,-1.52929732645042,-1.3314545848688488,-1.3333333333333335,__nan__,__nan__,__nan__,0.3278076926691288
7,CD,Chindata Group Holdings Limited American Depositary Shares,"Chindata Group Holdings Limited provides carrier-neutral hyper scale data center solutions in China, India, Malaysia, and Southeast Asia. It offers artificial intelligence, cloud computing, smart cities and homes, online entertainment, and other on-demand services. The company also provides internet data center colocation and rental services; and technical and consulting services. Its integrated data center solutions include infrastructure, power supply, connectivity and operation and maintenance, tailor-made to their scale and requirements throughout the planning, design, construction, and operation process. The company was formerly known as BCPE Bridge Stack Limited and changed its name to Chindata Group Holdings Limited in April 2020. Chindata Group Holdings Limited was founded in 2015 and is headquartered in Beijing, China.",Mr. Huapeng  Wu,Information Technology Services,8.45,USD,3097770000,https://images.financialmodelingprep.com/symbol/CD.png,2173064,26.40625,-0.14,11291061,2098286000,651630000,"[{'period': '2022', 'revenue': 4550.0, 'unit': 'M', 'net_profit': 651.63}, {'period': '2021', 'revenue': 2850.0, 'unit': 'M', 'net_profit': 316.42}, {'period': '2020', 'revenue': 1830.0, 'unit': 'M', 'net_profit': -283.35}, {'period': '2019', 'revenue': 853.01, 'unit': 'M', 'net_profit': -169.7}]","[{'period': ""Q2 '23"", 'revenue': 1550.0, 'unit': 'M', 'net_profit': 219.22}, {'period': ""Q1 '23"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 252.97}, {'period': ""Q4 '22"", 'revenue': 1390.0, 'unit': 'M', 'net_profit': 116.46}, {'period': ""Q3 '22"", 'revenue': 1200.0, 'unit': 'M', 'net_profit': 241.04}, {'period': ""Q2 '22"", 'revenue': 1040.0, 'unit': 'M', 'net_profit': 199.56}, {'period': ""Q1 '22"", 'revenue': 920.61, 'unit': 'M', 'net_profit': 94.57}]",1.78,1.78,23100231000,6756422000,3115914000,12190677000,2375271000,0,4255680000,3115914000,-3824620000,0.560046542231871,1.059383098413501,1.0227272727272727,__nan__,__nan__,__nan__,0.5277296577683573
8,CDAK,Codiak BioSciences Inc. Common Stock,"Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.",Dr. Douglas Edward Williams Ph.D.,Biotechnology,0.057,USD,0,https://images.financialmodelingprep.com/symbol/CDAK.png,1599191,-0.12391304347826088,0.0,12929980,-61326000,-41633000,"[{'period': '2021', 'revenue': 22.93, 'unit': 'M', 'net_profit': -41.63}, {'period': '2020', 'revenue': 2.92, 'unit': 'M', 'net_profit': -88.93}, {'period': '2019', 'revenue': 0.388, 'unit': 'M', 'net_profit': -79.25}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -44.54}]","[{'period': ""Q3 '22"", 'revenue': 0.028, 'unit': 'M', 'net_profit': -17.16}, {'period': ""Q2 '22"", 'revenue': 13.14, 'unit': 'M', 'net_profit': -6.53}, {'period': ""Q1 '22"", 'revenue': 12.7, 'unit': 'M', 'net_profit': -7.8}, {'period': ""Q4 '21"", 'revenue': 7.7, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q3 '21"", 'revenue': 1.16, 'unit': 'M', 'net_profit': -21.7}, {'period': ""Q2 '21"", 'revenue': 0.89, 'unit': 'M', 'net_profit': -21.81}]",-1.91,-1.91,171670000,90171000,76938000,118165000,0,0,27165000,76938000,-77389000,0.31677046312904555,0.5318505358086606,0.863960113960114,__nan__,__nan__,__nan__,0.6883264402632958
9,CDEV,Centennial Resource Development Inc. Class A Common Stock,"Centennial Resource Development, Inc., an independent oil and natural gas company, focuses on the development of crude oil and related liquids-rich natural gas reserves in the United States. Its assets primarily focus on the Delaware Basin, a sub-basin of the Permian Basin. The company's properties consist of acreage blocks primarily in Reeves County, West Texas and Lea County, New Mexico. As of December 31, 2021, it leased or acquired approximately 73,675 net acres; and owned 991 net mineral acres in the Delaware Basin. The company was formerly known as Silver Run Acquisition Corporation and changed its name to Centennial Resource Development, Inc. in October 2016. The company was incorporated in 2015 and is headquartered in Denver, Colorado.",Mr. Mark Papa,Oil & Gas Exploration & Production,7.62,USD,4181414109,https://images.financialmodelingprep.com/symbol/CDEV.png,0,5.521739130434782,-0.60999966,17581515,3617132000,984701000,"[{'period': '2024', 'revenue': 5000.0, 'unit': 'M', 'net_profit': 984.7}, {'period': '2023', 'revenue': 3120.0, 'unit': 'M', 'net_profit': 476.31}, {'period': '2022', 'revenue': 2130.0, 'unit': 'M', 'net_profit': 749.84}, {'period': '2021', 'revenue': 1030.0, 'unit': 'M', 'net_profit': 138.18}]","[{'period': ""Q4 '24"", 'revenue': 1300.0, 'unit': 'M', 'net_profit': 216.65}, {'period': ""Q3 '24"", 'revenue': 1220.0, 'unit': 'M', 'net_profit': 386.38}, {'period': ""Q2 '24"", 'revenue': 1250.0, 'unit': 'M', 'net_profit': 235.1}, {'period': ""Q1 '24"", 'revenue': 1240.0, 'unit': 'M', 'net_profit': 146.57}, {'period': ""Q4 '23"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 255.35}, {'period': ""Q3 '23"", 'revenue': 758.54, 'unit': 'M', 'net_profit': 45.43}]",1.54,1.45,16897900000,1121594000,479343000,6379381000,530452000,0,1327337000,479343000,291328000,0.6290210062631928,1.067370555903138,0.11594202898550736,__nan__,__nan__,__nan__,0.37752507708058397
10,CDK,CDK Global Inc. Common Stock,"CDK Global, Inc., together with its subsidiaries, provides integrated data and technology solutions to the automotive, heavy truck, recreation, and heavy equipment industries in the United States and internationally. It offers subscription-based software and technology solutions to automotive retailers, as well as to retailers and manufacturers of heavy trucks, construction and agricultural equipment, motorcycles, boats, and other marine and recreational vehicles. The company's flagship Dealer Management System provides software solutions that facilitates the sale of new and used vehicles, consumer financing, repair and maintenance services, and vehicle and parts inventory management. It also provides a portfolio of layered software applications and services to address the needs of automotive retail workflows. In addition, the company offers data management and business intelligence solutions to automotive retailers and original equipment manufacturers through its Neuron intelligent data platform. Further, it offers professional services, custom programming, consulting, implementation, and training solutions, as well as customer support solutions. The company serves approximately 15,000 retail locations. CDK Global, Inc. was incorporated in 2014 and is headquartered in Hoffman Estates, Illinois.",Mr. Brian Krzanich,Software - Application,54.76,USD,0,https://images.financialmodelingprep.com/symbol/CDK.png,1874131,28.08205128205128,0.0,16774575,1352100000,1034300000,"[{'period': '2021', 'revenue': 1.67, 'unit': 'B', 'net_profit': 1.03}, {'period': '2020', 'revenue': 1960.0, 'unit': 'M', 'net_profit': 207.5}, {'period': '2019', 'revenue': 1910.0, 'unit': 'M', 'net_profit': 124.0}, {'period': '2018', 'revenue': 2270.0, 'unit': 'M', 'net_profit': 380.8}]","[{'period': ""Q3 '22"", 'revenue': 459.7, 'unit': 'M', 'net_profit': 70.1}, {'period': ""Q2 '22"", 'revenue': 436.7, 'unit': 'M', 'net_profit': 63.8}, {'period': ""Q1 '22"", 'revenue': 440.0, 'unit': 'M', 'net_profit': 71.7}, {'period': ""Q4 '21"", 'revenue': 420.1, 'unit': 'M', 'net_profit': 49.4}, {'period': ""Q3 '21"", 'revenue': 433.1, 'unit': 'M', 'net_profit': 860.9}, {'period': ""Q2 '21"", 'revenue': 406.3, 'unit': 'M', 'net_profit': 68.3}]",8.44,8.44,2712600000,562300000,157000000,2217700000,236400000,0,368300000,157000000,121300000,1.3646379853095487,3.984578313253012,3.964705882352941,"[0.15, 0.12]","['2022-06-16', '2014-11-26']",__nan__,0.8175551131755512
11,CDLX,Cardlytics Inc. Common Stock,"Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.",Mr. Amit  Gupta,Advertising Agencies,1.47,USD,76696486,https://images.financialmodelingprep.com/symbol/CDLX.png,1027727,-0.38,-0.03,336003,-152525000,-189304000,"[{'period': '2024', 'revenue': 278.3, 'unit': 'M', 'net_profit': -189.3}, {'period': '2023', 'revenue': 309.2, 'unit': 'M', 'net_profit': -134.7}, {'period': '2022', 'revenue': 298.54, 'unit': 'M', 'net_profit': -465.26}, {'period': '2021', 'revenue': 267.12, 'unit': 'M', 'net_profit': -128.56}]","[{'period': ""Q4 '24"", 'revenue': 74.0, 'unit': 'M', 'net_profit': -15.59}, {'period': ""Q3 '24"", 'revenue': 67.06, 'unit': 'M', 'net_profit': -145.18}, {'period': ""Q2 '24"", 'revenue': 69.64, 'unit': 'M', 'net_profit': -4.26}, {'period': ""Q1 '24"", 'revenue': 67.61, 'unit': 'M', 'net_profit': -24.27}, {'period': ""Q4 '23"", 'revenue': 89.17, 'unit': 'M', 'net_profit': -100.84}, {'period': ""Q3 '23"", 'revenue': 79.0, 'unit': 'M', 'net_profit': -23.97}]",-3.91,-3.91,392711000,177983000,65594000,322718000,107053000,0,148955000,65594000,-8824000,-0.5405943194214375,-0.40535404077148074,-0.05962059620596211,__nan__,__nan__,__nan__,0.8217696983277779
12,CDMO,Avid Bioservices Inc. Common Stock,"Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.","Mr. Nicholas Stewart Green B.Sc., MBA",Biotechnology,12.49,USD,798901617,https://images.financialmodelingprep.com/symbol/CDMO.png,1584407,-5.182572614107884,0.0,0,-11481000,-140753000,"[{'period': '2024', 'revenue': 139.91, 'unit': 'M', 'net_profit': -140.75}, {'period': '2023', 'revenue': 149270.0, 'unit': 'K', 'net_profit': 560.0}, {'period': '2022', 'revenue': 119.6, 'unit': 'M', 'net_profit': 127.67}, {'period': '2021', 'revenue': 95.87, 'unit': 'M', 'net_profit': 11.21}]","[{'period': ""Q2 '25"", 'revenue': 33.48, 'unit': 'M', 'net_profit': -17.41}, {'period': ""Q1 '25"", 'revenue': 40.17, 'unit': 'M', 'net_profit': -5.53}, {'period': ""Q4 '24"", 'revenue': 42.98, 'unit': 'M', 'net_profit': -123.1}, {'period': ""Q3 '24"", 'revenue': 33.81, 'unit': 'M', 'net_profit': -6.01}, {'period': ""Q2 '24"", 'revenue': 25.39, 'unit': 'M', 'net_profit': -9.51}, {'period': ""Q1 '24"", 'revenue': 37.73, 'unit': 'M', 'net_profit': -2.09}]",-2.23,-2.23,336557000,104002000,38106000,275668000,29008000,0,70566000,38106000,-20853000,-2.0522408578498763,-252.34464285714284,-248.77777777777777,"[0.66, 0.66]","['2018-03-16', '2018-03-16']",__nan__,0.8190826516756449
13,CDNA,CareDx Inc. Common Stock,"CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.",Mr. John Walter Hanna Jr.,Medical - Diagnostics & Research,16.94,USD,938914746,https://images.financialmodelingprep.com/symbol/CDNA.png,800768,18.22,-0.68,505494,-33995000,52549000,"[{'period': '2024', 'revenue': 333.79, 'unit': 'M', 'net_profit': 52.55}, {'period': '2023', 'revenue': 280.32, 'unit': 'M', 'net_profit': -190.28}, {'period': '2022', 'revenue': 321.79, 'unit': 'M', 'net_profit': -76.61}, {'period': '2021', 'revenue': 296.4, 'unit': 'M', 'net_profit': -30.66}]","[{'period': ""Q4 '24"", 'revenue': 86.58, 'unit': 'M', 'net_profit': 78.01}, {'period': ""Q3 '24"", 'revenue': 82.88, 'unit': 'M', 'net_profit': -7.41}, {'period': ""Q2 '24"", 'revenue': 92.27, 'unit': 'M', 'net_profit': -1.39}, {'period': ""Q1 '24"", 'revenue': 72.05, 'unit': 'M', 'net_profit': -16.66}, {'period': ""Q4 '23"", 'revenue': 65.57, 'unit': 'M', 'net_profit': -118.1}, {'period': ""Q3 '23"", 'revenue': 67.19, 'unit': 'M', 'net_profit': -23.48}]",1.0,0.93,491050000,351832000,260653000,112617000,64605000,0,89371000,114689000,38048000,0.6208327291789821,1.2761608963444115,1.2824858757062148,__nan__,__nan__,__nan__,0.2293391711638326
14,CDNS,Cadence Design Systems Inc. Common Stock,"Cadence Design Systems, Inc. provides software, hardware, services, and reusable integrated circuit (IC) design blocks worldwide. The company offers functional verification services, including emulation and prototyping hardware. Its functional verification offering consists of JasperGold, a formal verification platform; Xcelium, a parallel logic simulation platform; Palladium, an enterprise emulation platform; and Protium, a prototyping platform for chip verification. The company also provides digital IC design and sign off products, including Genus logic synthesis and Joules RTL power solutions, as well as Modus software solution to reduce systems-on-chip design-for-test time; physical implementation tools, such as place and route, optimization, and multiple patterning preparation; and signoff products to signoff the design as ready for silicon manufacturing. In addition, it offers custom IC design and simulation products to create schematic and physical representations of circuits down to the transistor level for analog, mixed-signal, custom digital, memory, and radio frequency designs; and system design and analysis products to develop printed circuit boards and IC packages, as well as to analyze electromagnetic, electro-thermal, and other multi-physics effects. Further, the company provides intellectual property (IP) products comprising pre-verified and customizable functional blocks to integrate into customer's ICs; and verification IP and memory models to emulate and model the expected behavior and interaction of standard industry system interface protocols. Additionally, it offers services related to methodology, education, and hosted design solutions, as well as technical support and maintenance services. The company serves 5G communications, aerospace and defense, automotive, industrial and healthcare, mobile, consumer, and hyperscale computing markets. Cadence Design Systems, Inc. was incorporated in 1987 and is headquartered in San Jose, California.",Dr. Anirudh  Devgan Ph.D.,Software - Application,251.56,USD,69006329216,https://images.financialmodelingprep.com/symbol/CDNS.png,2334326,65.34,-8.66,1251011,1666833000,1055484000,"[{'period': '2024', 'revenue': 4.64, 'unit': 'B', 'net_profit': 1.06}, {'period': '2023', 'revenue': 4.09, 'unit': 'B', 'net_profit': 1.04}, {'period': '2022', 'revenue': 3560.0, 'unit': 'M', 'net_profit': 848.95}, {'period': '2021', 'revenue': 2990.0, 'unit': 'M', 'net_profit': 695.96}]","[{'period': ""Q4 '24"", 'revenue': 1360.0, 'unit': 'M', 'net_profit': 340.21}, {'period': ""Q3 '24"", 'revenue': 1220.0, 'unit': 'M', 'net_profit': 238.11}, {'period': ""Q2 '24"", 'revenue': 1060.0, 'unit': 'M', 'net_profit': 229.52}, {'period': ""Q1 '24"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 247.64}, {'period': ""Q4 '23"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 323.9}, {'period': ""Q3 '23"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 254.32}]",3.89,3.85,8974482000,4016079000,2644030000,4300904000,680460000,124086000,1370105000,2644030000,1118009000,0.17413199213879674,0.013773310896475415,0.007772020725388666,__nan__,__nan__,__nan__,0.47923701891652354
15,CDTX,Cidara Therapeutics Inc. Common Stock,"Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.",Dr. Jeffrey L. Stein Ph.D.,Biotechnology,20.685,USD,226572941,https://images.financialmodelingprep.com/symbol/CDTX.png,137218,-0.77,1.245,62694,-176102000,-169827000,"[{'period': '2024', 'revenue': 1.27, 'unit': 'M', 'net_profit': -169.83}, {'period': '2023', 'revenue': 63.91, 'unit': 'M', 'net_profit': -22.93}, {'period': '2022', 'revenue': 64.29, 'unit': 'M', 'net_profit': -29.8}, {'period': '2021', 'revenue': 49.57, 'unit': 'M', 'net_profit': -43.91}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.31}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.54}, {'period': ""Q2 '24"", 'revenue': 0.302, 'unit': 'M', 'net_profit': -89.41}, {'period': ""Q1 '24"", 'revenue': 8.46, 'unit': 'M', 'net_profit': -10.33}, {'period': ""Q4 '23"", 'revenue': 17.58, 'unit': 'M', 'net_profit': -5.61}, {'period': ""Q3 '23"", 'revenue': 12.72, 'unit': 'M', 'net_profit': -8.17}]",-26.75,-26.75,214796000,210737000,189825000,51488000,1694000,0,49554000,189825000,-176662000,-6.227662630822902,-6.406000610527234,-4.095238095238095,__nan__,__nan__,__nan__,0.23970651222555356
16,CDW,CDW Corporation Common Stock,"CDW Corporation provides information technology (IT) solutions in the United States, the United Kingdom, and Canada. It operates through three segments: Corporate, Small Business, and Public. The company offers discrete hardware and software products and services, as well as integrated IT solutions, including on-premise, hybrid, and cloud capabilities across data center and networking, digital workspace, and security. Its hardware products comprise notebooks/mobile devices, network communications, desktop computers, video monitors, enterprise and data storage, and others; and software products consists of application suites, security, virtualization, operating systems, and network management. The company also provides advisory and design, software development, implementation, managed, professional, configuration, and telecom services, as well as warranties; mission critical software, systems, and network solutions; and implementation and installation, and repair services to its customers through various third-party service providers. It serves government, education, and healthcare customers; and small, medium, and large business customers. The company was founded in 1984 and is headquartered in Vernon Hills, Illinois.",Ms. Christine A. Leahy J.D.,Information Technology Services,148.42,USD,19556814950,https://images.financialmodelingprep.com/symbol/CDW.png,1540783,18.62,-3.05,1450206,1651300000,1077800000,"[{'period': '2024', 'revenue': 21.0, 'unit': 'B', 'net_profit': 1.08}, {'period': '2023', 'revenue': 21.38, 'unit': 'B', 'net_profit': 1.1}, {'period': '2022', 'revenue': 23.75, 'unit': 'B', 'net_profit': 1.11}, {'period': '2021', 'revenue': 20820.0, 'unit': 'M', 'net_profit': 988.6}]","[{'period': ""Q4 '24"", 'revenue': 5190.0, 'unit': 'M', 'net_profit': 264.2}, {'period': ""Q3 '24"", 'revenue': 5520.0, 'unit': 'M', 'net_profit': 316.4}, {'period': ""Q2 '24"", 'revenue': 5420.0, 'unit': 'M', 'net_profit': 281.1}, {'period': ""Q1 '24"", 'revenue': 4870.0, 'unit': 'M', 'net_profit': 216.1}, {'period': ""Q4 '23"", 'revenue': 5020.0, 'unit': 'M', 'net_profit': 296.1}, {'period': ""Q3 '23"", 'revenue': 5630.0, 'unit': 'M', 'net_profit': 315.5}]",8.06,7.97,14678400000,7373100000,717700000,12325700000,5645700000,0,5474400000,503500000,1154700000,-0.15222302084402917,-0.02399710223671104,-0.017073170731707173,"[0.625, 0.0425]","['2025-02-25', '2013-11-13']",__nan__,0.8397168628733377
17,CDXC,ChromaDex Corporation Common Stock,"ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.",Mr. Frank Louis Jaksch Jr.,Biotechnology,7.87,USD,611895648,https://images.financialmodelingprep.com/symbol/CDXC.png,809373,71.54545454545455,-0.07,541672,7726000,8550000,"[{'period': '2024', 'revenue': 61.59, 'unit': 'M', 'net_profit': 8.55}, {'period': '2023', 'revenue': 83.57, 'unit': 'M', 'net_profit': -4.94}, {'period': '2022', 'revenue': 72.05, 'unit': 'M', 'net_profit': -14.45}, {'period': '2021', 'revenue': 67.45, 'unit': 'M', 'net_profit': -25.56}]","[{'period': ""Q4 '24"", 'revenue': 18.2, 'unit': 'M', 'net_profit': 7.18}, {'period': ""Q3 '24"", 'revenue': 34.92, 'unit': 'M', 'net_profit': 1.88}, {'period': ""Q2 '24"", 'revenue': 22740.0, 'unit': 'K', 'net_profit': -15.0}, {'period': ""Q1 '24"", 'revenue': 22150.0, 'unit': 'K', 'net_profit': -492.0}, {'period': ""Q4 '23"", 'revenue': 21200.0, 'unit': 'K', 'net_profit': 114.0}, {'period': ""Q3 '23"", 'revenue': 19500.0, 'unit': 'K', 'net_profit': -959.0}]",0.11,0.11,68278000,64102000,44660000,22184000,7768000,0,17948000,44660000,11946000,2.9840780688238318,2.7314702308626972,2.669195751138088,__nan__,__nan__,__nan__,0.32490699786168314
18,CDXS,Codexis Inc. Common Stock,"Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.","Dr. Stephen George Dilly MBBS, Ph.D.",Biotechnology,2.13,USD,176443470,https://images.financialmodelingprep.com/symbol/CDXS.png,926344,-2.39,0.02,650661,-58519000,-65276000,"[{'period': '2024', 'revenue': 59.34, 'unit': 'M', 'net_profit': -65.28}, {'period': '2023', 'revenue': 70.14, 'unit': 'M', 'net_profit': -76.24}, {'period': '2022', 'revenue': 138.59, 'unit': 'M', 'net_profit': -33.59}, {'period': '2021', 'revenue': 104.75, 'unit': 'M', 'net_profit': -21.28}]","[{'period': ""Q4 '24"", 'revenue': 21.46, 'unit': 'M', 'net_profit': -10.38}, {'period': ""Q3 '24"", 'revenue': 12.83, 'unit': 'M', 'net_profit': -20.64}, {'period': ""Q2 '24"", 'revenue': 7.98, 'unit': 'M', 'net_profit': -22.75}, {'period': ""Q1 '24"", 'revenue': 17.07, 'unit': 'M', 'net_profit': -11.51}, {'period': ""Q4 '23"", 'revenue': 26.56, 'unit': 'M', 'net_profit': -7.19}, {'period': ""Q3 '23"", 'revenue': 9.28, 'unit': 'M', 'net_profit': -34.91}]",-0.89,-0.89,149011000,98772000,73458000,82084000,18884000,2798000,23648000,19264000,-53715000,-0.18740742243775743,0.1438090241343127,0.20535714285714293,__nan__,__nan__,__nan__,0.5508586614411016
19,CDZI,CADIZ Inc. Common Stock,"Cadiz Inc., together with its subsidiaries, operates as a natural resources development company in the United States. It engages in the water resource and agricultural development activities in San Bernardino County properties. The company owns approximately 35,000 acres of land in the Cadiz and Fenner valleys of eastern San Bernardino County; and approximately 11,000 acres of land in the eastern Mojave Desert portion of San Bernardino County. It is also involved in the cultivation of lemons, and spring and fall plantings of vegetables and grains. Cadiz Inc. was founded in 1983 and is headquartered in Los Angeles, California.",Ms. Susan P. Kennedy,Regulated Water,2.56,USD,209369626,https://images.financialmodelingprep.com/symbol/CDZI.png,630213,-4.83,-0.16,244963,-21748000,-31140000,"[{'period': '2024', 'revenue': 9.61, 'unit': 'M', 'net_profit': -31.14}, {'period': '2023', 'revenue': 1.99, 'unit': 'M', 'net_profit': -31.45}, {'period': '2022', 'revenue': 1.5, 'unit': 'M', 'net_profit': -24.83}, {'period': '2021', 'revenue': 0.5640000000000001, 'unit': 'M', 'net_profit': -30.31}]","[{'period': ""Q4 '24"", 'revenue': 4.75, 'unit': 'M', 'net_profit': -8.62}, {'period': ""Q3 '24"", 'revenue': 3.22, 'unit': 'M', 'net_profit': -6.79}, {'period': ""Q2 '24"", 'revenue': 0.513, 'unit': 'M', 'net_profit': -8.87}, {'period': ""Q1 '24"", 'revenue': 1.12, 'unit': 'M', 'net_profit': -6.85}, {'period': ""Q4 '23"", 'revenue': 0.684, 'unit': 'M', 'net_profit': -6.75}, {'period': ""Q3 '23"", 'revenue': 0.368, 'unit': 'M', 'net_profit': -6.94}]",-0.38,-0.38,134494000,25786000,17292000,100533000,4586000,0,14406000,17292000,-22466000,0.11200032665060634,0.009730967372638809,0.3214285714285715,__nan__,__nan__,__nan__,0.7474905943759573
20,CECE,CECO Environmental Corp. Common Stock,"CECO Environmental Corp. provides industrial air quality and fluid handling systems worldwide. It operates in two segments: Engineered Systems Segment and Industrial Process Solutions Segment. The company engineers, designs, builds, and installs systems that capture, clean, and destroy air- and water-borne emissions from industrial facilities as well as fluid handling, gas separation, and filtration systems. It offers dampers and diverters, selective catalytic reduction and selective non-catalytic reduction systems, cyclonic technology, thermal oxidizers, filtration systems, scrubbers, and water and fluid handling equipment, as well as plant engineering services and engineered design build fabrication. The company markets its products and services to natural gas processors, transmission and distribution companies, refineries, power generators, industrial manufacturing, engineering and construction companies, semiconductor manufacturers, compressor manufacturers, beverage can manufacturers, metals and minerals, and electric vehicle producer companies. CECO Environmental Corp. was incorporated in 1966 and is headquartered in Dallas, Texas.",Mr. Dennis Sadlowski,Industrial - Pollution & Treatment Controls,11.65,USD,400991835,https://images.financialmodelingprep.com/symbol/CECE.png,316688,58.25,0.25,201410,45234000,12957000,"[{'period': '2024', 'revenue': 557.93, 'unit': 'M', 'net_profit': 12.96}, {'period': '2023', 'revenue': 544.85, 'unit': 'M', 'net_profit': 12.91}, {'period': '2022', 'revenue': 422.63, 'unit': 'M', 'net_profit': 17.42}, {'period': '2021', 'revenue': 324.14, 'unit': 'M', 'net_profit': 1.98}]","[{'period': ""Q4 '24"", 'revenue': 158.57, 'unit': 'M', 'net_profit': 4.88}, {'period': ""Q3 '24"", 'revenue': 135.51, 'unit': 'M', 'net_profit': 2.09}, {'period': ""Q2 '24"", 'revenue': 137.52, 'unit': 'M', 'net_profit': 4.49}, {'period': ""Q1 '24"", 'revenue': 126.33, 'unit': 'M', 'net_profit': 1.51}, {'period': ""Q4 '23"", 'revenue': 153.71, 'unit': 'M', 'net_profit': 3.88}, {'period': ""Q3 '23"", 'revenue': 149.39, 'unit': 'M', 'net_profit': 3.33}]",0.37,0.36,759699000,330971000,37832000,507806000,159572000,0,244662000,37832000,7460000,-0.04666160849772382,0.003562853380838045,0.0,"[0.075, 0.025]","['2017-09-15', '2011-09-13']",__nan__,0.668430523141402
21,CELC,Celcuity Inc. Common Stock,"Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.",Mr. Brian F. Sullivan,Biotechnology,10.45,USD,395421667,https://images.financialmodelingprep.com/symbol/CELC.png,279198,-3.69,0.21,164383,-113266951,-111779105,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -111.78}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -63.78}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.35}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.56}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.65}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.79}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.72}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.61}, {'period': ""Q4 '23"", 'revenue': 0.22965000000000002, 'unit': 'M', 'net_profit': -18.85}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.4}]",-2.83,-2.83,245123047,244571030,22514823,129504012,1600621,0,31722907,22514823,-83716621,-0.9424975909345981,-0.7525972765128949,-0.05204460966542756,__nan__,__nan__,__nan__,0.528322463289223
22,CELH,Celsius Holdings Inc. Common Stock,"Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. It offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. The company also provides CELSIUS On-the-Go, a powdered form of the active ingredients in functional energy drinks in individual On-The-Go packets and canisters; and sparkling grapefruit, cucumber lime, and orange pomegranate, as well as pineapple coconut, watermelon berry, and strawberries and cream non-carbonated functional energy drinks under the CELSIUS Sweetened. It distributes its products through direct-to-store delivery distributors and direct to retailers, including supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.",Mr. Richard Stephen Mattessich,Beverages - Non-Alcoholic,36.09,USD,9301632295,https://images.financialmodelingprep.com/symbol/CELH.png,10325168,80.2,-1.15,5935365,163002000,145074000,"[{'period': '2024', 'revenue': 1360.0, 'unit': 'M', 'net_profit': 145.07}, {'period': '2023', 'revenue': 1320.0, 'unit': 'M', 'net_profit': 226.8}, {'period': '2022', 'revenue': 653.6, 'unit': 'M', 'net_profit': -187.28}, {'period': '2021', 'revenue': 314.27, 'unit': 'M', 'net_profit': 3.94}]","[{'period': ""Q4 '24"", 'revenue': 332.2, 'unit': 'M', 'net_profit': -18.88}, {'period': ""Q3 '24"", 'revenue': 265.75, 'unit': 'M', 'net_profit': 6.36}, {'period': ""Q2 '24"", 'revenue': 401.98, 'unit': 'M', 'net_profit': 79.78}, {'period': ""Q1 '24"", 'revenue': 355.71, 'unit': 'M', 'net_profit': 77.81}, {'period': ""Q4 '23"", 'revenue': 347.44, 'unit': 'M', 'net_profit': 50.12}, {'period': ""Q3 '23"", 'revenue': 384.76, 'unit': 'M', 'net_profit': 83.95}]",0.62,0.61,1766881000,1324580000,890190000,542464000,270342000,0,365535000,890190000,239508000,-0.39537523368645955,-0.3603467356845869,-0.21518987341772156,__nan__,__nan__,__nan__,0.30701784670274906
23,CEMI,Chembio Diagnostics Inc. Common Stock,"Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.",Mr. Richard L. Eberly,Medical - Diagnostics & Research,0.455,USD,16710285,https://images.financialmodelingprep.com/symbol/CEMI.png,538392,-0.6319444444444444,0.001,351642,-14612706,-23290657,"[{'period': '2022', 'revenue': 48.34, 'unit': 'M', 'net_profit': -23.29}, {'period': '2021', 'revenue': 36.93, 'unit': 'M', 'net_profit': -33.9}, {'period': '2020', 'revenue': 30.45, 'unit': 'M', 'net_profit': -25.52}, {'period': '2019', 'revenue': 34.46, 'unit': 'M', 'net_profit': -13.68}]","[{'period': ""Q4 '22"", 'revenue': 9160.0, 'unit': 'K', 'net_profit': -855.12}, {'period': ""Q3 '22"", 'revenue': 11.2, 'unit': 'M', 'net_profit': -8.33}, {'period': ""Q2 '22"", 'revenue': 9.16, 'unit': 'M', 'net_profit': -6.95}, {'period': ""Q1 '22"", 'revenue': 18.82, 'unit': 'M', 'net_profit': -8.79}, {'period': ""Q4 '21"", 'revenue': 17.71, 'unit': 'M', 'net_profit': -13.97}, {'period': ""Q3 '21"", 'revenue': 9.66, 'unit': 'M', 'net_profit': -6.37}]",-0.96,-0.96,62611405,48451695,18178985,44813048,18722737,0,39300116,18178985,-14145186,0.3066137228332239,0.3130314841266229,0.3142857142857143,__nan__,__nan__,__nan__,0.7157329882630808
24,CENH,Centricus Acquisition Corp. Class A Ordinary Share,"Centricus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in London, the United Kingdom.",Mr. Garth  Ritchie,Shell Companies,8.35,USD,0,https://images.financialmodelingprep.com/symbol/CENH.png,314168,0,-0.03999996,150445,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.69}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0,0.0,216584,0,0,196584,0,0,196584,0,,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.9076570753148894
25,CENHU,Centricus Acquisition Corp. Unit,,,,,,,,,,,,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.69}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0,0.0,216584,0,0,196584,0,0,196584,0,,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.9076570753148894
26,CENHW,Centricus Acquisition Corp. Warrant,"Centricus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in London, the United Kingdom.",Mr. Garth  Ritchie,Shell Companies,1.01,USD,0,https://images.financialmodelingprep.com/symbol/CENHW.png,0,0,0.01999998,149625,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.69}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0,0.0,216584,0,0,196584,0,0,196584,0,,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.9076570753148894
27,CENT,Central Garden & Pet Company Common Stock,"Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments, Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and grooming products, waste management and training pads, and pet containment; supplies for aquatics, small animals, reptiles, and pet birds, including toys, cages and habitats, bedding, and food and supplements; animal and household health and insect control products; live fish and products for fish, reptiles, and other aquarium-based pets, such as aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food, and supplements; and products for horses and livestock, as well as outdoor cushions and pillows. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, Kaytee, K&H Pet Products, Nylabone, and Zilla brands. The Garden segment offers lawn and garden supplies products that include grass seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative outdoor lifestyle products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the AMDRO, Ferry-Morse, Pennington, and Sevin brands, as well as under Bell Nursery, Lilly Miller, and Over-N-Out other brand names. Central Garden & Pet Company was founded in 1955 and is based in Walnut Creek, California.",Mr. Nicholas  Lahanas,Packaged Foods,34.32,USD,2037864560,https://images.financialmodelingprep.com/symbol/CENT.png,224016,18.86,-0.48,123014,290759000,107983000,"[{'period': '2024', 'revenue': 3200.0, 'unit': 'M', 'net_profit': 107.98}, {'period': '2023', 'revenue': 3310.0, 'unit': 'M', 'net_profit': 125.64}, {'period': '2022', 'revenue': 3340.0, 'unit': 'M', 'net_profit': 152.15}, {'period': '2021', 'revenue': 3300.0, 'unit': 'M', 'net_profit': 151.75}]","[{'period': ""Q1 '25"", 'revenue': 656.44, 'unit': 'M', 'net_profit': 14.01}, {'period': ""Q4 '24"", 'revenue': 669.49, 'unit': 'M', 'net_profit': -34.16}, {'period': ""Q3 '24"", 'revenue': 996.35, 'unit': 'M', 'net_profit': 79.72}, {'period': ""Q2 '24"", 'revenue': 900.09, 'unit': 'M', 'net_profit': 61.99}, {'period': ""Q1 '24"", 'revenue': 634530.0, 'unit': 'K', 'net_profit': 430.0}, {'period': ""Q4 '23"", 'revenue': 750.15, 'unit': 'M', 'net_profit': 2.83}]",1.64,1.62,3495750000,1886806000,753550000,1940096000,326220000,0,515384000,753550000,351757000,-0.05342644138424976,-0.14055697492100636,-0.30212765957446813,"[29.2, 29.2]","['2007-02-06', '2007-02-06']",__nan__,0.5549870557105057
28,CENTA,Central Garden & Pet Company Class A Common Stock Nonvoting,"Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments, Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and grooming products, waste management and training pads, and pet containment; supplies for aquatics, small animals, reptiles, and pet birds, including toys, cages and habitats, bedding, and food and supplements; animal and household health and insect control products; live fish and products for fish, reptiles, and other aquarium-based pets, such as aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food, and supplements; and products for horses and livestock, as well as outdoor cushions and pillows. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, Kaytee, K&H Pet Products, Nylabone, and Zilla brands. The Garden segment offers lawn and garden supplies products that include grass seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative outdoor lifestyle products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the AMDRO, Ferry-Morse, Pennington, and Sevin brands, as well as under Bell Nursery, Lilly Miller, and Over-N-Out other brand names. Central Garden & Pet Company was founded in 1955 and is based in Walnut Creek, California.",Mr. Nicholas  Lahanas,Packaged Foods,30.31,USD,2034152566,https://images.financialmodelingprep.com/symbol/CENTA.png,350227,16.65,-0.48,265728,290759000,107983000,"[{'period': '2024', 'revenue': 3200.0, 'unit': 'M', 'net_profit': 107.98}, {'period': '2023', 'revenue': 3310.0, 'unit': 'M', 'net_profit': 125.64}, {'period': '2022', 'revenue': 3340.0, 'unit': 'M', 'net_profit': 152.15}, {'period': '2021', 'revenue': 3300.0, 'unit': 'M', 'net_profit': 151.75}]","[{'period': ""Q1 '25"", 'revenue': 656.44, 'unit': 'M', 'net_profit': 14.01}, {'period': ""Q4 '24"", 'revenue': 669.49, 'unit': 'M', 'net_profit': -34.16}, {'period': ""Q3 '24"", 'revenue': 996.35, 'unit': 'M', 'net_profit': 79.72}, {'period': ""Q2 '24"", 'revenue': 900.09, 'unit': 'M', 'net_profit': 61.99}, {'period': ""Q1 '24"", 'revenue': 634530.0, 'unit': 'K', 'net_profit': 430.0}, {'period': ""Q4 '23"", 'revenue': 750.15, 'unit': 'M', 'net_profit': 2.83}]",1.64,1.62,3495750000,1886806000,753550000,1940096000,326220000,0,515384000,753550000,351757000,-0.05342644138424976,-0.14055697492100636,-0.30212765957446813,__nan__,__nan__,__nan__,0.5549870557105057
29,CENX,Century Aluminum Company Common Stock,"Century Aluminum Company, together with its subsidiaries, produces standard-grade and value-added primary aluminum products in the United States and Iceland. It also owns and operates a carbon anode production facility in the Netherlands. The company was incorporated in 1981 and is headquartered in Chicago, Illinois.",Mr. Jesse E. Gary J.D.,Aluminum,15.19,USD,1401935835,https://images.financialmodelingprep.com/symbol/CENX.png,1953150,4.65,-0.4,1056090,448700000,336800000,"[{'period': '2024', 'revenue': 2220.0, 'unit': 'M', 'net_profit': 336.8}, {'period': '2023', 'revenue': 2190.0, 'unit': 'M', 'net_profit': -43.1}, {'period': '2022', 'revenue': 2780.0, 'unit': 'M', 'net_profit': -14.0}, {'period': '2021', 'revenue': 2210.0, 'unit': 'M', 'net_profit': -167.0}]","[{'period': ""Q4 '24"", 'revenue': 630.9, 'unit': 'M', 'net_profit': 45.2}, {'period': ""Q3 '24"", 'revenue': 539.1, 'unit': 'M', 'net_profit': 47.3}, {'period': ""Q2 '24"", 'revenue': 560.8, 'unit': 'M', 'net_profit': -2.5}, {'period': ""Q1 '24"", 'revenue': 489.5, 'unit': 'M', 'net_profit': 246.8}, {'period': ""Q4 '23"", 'revenue': 512.3, 'unit': 'M', 'net_profit': 30.0}, {'period': ""Q3 '23"", 'revenue': 545.2, 'unit': 'M', 'net_profit': -42.0}]",3.82,3.6,1939400000,802800000,32900000,1276700000,146200000,0,463700000,32900000,-106900000,9.338709677419354,8.814385150812065,9.127659574468085,"[0.05, 0.05]","['2002-09-18', '1996-06-12']",__nan__,0.6582963803238114
30,CERC,Cerecor Inc. Common Stock,"Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.",Mr. Michael Cola,Biotechnology,2.93,USD,38629413,https://images.financialmodelingprep.com/symbol/CERC.png,639167,-3.3794694348327567,-0.04999995,258592,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
31,CERE,Cerevel Therapeutics Holdings Inc. Common Stock,"Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.","Mr. Ronald C. Renaud Jr., M.B.A.",Biotechnology,44.96,USD,8191487560,https://images.financialmodelingprep.com/symbol/CERE.png,2056487,-16.468864468864467,0.33,15033754,-441638000,-432842000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -432.84}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -351.51}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -222.45}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -152.14}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -131.91}, {'period': ""Q4 '23"", 'revenue': 8.25, 'unit': 'M', 'net_profit': -132.66}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -96.36}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -99.53}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -104.29}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -92.81}]",-2.67,-2.67,1243298000,1006938000,990965000,569553000,5291000,187159000,92179000,990965000,-346109000,-0.20059916052282464,-0.2313754050371112,-0.1508620689655173,__nan__,__nan__,__nan__,0.4580985411381664
32,CEREW,Cerevel Therapeutics Holdings Inc. Warrant,,,,,,,,,,,,-151769000,-152142000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -152.14}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -128.39}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -53.24}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -50.98}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -69.33}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.89}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.72}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -53.21}]",0,0,445273000,390560000,383623000,60753000,0,0,29548000,383623000,-136694000,-0.18415036631894324,-0.18500806143828522,0,__nan__,__nan__,__nan__,0.13643989193146677
33,CERN,Cerner Corporation Common Stock,"Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri. As of June 8, 2022, Cerner Corporation operates as a subsidiary of Oracle Corporation.",Mr. Brent Shafer,Medical - Healthcare Information Services,94.92,USD,0,https://images.financialmodelingprep.com/symbol/CERN.png,3526650,55.83529411764706,0,38200339,1461788000,555596000,"[{'period': '2021', 'revenue': 5760.0, 'unit': 'M', 'net_profit': 555.6}, {'period': '2020', 'revenue': 5510.0, 'unit': 'M', 'net_profit': 780.09}, {'period': '2019', 'revenue': 5690.0, 'unit': 'M', 'net_profit': 529.45}, {'period': '2018', 'revenue': 5370.0, 'unit': 'M', 'net_profit': 630.06}]","[{'period': ""Q1 '22"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 206.13}, {'period': ""Q4 '21"", 'revenue': 1450.0, 'unit': 'M', 'net_profit': 174.84}, {'period': ""Q3 '21"", 'revenue': 1470.0, 'unit': 'M', 'net_profit': 175.79}, {'period': ""Q2 '21"", 'revenue': 1460.0, 'unit': 'M', 'net_profit': 32.71}, {'period': ""Q1 '21"", 'revenue': 1390.0, 'unit': 'M', 'net_profit': 172.25}, {'period': ""Q4 '20"", 'revenue': 1400.0, 'unit': 'M', 'net_profit': 141.5}]",1.81,1.81,7434158000,2449454000,842469000,3753696000,1161361000,461984000,1626258000,589847000,1144403000,-0.14912199006272497,-0.28777778917250363,-0.28174603174603174,"[0.27, 0.18]","['2022-03-25', '2019-06-17']",__nan__,0.5049255073674787
34,CERS,Cerus Corporation Common Stock,"Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.",Mr. William M. Greenman,Medical - Devices,1.29,USD,239668855,https://images.financialmodelingprep.com/symbol/CERS.png,1503380,-11.73,-0.01,1282882,-10024000,-20918000,"[{'period': '2024', 'revenue': 180.27, 'unit': 'M', 'net_profit': -20.92}, {'period': '2023', 'revenue': 156.37, 'unit': 'M', 'net_profit': -37.49}, {'period': '2022', 'revenue': 162.05, 'unit': 'M', 'net_profit': -42.83}, {'period': '2021', 'revenue': 130.86, 'unit': 'M', 'net_profit': -54.38}]","[{'period': ""Q4 '24"", 'revenue': 50.81, 'unit': 'M', 'net_profit': -2.52}, {'period': ""Q3 '24"", 'revenue': 46.02, 'unit': 'M', 'net_profit': -2.93}, {'period': ""Q2 '24"", 'revenue': 45.08, 'unit': 'M', 'net_profit': -5.78}, {'period': ""Q1 '24"", 'revenue': 38.37, 'unit': 'M', 'net_profit': -9.69}, {'period': ""Q4 '23"", 'revenue': 46.77, 'unit': 'M', 'net_profit': -1.33}, {'period': ""Q3 '23"", 'revenue': 39.77, 'unit': 'M', 'net_profit': -7.27}]",-0.11,-0.11,200917000,152022000,80452000,144021000,29777000,0,63608000,20266000,8522000,0.622249020198975,0.44202299341140067,0.47619047619047616,__nan__,__nan__,__nan__,0.7168183876924302
35,CERT,Certara Inc. Common Stock,"Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.",Dr. William F. Feehery Ph.D.,Medical - Healthcare Information Services,14.47,USD,2329930460,https://images.financialmodelingprep.com/symbol/CERT.png,1816922,-180.87,0.32,2123756,-36710000,-12051000,"[{'period': '2024', 'revenue': 385.15, 'unit': 'M', 'net_profit': -12.05}, {'period': '2023', 'revenue': 354.34, 'unit': 'M', 'net_profit': -55.36}, {'period': '2022', 'revenue': 335.64, 'unit': 'M', 'net_profit': 14.73}, {'period': '2021', 'revenue': 286.1, 'unit': 'M', 'net_profit': -13.27}]","[{'period': ""Q4 '24"", 'revenue': 100.36, 'unit': 'M', 'net_profit': 6.58}, {'period': ""Q3 '24"", 'revenue': 94.82, 'unit': 'M', 'net_profit': -1.37}, {'period': ""Q2 '24"", 'revenue': 93.31, 'unit': 'M', 'net_profit': -12.57}, {'period': ""Q1 '24"", 'revenue': 96.65, 'unit': 'M', 'net_profit': -4.68}, {'period': ""Q4 '23"", 'revenue': 88.01, 'unit': 'M', 'net_profit': -12.46}, {'period': ""Q3 '23"", 'revenue': 85.58, 'unit': 'M', 'net_profit': -48.97}]",-0.0751,-0.0751,1575104000,310852000,179183000,516448000,102189000,0,146088000,179183000,78841000,-2.5395907372752364,0.7823039543327853,0.7854285714285714,__nan__,__nan__,__nan__,0.3278818414530088
36,CETX,Cemtrex Inc. Common Stock,"Cemtrex, Inc. operates as a technology company in the United States and internationally. The company operates through Advanced Technologies and Industrial Services segments. The Advanced Technologies segment provides Internet of Things products and smart devices under the SmartDesk name for mobile, web, virtual and augmented reality, wearables, and television markets; and security and video surveillance solutions, and virtual and augmented reality solutions for various commercial and industrial applications. This segment also offers browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. The Industrial Services segment offers single-source services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly; installs high precision equipment in various industrial markets comprising automotive, printing and graphics, industrial automation, packaging, chemicals and others; and provides maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The company was formerly known as Diversified American Holding, Inc. and changed its name to Cemtrex, Inc. in December 2004. Cemtrex, Inc. was incorporated in 1998 and is based in Brooklyn, New York.",Mr. Saagar  Govil,Software - Infrastructure,1.21,USD,2159343,https://images.financialmodelingprep.com/symbol/CETX.png,98826,-0.06,-0.02,15088,-3978139,-7229491,"[{'period': '2024', 'revenue': 43.33, 'unit': 'M', 'net_profit': -7.23}, {'period': '2023', 'revenue': 59.37, 'unit': 'M', 'net_profit': -9.2}, {'period': '2022', 'revenue': 50.27, 'unit': 'M', 'net_profit': -13.29}, {'period': '2021', 'revenue': 43130.0, 'unit': 'K', 'net_profit': 393.78}]","[{'period': ""Q1 '25"", 'revenue': 13.74, 'unit': 'M', 'net_profit': -28.75}, {'period': ""Q4 '24"", 'revenue': -5.39, 'unit': 'M', 'net_profit': 4.43}, {'period': ""Q3 '24"", 'revenue': 14.69, 'unit': 'M', 'net_profit': -8.98}, {'period': ""Q2 '24"", 'revenue': 17.16, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q1 '24"", 'revenue': 16.88, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q4 '23"", 'revenue': 16.59, 'unit': 'M', 'net_profit': -1.1}]",-509.98,-509.98,44115458,26696279,3911382,39154616,11159676,1200000,18592822,3897511,-5246706,-454.0084639139459,0.21391874957526333,0.317396367335466,"[857.5, 857.5]","['2017-03-29', '2017-03-29']",__nan__,0.8875486683148569
37,CETXP,Cemtrex Inc. Series 1 Preferred Stock,"Cemtrex, Inc. operates as a technology company in the United States and internationally. The company operates through Advanced Technologies and Industrial Services segments. The Advanced Technologies segment provides Internet of Things products and smart devices under the SmartDesk name for mobile, web, virtual and augmented reality, wearables, and television markets; and security and video surveillance solutions, and virtual and augmented reality solutions for various commercial and industrial applications. This segment also offers browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. The Industrial Services segment offers single-source services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly; installs high precision equipment in various industrial markets comprising automotive, printing and graphics, industrial automation, packaging, chemicals and others; and provides maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The company was formerly known as Diversified American Holding, Inc. and changed its name to Cemtrex, Inc. in December 2004. Cemtrex, Inc. was incorporated in 1998 and is based in Brooklyn, New York.",Mr. Saagar  Govil,Software - Infrastructure,0.05,USD,228041,https://images.financialmodelingprep.com/symbol/CETXP.png,734,-0.06,0,8354,-3978139,-7229491,"[{'period': '2024', 'revenue': 43.33, 'unit': 'M', 'net_profit': -7.23}, {'period': '2023', 'revenue': 59.37, 'unit': 'M', 'net_profit': -9.2}, {'period': '2022', 'revenue': 50.27, 'unit': 'M', 'net_profit': -13.29}, {'period': '2021', 'revenue': 43130.0, 'unit': 'K', 'net_profit': 393.78}]","[{'period': ""Q1 '25"", 'revenue': 13.74, 'unit': 'M', 'net_profit': -28.75}, {'period': ""Q4 '24"", 'revenue': -5.39, 'unit': 'M', 'net_profit': 4.43}, {'period': ""Q3 '24"", 'revenue': 14.69, 'unit': 'M', 'net_profit': -8.98}, {'period': ""Q2 '24"", 'revenue': 17.16, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q1 '24"", 'revenue': 16.88, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q4 '23"", 'revenue': 16.59, 'unit': 'M', 'net_profit': -1.1}]",-509.98,-509.98,44115458,26696279,3911382,39154616,11159676,1200000,18592822,3897511,-5246706,-454.0084639139459,0.21391874957526333,0.317396367335466,"[1.2411, 1.2411]","['2017-03-22', '2017-03-22']",__nan__,0.8875486683148569
38,CETXW,Cemtrex Inc. Series 1 Warrant,,None,,0.0129,USD,0,https://images.financialmodelingprep.com/symbol/CETXW.png,0,0,-0.0067,116198,-7678629,-7229491,"[{'period': '2024', 'revenue': 43.33, 'unit': 'M', 'net_profit': -7.23}, {'period': '2021', 'revenue': 43.13, 'unit': 'M', 'net_profit': -7.81}, {'period': '2020', 'revenue': 43.52, 'unit': 'M', 'net_profit': -9.71}, {'period': '2019', 'revenue': 39.27, 'unit': 'M', 'net_profit': -22.36}]","[{'period': ""Q1 '25"", 'revenue': 13.74, 'unit': 'M', 'net_profit': -28.75}, {'period': ""Q4 '24"", 'revenue': 7.63, 'unit': 'M', 'net_profit': 7.28}, {'period': ""Q3 '24"", 'revenue': 6190000.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q1 '22"", 'revenue': 10.67, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q4 '21"", 'revenue': 14.71, 'unit': 'M', 'net_profit': -9.67}, {'period': ""Q3 '21"", 'revenue': 10.33, 'unit': 'M', 'net_profit': 1.1}]",-17.69,-17.69,44115458,26696279,3897511,20561794,11159676,0,18592822,3897511,-1295322,0,0,0,__nan__,__nan__,__nan__,0.4660904574537116
39,CEVA,CEVA Inc. Common Stock,"CEVA, Inc. operates as a licensor of wireless connectivity and smart sensing technologies to semiconductor and original equipment manufacturer (OEM) companies worldwide. It designs and licenses various digital signal processors, AI processors, wireless platforms, and complementary software for sensor fusion, image enhancement, computer vision, voice input, and artificial intelligence (AI). The company licenses a family of wireless connectivity and smart sensing technologies, and integrated IP solutions, including DSP-based platforms for 5G baseband processing in mobile, IoT, and infrastructure; imaging and computer vision for any camera-enabled devices; audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets; sensor fusion software and inertial measurement unit solutions for hearables, wearables, AR/VR, PC, robotics, remote controls, and IoT; and wireless IoT for Bluetooth, Wi-Fi 4/5/6/6E, Ultra-wideband (UWB), and NB-IoT. Its technologies are licensed to companies, which design, manufacture, market, and sell application-specific integrated circuits and application-specific standard products to mobile, consumer, automotive, robotics, industrial, aerospace and defense, and IoT companies for incorporation into various end products. The company delivers its DSP cores, platforms, and AI processors in the form of a hardware description language definition; and offers development platforms, software development kits, and software debug tools that facilitate system design, debug, and software development. The company licenses its technology through a direct sales force. The company was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. CEVA, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.",Mr. Amir  Panush,Semiconductors,22.68,USD,542288348,https://images.financialmodelingprep.com/symbol/CEVA.png,280159,-61.3,-0.29,137438,-7545000,4884000,"[{'period': '2024', 'revenue': 106.94, 'unit': 'M', 'net_profit': 4.88}, {'period': '2023', 'revenue': 97.42, 'unit': 'M', 'net_profit': -11.88}, {'period': '2022', 'revenue': 134.65, 'unit': 'M', 'net_profit': -23.18}, {'period': '2021', 'revenue': 122710.0, 'unit': 'K', 'net_profit': 396.0}]","[{'period': ""Q4 '24"", 'revenue': 29.22, 'unit': 'M', 'net_profit': -1.74}, {'period': ""Q3 '24"", 'revenue': 27.21, 'unit': 'M', 'net_profit': -1.31}, {'period': ""Q2 '24"", 'revenue': 28440.0, 'unit': 'K', 'net_profit': -291.0}, {'period': ""Q1 '24"", 'revenue': 22.07, 'unit': 'M', 'net_profit': -5.45}, {'period': ""Q4 '23"", 'revenue': 24.16, 'unit': 'M', 'net_profit': 3.77}, {'period': ""Q3 '23"", 'revenue': 24.07, 'unit': 'M', 'net_profit': -4.96}]",0.21,0.21,308948000,216341000,161615000,42392000,37209000,312000,30529000,18498000,516000,0.12103914259086673,1.4111803333894595,1.4117647058823528,__nan__,__nan__,__nan__,0.1372140295454251
40,CFAC,CF Finance Acquisition Corp. III Common Stock,,,,,,,,,,,,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
41,CFACU,CF Finance Acquisition Corp. III Unit,"CF Finance Acquisition Corp. III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2016 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,8.89,USD,0,https://images.financialmodelingprep.com/symbol/CFACU.png,2709,-88.01980198019803,0.01000023,1312,-152883,-152883,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -152.88}, {'period': '2019', 'revenue': 0.0, 'unit': '', 'net_profit': -548.0}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.91}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -152.38}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -505.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '19"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0,0,230804152,438750,1250,484647,0,0,484647,1250,0,-277.9835766423358,-277.9835766423358,0,__nan__,__nan__,__nan__,0.002099819244152939
42,CFACW,CF Finance Acquisition Corp. III Warrant,,,,,,,,,,,,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
43,CFB,CrossFirst Bankshares Inc. Common Stock,"CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks. The company offers commercial real estate, construction and development, 1-4 family real estate, commercial, energy, and consumer loans. It also provides a range of deposit products consisting of noninterest-bearing demand and interest-bearing deposits, which include transaction accounts, savings accounts, money market accounts, and certificates of deposit; and personal and business checking and savings accounts, as well as negotiable order of withdrawal accounts; and brokered and reciprocal deposits. In addition, the company offers international banking services; treasury management services; automated teller machine access; and mobile banking services. Further, it holds investments in marketable securities. As of December 31, 2021, it had nine full-service banking offices in Kansas, Missouri, Oklahoma, Arizona, and Texas. CrossFirst Bankshares, Inc. was founded in 2007 and is headquartered in Leawood, Kansas.",Mr. Michael J. Maddox,Banks - Regional,15.99,USD,788642790,https://images.financialmodelingprep.com/symbol/CFB.png,236111,10.25,0,1823043,93570000,66669000,"[{'period': '2023', 'revenue': 231.02, 'unit': 'M', 'net_profit': 66.67}, {'period': '2022', 'revenue': 0.077, 'unit': 'M', 'net_profit': 61.6}, {'period': '2021', 'revenue': 182.35, 'unit': 'M', 'net_profit': 69.41}, {'period': '2020', 'revenue': 171.98, 'unit': 'M', 'net_profit': 12.6}]","[{'period': ""Q3 '24"", 'revenue': 67.13, 'unit': 'M', 'net_profit': 19.65}, {'period': ""Q2 '24"", 'revenue': 128.69, 'unit': 'M', 'net_profit': 18.62}, {'period': ""Q1 '24"", 'revenue': 124.44, 'unit': 'M', 'net_profit': 18.22}, {'period': ""Q4 '23"", 'revenue': 122.36, 'unit': 'M', 'net_profit': 17.65}, {'period': ""Q3 '23"", 'revenue': 61.11, 'unit': 'M', 'net_profit': 16.86}, {'period': ""Q2 '23"", 'revenue': 60.32, 'unit': 'M', 'net_profit': 16.05}]",1.35,1.34,7380680000,234029000,234029000,6672537000,0,11881000,2662652000,234029000,90401000,0.1290225273598224,0.08230653095017776,0.08870967741935491,__nan__,__nan__,__nan__,0.9040545044630034
44,CFBK,CF Bankshares Inc. Common Stock,"CF Bankshares Inc. operates as the bank holding company for CFBank, National Association that provides various banking products and services in the United States. The company accepts savings, retail and business checking accounts, and money market accounts, as well as certificates of deposit. It also offers single-family mortgage loans; commercial real estate and multi-family residential mortgage loans; commercial loans; construction and land loans; and consumer loans, such as home equity lines of credit, home improvement loans, and loans secured by deposits and purchased loans, as well as other loans. In addition, the company provides Internet and mobile banking, remote deposit, and treasury management depository services. As of December 31, 2021, it operated five branch offices located in Franklin, Cuyahoga, Hamilton, and Summit counties, Ohio; and a loan production office located in Franklin County, Ohio. The company was formerly known as Central Federal Corporation and changed its name to CF Bankshares Inc. in July 2020. CF Bankshares Inc. was founded in 1892 and is based in Worthington, Ohio.",Mr. Timothy T. O'Dell,Banks - Regional,20.75,USD,132744660,https://images.financialmodelingprep.com/symbol/CFBK.png,11975,10.07,-0.275,21669,0,13387000,"[{'period': '2024', 'revenue': 50.42, 'unit': 'M', 'net_profit': 13.39}, {'period': '2023', 'revenue': 49.35, 'unit': 'M', 'net_profit': 16.94}, {'period': '2022', 'revenue': 51.31, 'unit': 'M', 'net_profit': 18.16}, {'period': '2021', 'revenue': 53.33, 'unit': 'M', 'net_profit': 18.45}]","[{'period': ""Q4 '24"", 'revenue': 29.99, 'unit': 'M', 'net_profit': 4.42}, {'period': ""Q3 '24"", 'revenue': 12.51, 'unit': 'M', 'net_profit': 4.07}, {'period': ""Q2 '24"", 'revenue': 4.45, 'unit': 'M', 'net_profit': 1.7}, {'period': ""Q1 '24"", 'revenue': 11.74, 'unit': 'M', 'net_profit': 3.07}, {'period': ""Q4 '23"", 'revenue': 11.91, 'unit': 'M', 'net_profit': 4.24}, {'period': ""Q3 '23"", 'revenue': 12.82, 'unit': 'M', 'net_profit': 4.03}]",2.15,2.18,2065523000,243955000,243955000,1897086000,7680000,0,0,235272000,13923000,0,-0.20960028340320008,-0.1856060606060607,"[0.07, 0.0018]","['2025-04-14', '1999-06-22']",__nan__,0.9184530988035475
45,CFFE,CF Acquisition Corp. VIII Class A Common Stock,"CF Acquisition Corp. VIII does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,16.52,USD,123839206,https://images.financialmodelingprep.com/symbol/CFFE.png,46759,-6.661290322580645,3.12,16936,5770000,-6533000,"[{'period': '2024', 'revenue': 142.41, 'unit': 'M', 'net_profit': -6.53}, {'period': '2023', 'revenue': 166.57, 'unit': 'M', 'net_profit': -11.05}, {'period': '2022', 'revenue': 180.49, 'unit': 'M', 'net_profit': -7.93}, {'period': '2021', 'revenue': 205.95, 'unit': 'M', 'net_profit': -12.73}]","[{'period': ""Q4 '24"", 'revenue': 30.62, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q3 '24"", 'revenue': 35.33, 'unit': 'M', 'net_profit': -1.23}, {'period': ""Q2 '24"", 'revenue': 36.11, 'unit': 'M', 'net_profit': -4.72}, {'period': ""Q1 '24"", 'revenue': 40.35, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q3 '23"", 'revenue': 40.24, 'unit': 'M', 'net_profit': -2.89}, {'period': ""Q2 '23"", 'revenue': 42370.0, 'unit': 'K', 'net_profit': -558.0}]",-0.22,-0.22,88045000,41338000,12099000,109391000,19810000,0,68765000,12099000,-6490000,8.537190082644628,0.4086177242690323,0.5510204081632654,__nan__,__nan__,__nan__,1.2424442046680675
46,CFFEU,CF Acquisition Corp. VIII Unit,"CF Acquisition Corp. VIII does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,16.59,USD,119816663,https://images.financialmodelingprep.com/symbol/CFFEU.png,2681,149.45945945945945,5.04,13380,5770000,-6533000,"[{'period': '2024', 'revenue': 142.41, 'unit': 'M', 'net_profit': -6.53}, {'period': '2023', 'revenue': 166.57, 'unit': 'M', 'net_profit': -11.05}, {'period': '2022', 'revenue': 180.49, 'unit': 'M', 'net_profit': -7.93}, {'period': '2021', 'revenue': 205.95, 'unit': 'M', 'net_profit': -12.73}]","[{'period': ""Q4 '24"", 'revenue': 30.62, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q3 '24"", 'revenue': 35.33, 'unit': 'M', 'net_profit': -1.23}, {'period': ""Q2 '24"", 'revenue': 36.11, 'unit': 'M', 'net_profit': -4.72}, {'period': ""Q1 '24"", 'revenue': 40.35, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q3 '23"", 'revenue': 40.24, 'unit': 'M', 'net_profit': -2.89}, {'period': ""Q2 '23"", 'revenue': 42370.0, 'unit': 'K', 'net_profit': -558.0}]",-0.22,-0.22,88045000,41338000,12099000,109391000,19810000,0,68765000,12099000,-6490000,8.537190082644628,0.4086177242690323,0.5510204081632654,__nan__,__nan__,__nan__,1.2424442046680675
47,CFFEW,CF Acquisition Corp. VIII Warrant,"CF Acquisition Corp. VIII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,0.11,USD,123839206,https://images.financialmodelingprep.com/symbol/CFFEW.png,0,0,0.059,220969,5770000,-6533000,"[{'period': '2024', 'revenue': 142.41, 'unit': 'M', 'net_profit': -6.53}, {'period': '2023', 'revenue': 166.57, 'unit': 'M', 'net_profit': -11.05}, {'period': '2022', 'revenue': 180.49, 'unit': 'M', 'net_profit': -7.93}, {'period': '2021', 'revenue': 205.95, 'unit': 'M', 'net_profit': -12.73}]","[{'period': ""Q4 '24"", 'revenue': 30.62, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q3 '24"", 'revenue': 35.33, 'unit': 'M', 'net_profit': -1.23}, {'period': ""Q2 '24"", 'revenue': 36.11, 'unit': 'M', 'net_profit': -4.72}, {'period': ""Q1 '24"", 'revenue': 40.35, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q3 '23"", 'revenue': 40.24, 'unit': 'M', 'net_profit': -2.89}, {'period': ""Q2 '23"", 'revenue': 42370.0, 'unit': 'K', 'net_profit': -558.0}]",-0.22,-0.22,88045000,41338000,12099000,109391000,19810000,0,68765000,12099000,-6490000,8.537190082644628,0.4086177242690323,0.5510204081632654,__nan__,__nan__,__nan__,1.2424442046680675
48,CFFI,C&F Financial Corporation Common Stock,"C&F Financial Corporation operates as a bank holding company for Citizens and Farmers Bank that provides banking services to individuals and businesses. The company's Retail Banking offers various banking services, including checking and savings deposit accounts, as well as business, real estate, development, mortgage, home equity, and installment loans. It also provides ATMs, Internet and mobile banking, and debit and credit cards, as well as safe deposit box rentals, notary public, electronic transfer, and other customary bank services. This segment offers its services through its main office in West Point, Virginia, as well as through 30 Virginia branches located 1 each in Albermarle, Goochland, Hanover, Middlesex, Powhatan, Stafford, York, Charlottesville, Hampton, Montross, Newport News, Richmond, Warsaw, and Williamsburg; 2 each in the counties of Cumberland, James City, King George, and New Kent; and four each in the counties of Chesterfield and Henrico. The company's Mortgage Banking segment provides various residential mortgage loans; originates conventional mortgage loans, mortgage loans insured by the Federal Housing Administration, and mortgage loans guaranteed by the United States Department of Agriculture and the Veterans Administration; and ancillary mortgage loan origination services for residential appraisals, as well as various mortgage origination functions to third parties. It provides mortgage loan origination services through 11 offices in Virginia, 1 office in Maryland, and 2 offices in North Carolina, as well as through 1 each in South Carolina and West Virginia. The company's Consumer Finance segment provides automobile loans through its offices in Richmond and Hampton, Virginia. It also offers brokerage and wealth management services; and insurance products. In addition, the company provides title and settlement agency, and insurance services. C&F Financial Corporation was founded in 1927 and is headquartered in West Point, Virginia.",Mr. Thomas F. Cherry,Banks - Regional,60.59,USD,196303542,https://images.financialmodelingprep.com/symbol/CFFI.png,12288,10.08,0.84,8494,0,19834000,"[{'period': '2024', 'revenue': 139.59, 'unit': 'M', 'net_profit': 19.83}, {'period': '2023', 'revenue': 119.05, 'unit': 'M', 'net_profit': 23.6}, {'period': '2022', 'revenue': 115.56, 'unit': 'M', 'net_profit': 29.16}, {'period': '2021', 'revenue': 131.62, 'unit': 'M', 'net_profit': 28.67}]","[{'period': ""Q4 '24"", 'revenue': 31.12, 'unit': 'M', 'net_profit': 6.04}, {'period': ""Q3 '24"", 'revenue': 29.76, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q2 '24"", 'revenue': 30.73, 'unit': 'M', 'net_profit': 5.01}, {'period': ""Q1 '24"", 'revenue': 30.3, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q4 '23"", 'revenue': 40.21, 'unit': 'M', 'net_profit': 5.07}, {'period': ""Q3 '23"", 'revenue': 37.71, 'unit': 'M', 'net_profit': 5.79}]",6.09,6.09,2563374000,445380000,434788000,2336404000,10592000,0,33397000,16163000,38488000,0,-0.1597186917471615,-0.11994219653179192,"[0.46, 0.22]","['2025-03-14', '1998-06-26']",__nan__,0.9114565412616341
49,CFFN,Capitol Federal Financial Inc. Common Stock,"Capitol Federal Financial, Inc. operates as the holding company for Capitol Federal Savings Bank that provides various retail banking products and services in the United States. The company accepts a range of deposit products, including savings accounts, money market deposit accounts, interest-bearing and non-interest-bearing checking accounts, and certificates of deposit. It also provides various loan products, such as one- to four-family residential real estate loans, commercial real estate, commercial and industrial, and construction loans, as well as consumer loans, which include home equity, loans and lines of credit, home improvement loans, vehicle loans, and loans secured by saving deposits. In addition, the company offers mobile, telephone, and online banking services, as well as bill payment services; operates a call center; and invests in various securities. It operates a network of 54 branches, including 45 traditional branches and nine in-store branches located in nine counties throughout Kansas and two counties in Missouri. The company serves the metropolitan areas of Topeka, Wichita, Lawrence, Manhattan, Emporia, and Salina, Kansas, and a portion of the metropolitan area of greater Kansas City. Capitol Federal Financial, Inc. was founded in 1893 and is headquartered in Topeka, Kansas.",Mr. John B. Dicus,Banks - Regional,5.16,USD,685177618,https://images.financialmodelingprep.com/symbol/CFFN.png,753057,13.23,-0.1,619248,0,38010000,"[{'period': '2024', 'revenue': 164.59, 'unit': 'M', 'net_profit': 38.01}, {'period': '2023', 'revenue': -25.02, 'unit': 'M', 'net_profit': -101.61}, {'period': '2022', 'revenue': 220.05, 'unit': 'M', 'net_profit': 84.45}, {'period': '2021', 'revenue': 210.66, 'unit': 'M', 'net_profit': 76.08}]","[{'period': ""Q1 '25"", 'revenue': 97.62, 'unit': 'M', 'net_profit': 15.43}, {'period': ""Q4 '24"", 'revenue': 45.03, 'unit': 'M', 'net_profit': 12.06}, {'period': ""Q3 '24"", 'revenue': 99.7, 'unit': 'M', 'net_profit': 9.65}, {'period': ""Q2 '24"", 'revenue': 97.93, 'unit': 'M', 'net_profit': 13.76}, {'period': ""Q1 '24"", 'revenue': 30.58, 'unit': 'M', 'net_profit': 2.54}, {'period': ""Q4 '23"", 'revenue': -157.93, 'unit': 'M', 'net_profit': -140.32}]",0.29,0.29,9527608000,217666000,217307000,8495338000,359000,293313000,0,217307000,28719000,1,1.3740847177387607,1.381578947368421,"[0.085, 0.1]","['2025-02-07', '1999-05-03']",__nan__,0.8916548623746905
50,CFFVU,CF Acquisition Corp. V Unit,,,,,,,,,,,,,,[],"[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.3}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",,,156695,25000,25000,132200,0,0,132200,25000,,,,,__nan__,__nan__,__nan__,0.843677207313571
51,CFFVW,CF Acquisition Corp. V Warrant,"CF Acquisition Corp. V, a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,0.5492,USD,0,https://images.financialmodelingprep.com/symbol/CFFVW.png,0,0,-0.10290003,33876,,,[],[],,,156695,25000,25000,132200,0,0,132200,25000,,,,,__nan__,__nan__,__nan__,0.843677207313571
52,CFIV,CF Acquisition Corp. IV Class A common stock,"CF Acquisition Corp. IV does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate, technology, and software industries. CF Acquisition Corp. IV was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,10.58,USD,221290222,https://images.financialmodelingprep.com/symbol/CFIV.png,43612,529,0.015,441,13291770,11070791,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.07}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.45}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.32}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 513.7}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 179.72}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.19}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.54}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.08}]",0.17,0.17,104549809,370444,370444,7812963,0,0,5466319,370444,13686,6.931072180773213,0.3093958108241567,0.30769230769230776,__nan__,__nan__,__nan__,0.07472957698086277
53,CFIVU,CF Acquisition Corp. IV Unit,"CF Acquisition Corp. IV does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate, technology, and software industries. CF Acquisition Corp. IV was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,10.395,USD,221290215,https://images.financialmodelingprep.com/symbol/CFIVU.png,268,102.92079207920793,-0.215,200,13291770,11070791,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.07}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.45}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.32}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 513.7}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 179.72}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.19}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.54}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.08}]",0.17,0.17,104549809,370444,370444,7812963,0,0,5466319,370444,13686,6.931072180773213,0.3093958108241567,0.30769230769230776,__nan__,__nan__,__nan__,0.07472957698086277
54,CFIVW,CF Acquisition Corp. IV Warrant,"CF Acquisition Corp. IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,0.0005,USD,221290222,https://images.financialmodelingprep.com/symbol/CFIVW.png,21272,0,0.0001,154877,13291770,11070791,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.07}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.45}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.32}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 513.7}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 179.72}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.19}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.54}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.08}]",0.17,0.17,104549809,370444,370444,7812963,0,0,5466319,370444,13686,6.931072180773213,0.3093958108241567,0.30769230769230776,__nan__,__nan__,__nan__,0.07472957698086277
55,CFMS,Conformis Inc. Common Stock,"Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.",Mr. Mark A. Augusti,Medical - Devices,2.27,USD,17881902,https://images.financialmodelingprep.com/symbol/CFMS.png,156850,-0.39824561403508774,0.01,7081,-46225000,-50473000,"[{'period': '2022', 'revenue': 62.05, 'unit': 'M', 'net_profit': -50.47}, {'period': '2021', 'revenue': 99.86, 'unit': 'M', 'net_profit': -2.41}, {'period': '2020', 'revenue': 68.76, 'unit': 'M', 'net_profit': -24.29}, {'period': '2019', 'revenue': 77.43, 'unit': 'M', 'net_profit': -28.48}]","[{'period': ""Q2 '23"", 'revenue': 13.02, 'unit': 'M', 'net_profit': -13.01}, {'period': ""Q1 '23"", 'revenue': 12.84, 'unit': 'M', 'net_profit': -9.57}, {'period': ""Q4 '22"", 'revenue': 17.42, 'unit': 'M', 'net_profit': -3.72}, {'period': ""Q3 '22"", 'revenue': 13.78, 'unit': 'M', 'net_profit': -15.2}, {'period': ""Q2 '22"", 'revenue': 15.29, 'unit': 'M', 'net_profit': -15.52}, {'period': ""Q1 '22"", 'revenue': 15.55, 'unit': 'M', 'net_profit': -16.03}]",-6.99,-6.99,94048000,79269000,48667000,39869000,9773000,0,14073000,48667000,-52071000,-11.648468094909006,-19.91711562370493,-18.416666666666668,__nan__,__nan__,__nan__,0.42392182715209253
56,CFRX,ContraFect Corporation Common Stock,"ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also initiated an expanded access program to provide Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York.",Mr. Michael  Messinger CPA,Biotechnology,0.05,USD,0,https://images.financialmodelingprep.com/symbol/CFRX.png,262784,-0.0046168051708217915,-0.0194,910216,-53203000,-65153000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -65.15}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.85}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.99}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.63}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.36}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.57}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.12}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.22}, {'period': ""Q3 '22"", 'revenue': 4.83, 'unit': 'M', 'net_profit': -12.23}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.09}]",-124.97,-124.97,20679000,17706000,13682000,32531000,0,0,20840000,8907000,-46036000,-0.12563207447371205,-10.512775587677034,-9.38724832214765,__nan__,__nan__,__nan__,1.5731418347115431
57,CFV,CF Acquisition Corp. V Class A Common Stock,"CF Acquisition Corp. V, a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,8.65,USD,0,https://images.financialmodelingprep.com/symbol/CFV.png,79506,0,-3.6800003,53899,,,[],[],,,156695,25000,25000,132200,0,0,132200,25000,,,,,__nan__,__nan__,__nan__,0.843677207313571
58,CFVI,CF Acquisition Corp. VI Class A Common Stock,"CF Acquisition Corp. VI does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate services, technology, and software industries CF Acquisition Corp. VI was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,12.04,USD,3360725007,https://images.financialmodelingprep.com/symbol/CFVI.png,0,-18.55161787365177,0.42000008,2829591,-326757207,-338362779,"[{'period': '2024', 'revenue': 95.49, 'unit': 'M', 'net_profit': -338.36}, {'period': '2023', 'revenue': 80.96, 'unit': 'M', 'net_profit': -116.42}, {'period': '2022', 'revenue': 39.38, 'unit': 'M', 'net_profit': -11.4}, {'period': '2021', 'revenue': 9.47, 'unit': 'M', 'net_profit': -13.41}]","[{'period': ""Q4 '24"", 'revenue': 30.23, 'unit': 'M', 'net_profit': -236.75}, {'period': ""Q3 '24"", 'revenue': 25.06, 'unit': 'M', 'net_profit': -31.54}, {'period': ""Q2 '24"", 'revenue': 22.47, 'unit': 'M', 'net_profit': -26.78}, {'period': ""Q1 '24"", 'revenue': 17.73, 'unit': 'M', 'net_profit': -43.29}, {'period': ""Q4 '23"", 'revenue': 20.39, 'unit': 'M', 'net_profit': -29.28}, {'period': ""Q3 '23"", 'revenue': 17.98, 'unit': 'M', 'net_profit': -29.02}]",-1.66,-1.66,195312807,136127630,114018900,258428209,9778941,0,216736997,114018900,-94178011,-1.4854644383978695,-1.9063858121435733,-1.8620689655172415,__nan__,__nan__,__nan__,1.3231503502993534
59,CFVIU,CF Acquisition Corp. VI Unit,"CF Acquisition Corp. VI does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate services, technology, and software industries CF Acquisition Corp. VI was incorporated in 2020 and is based in New York, New York.",Mr. Howard W. Lutnick,Shell Companies,13.1,USD,0,https://images.financialmodelingprep.com/symbol/CFVIU.png,0,-20.184899845916796,0.46000004,623,-326757207,-338362779,"[{'period': '2024', 'revenue': 95.49, 'unit': 'M', 'net_profit': -338.36}, {'period': '2023', 'revenue': 80.96, 'unit': 'M', 'net_profit': -116.42}, {'period': '2022', 'revenue': 39.38, 'unit': 'M', 'net_profit': -11.4}, {'period': '2021', 'revenue': 9.47, 'unit': 'M', 'net_profit': -13.41}]","[{'period': ""Q4 '24"", 'revenue': 30.23, 'unit': 'M', 'net_profit': -236.75}, {'period': ""Q3 '24"", 'revenue': 25.06, 'unit': 'M', 'net_profit': -31.54}, {'period': ""Q2 '24"", 'revenue': 22.47, 'unit': 'M', 'net_profit': -26.78}, {'period': ""Q1 '24"", 'revenue': 17.73, 'unit': 'M', 'net_profit': -43.29}, {'period': ""Q4 '23"", 'revenue': 20.39, 'unit': 'M', 'net_profit': -29.28}, {'period': ""Q3 '23"", 'revenue': 17.98, 'unit': 'M', 'net_profit': -29.02}]",-1.66,-1.66,195312807,136127630,114018900,258428209,9778941,0,216736997,114018900,-94178011,-1.4854644383978695,-1.9063858121435733,-1.8620689655172415,__nan__,__nan__,__nan__,1.3231503502993534
60,CFVIW,CF Acquisition Corp. VI Warrant,"CF Acquisition Corp. VI does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is New York, New York.",Mr. Howard W. Lutnick,Shell Companies,3.86,USD,0,https://images.financialmodelingprep.com/symbol/CFVIW.png,0,0,0.31,260729,-326757207,-338362779,"[{'period': '2024', 'revenue': 95.49, 'unit': 'M', 'net_profit': -338.36}, {'period': '2023', 'revenue': 80.96, 'unit': 'M', 'net_profit': -116.42}, {'period': '2022', 'revenue': 39.38, 'unit': 'M', 'net_profit': -11.4}, {'period': '2021', 'revenue': 9.47, 'unit': 'M', 'net_profit': -13.41}]","[{'period': ""Q4 '24"", 'revenue': 30.23, 'unit': 'M', 'net_profit': -236.75}, {'period': ""Q3 '24"", 'revenue': 25.06, 'unit': 'M', 'net_profit': -31.54}, {'period': ""Q2 '24"", 'revenue': 22.47, 'unit': 'M', 'net_profit': -26.78}, {'period': ""Q1 '24"", 'revenue': 17.73, 'unit': 'M', 'net_profit': -43.29}, {'period': ""Q4 '23"", 'revenue': 20.39, 'unit': 'M', 'net_profit': -29.28}, {'period': ""Q3 '23"", 'revenue': 17.98, 'unit': 'M', 'net_profit': -29.02}]",-1.66,-1.66,195312807,136127630,114018900,258428209,9778941,0,216736997,114018900,-94178011,-1.4854644383978695,-1.9063858121435733,-1.8620689655172415,__nan__,__nan__,__nan__,1.3231503502993534
61,CG,The Carlyle Group Inc. Common Stock,"The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. It typically holds its investments for three to five years. Within automotive and transportation sectors, the firm seeks to hold its investments in for four to six years. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices in 21 countries across 5 continents (North America, South America, Asia, Australia and Europe).",Mr. Harvey Mitchell Schwartz,Asset Management,34.78,USD,12562636166,https://images.financialmodelingprep.com/symbol/CG.png,3388636,12.56,-1.06,7359835,0,1020400000,"[{'period': '2024', 'revenue': 3.4, 'unit': 'B', 'net_profit': 1.02}, {'period': '2023', 'revenue': 1320.0, 'unit': 'M', 'net_profit': -608.4}, {'period': '2022', 'revenue': 3.36, 'unit': 'B', 'net_profit': 1.23}, {'period': '2021', 'revenue': 5.53, 'unit': 'B', 'net_profit': 2.97}]","[{'period': ""Q4 '24"", 'revenue': 771.3, 'unit': 'M', 'net_profit': 210.9}, {'period': ""Q3 '24"", 'revenue': 1830.0, 'unit': 'M', 'net_profit': 595.7}, {'period': ""Q2 '24"", 'revenue': 737.9, 'unit': 'M', 'net_profit': 148.2}, {'period': ""Q1 '24"", 'revenue': 598.8, 'unit': 'M', 'net_profit': 65.6}, {'period': ""Q4 '23"", 'revenue': 921.2, 'unit': 'M', 'net_profit': -692.0}, {'period': ""Q3 '23"", 'revenue': 627.3, 'unit': 'M', 'net_profit': 81.3}]",2.85,2.77,23103500000,2071600000,1266000000,16755900000,805600000,0,380600000,1266000000,-837200000,0,2.6771860618014465,2.6964285714285716,"[0.35, 0.11]","['2025-02-21', '2012-08-16']",__nan__,0.7252537494319042
62,CGABL,The Carlyle Group Inc. 4.625% Subordinated Notes due 2061,,,Financial - Credit Services,16.57,USD,5941740244,https://images.financialmodelingprep.com/symbol/CGABL.png,26954,,-0.08,22997,0,1020400000,"[{'period': '2024', 'revenue': 5.43, 'unit': 'B', 'net_profit': 1.02}, {'period': '2023', 'revenue': 2960.0, 'unit': 'M', 'net_profit': -608.4}, {'period': '2022', 'revenue': 4.44, 'unit': 'B', 'net_profit': 1.28}, {'period': '2021', 'revenue': 8.78, 'unit': 'B', 'net_profit': 3.04}]","[{'period': ""Q4 '24"", 'revenue': 1840.0, 'unit': 'M', 'net_profit': 210.9}, {'period': ""Q3 '24"", 'revenue': 1830.0, 'unit': 'M', 'net_profit': 595.7}, {'period': ""Q2 '24"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 148.2}, {'period': ""Q1 '24"", 'revenue': 688.4, 'unit': 'M', 'net_profit': 65.6}, {'period': ""Q4 '23"", 'revenue': 926.2, 'unit': 'M', 'net_profit': -716.6}, {'period': ""Q3 '23"", 'revenue': 716.6, 'unit': 'M', 'net_profit': 81.3}]",2.85,2.77,23103500000,2071600000,1266000000,16755900000,805600000,0,138700000,1266000000,1011200000,1,2.6771860618014465,2.6964285714285716,"[0.28906, 0.302]","['2025-05-01', '2021-07-29']",__nan__,0.7252537494319042
63,CGBD,TCG BDC Inc. Common Stock,"TCG BDC, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.","Mr. Justin V. Plouffe CFA, J.D.",Asset Management,14.1,USD,1027932089,https://images.financialmodelingprep.com/symbol/CGBD.png,282359,8.92,-0.49,413265,0,88978000,"[{'period': '2024', 'revenue': 99.28, 'unit': 'M', 'net_profit': 88.98}, {'period': '2023', 'revenue': 241.63, 'unit': 'M', 'net_profit': 92.28}, {'period': '2022', 'revenue': 162.16, 'unit': 'M', 'net_profit': 85.64}, {'period': '2021', 'revenue': 169.89, 'unit': 'M', 'net_profit': 160.35}]","[{'period': ""Q4 '24"", 'revenue': 23.63, 'unit': 'M', 'net_profit': 21.36}, {'period': ""Q3 '24"", 'revenue': 44.49, 'unit': 'M', 'net_profit': 19.61}, {'period': ""Q2 '24"", 'revenue': 62.46, 'unit': 'M', 'net_profit': 18.75}, {'period': ""Q1 '24"", 'revenue': 42.82, 'unit': 'M', 'net_profit': 29.26}, {'period': ""Q4 '23"", 'revenue': 62.9, 'unit': 'M', 'net_profit': 29.59}, {'period': ""Q3 '23"", 'revenue': 51.03, 'unit': 'M', 'net_profit': 29.99}]",1.75,1.58,1925993000,89011000,56575000,1020789000,32436000,1805406000,47907000,56575000,104265000,-1,-0.035782401387082795,0.02941176470588238,"[0.45, 0.37]","['2025-03-24', '2017-06-28']",__nan__,0.5300065991932473
64,CGC,Canopy Growth Corporation Common Shares,"Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.",Mr. Luc  Mongeau,Drug Manufacturers - Specialty & Generic,1.08,USD,195578382,https://images.financialmodelingprep.com/symbol/CGC.png,7929027,-0.3,-0.11,6886538,-312827000,-657269000,"[{'period': '2023', 'revenue': 297.15, 'unit': 'M', 'net_profit': -657.27}, {'period': '2022', 'revenue': 0.4029, 'unit': 'B', 'net_profit': -3.31}, {'period': '2021', 'revenue': 520.33, 'unit': 'M', 'net_profit': -320.49}, {'period': '2020', 'revenue': 0.54665, 'unit': 'B', 'net_profit': -1.67}]","[{'period': ""Q3 '24"", 'revenue': 86.24, 'unit': 'M', 'net_profit': -121.9}, {'period': ""Q2 '24"", 'revenue': 62.99, 'unit': 'M', 'net_profit': -128.29}, {'period': ""Q1 '24"", 'revenue': 66.21, 'unit': 'M', 'net_profit': -127.14}, {'period': ""Q4 '23"", 'revenue': 72.79, 'unit': 'M', 'net_profit': -92.34}, {'period': ""Q3 '23"", 'revenue': 78.5, 'unit': 'M', 'net_profit': -216.8}, {'period': ""Q2 '23"", 'revenue': 69.59, 'unit': 'M', 'net_profit': -310.01}]",-6.47,-8.79,1300330000,371180000,203461000,799823000,44943000,136221000,234715000,170300000,-285946000,0.8913783069811887,0.8014020654192449,0.9093456634440241,__nan__,__nan__,__nan__,0.6150923227180792
65,CGEM,Cullinan Oncology Inc. Common Stock,"Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.",Mr. Nadim  Ahmed,Biotechnology,8.1,USD,473953883,https://images.financialmodelingprep.com/symbol/CGEM.png,459939,-2.91,0.21,319158,-190339000,-153162000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -153.16}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 111.21}, {'period': '2021', 'revenue': 18.94, 'unit': 'M', 'net_profit': -65.04}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -50.85}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -47.65}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.56}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.03}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.15}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.8}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.18}]",-3.69,-3.69,621824000,414668000,398977000,31496000,0,204440000,30647000,83005000,-145303000,-2.257118136966759,-2.3771827287931377,-2.5,__nan__,__nan__,__nan__,0.05065098806093042
66,CGEN,Compugen Ltd. Ordinary Shares,"Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients with advanced malignancies as a monotherapy; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with solid tumors; and AZD2936, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase I/II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused primarily on myeloid targets. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.",Dr. Anat  Cohen-Dayag Ph.D.,Biotechnology,1.39,USD,129983049,https://images.financialmodelingprep.com/symbol/CGEN.png,424490,-8.69,-0.08,200624,-14405000,-14231000,"[{'period': '2024', 'revenue': 27.86, 'unit': 'M', 'net_profit': -14.23}, {'period': '2023', 'revenue': 33.46, 'unit': 'M', 'net_profit': -18.75}, {'period': '2022', 'revenue': 7.5, 'unit': 'M', 'net_profit': -33.69}, {'period': '2021', 'revenue': 6.0, 'unit': 'M', 'net_profit': -32.87}]","[{'period': ""Q4 '24"", 'revenue': 1.47, 'unit': 'M', 'net_profit': -6.12}, {'period': ""Q3 '24"", 'revenue': 17.13, 'unit': 'M', 'net_profit': 1.28}, {'period': ""Q2 '24"", 'revenue': 6.7, 'unit': 'M', 'net_profit': -2.12}, {'period': ""Q1 '24"", 'revenue': 2.56, 'unit': 'M', 'net_profit': -7.27}, {'period': ""Q4 '23"", 'revenue': 33.46, 'unit': 'M', 'net_profit': 9.71}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.85}]",-0.16,-0.16,114995000,105997000,103255000,60081000,269000,0,20160000,18229000,49486000,-0.15092681367849153,0.24117521595392982,0.23809523809523805,__nan__,__nan__,__nan__,0.5224661941823557
67,CGNT,Cognyte Software Ltd. Ordinary Shares,"Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions. Its solutions are designed to support various use cases and support a range of users, including data analysts, investigation managers, and security operations center operators, as well as operational field teams. In addition, the company provides customer support, professional, and integration services. Its government customers include national, regional, and local government agencies; and enterprise customers consist of commercial and physical security customers. The company was incorporated in 2020 and is headquartered in Herzliya, Israel.",Mr. Elad  Sharon,Software - Infrastructure,9.18,USD,660557824,https://images.financialmodelingprep.com/symbol/CGNT.png,380298,-54,-0.325,253269,9382000,-12051000,"[{'period': '2025', 'revenue': 350.63, 'unit': 'M', 'net_profit': -12.05}, {'period': '2024', 'revenue': 313.4, 'unit': 'M', 'net_profit': -15.57}, {'period': '2023', 'revenue': 312.06, 'unit': 'M', 'net_profit': -109.95}, {'period': '2022', 'revenue': 474.04, 'unit': 'M', 'net_profit': -10.26}]","[{'period': ""Q4 '25"", 'revenue': 94.5, 'unit': 'M', 'net_profit': -1.23}, {'period': ""Q3 '25"", 'revenue': 89.0, 'unit': 'M', 'net_profit': -3.77}, {'period': ""Q2 '25"", 'revenue': 84.41, 'unit': 'M', 'net_profit': -1.93}, {'period': ""Q1 '25"", 'revenue': 82.71, 'unit': 'M', 'net_profit': -5.12}, {'period': ""Q4 '24"", 'revenue': 83.69, 'unit': 'M', 'net_profit': -2.61}, {'period': ""Q3 '24"", 'revenue': 79.39, 'unit': 'M', 'net_profit': 5.22}]",-0.17,-0.17,497820000,286153000,112719000,280717000,122802000,6410000,219361000,112719000,33594000,15.37350152443547,0.22601156069364162,0.2272727272727272,__nan__,__nan__,__nan__,0.5638925716122293
68,CGNX,Cognex Corporation Common Stock,"Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.",Mr. Robert J. Willett,"Hardware, Equipment & Parts",23.49,USD,3990152340,https://images.financialmodelingprep.com/symbol/CGNX.png,2445855,37.89,-0.28,5166056,115065000,106171000,"[{'period': '2024', 'revenue': 914.51, 'unit': 'M', 'net_profit': 106.17}, {'period': '2023', 'revenue': 837.55, 'unit': 'M', 'net_profit': 113.23}, {'period': '2022', 'revenue': 1010.0, 'unit': 'M', 'net_profit': 215.53}, {'period': '2021', 'revenue': 1040.0, 'unit': 'M', 'net_profit': 279.88}]","[{'period': ""Q4 '24"", 'revenue': 229.68, 'unit': 'M', 'net_profit': 28.35}, {'period': ""Q3 '24"", 'revenue': 234.74, 'unit': 'M', 'net_profit': 29.59}, {'period': ""Q2 '24"", 'revenue': 239.29, 'unit': 'M', 'net_profit': 36.21}, {'period': ""Q1 '24"", 'revenue': 210.8, 'unit': 'M', 'net_profit': 12.02}, {'period': ""Q4 '23"", 'revenue': 196.67, 'unit': 'M', 'net_profit': 11.23}, {'period': ""Q3 '23"", 'revenue': 197.24, 'unit': 'M', 'net_profit': 18.92}]",0.62,0.62,1992850000,613367000,186094000,475345000,143359000,340898000,169380000,186094000,134038000,-0.20415404407187618,-0.062375258314640476,-0.060606060606060656,"[0.08, 0.06]","['2025-02-27', '2003-08-27']",__nan__,0.23852522768898812
69,CGO,Calamos Global Total Return Fund Common Stock,"Calamos Global Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in equities, convertible bonds, and high yield corporate bonds. It employs both fundamental and quantitative analysis to create its portfolio. The fund benchmarks the performance of its portfolio against MSCI World Index. Calamos Global Total Return Fund was formed on March 30, 2004 and is domiciled in the United States.",Mr. John Peter Calamos Sr.,Asset Management - Global,9.67,USD,94967890,https://images.financialmodelingprep.com/symbol/CGO.png,30363,2.66,-0.15,37482,0,35751085,"[{'period': '2024', 'revenue': 36.14, 'unit': 'M', 'net_profit': 35.75}, {'period': '2023', 'revenue': 5.28, 'unit': 'M', 'net_profit': 4.8}, {'period': '2022', 'revenue': -47.89, 'unit': 'M', 'net_profit': -48.46}, {'period': '2021', 'revenue': 45.4, 'unit': 'M', 'net_profit': 44.94}]","[{'period': ""Q4 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '22"", 'revenue': -2.8, 'unit': 'M', 'net_profit': -16.63}, {'period': ""Q2 '22"", 'revenue': 7.91, 'unit': 'M', 'net_profit': -31.83}, {'period': ""Q4 '21"", 'revenue': 2.56, 'unit': 'M', 'net_profit': 9.31}, {'period': ""Q2 '21"", 'revenue': 12.15, 'unit': 'M', 'net_profit': 35.63}]",0,0,179473766,18,18,63556611,1466932,171043168,0,18,-2804795,-1,6.444231385093082,-1,"[0.08, 0.1]","['2025-04-11', '2005-12-28']",__nan__,0.35412758319229787
70,CGRN,Capstone Green Energy Corporation Common Stock,"Capstone Green Energy Corporation develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation and distribution networks applications worldwide. It offers microturbines, components, and accessories for various applications, including cogeneration combined heat and power (CHP), integrated CHP, and combined cooling, heat, and power, as well as renewable energy, natural resources, and critical power supply. The company's microturbines are also used as battery charging generators for use in hybrid electric vehicles. It also provides various accessories, including rotary gas compressors with digital controls; integrated heat recovery modules for CHP applications; dual mode controllers that allow automatic transition between grid connect and stand-alone modes; batteries with digital controls for stand-alone or dual-mode operations; power servers for multipacked installations; protocol converters for Internet access; packaging options; and miscellaneous parts, such as frames, exhaust ducting, backflow dampers, and installation hardware. In addition, the company offers rental solutions and aftermarket spare parts. Further, it provides energy conversion products including hybrid energy stations, baker hughes, and industrial gas turbines; hydrogen energy solutions, such as hydrogen-based combined heat and power products; and energy storage products comprising microgrid storage systems and lithium-ion battery energy storage systems. The company markets and sells its products primarily through distributors and original equipment manufacturers. The company was formerly known as Capstone Turbine Corporation and changed its name to Capstone Green Energy Corporation in April 2021. Capstone Green Energy Corporation was founded in 1988 and is headquartered in Van Nuys, California.",Mr. Robert C. Flexon,Industrial - Machinery,0.37,USD,6788686,https://images.financialmodelingprep.com/symbol/CGRN.png,210565,-0.42045454545454547,0.06,1584043,-14566000,-20211000,"[{'period': '2022', 'revenue': 69.64, 'unit': 'M', 'net_profit': -20.21}, {'period': '2021', 'revenue': 67.64, 'unit': 'M', 'net_profit': -18.39}, {'period': '2020', 'revenue': 68.93, 'unit': 'M', 'net_profit': -21.9}, {'period': '2019', 'revenue': 83.41, 'unit': 'M', 'net_profit': -16.66}]","[{'period': ""Q3 '23"", 'revenue': 19.61, 'unit': 'M', 'net_profit': -7.07}, {'period': ""Q2 '23"", 'revenue': 20.77, 'unit': 'M', 'net_profit': -4.92}, {'period': ""Q1 '23"", 'revenue': 18.65, 'unit': 'M', 'net_profit': -2.06}, {'period': ""Q4 '22"", 'revenue': 15.76, 'unit': 'M', 'net_profit': -6.89}, {'period': ""Q3 '22"", 'revenue': 20.61, 'unit': 'M', 'net_profit': -5.15}, {'period': ""Q2 '22"", 'revenue': 17.2, 'unit': 'M', 'net_profit': -5.99}]",-1.37,-1.37,100773000,71208000,22559000,95359000,25877000,0,37620000,22559000,-37422000,-0.6311310190369541,-0.0992005221080111,0.15950920245398761,__nan__,__nan__,__nan__,0.946275291992895
71,CHCI,Comstock Holding Companies Inc. Class A Common Stock,"Comstock Holding Companies, Inc. develops, operates, and manages of mixed-use and transit-oriented properties primarily in the Washington, D.C. metropolitan area. The company operates a portfolio of 34 operating assets, which include 14 commercial assets totaling approximately 2.2 million square feet; 6 multifamily assets totaling 1,636 units; and 14 commercial garages with approximately 11,000 parking spaces. It also has 18 development pipeline assets consisting of approximately 2.0 million square feet of additional planned commercial development; approximately 1,900 multifamily units; and 2 hotel assets. In addition, the company provides real estate development and management services. It primarily serves private and institutional owners; investors in commercial, residential, and mixed-use real estate; and various governmental bodies. The company was formerly known as Comstock Homebuilding Companies, Inc. and changed its name to Comstock Holding Companies, Inc. in June 2012. Comstock Holding Companies, Inc. was founded in 1985 and is headquartered in Reston, Virginia.",Mr. Christopher  Clemente,Real Estate - Diversified,10.07,USD,98948485,https://images.financialmodelingprep.com/symbol/CHCI.png,28131,7.14,-0.38,38885,10589000,14560000,"[{'period': '2024', 'revenue': 51.29, 'unit': 'M', 'net_profit': 14.56}, {'period': '2023', 'revenue': 44.72, 'unit': 'M', 'net_profit': 7.78}, {'period': '2022', 'revenue': 39.31, 'unit': 'M', 'net_profit': 7.35}, {'period': '2021', 'revenue': 31.09, 'unit': 'M', 'net_profit': 13.61}]","[{'period': ""Q4 '24"", 'revenue': 16.91, 'unit': 'M', 'net_profit': 10.33}, {'period': ""Q3 '24"", 'revenue': 12.99, 'unit': 'M', 'net_profit': 2.38}, {'period': ""Q2 '24"", 'revenue': 10750.0, 'unit': 'K', 'net_profit': 946.0}, {'period': ""Q1 '24"", 'revenue': 10640.0, 'unit': 'K', 'net_profit': 910.0}, {'period': ""Q4 '23"", 'revenue': 11.02, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q3 '23"", 'revenue': 14.46, 'unit': 'M', 'net_profit': 4.68}]",1.48,1.41,64867000,36727000,28761000,12498000,282000,6228000,6655000,28761000,10307000,0.12937286689419794,0.8705035971223022,0.8271604938271604,__nan__,__nan__,__nan__,0.19267115790771888
72,CHCO,City Holding Company Common Stock,"City Holding Company operates as a holding company for City National Bank of West Virginia that provides various banking, trust and investment management, and other financial solutions in the United States. The company offers checking, savings, and money market accounts, as well as certificates of deposit and individual retirement accounts. It also provides commercial and industrial loans that consist of loans to corporate and other legal entity borrowers primarily in small to mid-size industrial and commercial companies; commercial real estate loans comprising commercial mortgages, which are secured by nonresidential and multi-family residential properties; residential real estate loans to consumers for the purchase or refinance of residence; first-priority home equity loans; consumer loans that are secured and unsecured by automobiles, boats, recreational vehicles, certificates of deposit, and other personal property; and demand deposit account overdrafts. In addition, the company offers mortgage banking services, including fixed and adjustable-rate mortgages, construction financing, land loans, production of conventional and government insured mortgages, secondary marketing, and mortgage servicing. Further, it provides deposit services for commercial customers comprising treasury management, lockbox, and other cash management services; merchant credit card services; wealth management, trust, investment, and custodial services for commercial and individual customers; and corporate trust and institutional custody, financial and estate planning, and retirement plan services, as well as automated-teller-machine, interactive-teller-machine, mobile banking, interactive voice response systems, and credit and debit card services. The company operates through a network of 94 branches and 905 full-time equivalent associates in West Virginia, Virginia, Kentucky, and Ohio. City Holding Company was founded in 1957 and is headquartered in Charleston, West Virginia.",Mr. Charles R. Hageboeck,Banks - Regional,112.29,USD,1652381598,https://images.financialmodelingprep.com/symbol/CHCO.png,70422,14.23,-1.45,64229,0,117101000,"[{'period': '2024', 'revenue': 285.06, 'unit': 'M', 'net_profit': 117.1}, {'period': '2023', 'revenue': 286.63, 'unit': 'M', 'net_profit': 114.36}, {'period': '2022', 'revenue': 246.08, 'unit': 'M', 'net_profit': 102.07}, {'period': '2021', 'revenue': 218.76, 'unit': 'M', 'net_profit': 88.08}]","[{'period': ""Q4 '24"", 'revenue': 70.05, 'unit': 'M', 'net_profit': 28.65}, {'period': ""Q3 '24"", 'revenue': 74.75, 'unit': 'M', 'net_profit': 29.53}, {'period': ""Q2 '24"", 'revenue': 94.53, 'unit': 'M', 'net_profit': 29.11}, {'period': ""Q1 '24"", 'revenue': 91.44, 'unit': 'M', 'net_profit': 29.52}, {'period': ""Q4 '23"", 'revenue': 85.78, 'unit': 'M', 'net_profit': 27.45}, {'period': ""Q3 '23"", 'revenue': 70.84, 'unit': 'M', 'net_profit': 29.84}]",8.2,8.19,6459459000,1559536000,1538886000,5728795000,20650000,0,0,225389000,112412000,0,0.023923403139072267,0.07611548556430435,"[0.79, 0.385]","['2025-04-15', '1987-07-06']",__nan__,0.8868846446738031
73,CHDN,Churchill Downs Incorporated Common Stock,"Churchill Downs Incorporated operates as a racing, online wagering, and gaming entertainment company in the United States. It operates through three segments: Live and Historical Racing, TwinSpires, and Gaming. As of December 31, 2021, the company owned and operated three pari-mutuel gaming entertainment venues with approximately 3,050 historical racing machines (HRMs) in Kentucky; TwinSpires, an online wagering platform for horse racing, sports, and iGaming; nine retail sportsbooks; and casino gaming in eight states with approximately 11,000 slot machines and video lottery terminals, and 200 table games. It also offers streaming video of live horse races, replays, and an assortment of racing and handicapping information; and provides the Bloodstock Research Information Services platform for horse racing statistical data. In addition, the company manufactures and operates pari-mutuel wagering systems for racetracks, off-track betting facilities, and other pari-mutuel wagering businesses. Churchill Downs Incorporated was founded in 1875 and is headquartered in Louisville, Kentucky.",Mr. William C. Carstanjen,"Gambling, Resorts & Casinos",100,USD,7348785000,https://images.financialmodelingprep.com/symbol/CHDN.png,649852,17.61,-1.36,683408,1067700000,426800000,"[{'period': '2024', 'revenue': 2730.0, 'unit': 'M', 'net_profit': 426.8}, {'period': '2023', 'revenue': 2460.0, 'unit': 'M', 'net_profit': 417.3}, {'period': '2022', 'revenue': 1810.0, 'unit': 'M', 'net_profit': 439.4}, {'period': '2021', 'revenue': 1600.0, 'unit': 'M', 'net_profit': 249.1}]","[{'period': ""Q4 '24"", 'revenue': 624.2, 'unit': 'M', 'net_profit': 71.7}, {'period': ""Q3 '24"", 'revenue': 628.5, 'unit': 'M', 'net_profit': 64.4}, {'period': ""Q2 '24"", 'revenue': 890.7, 'unit': 'M', 'net_profit': 209.3}, {'period': ""Q1 '24"", 'revenue': 590.9, 'unit': 'M', 'net_profit': 80.4}, {'period': ""Q4 '23"", 'revenue': 561.2, 'unit': 'M', 'net_profit': 57.6}, {'period': ""Q3 '23"", 'revenue': 572.5, 'unit': 'M', 'net_profit': 61.0}]",5.77,5.72,7275900000,412300000,175500000,6172600000,113200000,0,89900000,175500000,225700000,0.06196538691068232,0.022765396597172298,0.039639639639639596,"[0.409, 0.5]","['2024-12-06', '1993-12-27']",__nan__,0.8483624019021702
74,CHEF,The Chefs' Warehouse Inc. Common Stock,"The Chefs' Warehouse, Inc., together with its subsidiaries, engages in distribution of specialty food products in the United States and Canada. The company's product portfolio includes approximately 50,000 stock-keeping units, such as specialty food products, such as artisan charcuterie, specialty cheeses, unique oils and vinegars, truffles, caviar, chocolate, and pastry products. It also offers a line of center-of-the-plate products, including custom cut beef, seafood, and hormone-free poultry, as well as food products, such as cooking oils, butter, eggs, milk, and flour. The company serves menu-driven independent restaurants, fine dining establishments, country clubs, hotels, caterers, culinary schools, bakeries, patisseries, chocolatiers, cruise lines, casinos, and specialty food stores. It markets its center-of-the-plate products directly to consumers through a mail and e-commerce platform. The company was founded in 1985 and is headquartered in Ridgefield, Connecticut.",Mr. Christopher  Pappas,Food Distribution,52.495,USD,2151690048,https://images.financialmodelingprep.com/symbol/CHEF.png,546119,39.77,-1.205,283845,128207000,55479000,"[{'period': '2024', 'revenue': 3790.0, 'unit': 'M', 'net_profit': 55.48}, {'period': '2023', 'revenue': 3430.0, 'unit': 'M', 'net_profit': 34.59}, {'period': '2022', 'revenue': 2610.0, 'unit': 'M', 'net_profit': 27.75}, {'period': '2021', 'revenue': 1750.0, 'unit': 'M', 'net_profit': -4.92}]","[{'period': ""Q4 '24"", 'revenue': 1030.0, 'unit': 'M', 'net_profit': 23.93}, {'period': ""Q3 '24"", 'revenue': 931.45, 'unit': 'M', 'net_profit': 14.1}, {'period': ""Q2 '24"", 'revenue': 954.7, 'unit': 'M', 'net_profit': 15.52}, {'period': ""Q1 '24"", 'revenue': 874.49, 'unit': 'M', 'net_profit': 1.93}, {'period': ""Q4 '23"", 'revenue': 950.47, 'unit': 'M', 'net_profit': 16.0}, {'period': ""Q3 '23"", 'revenue': 881.83, 'unit': 'M', 'net_profit': 7.32}]",1.46,1.21,1858691000,868043000,114655000,1321045000,366311000,0,425396000,114655000,103555000,-0.18104235734498464,0.6039028620988726,0.37735849056603765,__nan__,__nan__,__nan__,0.7107394397454984
75,CHEK,Check-Cap Ltd. Ordinary Share,"Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.",Dr. Yoav  Kimchy Ph.D.,Medical - Diagnostics & Research,0.6501,USD,3803322,https://images.financialmodelingprep.com/symbol/CHEK.png,168716,-0.3,-0.0598,4671,-17649000,-17568000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.57}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.25}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.09}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.76}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.66}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.59}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.88}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.03}]",-3,-3,25017000,24856000,24756000,1330000,0,0,1330000,8844000,-17037000,0.055748756085816704,0.08756622000623247,0.11504424778761065,__nan__,__nan__,__nan__,0.05316384858296359
76,CHEKZ,Check-Cap Ltd. Series C Warrant,,None,,0.0101,USD,0,https://images.financialmodelingprep.com/symbol/CHEKZ.png,0,0,0,48250,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
77,CHI,Calamos Convertible Opportunities and Income Fund Common Stock,"Calamos Convertible Opportunities and Income Fund is a closed ended fixed income mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in the fixed income markets of the United States. It primarily invests in a diversified portfolio of convertible securities and high yield corporate bonds rated Ba or lower by Moody's or BB or lower by Standard & Poor's. The fund employs both fundamental and quantitative analysis with a focus on such factors as financial soundness, ability to make interest and dividend payments, earnings and cash-flow forecast, and quality of management to create its portfolio. Calamos Convertible Opportunities and Income Fund was formed on April 17, 2002 and is domiciled in the United States.",Mr. John Peter Calamos Sr.,Asset Management - Income,9.44,USD,698225673,https://images.financialmodelingprep.com/symbol/CHI.png,279150,4.31,-0.175,416049,0,164031248,"[{'period': '2024', 'revenue': 164.71, 'unit': 'M', 'net_profit': 164.03}, {'period': '2023', 'revenue': -9.13, 'unit': 'M', 'net_profit': -9.83}, {'period': '2022', 'revenue': -297.27, 'unit': 'M', 'net_profit': -298.1}, {'period': '2021', 'revenue': 287.78, 'unit': 'M', 'net_profit': 287.01}]","[{'period': ""Q2 '24"", 'revenue': 13.31, 'unit': 'M', 'net_profit': 98.68}, {'period': ""Q4 '23"", 'revenue': 50.8, 'unit': 'M', 'net_profit': -28.7}, {'period': ""Q2 '23"", 'revenue': 61.44, 'unit': 'M', 'net_profit': 18.87}, {'period': ""Q4 '22"", 'revenue': 7.8, 'unit': 'M', 'net_profit': -90.76}, {'period': ""Q2 '22"", 'revenue': 81.64, 'unit': 'M', 'net_profit': -207.33}, {'period': ""Q4 '21"", 'revenue': -25.95, 'unit': 'M', 'net_profit': 52.31}]",2.18,2.18,1215431322,0,0,456224884,10564437,1176563182,0,0,83193972,-1,17.686396402609986,17.76923076923077,"[0.095, 0.0969]","['2025-04-11', '2002-08-15']",__nan__,0.37536047964378527
78,CHK,Chesapeake Energy Corporation Common Stock,"Chesapeake Energy Corporation, an independent exploration and production company, engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids from underground reservoirs in the United States. The company holds interests in natural gas resource plays in the Marcellus Shale in the northern Appalachian Basin in Pennsylvania and the Haynesville/Bossier Shales in northwestern Louisiana; and the liquids-rich resource play in the Eagle Ford Shale in South Texas. As of December 31, 2021, it owned interests in approximately 8,200 gross productive wells, including 6,500 wells with working interest and 1,700 wells with an overriding or royalty interest; and had estimated proved reserves of 661 million barrels of oil equivalent. The company was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.",Mr. Domenic J. Dell'Osso Jr.,Oil & Gas Exploration & Production,81.46,USD,10695127780,https://images.financialmodelingprep.com/symbol/CHK.png,2329734,26.884488448844884,-0.79,2992655,4756000000,2419000000,"[{'period': '2023', 'revenue': 7.78, 'unit': 'B', 'net_profit': 2.42}, {'period': '2022', 'revenue': 11.44, 'unit': 'B', 'net_profit': 4.94}, {'period': '2021', 'revenue': 7.3, 'unit': 'B', 'net_profit': 6.33}, {'period': '2020', 'revenue': 5.21, 'unit': 'B', 'net_profit': -9.75}]","[{'period': ""Q2 '24"", 'revenue': 514.0, 'unit': 'M', 'net_profit': -227.0}, {'period': ""Q1 '24"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '23"", 'revenue': 1810.0, 'unit': 'M', 'net_profit': 569.0}, {'period': ""Q3 '23"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': 70.0}, {'period': ""Q2 '23"", 'revenue': 1420.0, 'unit': 'M', 'net_profit': 391.0}, {'period': ""Q1 '23"", 'revenue': 3.04, 'unit': 'B', 'net_profit': 1.39}]",18.21,16.92,14376000000,2609000000,1079000000,3647000000,626000000,312000000,1314000000,1079000000,551000000,-0.14567989940722112,-0.5099270664505673,-0.5295789201756652,"[0.575, 0.34375]","['2024-08-15', '2021-05-21']",__nan__,0.2536867000556483
79,CHKEL,Chesapeake Energy Corporation Class C Warrants,"Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. The company holds interests in natural gas resource plays, including the Marcellus in Northern Appalachian Basin in Pennsylvania; Haynesville located in Northwestern Louisiana; Eagle Ford in South Texas; Brazos Valley in Southeast Texas; Powder River Basin in Wyoming; and Mid-Continent in Anadarko Basin of northwestern Oklahoma. As of December 31, 2019, it owned interests in approximately 13,500 oil and natural gas wells; and had estimated proved reserves of 1,572 one million barrels of oil equivalent. The company was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.",Mr. Domenic J. Dell'Osso Jr.,Oil & Gas Exploration & Production,62.5,USD,8205426750,https://images.financialmodelingprep.com/symbol/CHKEL.png,196,0,-0.19,1799,765000000,-714000000,"[{'period': '2024', 'revenue': 4240.0, 'unit': 'M', 'net_profit': -714.0}, {'period': '2023', 'revenue': 6.04, 'unit': 'B', 'net_profit': 2.42}, {'period': '2022', 'revenue': 11.44, 'unit': 'B', 'net_profit': 4.94}, {'period': '2021', 'revenue': 5550.0, 'unit': 'K', 'net_profit': 945.0}]","[{'period': ""Q4 '24"", 'revenue': 1.71, 'unit': 'B', 'net_profit': -1.08}, {'period': ""Q3 '24"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 569.0}, {'period': ""Q2 '24"", 'revenue': 503.0, 'unit': 'M', 'net_profit': -227.0}, {'period': ""Q1 '24"", 'revenue': 922.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '23"", 'revenue': 1090.0, 'unit': 'M', 'net_profit': 569.0}, {'period': ""Q3 '23"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': 70.0}]",-4.55,-4.55,27894000000,1997000000,317000000,10329000000,1226000000,0,3123000000,317000000,8000000,-0.8391505466778806,-1.295163290615957,-1.2498627127951676,__nan__,__nan__,__nan__,0.3702946870294687
80,CHKEW,Chesapeake Energy Corporation Class A Warrants,"Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. The company holds interests in natural gas resource plays, including the Marcellus in Northern Appalachian Basin in Pennsylvania; Haynesville located in Northwestern Louisiana; Eagle Ford in South Texas; Brazos Valley in Southeast Texas; Powder River Basin in Wyoming; and Mid-Continent in Anadarko Basin of northwestern Oklahoma. As of December 31, 2019, it owned interests in approximately 13,500 oil and natural gas wells; and had estimated proved reserves of 1,572 one million barrels of oil equivalent. The company was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.",Mr. Domenic J. Dell'Osso Jr.,Oil & Gas Exploration & Production,71.89,USD,9438210065,https://images.financialmodelingprep.com/symbol/CHKEW.png,35,0,-3.07,3,1011000000,-714000000,"[{'period': '2024', 'revenue': 4220.0, 'unit': 'M', 'net_profit': -714.0}, {'period': '2023', 'revenue': 7.78, 'unit': 'B', 'net_profit': 2.42}, {'period': '2022', 'revenue': 11.44, 'unit': 'B', 'net_profit': 4.94}, {'period': '2021', 'revenue': 7.3, 'unit': 'B', 'net_profit': 6.33}]","[{'period': ""Q4 '24"", 'revenue': 2000.0, 'unit': 'M', 'net_profit': -399.0}, {'period': ""Q3 '24"", 'revenue': 646.0, 'unit': 'M', 'net_profit': -114.0}, {'period': ""Q2 '24"", 'revenue': 514.0, 'unit': 'M', 'net_profit': -227.0}, {'period': ""Q1 '24"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '23"", 'revenue': 1810.0, 'unit': 'M', 'net_profit': 569.0}, {'period': ""Q3 '23"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': 70.0}]",-4.55,-4.55,27894000000,1997000000,317000000,10329000000,1226000000,0,3123000000,317000000,8000000,-0.7870682392586352,-1.295163290615957,-1.2498627127951676,__nan__,__nan__,__nan__,0.3702946870294687
81,CHKEZ,Chesapeake Energy Corporation Class B Warrants,"Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. The company holds interests in natural gas resource plays, including the Marcellus in Northern Appalachian Basin in Pennsylvania; Haynesville located in Northwestern Louisiana; Eagle Ford in South Texas; Brazos Valley in Southeast Texas; Powder River Basin in Wyoming; and Mid-Continent in Anadarko Basin of northwestern Oklahoma. As of December 31, 2019, it owned interests in approximately 13,500 oil and natural gas wells; and had estimated proved reserves of 1,572 one million barrels of oil equivalent. The company was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.",Mr. Domenic J. Dell'Osso Jr.,Oil & Gas Exploration & Production,64.04,USD,8407608465,https://images.financialmodelingprep.com/symbol/CHKEZ.png,338,0,2.04,100,1018000000,-714000000,"[{'period': '2024', 'revenue': 4220.0, 'unit': 'M', 'net_profit': -714.0}, {'period': '2023', 'revenue': 7.78, 'unit': 'B', 'net_profit': 2.42}, {'period': '2022', 'revenue': 11.44, 'unit': 'B', 'net_profit': 4.94}, {'period': '2021', 'revenue': 7.3, 'unit': 'B', 'net_profit': 6.33}]","[{'period': ""Q4 '24"", 'revenue': 2000.0, 'unit': 'M', 'net_profit': -399.0}, {'period': ""Q3 '24"", 'revenue': 646.0, 'unit': 'M', 'net_profit': -114.0}, {'period': ""Q2 '24"", 'revenue': 503.0, 'unit': 'M', 'net_profit': -227.0}, {'period': ""Q1 '24"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '23"", 'revenue': 1810.0, 'unit': 'M', 'net_profit': 569.0}, {'period': ""Q3 '23"", 'revenue': 1410.0, 'unit': 'M', 'net_profit': 70.0}]",-5.403,-5.016,27894000000,1997000000,317000000,10329000000,1226000000,0,3123000000,317000000,8000000,-0.785999579566954,-1.295163290615957,0,__nan__,__nan__,__nan__,0.3702946870294687
82,CHKP,Check Point Software Technologies Ltd. Ordinary Shares,"Check Point Software Technologies Ltd. develops, markets, and supports a range of products and services for IT security worldwide. The company offers a portfolio of network security, endpoint security, data security, and management solutions. It provides Check Point Infinity Architecture, a cyber security architecture that protects against 5th and 6th generation cyber-attacks across various networks, endpoint, cloud, workloads, Internet of Things, and mobile. The company also offers security gateways and software platforms that support small and medium sized business (SMB) to large enterprise data center and telco-grade environments; and threat prevention technologies and zero-day protections. In addition, the company provides cloud network security, security and posture management, cloud workload protection, and cloud web application protection for web applications and APIs; and Check Point Harmony that delivers endpoint and secure connectivity for remote user access. Further, the company provides technical customer support programs and plans; professional services in implementing, upgrading, and optimizing Check Point products comprising design planning and security implementation; and certification and educational training services on Check Point products. It sells its products through multiple distribution channels, including distributors, resellers, system integrators, original equipment manufacturers, and managed security service providers. Check Point Software Technologies Ltd. was incorporated in 1993 and is headquartered in Tel Aviv, Israel.",Brig.Gen. Nadav  Zafrir,Software - Infrastructure,207.36,USD,22471296307,https://images.financialmodelingprep.com/symbol/CHKP.png,1055519,27.8,-7.6,742765,934600000,845700000,"[{'period': '2024', 'revenue': 2560.0, 'unit': 'M', 'net_profit': 845.7}, {'period': '2023', 'revenue': 2410.0, 'unit': 'M', 'net_profit': 840.3}, {'period': '2022', 'revenue': 2330.0, 'unit': 'M', 'net_profit': 796.9}, {'period': '2021', 'revenue': 2170.0, 'unit': 'M', 'net_profit': 815.6}]","[{'period': ""Q4 '24"", 'revenue': 703.7, 'unit': 'M', 'net_profit': 257.5}, {'period': ""Q3 '24"", 'revenue': 635.1, 'unit': 'M', 'net_profit': 206.9}, {'period': ""Q2 '24"", 'revenue': 627.4, 'unit': 'M', 'net_profit': 197.4}, {'period': ""Q1 '24"", 'revenue': 598.8, 'unit': 'M', 'net_profit': 183.9}, {'period': ""Q4 '23"", 'revenue': 663.5, 'unit': 'M', 'net_profit': 249.2}, {'period': ""Q3 '23"", 'revenue': 596.3, 'unit': 'M', 'net_profit': 205.0}]",7.65,7.46,5743400000,2193400000,1371900000,2954000000,728800000,1411900000,1944200000,506200000,1034599999,-0.08641251221896383,0.006426276329882185,0.06397774687065368,__nan__,__nan__,__nan__,0.5143294912421214
83,CHMA,Chiasma Inc. Common Stock,"Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.",Mr. Raj Kannan,Biotechnology,3.76,USD,0,https://images.financialmodelingprep.com/symbol/CHMA.png,996380,-2.390336935791481,-0.24000001,8196718,-68651000,-74779000,"[{'period': '2020', 'revenue': 1.11, 'unit': 'M', 'net_profit': -74.78}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.32}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.26}, {'period': '2017', 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.83}]","[{'period': ""Q1 '21"", 'revenue': 1.92, 'unit': 'M', 'net_profit': -30.55}, {'period': ""Q4 '20"", 'revenue': 0.964, 'unit': 'M', 'net_profit': -19.81}, {'period': ""Q3 '20"", 'revenue': 0.14200000000000002, 'unit': 'M', 'net_profit': -18.46}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.13}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.39}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.05}]",-1.43,-1.43,176338000,153358000,135421000,84553000,538000,0,16731000,15462000,-75698000,-0.9260724405914205,-1.0588931718061674,-0.3490566037735848,__nan__,__nan__,__nan__,0.47949392643672945
84,CHMG,Chemung Financial Corp Common Stock,"Chemung Financial Corporation operates as the holding company for Chemung Canal Trust Company that provides a range of banking, financing, fiduciary, and other financial services. The company provides demand, savings, and time deposits; non-interest and interest-bearing checking accounts; and insured money market accounts. It also offers commercial and agricultural loans comprising loans to small to mid-sized businesses; commercial mortgage loans; residential mortgage loans; consumer loans, including home equity lines of credit and home equity term loans; and interest rate swaps, letters of credit, wealth management, employee benefit plans, mutual fund, insurance products, and brokerage services. Further, it provides securities, insurance, and tax preparation services. Additionally, it offers guardian, custodian, and trustee services, as well as acts as an agent for pension, profit-sharing, and other employee benefit trusts; and various investment, pension, estate planning, and employee benefit administrative services. The company operates 31 branch offices located in 13 counties in New York and Bradford County in Pennsylvania. Chemung Financial Corporation was founded in 1833 and is headquartered in Elmira, New York.",Mr. Anders M. Tomson,Banks - Regional,42.14,USD,201803361,https://images.financialmodelingprep.com/symbol/CHMG.png,17640,8.5,-0.37,5252,0,23671000,"[{'period': '2024', 'revenue': 96.11, 'unit': 'M', 'net_profit': 23.67}, {'period': '2023', 'revenue': 95.74, 'unit': 'M', 'net_profit': 25.0}, {'period': '2022', 'revenue': 94.61, 'unit': 'M', 'net_profit': 28.78}, {'period': '2021', 'revenue': 88.42, 'unit': 'M', 'net_profit': 26.43}]","[{'period': ""Q4 '24"", 'revenue': 32.6, 'unit': 'M', 'net_profit': 5.91}, {'period': ""Q3 '24"", 'revenue': 32.36, 'unit': 'M', 'net_profit': 5.72}, {'period': ""Q2 '24"", 'revenue': 36.96, 'unit': 'M', 'net_profit': 4.99}, {'period': ""Q1 '24"", 'revenue': 36.73, 'unit': 'M', 'net_profit': 7.05}, {'period': ""Q4 '23"", 'revenue': 35.7, 'unit': 'M', 'net_profit': 3.8}, {'period': ""Q3 '23"", 'revenue': 25.58, 'unit': 'M', 'net_profit': 7.65}]",4.96,4.96,2776147000,591637000,591637000,2560838000,0,0,109110000,47035000,26189000,-1,-0.05316,-0.060606060606060656,"[0.32, 0.24]","['2025-03-18', '1995-03-17']",__nan__,0.9224432279702768
85,CHNG,Change Healthcare Inc. Common Stock,"Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for revenue cycle management, provider network management, payment accuracy, clinical decision support, value-based payment, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. The Network Solutions segment provides solutions for financial, administrative, and clinical and pharmacy transactions; connected consumer health; network; electronic payments; data; pharmacy; and aggregation and analytics of clinical and financial data. The Technology-Enabled Services segment offers solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration, and healthcare consulting. The company serves commercial insurers, private insurers, BlueCross Blue Shield plans, Medicare/Medicaid plans, provider-sponsored payers, third party administrators, emerging technology and data-driven health plans, and other specialty health benefits insurers, as well as hospitals and health systems, physician practices, dentists, pharmacies, skilled nursing facilities, home health agencies, telehealth providers, senior care facilities, laboratories, and other healthcare providers. Change Healthcare Inc. was incorporated in 2016 and is headquartered in Nashville, Tennessee.",Mr. Neil E. de Crescenzo IV,Medical - Healthcare Information Services,27.49,USD,0,https://images.financialmodelingprep.com/symbol/CHNG.png,0,-152.72222222222223,0.07,28984942,907273000,-154612000,"[{'period': '2022', 'revenue': 3480.0, 'unit': 'M', 'net_profit': -154.61}, {'period': '2021', 'revenue': 3090.0, 'unit': 'M', 'net_profit': -112.21}, {'period': '2020', 'revenue': 196.79, 'unit': 'M', 'net_profit': -947.6}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.01}]","[{'period': ""Q1 '23"", 'revenue': 884.47, 'unit': 'M', 'net_profit': -41.79}, {'period': ""Q4 '22"", 'revenue': 920.13, 'unit': 'M', 'net_profit': -19.51}, {'period': ""Q3 '22"", 'revenue': 866.07, 'unit': 'M', 'net_profit': -24.47}, {'period': ""Q2 '22"", 'revenue': 826.76, 'unit': 'M', 'net_profit': -36.4}, {'period': ""Q1 '22"", 'revenue': 867.86, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q4 '21"", 'revenue': 855.16, 'unit': 'M', 'net_profit': -13.09}]",-0.48,-0.48,9932495000,1312907000,252298000,6656388000,720122000,-563606000000,1079666000,252298000,420602000,-0.3668358085837371,-0.3778807592906158,-0.37142857142857144,"[2, 2]","['2022-09-30', '2022-09-30']",__nan__,0.6701627335327126
86,CHNGU,Change Healthcare Inc. Tangible Equity Units,,None,Medical - Healthcare Information Services,73.71,USD,0,https://images.financialmodelingprep.com/symbol/CHNGU.png,39262,0,0,275964,907273000,-154612000,"[{'period': '2022', 'revenue': 3480.0, 'unit': 'M', 'net_profit': -154.61}, {'period': '2021', 'revenue': 3090.0, 'unit': 'M', 'net_profit': -112.21}, {'period': '2020', 'revenue': 196.79, 'unit': 'M', 'net_profit': -947.6}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.01}]","[{'period': ""Q1 '23"", 'revenue': 884.47, 'unit': 'M', 'net_profit': -41.79}, {'period': ""Q4 '22"", 'revenue': 920.13, 'unit': 'M', 'net_profit': -19.51}, {'period': ""Q3 '22"", 'revenue': 866.07, 'unit': 'M', 'net_profit': -24.47}, {'period': ""Q2 '22"", 'revenue': 826.76, 'unit': 'M', 'net_profit': -36.4}, {'period': ""Q1 '22"", 'revenue': 867.86, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q4 '21"", 'revenue': 855.16, 'unit': 'M', 'net_profit': -13.09}]",-0.48,-0.48,9932495000,1312907000,252298000,6656388000,720122000,-563606000000,1079666000,252298000,420602000,-0.3668358085837371,-0.3778807592906158,-0.37142857142857144,"[0.75, 0.742]","['2022-06-14', '2019-09-13']",__nan__,0.6701627335327126
87,CHNR,China Natural Resources Inc. Common Stock,"China Natural Resources, Inc., through its subsidiaries, engages in the exploration and mining of metal properties in the People's Republic of China. It explores for lead, silver, and other nonferrous metals. The company holds interest in the Moruogu Tong mine that covers an area of 7.81 square kilometers located in Bayannaoer City, Inner Mongolia. It also offers equipment for rural wastewater treatment; and engineering, procurement, and construction services related to wastewater treatment. The company was incorporated in 1993 and is headquartered in Sheung Wan, Hong Kong. China Natural Resources, Inc. is a subsidiary of Feishang Group Limited.",Mr. Wah On  Wong,Waste Management,0.47,USD,4636910,https://images.financialmodelingprep.com/symbol/CHNR.png,53265,-11.75,-0.029,23646,-12340000,-12443000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.44}, {'period': '2022', 'revenue': 20.31, 'unit': 'M', 'net_profit': -22.3}, {'period': '2021', 'revenue': 18.73, 'unit': 'M', 'net_profit': -54.97}, {'period': '2020', 'revenue': 6.87, 'unit': 'M', 'net_profit': 24.34}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -61.0}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -61.0}, {'period': ""Q2 '23"", 'revenue': 1.76, 'unit': 'M', 'net_profit': -1.55}, {'period': ""Q1 '23"", 'revenue': 6.11, 'unit': 'M', 'net_profit': -5.37}, {'period': ""Q4 '22"", 'revenue': 0.6063500000000001, 'unit': 'M', 'net_profit': -3.81}, {'period': ""Q3 '22"", 'revenue': 2.12, 'unit': 'M', 'net_profit': -13.29}]",-0.68,-1.01,253807000,5878000,4756000,177812000,3000,0,177812000,4753000,13316000,0.4896186615931839,0.4419178327951202,0.9500367376928729,__nan__,__nan__,__nan__,0.7005795742434212
88,CHPM,CHP Merger Corp. Class A Common Stock,"CHP Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses with a focus on the healthcare sector. The company was incorporated in 2019 and is based in Summit, New Jersey.",Mr. James T. Olsen,Shell Companies,10.18,USD,0,https://images.financialmodelingprep.com/symbol/CHPM.png,114092,10.241448692152918,-0.00999928,87931,22287767,48112294,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 48.11}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': 959.91}]","[{'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.27}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.61}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 36.41}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -133.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 400.86}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 751.95}]",1.28,1.28,188792288,401198,98614,25697392,0,0,4253225,98614,-1769146,5.7102804329211825,49.12151517897976,48.99999999999999,__nan__,__nan__,__nan__,0.13611462773309893
89,CHPMW,CHP Merger Corp. Warrant,,None,Shell Companies,0.0041,USD,0,https://images.financialmodelingprep.com/symbol/CHPMW.png,0,0,0.0003,665347,22287767,48112294,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 48.11}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': 959.91}]","[{'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.27}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.61}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 36.41}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -133.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 400.86}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 751.95}]",1.28,1.28,188792288,401198,98614,25697392,0,0,4253225,98614,-1769146,5.7102804329211825,49.12151517897976,48.99999999999999,__nan__,__nan__,__nan__,0.13611462773309893
90,CHRS,Coherus BioSciences Inc. Common Stock,"Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; and CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.",Mr. Dennis M. Lanfear,Biotechnology,1.06,USD,122850661,https://images.financialmodelingprep.com/symbol/CHRS.png,2017783,4.24,-0.06,1588543,60941000,28507000,"[{'period': '2024', 'revenue': 266.96, 'unit': 'M', 'net_profit': 28.51}, {'period': '2023', 'revenue': 257.24, 'unit': 'M', 'net_profit': -237.89}, {'period': '2022', 'revenue': 211.04, 'unit': 'M', 'net_profit': -326.63}, {'period': '2021', 'revenue': 326.55, 'unit': 'M', 'net_profit': -306.32}]","[{'period': ""Q4 '24"", 'revenue': 54.14, 'unit': 'M', 'net_profit': -50.7}, {'period': ""Q3 '24"", 'revenue': 70.77, 'unit': 'M', 'net_profit': -10.75}, {'period': ""Q2 '24"", 'revenue': 64.98, 'unit': 'M', 'net_profit': -12.92}, {'period': ""Q1 '24"", 'revenue': 77.06, 'unit': 'M', 'net_profit': 102.88}, {'period': ""Q4 '23"", 'revenue': 91.52, 'unit': 'M', 'net_profit': -79.65}, {'period': ""Q3 '23"", 'revenue': 74.57, 'unit': 'M', 'net_profit': -39.64}]",0.25,0.25,448533000,341583000,125987000,580523000,122334000,0,282981000,125987000,-20440000,1.3142276695249537,1.1198316883291577,1.098814229249012,__nan__,__nan__,__nan__,1.2942704327217842
91,CHRW,C.H. Robinson Worldwide Inc. Common Stock,"C.H. Robinson Worldwide, Inc., together with its subsidiaries, provides freight transportation services and logistics solutions to companies in various industries worldwide. The company operates in two segments, North American Surface Transportation and Global Forwarding. It offers transportation and logistics services, such as truckload; less than truckload transportation brokerage services, which include the shipment of single or multiple pallets of freight; intermodal transportation that comprise the shipment service of freight in containers or trailers by a combination of truck and rail; and non-vessel ocean common carrier and freight forwarding services, as well as organizes air shipments and provides door-to-door services. The company also offers customs broker services; and other logistics services, such as fee-based managed, warehousing, small parcel, and other services. It has contractual relationships with approximately 85,000 transportation companies, including motor carriers, railroads, and air and ocean carriers. In addition, the company is involved in buying, selling, and/or marketing of fresh produce, including fresh fruits, vegetables, and other value-added perishable items under the Robinson Fresh name. Further, it provides transportation management services or managed TMS; and other surface transportation services. The company offers its fresh produce to grocery retailers, restaurants, produce wholesalers, and foodservice distributors through a network of independent produce growers and suppliers. C.H. Robinson Worldwide, Inc. was founded in 1905 and is headquartered in Eden Prairie, Minnesota.",Mr. David P. Bozeman,Integrated Freight & Logistics,89.27,USD,10554126075,https://images.financialmodelingprep.com/symbol/CHRW.png,1450165,23.13,-1.87,908302,766301000,465690000,"[{'period': '2024', 'revenue': 17720.0, 'unit': 'M', 'net_profit': 465.69}, {'period': '2023', 'revenue': 17600.0, 'unit': 'M', 'net_profit': 325.13}, {'period': '2022', 'revenue': 24700.0, 'unit': 'M', 'net_profit': 940.52}, {'period': '2021', 'revenue': 23100.0, 'unit': 'M', 'net_profit': 844.25}]","[{'period': ""Q4 '24"", 'revenue': 4180.0, 'unit': 'M', 'net_profit': 149.31}, {'period': ""Q3 '24"", 'revenue': 4640.0, 'unit': 'M', 'net_profit': 97.23}, {'period': ""Q2 '24"", 'revenue': 4480.0, 'unit': 'M', 'net_profit': 126.25}, {'period': ""Q1 '24"", 'revenue': 4410.0, 'unit': 'M', 'net_profit': 92.9}, {'period': ""Q4 '23"", 'revenue': 4220.0, 'unit': 'M', 'net_profit': 30.97}, {'period': ""Q3 '23"", 'revenue': 4340.0, 'unit': 'M', 'net_profit': 81.95}]",3.89,3.86,5297926000,2969603000,145762000,3575875000,2383709000,0,2324898000,145762000,486431000,0.24887710400396354,0.4323237853282851,0.4197080291970802,"[0.62, 0.06]","['2025-03-07', '1997-12-10']",__nan__,0.6749575211129789
92,CHSCL,CHS Inc Class B Cumulative Redeemable Preferred Stock Series 4,"CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Energy, Ag, Nitrogen Production, and Foods. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, refined and renewable fuels, and propane, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; manufactures, packages, and distributes vegetable oil-based products, such as packaged oils, margarine, mayonnaise, flavored dressings, sauces, and other food products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services. CHS Inc. was incorporated in 1936 and is headquartered in Inver Grove Heights, Minnesota.",Mr. Jay D. Debertin,Agricultural Farm Products,25.3864,USD,331166578,https://images.financialmodelingprep.com/symbol/CHSCL.png,39749,,0.0264,34780,1683575000,1102319000,"[{'period': '2024', 'revenue': 39.26, 'unit': 'B', 'net_profit': 1.1}, {'period': '2023', 'revenue': 45.59, 'unit': 'B', 'net_profit': 1.73}, {'period': '2022', 'revenue': 47.79, 'unit': 'B', 'net_profit': 1.68}, {'period': '2021', 'revenue': 38450.0, 'unit': 'M', 'net_profit': 553.95}]","[{'period': ""Q2 '25"", 'revenue': 7800.0, 'unit': 'M', 'net_profit': -75.75}, {'period': ""Q1 '25"", 'revenue': 9290.0, 'unit': 'M', 'net_profit': 244.79}, {'period': ""Q4 '24"", 'revenue': 9170.0, 'unit': 'M', 'net_profit': 111.81}, {'period': ""Q3 '24"", 'revenue': 9610.0, 'unit': 'M', 'net_profit': 255.11}, {'period': ""Q2 '24"", 'revenue': 9090.0, 'unit': 'M', 'net_profit': 170.31}, {'period': ""Q1 '24"", 'revenue': 11390.0, 'unit': 'M', 'net_profit': 522.92}]",0,0,18715075000,8708783000,1374783000,7225008000,3549917000,3878192000,5400814000,794865000,441369000,-0.35491157298772796,-0.3634726320469808,0,"[0.46875, 0.37]","['2025-06-13', '2015-03-13']",__nan__,0.386052847771115
93,CHSCM,CHS Inc Class B Reset Rate Cumulative Redeemable Preferred Stock Series 3,"CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Energy, Ag, Nitrogen Production, and Foods. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, refined and renewable fuels, and propane, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; manufactures, packages, and distributes vegetable oil-based products, such as packaged oils, margarine, mayonnaise, flavored dressings, sauces, and other food products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services. CHS Inc. was incorporated in 1936 and is headquartered in Inver Grove Heights, Minnesota.",Mr. Jay D. Debertin,Agricultural Farm Products,24.11,USD,331069358,https://images.financialmodelingprep.com/symbol/CHSCM.png,24591,,-0.19,51874,1683575000,1102319000,"[{'period': '2024', 'revenue': 39.26, 'unit': 'B', 'net_profit': 1.1}, {'period': '2023', 'revenue': 45.59, 'unit': 'B', 'net_profit': 1.73}, {'period': '2022', 'revenue': 47.79, 'unit': 'B', 'net_profit': 1.68}, {'period': '2021', 'revenue': 38450.0, 'unit': 'M', 'net_profit': 553.95}]","[{'period': ""Q2 '25"", 'revenue': 7800.0, 'unit': 'M', 'net_profit': -75.75}, {'period': ""Q1 '25"", 'revenue': 9290.0, 'unit': 'M', 'net_profit': 244.79}, {'period': ""Q4 '24"", 'revenue': 9170.0, 'unit': 'M', 'net_profit': 111.81}, {'period': ""Q3 '24"", 'revenue': 9610.0, 'unit': 'M', 'net_profit': 255.11}, {'period': ""Q2 '24"", 'revenue': 9090.0, 'unit': 'M', 'net_profit': 170.31}, {'period': ""Q1 '24"", 'revenue': 11390.0, 'unit': 'M', 'net_profit': 522.92}]",0,0,18715075000,8708783000,1374783000,7225008000,3549917000,3878192000,5400814000,794865000,441369000,-0.35491157298772796,-0.3634726320469808,0,"[0.42188, 0.497]","['2025-06-13', '2014-12-15']",__nan__,0.386052847771115
94,CHSCN,CHS Inc Preferred Class B Series 2 Reset Rate,"CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Energy, Ag, Nitrogen Production, and Foods. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, refined and renewable fuels, and propane, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; manufactures, packages, and distributes vegetable oil-based products, such as packaged oils, margarine, mayonnaise, flavored dressings, sauces, and other food products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services. CHS Inc. was incorporated in 1936 and is headquartered in Inver Grove Heights, Minnesota.",Mr. Jay D. Debertin,Agricultural Farm Products,24.86,USD,331210750,https://images.financialmodelingprep.com/symbol/CHSCN.png,20831,,-0.09,24521,1683575000,1102319000,"[{'period': '2024', 'revenue': 39.26, 'unit': 'B', 'net_profit': 1.1}, {'period': '2023', 'revenue': 45.59, 'unit': 'B', 'net_profit': 1.73}, {'period': '2022', 'revenue': 47.79, 'unit': 'B', 'net_profit': 1.68}, {'period': '2021', 'revenue': 38450.0, 'unit': 'M', 'net_profit': 553.95}]","[{'period': ""Q2 '25"", 'revenue': 7800.0, 'unit': 'M', 'net_profit': -75.75}, {'period': ""Q1 '25"", 'revenue': 9290.0, 'unit': 'M', 'net_profit': 244.79}, {'period': ""Q4 '24"", 'revenue': 9170.0, 'unit': 'M', 'net_profit': 111.81}, {'period': ""Q3 '24"", 'revenue': 9610.0, 'unit': 'M', 'net_profit': 255.11}, {'period': ""Q2 '24"", 'revenue': 9090.0, 'unit': 'M', 'net_profit': 170.31}, {'period': ""Q1 '24"", 'revenue': 11390.0, 'unit': 'M', 'net_profit': 522.92}]",0,0,18715075000,8708783000,1374783000,7225008000,3549917000,3878192000,5400814000,794865000,441369000,-0.35491157298772796,-0.3634726320469808,0,"[0.44375, 0.404]","['2025-06-13', '2014-06-12']",__nan__,0.386052847771115
95,CHSCO,CHS Inc. Class B Cumulative Redeemable Preferred Stock,"CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Energy, Ag, Nitrogen Production, and Foods. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, refined and renewable fuels, and propane, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; manufactures, packages, and distributes vegetable oil-based products, such as packaged oils, margarine, mayonnaise, flavored dressings, sauces, and other food products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services. CHS Inc. was incorporated in 1936 and is headquartered in Inver Grove Heights, Minnesota.",Mr. Jay D. Debertin,Agricultural Farm Products,26.09,USD,347430746,https://images.financialmodelingprep.com/symbol/CHSCO.png,29926,,0.08,11301,1683575000,1102319000,"[{'period': '2024', 'revenue': 39.26, 'unit': 'B', 'net_profit': 1.1}, {'period': '2023', 'revenue': 45.59, 'unit': 'B', 'net_profit': 1.73}, {'period': '2022', 'revenue': 47.79, 'unit': 'B', 'net_profit': 1.68}, {'period': '2021', 'revenue': 38450.0, 'unit': 'M', 'net_profit': 553.95}]","[{'period': ""Q2 '25"", 'revenue': 7800.0, 'unit': 'M', 'net_profit': -75.75}, {'period': ""Q1 '25"", 'revenue': 9290.0, 'unit': 'M', 'net_profit': 244.79}, {'period': ""Q4 '24"", 'revenue': 9170.0, 'unit': 'M', 'net_profit': 111.81}, {'period': ""Q3 '24"", 'revenue': 9610.0, 'unit': 'M', 'net_profit': 255.11}, {'period': ""Q2 '24"", 'revenue': 9090.0, 'unit': 'M', 'net_profit': 170.31}, {'period': ""Q1 '24"", 'revenue': 11390.0, 'unit': 'M', 'net_profit': 522.92}]",0,0,18715075000,8708783000,1374783000,7225008000,3549917000,3878192000,5400814000,794865000,441369000,-0.35491157298772796,-0.3634726320469808,0,"[0.49219, 0.492]","['2025-06-13', '2013-12-12']",__nan__,0.386052847771115
96,CHSCP,CHS Inc. 8%  Cumulative Redeemable Preferred Stock,"CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Energy, Ag, Nitrogen Production, and Foods. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, refined and renewable fuels, and propane, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; manufactures, packages, and distributes vegetable oil-based products, such as packaged oils, margarine, mayonnaise, flavored dressings, sauces, and other food products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services. CHS Inc. was incorporated in 1936 and is headquartered in Inver Grove Heights, Minnesota.",Mr. Jay D. Debertin,Agricultural Farm Products,27.05,USD,331957600,https://images.financialmodelingprep.com/symbol/CHSCP.png,18763,,0.05,10996,1683575000,1102319000,"[{'period': '2024', 'revenue': 39.26, 'unit': 'B', 'net_profit': 1.1}, {'period': '2023', 'revenue': 45.59, 'unit': 'B', 'net_profit': 1.73}, {'period': '2022', 'revenue': 47.79, 'unit': 'B', 'net_profit': 1.68}, {'period': '2021', 'revenue': 38450.0, 'unit': 'M', 'net_profit': 553.95}]","[{'period': ""Q2 '25"", 'revenue': 7800.0, 'unit': 'M', 'net_profit': -75.75}, {'period': ""Q1 '25"", 'revenue': 9290.0, 'unit': 'M', 'net_profit': 244.79}, {'period': ""Q4 '24"", 'revenue': 9170.0, 'unit': 'M', 'net_profit': 111.81}, {'period': ""Q3 '24"", 'revenue': 9610.0, 'unit': 'M', 'net_profit': 255.11}, {'period': ""Q2 '24"", 'revenue': 9090.0, 'unit': 'M', 'net_profit': 170.31}, {'period': ""Q1 '24"", 'revenue': 11390.0, 'unit': 'M', 'net_profit': 522.92}]",0,0,18715075000,8708783000,1374783000,7225008000,3549917000,3878192000,5400814000,794865000,441369000,-0.35491157298772796,-0.3634726320469808,0,"[0.5, 0.5]","['2025-06-13', '2003-06-13']",__nan__,0.386052847771115
97,CHTR,Charter Communications Inc. Class A Common Stock New,"Charter Communications, Inc. operates as a broadband connectivity and cable operator company serving residential and commercial customers in the United States. The company offers subscription-based video services, including video on demand, high-definition television, digital video recorder, pay-per-view services. It provides Internet services, such as security suite that protects computers from viruses and spyware, and threats from malicious actors; in-home WiFi, which provides customers with high performance wireless routers to enhance their in-home wireless Internet experience; out-of-home WiFi; and Spectrum WiFi services, as well as video services. The company also offers voice communications services using voice over Internet protocol technology; and broadband communications solutions, such as Internet access, data networking, fiber connectivity, video entertainment, and business telephone services to cellular towers and office buildings for business and carrier organizations. In addition, it provides mobile services; offers video programming, static IP and business WiFi, email and security, and multi-line telephone services, as well as Web-based service management; sells local advertising across various platforms for networks, such as TBS, CNN, and ESPN; sells advertising inventory to local sports and news channels; and offers Audience App for optimizes linear inventory. Further, the company offers communications products and managed service solutions; data connectivity services to mobile and wireline carriers on a wholesale basis; and owns and operates regional sports and news networks. It serves approximately 32 million customers in 41 states. The company was founded in 1993 and is headquartered in Stamford, Connecticut.",Mr. Christopher L. Winfrey,Telecommunications Services,322.43,USD,45768293640,https://images.financialmodelingprep.com/symbol/CHTR.png,1310757,9.22,-16.53,1219169,21404000000,5083000000,"[{'period': '2024', 'revenue': 55.09, 'unit': 'B', 'net_profit': 5.08}, {'period': '2023', 'revenue': 54.61, 'unit': 'B', 'net_profit': 4.56}, {'period': '2022', 'revenue': 54.02, 'unit': 'B', 'net_profit': 5.05}, {'period': '2021', 'revenue': 51.68, 'unit': 'B', 'net_profit': 4.65}]","[{'period': ""Q4 '24"", 'revenue': 13.93, 'unit': 'B', 'net_profit': 1.47}, {'period': ""Q3 '24"", 'revenue': 13.79, 'unit': 'B', 'net_profit': 1.28}, {'period': ""Q2 '24"", 'revenue': 13.69, 'unit': 'B', 'net_profit': 1.23}, {'period': ""Q1 '24"", 'revenue': 13.68, 'unit': 'B', 'net_profit': 1.11}, {'period': ""Q4 '23"", 'revenue': 13.71, 'unit': 'B', 'net_profit': 1.06}, {'period': ""Q3 '23"", 'revenue': 13.58, 'unit': 'B', 'net_profit': 1.25}]",35.53,34.97,150020000000,4233000000,459000000,130313000000,3097000000,0,13486000000,459000000,3161000000,0.032114958048027775,0.11542681588764538,0.16339227242960058,__nan__,__nan__,__nan__,0.8686375149980002
98,CHUY,Chuy's Holdings Inc. Common Stock,"Chuy's Holdings, Inc., through its subsidiaries, owns and operates full-service restaurants under the Chuy's name in the United States. As of December 26, 2021, it operated 96 restaurants in 17 states, including the Southeastern and Midwestern United States. The company was founded in 1982 and is headquartered in Austin, Texas.",Mr. Steven J. Hislop,Restaurants,37.48,USD,645874100,https://images.financialmodelingprep.com/symbol/CHUY.png,468834,24.18064516129032,0.01,999863,68111000,31510000,"[{'period': '2023', 'revenue': 461.31, 'unit': 'M', 'net_profit': 31.51}, {'period': '2022', 'revenue': 422.21, 'unit': 'M', 'net_profit': 20.86}, {'period': '2021', 'revenue': 396.47, 'unit': 'M', 'net_profit': 30.18}, {'period': '2020', 'revenue': 320.95, 'unit': 'M', 'net_profit': -3.29}]","[{'period': ""Q2 '24"", 'revenue': 119.8, 'unit': 'M', 'net_profit': 7.41}, {'period': ""Q1 '24"", 'revenue': 110.46, 'unit': 'M', 'net_profit': 6.92}, {'period': ""Q4 '23"", 'revenue': 116.35, 'unit': 'M', 'net_profit': 5.48}, {'period': ""Q3 '23"", 'revenue': 113.46, 'unit': 'M', 'net_profit': 7.07}, {'period': ""Q2 '23"", 'revenue': 119.0, 'unit': 'M', 'net_profit': 10.73}, {'period': ""Q1 '23"", 'revenue': 112.5, 'unit': 'M', 'net_profit': 8.22}]",1.77,1.76,476634000,80370000,67774000,226787000,3284000,0,48766000,67774000,20473000,0.2858410420993015,0.5109086549988012,0.5803571428571427,__nan__,__nan__,__nan__,0.47580953100282397
99,CHW,Calamos Global Dynamic Income Fund Common Stock,"Calamos Global Dynamic Income Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The fund is managed by Calamos Advisors LLC. It invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in growth stocks of companies across all market capitalizations, as well as in higher yield corporate bonds, government bonds, convertibles, and alternative investments such as arbitrage and call writes. The fund employs both fundamental and quantitative analysis, focusing on such factors as source, sustainability, and risk of investment opportunities to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Index and Merrill Lynch Global Broad Markets Index. The fund was formerly known as Calamos Global Diversified Income & Opportunities Fund. Calamos Global Dynamic Income Fund was formed on April 10, 2007 and is domiciled in the United States.",Mr. John Peter Calamos Sr.,Asset Management - Income,5.98,USD,381719103,https://images.financialmodelingprep.com/symbol/CHW.png,224904,2.57,-0.05,152725,0,148775830,"[{'period': '2024', 'revenue': 149.86, 'unit': 'M', 'net_profit': 148.78}, {'period': '2023', 'revenue': 31.16, 'unit': 'M', 'net_profit': 30.08}, {'period': '2022', 'revenue': -195.99, 'unit': 'M', 'net_profit': -197.49}, {'period': '2021', 'revenue': 177.05, 'unit': 'M', 'net_profit': 175.66}]","[{'period': ""Q2 '24"", 'revenue': 49.08, 'unit': 'M', 'net_profit': 94.64}, {'period': ""Q4 '23"", 'revenue': 30.97, 'unit': 'M', 'net_profit': -17.57}, {'period': ""Q2 '23"", 'revenue': 1.07, 'unit': 'M', 'net_profit': 47.65}, {'period': ""Q4 '22"", 'revenue': -23.94, 'unit': 'M', 'net_profit': -71.86}, {'period': ""Q2 '22"", 'revenue': 40.47, 'unit': 'M', 'net_profit': -125.63}, {'period': ""Q4 '21"", 'revenue': 22.89, 'unit': 'M', 'net_profit': 32.19}]",2.33,2.33,760309835,14967,14967,266976769,6639674,731384974,0,14967,-8120750,-1,3.9455666595507193,3.957446808510639,"[0.05, 0.11]","['2025-04-11', '2007-08-09']",__nan__,0.3511420696011383
100,CHX,ChampionX Corporation Common Stock ,"ChampionX Corporation provides chemistry solutions, and engineered equipment and technologies to oil and gas companies worldwide. The company's Production Chemical Technologies segment offers onshore and offshore chemical solutions, such as corrosion inhibitors, scale inhibitors, emulsion breakers, and biocides to oil and natural gas production and midstream markets to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment, and water-related issues. The company's Production & Automation Technologies segment provides artificial lift equipment, end-to-end automation and digital solutions, and other production equipment, including electrical submersible pumping systems, gas lift systems, jet pumps, multiplex surface pumps, plunger lift equipment, progressive cavity pumping systems, downhole rod lift systems, emissions monitoring solutions, chemical injection systems, flow control valves, and gauges under the Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, and Windrock brands. The company's Drilling Technologies segment offers polycrystalline diamond cutter inserts, bearings, valves, and mining tools under the US Synthetic brand for use in oil and gas drill bits, renewable energy applications, mixers, and agitators; and high-density ceramic roof bolt mining tools for underground mining operations. The company's Reservoir Chemical Technologies segment provides chemistry-oriented solutions and technologies for well drilling, cementing, fracturing, acidizing, and other well interventions, as well as fracturing fluid packages, drilling and cement additives, and products for acidizing activities. ChampionX Corporation is headquartered in The Woodlands, Texas.",Mr. Sivasankaran  Somasundaram,Oil & Gas Equipment & Services,24.99,USD,4768092000,https://images.financialmodelingprep.com/symbol/CHX.png,4656614,15.15,-0.42,2070613,744568000,320266000,"[{'period': '2024', 'revenue': 3630.0, 'unit': 'M', 'net_profit': 320.27}, {'period': '2023', 'revenue': 3760.0, 'unit': 'M', 'net_profit': 314.24}, {'period': '2022', 'revenue': 3810.0, 'unit': 'M', 'net_profit': 154.97}, {'period': '2021', 'revenue': 3070.0, 'unit': 'M', 'net_profit': 113.3}]","[{'period': ""Q4 '24"", 'revenue': 912.04, 'unit': 'M', 'net_profit': 82.77}, {'period': ""Q3 '24"", 'revenue': 906.53, 'unit': 'M', 'net_profit': 72.01}, {'period': ""Q2 '24"", 'revenue': 893.27, 'unit': 'M', 'net_profit': 52.57}, {'period': ""Q1 '24"", 'revenue': 922.14, 'unit': 'M', 'net_profit': 112.92}, {'period': ""Q4 '23"", 'revenue': 943.55, 'unit': 'M', 'net_profit': 77.2}, {'period': ""Q3 '23"", 'revenue': 939.78, 'unit': 'M', 'net_profit': 77.71}]",1.68,1.65,3470252000,1563897000,507681000,1639074000,466782000,0,785872000,507681000,448371000,0.035048015169123495,0.01918291231486962,0.049999999999999906,"[0.095, 0.075]","['2025-04-04', '2022-04-07']",__nan__,0.4723213184518012
101,CHY,Calamos Convertible and High Income Fund Common Stock,"Calamos Convertible and High Income Fund is a closed ended fixed income mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in the fixed income markets of the United States. It primarily invests in a diversified portfolio of convertible securities and high yield corporate bonds rated Ba or lower by Moody's or BB or lower by Standard & Poor's. The fund employs both fundamental and quantitative analysis to create its portfolio. Calamos Convertible and High Income Fund was formed on March 12, 2003 and is domiciled in the United States.",Mr. John Peter Calamos Sr.,Asset Management - Income,9.67,USD,735005483,https://images.financialmodelingprep.com/symbol/CHY.png,281511,4.13,-0.2,284495,0,178731198,"[{'period': '2024', 'revenue': 179.45, 'unit': 'M', 'net_profit': 178.73}, {'period': '2023', 'revenue': -8.88, 'unit': 'M', 'net_profit': -9.61}, {'period': '2022', 'revenue': -324.71, 'unit': 'M', 'net_profit': -325.57}, {'period': '2021', 'revenue': 317.51, 'unit': 'M', 'net_profit': 316.68}]","[{'period': ""Q2 '24"", 'revenue': 14.06, 'unit': 'M', 'net_profit': 107.85}, {'period': ""Q4 '23"", 'revenue': -139.33, 'unit': 'M', 'net_profit': -31.53}, {'period': ""Q2 '23"", 'revenue': 69.57, 'unit': 'M', 'net_profit': 21.92}, {'period': ""Q4 '22"", 'revenue': 11.17, 'unit': 'M', 'net_profit': -97.56}, {'period': ""Q2 '22"", 'revenue': 89.95, 'unit': 'M', 'net_profit': -228.01}, {'period': ""Q4 '21"", 'revenue': 11.43, 'unit': 'M', 'net_profit': 59.12}]",2.33,2.33,1314506363,0,0,494924155,11472767,1274581172,0,0,95171811,1,19.595845474793293,18.923076923076923,"[0.1, 0.1219]","['2025-04-11', '2003-08-14']",__nan__,0.3765095163712037
102,CIDM,Cinedigm Corp. Class A Common Stock,"Cinedigm Corp., together with its subsidiaries, operates as distributor and aggregator of independent movie, television, and other short form content in the United States. The company operates through two segments, Cinema Equipment Business and Content and Entertainment Business. The company distributes its products for various brands, such as Hallmark, Televisa, ITV, Nelvana, ZDF, Konami, NFL, and NHL, as well as international and domestic content creators, movie producers, television producers, and other short form digital content producers. It also collaborates with producers, various brands, and other content owners to market, source, curate, and distribute content to targeted audiences through existing and emerging digital home entertainment platforms, including Apple, Amazon Prime, Netflix, Hulu, Xbox, Tubi, PlutoTV, Vudu, and cable/satellite video-on-demand; and distributes DVD and Blu-ray discs to wholesalers and retailers with sales coverage to approximately 48,000 retail storefronts, including Walmart, Target, Best Buy, and Amazon. In addition, the company operates various branded and curated over-the-top (OTT) entertainment channels and applications, including Docurama, CONtv, Dove Channel, Viewster Anime, Fandor, and Screambox; and Matchpoint, a software-as-a-service platform to automate the distribution of streaming content and OTT channels. Further, it provides monitoring, billing, collection, and verification support services to music and movie screens as well as directly to exhibitors and other third-party customers. The company was formerly known as Cinedigm Digital Cinema Corp. and changed its name to Cinedigm Corp. in September 2013. Cinedigm Corp. was incorporated in 2000 and is headquartered in New York, New York.",Mr. Christopher J. McGurk,Entertainment,0.2945,USD,55046470,https://images.financialmodelingprep.com/symbol/CIDM.png,681225,-4.908333333333333,0.0025,1093691,-2628000,-9694000,"[{'period': '2023', 'revenue': 68.03, 'unit': 'M', 'net_profit': -9.69}, {'period': '2022', 'revenue': 56.05, 'unit': 'M', 'net_profit': 1.65}, {'period': '2021', 'revenue': 31.42, 'unit': 'M', 'net_profit': -62.91}, {'period': '2020', 'revenue': 39.29, 'unit': 'M', 'net_profit': -14.72}]","[{'period': ""Q3 '24"", 'revenue': 13.28, 'unit': 'M', 'net_profit': -2.86}, {'period': ""Q2 '24"", 'revenue': 13010.0, 'unit': 'K', 'net_profit': -445.0}, {'period': ""Q1 '24"", 'revenue': 12.98, 'unit': 'M', 'net_profit': -3.64}, {'period': ""Q4 '23"", 'revenue': 12.55, 'unit': 'M', 'net_profit': -3.07}, {'period': ""Q3 '23"", 'revenue': 27.88, 'unit': 'M', 'net_profit': 5.01}, {'period': ""Q2 '23"", 'revenue': 14.01, 'unit': 'M', 'net_profit': -6.24}]",-1.09,-1.09,87988000,37577000,7152000,48915000,25387000,5200000,45331000,7152000,-10068000,-1.4424987371611382,-6.864488808227465,-6.45,__nan__,__nan__,__nan__,0.5559280811019685
103,CIGI,Colliers International Group Inc. Subordinate Voting Shares,"Colliers International Group Inc. provides commercial real estate professional and investment management services to corporate and institutional clients in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers sales brokerage services, including real estate sales, debt origination and placement, equity capital raising, market value opinions, acquisition advisory, and transaction management services; and landlord and tenant representation services. The company provides outsourcing and advisory services, such as corporate and workplace solutions; valuation and advisory services; workplace strategy services; loan servicing; property marketing; research services; and engineering design services for property and building, infrastructure, transportation, environmental and telecommunications end-markets. It also offers property management services comprising building operations and maintenance, facilities management, lease administration, property accounting and financial reporting, contract management and, construction management; and project management services, which include bid document review, construction monitoring and delivery management, contract administration and integrated cost control, development management, facility and engineering functionality, milestone and performance monitoring, quality assurance, risk management and strategic project consulting. In addition, the company provides investment management services that consists of asset management advisory and administration, transaction, and incentive services. The company was founded in 1972 and is headquartered in Toronto, Canada.",Mr. Jay Stewart Hennick CM,Real Estate - Services,111.2,USD,5480489776,https://images.financialmodelingprep.com/symbol/CIGI.png,138672,34.53,-2.86,93551,618494000,161725000,"[{'period': '2024', 'revenue': 4820.0, 'unit': 'M', 'net_profit': 161.72}, {'period': '2023', 'revenue': 4340.0, 'unit': 'M', 'net_profit': 65.54}, {'period': '2022', 'revenue': 4460.0, 'unit': 'M', 'net_profit': 194.54}, {'period': '2021', 'revenue': 4090.0, 'unit': 'M', 'net_profit': -237.56}]","[{'period': ""Q4 '24"", 'revenue': 1500.0, 'unit': 'M', 'net_profit': 75.12}, {'period': ""Q3 '24"", 'revenue': 1180.0, 'unit': 'M', 'net_profit': 37.23}, {'period': ""Q2 '24"", 'revenue': 1140.0, 'unit': 'M', 'net_profit': 36.72}, {'period': ""Q1 '24"", 'revenue': 997.5, 'unit': 'M', 'net_profit': 12.66}, {'period': ""Q4 '23"", 'revenue': 1270.0, 'unit': 'M', 'net_profit': 67.43}, {'period': ""Q3 '23"", 'revenue': 1060.0, 'unit': 'M', 'net_profit': 25.11}]",3.21,3.18,6100617000,1599384000,224830000,3622417000,998269000,62159000,1508041000,176257000,-58326000,0.21418559453463948,1.4674641075324597,1.2765957446808511,"[0.15, 5]","['2024-12-31', '2007-07-23']",__nan__,0.5937787931941966
104,CIH,China Index Holdings Limited American Depository Shares,"China Index Holdings Limited, together with its subsidiaries, operates a real estate information and analytics service platform in China. The company offers promotion services, including number of online and offline themed campaigns, such as industry forums, periodic updates, and online promotions to its customers to promote their brands. It provides listing services comprising commercial property listing and agent services for commercial properties; access and analytics tools, including appraisal and rating, and land modules, based on proprietary database of commercial real estate information; customized research reports; and data monitoring and survey services. The company serves real estate developers, commercial banks and other financial institutions, academic institutions, property managers, brokers, agents, consultants, and other participants in real estate related business. The company was formerly known as Selovo Investments Limited and changed its name to China Index Holdings Limited. China Index Holdings Limited was incorporated in 2007 and is based in Beijing, China.",Ms. Yu  Huang,Software - Application,0.9477,USD,85696152,https://images.financialmodelingprep.com/symbol/CIH.png,54746,2.7077142857142857,0,228927,306775000,279182000,"[{'period': '2021', 'revenue': 620.95, 'unit': 'M', 'net_profit': 279.18}, {'period': '2020', 'revenue': 635.91, 'unit': 'M', 'net_profit': 294.34}, {'period': '2019', 'revenue': 579.65, 'unit': 'M', 'net_profit': 245.45}, {'period': '2018', 'revenue': 421.02, 'unit': 'M', 'net_profit': 165.42}]","[{'period': ""Q3 '22"", 'revenue': 97.67, 'unit': 'M', 'net_profit': 27.6}, {'period': ""Q2 '22"", 'revenue': 110.22, 'unit': 'M', 'net_profit': 21.13}, {'period': ""Q1 '22"", 'revenue': 118.51, 'unit': 'M', 'net_profit': 41.83}, {'period': ""Q4 '21"", 'revenue': 173.78, 'unit': 'M', 'net_profit': 82.51}, {'period': ""Q3 '21"", 'revenue': 160.78, 'unit': 'M', 'net_profit': 72.86}, {'period': ""Q2 '21"", 'revenue': 152.66, 'unit': 'M', 'net_profit': 67.37}]",3.1,3.08,480797000,436269000,361521000,469942000,49217000,0,365084000,361521000,214329000,2.350378779541943,-0.051495044829261497,-0.05487804878048772,__nan__,__nan__,__nan__,0.9774229040530619
105,CINF,Cincinnati Financial Corporation Common Stock,"Cincinnati Financial Corporation, together with its subsidiaries, provides property casualty insurance products in the United States. The company operates through five segments: Commercial Lines Insurance, Personal Lines Insurance, Excess and Surplus Lines Insurance, Life Insurance, and Investments. The Commercial Lines Insurance segment offers coverage for commercial casualty, commercial property, commercial auto, and workers' compensation. It also provides director and officer liability insurance, contract and commercial surety bonds, and fidelity bonds; and machinery and equipment coverage. The Personal Lines Insurance segment offers personal auto insurance; homeowner insurance; and dwelling fire, inland marine, personal umbrella liability, and watercraft coverages to individuals. The Excess and Surplus Lines Insurance segment offers commercial casualty insurance that covers businesses for third-party liability from accidents occurring on their premises or arising out of their operations, such as injuries sustained from products; and commercial property insurance, which insures buildings, inventory, equipment, and business income from loss or damage due to various causes, such as fire, wind, hail, water, theft, and vandalism. The Life Insurance segment provides term life insurance products; universal life insurance products; worksite products, such as term life; and whole life insurance products. The Investments segment invests in fixed-maturity investments, including taxable and tax-exempt bonds, and redeemable preferred stocks; and equity investments comprising common and nonredeemable preferred stocks. The company also offers commercial leasing and financing services; and insurance brokerage services. Cincinnati Financial Corporation was founded in 1950 and is headquartered in Fairfield, Ohio.",Mr. Stephen Michael Spray,Insurance - Property & Casualty,127.72,USD,19991245280,https://images.financialmodelingprep.com/symbol/CINF.png,859932,8.79,-4.52,448518,3041000000,2292000000,"[{'period': '2024', 'revenue': 11.34, 'unit': 'B', 'net_profit': 2.29}, {'period': '2023', 'revenue': 10.01, 'unit': 'B', 'net_profit': 1.84}, {'period': '2022', 'revenue': 6560.0, 'unit': 'M', 'net_profit': -487.0}, {'period': '2021', 'revenue': 9.63, 'unit': 'B', 'net_profit': 2.97}]","[{'period': ""Q4 '24"", 'revenue': 2540.0, 'unit': 'M', 'net_profit': 405.0}, {'period': ""Q3 '24"", 'revenue': 3320.0, 'unit': 'M', 'net_profit': 820.0}, {'period': ""Q2 '24"", 'revenue': 2540.0, 'unit': 'M', 'net_profit': 312.0}, {'period': ""Q1 '24"", 'revenue': 2940.0, 'unit': 'M', 'net_profit': 755.0}, {'period': ""Q4 '23"", 'revenue': 3.36, 'unit': 'B', 'net_profit': 1.18}, {'period': ""Q3 '23"", 'revenue': 1810.0, 'unit': 'M', 'net_profit': -99.0}]",14.65,14.53,36501000000,983000000,983000000,22566000000,0,27665000000,850000000,983000000,2649000000,0.2452907452907453,0.24362452523060227,0.24787052810902896,"[0.87, 4.1887]","['2025-03-24', '1984-12-20']",__nan__,0.6182296375441769
106,CIVB,Civista Bancshares Inc. Common Stock,"Civista Bancshares, Inc. operates as the financial holding company for Civista Bank that provides community banking services. It collects a range of customer deposits; and offers commercial and agriculture, commercial and residential real estate, farm real estate, real estate construction, consumer, and other loans, as well as letters of credit. The company also purchases securities; and provides trust and third-party insurance services. It operates approximately 42 locations in Northern, Central, Southwestern, and Northwestern Ohio, as well as Southeastern Indiana and Northern Kentucky. The company was formerly known as First Citizens Banc Corp and changed its name to Civista Bancshares, Inc. in May 2015. Civista Bancshares, Inc. was founded in 1884 and is headquartered in Sandusky, Ohio.",Mr. Dennis G. Shaffer,Banks - Regional,19.93,USD,313628445,https://images.financialmodelingprep.com/symbol/CIVB.png,42393,9.92,0.07,41943,0,31683000,"[{'period': '2024', 'revenue': 151.91, 'unit': 'M', 'net_profit': 31.68}, {'period': '2023', 'revenue': 158.22, 'unit': 'M', 'net_profit': 42.96}, {'period': '2022', 'revenue': 137.03, 'unit': 'M', 'net_profit': 39.43}, {'period': '2021', 'revenue': 124.56, 'unit': 'M', 'net_profit': 40.55}]","[{'period': ""Q4 '24"", 'revenue': 39.7, 'unit': 'M', 'net_profit': 9.89}, {'period': ""Q3 '24"", 'revenue': 62.43, 'unit': 'M', 'net_profit': 8.19}, {'period': ""Q2 '24"", 'revenue': 61.14, 'unit': 'M', 'net_profit': 7.06}, {'period': ""Q1 '24"", 'revenue': 58.63, 'unit': 'M', 'net_profit': 6.36}, {'period': ""Q4 '23"", 'revenue': 57.42, 'unit': 'M', 'net_profit': 9.65}, {'period': ""Q3 '23"", 'revenue': 39.01, 'unit': 'M', 'net_profit': 10.39}]",2.06,2.06,4098469000,8879000,8879000,3709967000,58992000,680840000,339000000,64605000,48246000,0,-0.26256866213574154,-0.2454212454212454,"[0.17, 0.14]","['2025-04-29', '1997-01-16']",__nan__,0.9052080179208383
107,CIZN,Citizens Holding Company Common Stock,"Citizens Holding Company operates as the bank holding company for The Citizens Bank of Philadelphia that provides various commercial and personal banking products and services. It offers demand deposits; and savings and time deposit accounts. The company also provides secured and unsecured loans; mortgage loans; single and multi-family housing, farm, residential and commercial construction, and commercial real estate loans; commercial, industrial, and agricultural production loans; and consumer loans, as well as issues letters of credit. In addition, it offers personal and corporate trust services; credit life and title insurance; and online and mobile banking services. The company was founded in 1908 and is headquartered in Philadelphia, Mississippi.",Mr. Stacy M. Brantley,Banks - Regional,7.04,USD,39684902,https://images.financialmodelingprep.com/symbol/CIZN.png,3452,21.33,-0.06,100,0,1854000,"[{'period': '2023', 'revenue': 37.66, 'unit': 'M', 'net_profit': 1.85}, {'period': '2022', 'revenue': 44.97, 'unit': 'M', 'net_profit': 9.62}, {'period': '2021', 'revenue': 45.68, 'unit': 'M', 'net_profit': 7.49}, {'period': '2020', 'revenue': 43.59, 'unit': 'M', 'net_profit': 6.93}]","[{'period': ""Q4 '23"", 'revenue': 8029.999999999999, 'unit': 'K', 'net_profit': -793.0}, {'period': ""Q3 '23"", 'revenue': 10.62, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q2 '23"", 'revenue': 9680.0, 'unit': 'K', 'net_profit': 300.0}, {'period': ""Q1 '23"", 'revenue': 10.04, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q4 '22"", 'revenue': 11.31, 'unit': 'M', 'net_profit': 2.46}, {'period': ""Q3 '22"", 'revenue': 0.20500000000000002, 'unit': 'M', 'net_profit': 2.58}]",0.33,0.33,1404597000,277502000,272271000,1361824000,5231000,565594000,0,94476000,4805000,0,-0.8072765072765072,-0.8092485549132947,"[0.02, 0.2551]","['2025-03-21', '1999-12-13']",__nan__,0.9695478489559639
108,CJJD,China Jo-Jo Drugstores Inc. Common Stock,"China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.",Mr. Lei  Liu M.D.,Medical - Pharmaceuticals,1.52,USD,9947169,https://images.financialmodelingprep.com/symbol/CJJD.png,418361,-0.459214501510574,-0.09,5862,1226845,-4234228,"[{'period': '2024', 'revenue': 154.54, 'unit': 'M', 'net_profit': -4.23}, {'period': '2023', 'revenue': 148.81, 'unit': 'M', 'net_profit': -21.14}, {'period': '2022', 'revenue': 164.39, 'unit': 'M', 'net_profit': -3.2}, {'period': '2021', 'revenue': 133.13, 'unit': 'M', 'net_profit': -8.38}]","[{'period': ""Q2 '25"", 'revenue': 35.58, 'unit': 'M', 'net_profit': -1.14}, {'period': ""Q1 '25"", 'revenue': 35.58, 'unit': 'M', 'net_profit': -1.14}, {'period': ""Q4 '24"", 'revenue': 37.98, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q3 '24"", 'revenue': 37.98, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q2 '24"", 'revenue': 39290.0, 'unit': 'K', 'net_profit': -462.12}, {'period': ""Q1 '24"", 'revenue': 39290.0, 'unit': 'K', 'net_profit': -462.12}]",-2.93,-2.93,95057090,69682362,20149806,80763953,19075498,1195261,74360095,20149806,-4079077,1.061464000966314,0.799693804423974,0.9293294741919923,__nan__,__nan__,__nan__,0.8496362869934267
109,CKPT,Checkpoint Therapeutics Inc. Common Stock,"Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has collaboration agreements with TG Therapeutics, Inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.","Mr. James F. Oliviero III, C.F.A.",Biotechnology,4.04,USD,348732800,https://images.financialmodelingprep.com/symbol/CKPT.png,2663281,-2.85,0,855938,-56174000,-56240000,"[{'period': '2024', 'revenue': 0.041, 'unit': 'M', 'net_profit': -56.24}, {'period': '2023', 'revenue': 0.10300000000000001, 'unit': 'M', 'net_profit': -51.85}, {'period': '2022', 'revenue': 0.192, 'unit': 'M', 'net_profit': -66.92}, {'period': '2021', 'revenue': 0.268, 'unit': 'M', 'net_profit': -56.62}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.9}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.72}, {'period': ""Q2 '24"", 'revenue': 0.041, 'unit': 'M', 'net_profit': -6.67}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.95}, {'period': ""Q4 '23"", 'revenue': 0.006, 'unit': 'M', 'net_profit': -19.13}, {'period': ""Q3 '23"", 'revenue': 0.031, 'unit': 'M', 'net_profit': -5.72}]",-1.42,-1.42,7471000,7471000,6604000,20096000,0,0,20096000,6604000,-31101000,-0.07720334432768275,-0.08473007117094528,0.4873646209386282,__nan__,__nan__,__nan__,2.6898674876187925
110,CLAR,Clarus Corporation Common Stock,"Clarus Corporation develops, manufactures, and distributes outdoor equipment and lifestyle products focusing on the outdoor and consumer markets in the United States, Canada, Europe, the Middle East, Asia, Australia, New Zealand, Africa, and South America. Its Outdoor segment offers activity-based apparel, such as shells, insulation, midlayers, pants, and logowear; rock-climbing footwear and equipment, including carabiners, protection devices, harnesses, belay devices, helmets, and ice-climbing gears; technical backpacks and day packs; trekking poles; headlamps and lanterns; gloves and mittens; skincare and other products; and skis, ski poles, ski skins, and snow safety products, such as avalanche airbag systems, avalanche transceivers, shovels, and probes. This segment offers its products for climbing, mountaineering, trail running, backpacking, skiing, and other outdoor recreation activities under the Black Diamond Equipment, PIEPS, and SKINourishment brands. The company's Precision Sport segment manufactures bullets and ammunition products for precision target shooting, hunting, and military and law enforcement purposes under the Sierra and Barnes brands. The company sells its products to mountain, rock, ice, and gym climbers; and winter outdoor enthusiasts, trail runners, backpackers, competitive shooters, hunters, and outdoor consumers. Its Adventure segment offers engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, and accessories under the Rhino-Rack brand; and overlanding and off-road vehicle recovery and extraction tracks for the overland and the off-road market under the MAXTRAX brand. It markets and distributes its products through independent specialty stores and specialty chains, sporting goods and outdoor recreation stores, distributors, and original equipment manufacturers; and independent distributors, as well as through its websites. The company was incorporated in 1991 and is headquartered in Salt Lake City, Utah.",Mr. Warren B. Kanders,Leisure,3.32,USD,127362384,https://images.financialmodelingprep.com/symbol/CLAR.png,165196,-1.44,0.06,295929,-9353000,-52287000,"[{'period': '2024', 'revenue': 264.31, 'unit': 'M', 'net_profit': -52.29}, {'period': '2023', 'revenue': 286.02, 'unit': 'M', 'net_profit': -10.15}, {'period': '2022', 'revenue': 448.11, 'unit': 'M', 'net_profit': -69.78}, {'period': '2021', 'revenue': 375.79, 'unit': 'M', 'net_profit': 26.09}]","[{'period': ""Q4 '24"", 'revenue': 71.41, 'unit': 'M', 'net_profit': -65.52}, {'period': ""Q3 '24"", 'revenue': 67.11, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q2 '24"", 'revenue': 56.35, 'unit': 'M', 'net_profit': -5.49}, {'period': ""Q1 '24"", 'revenue': 69.25, 'unit': 'M', 'net_profit': 21.88}, {'period': ""Q4 '23"", 'revenue': 4.83, 'unit': 'M', 'net_profit': -8.39}, {'period': ""Q3 '23"", 'revenue': 100.08, 'unit': 'M', 'net_profit': -1.26}]",-1.37,-1.37,294094000,177780000,45359000,61001000,43678000,0,36037000,45359000,-14039000,-7.260374832663989,-4.153459491425192,-4.074074074074074,"[0.025, 0.025]","['2025-03-17', '2018-08-17']",__nan__,0.20742007657415656
111,CLBK,Columbia Financial Inc. Common Stock,"Columbia Financial, Inc., a bank holding company, provides financial services to businesses and consumers in the United States. The company offers non-interest-bearing demand deposits, such as individual and commercial checking accounts; interest bearing demand accounts comprising interest earning checking accounts and municipal accounts; and savings and club accounts, money market accounts, and certificates of deposit. It also provides loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family residential loans, construction loans, home equity loans and advances, and other consumer loans that include automobiles and personal loans, as well as unsecured and overdraft lines of credit. In addition, the company offers title insurance products; wealth management services; and cash management services, including remote deposit, lockbox service, and sweep accounts. As of December 31, 2021, it operated 62 full-service banking offices in 12 of New Jersey's 21 counties; and 2 branch offices in Freehold, New Jersey. The company was founded in 1927 and is headquartered in Fair Lawn, New Jersey. Columbia Financial, Inc. is a subsidiary of Columbia Bank MHC.",Mr. Thomas J. Kemly,Banks - Regional,13.07,USD,1368822734,https://images.financialmodelingprep.com/symbol/CLBK.png,148518,-118.82,-0.21,181868,0,-11653000,"[{'period': '2024', 'revenue': 451.43, 'unit': 'M', 'net_profit': -11.65}, {'period': '2023', 'revenue': 233.25, 'unit': 'M', 'net_profit': 36.09}, {'period': '2022', 'revenue': 297.18, 'unit': 'M', 'net_profit': 86.17}, {'period': '2021', 'revenue': 271.96, 'unit': 'M', 'net_profit': 92.05}]","[{'period': ""Q4 '24"", 'revenue': 22.71, 'unit': 'M', 'net_profit': -21.22}, {'period': ""Q3 '24"", 'revenue': 54.25, 'unit': 'M', 'net_profit': 6.18}, {'period': ""Q2 '24"", 'revenue': 122.36, 'unit': 'M', 'net_profit': 4.54}, {'period': ""Q1 '24"", 'revenue': 115.73, 'unit': 'M', 'net_profit': -1.16}, {'period': ""Q4 '23"", 'revenue': 118.35, 'unit': 'M', 'net_profit': 6.57}, {'period': ""Q3 '23"", 'revenue': 57.12, 'unit': 'M', 'net_profit': 9.13}]",-0.11,-0.11,10475493000,8186576000,289223000,9395117000,7897353000,0,0,289113000,-1359000,1,-1.3229230172366016,-1.3142857142857143,__nan__,__nan__,__nan__,0.8968663336417675
112,CLBS,Caladrius Biosciences Inc. Common Stock,"Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.",Dr. David Mazzo,Biotechnology,0.4264,USD,3351368,https://images.financialmodelingprep.com/symbol/CLBS.png,0,-1.0822335025380712,-0.08579999,26946654,-28919000,-27466000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.47}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.14}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.36}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.17}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.63}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.23}, {'period': ""Q4 '21"", 'revenue': 125.59, 'unit': 'M', 'net_profit': -6.79}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.93}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.68}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.06}]",-1.78,-1.78,97008000,94970000,95121000,5008000,0,0,4523000,94970000,-22305000,-0.5253441637217153,-2.3737870040535562,-2.3584905660377355,"[0.0021, 0.0002]","['2013-10-28', '2011-04-04']",__nan__,0.051624608279729506
113,CLDB,Cortland Bancorp Common Stock,"Cortland Bancorp, Inc. is a bank holding company, which provides commercial and retail banking services through its subsidiary, The Cortland Savings and Banking Company. The company is headquartered in Cortland, Ohio and currently employs 144 full-time employees. The firm's principal activity is to own, manage and supervise The Cortland Savings and Banking Company (Cortland Banks or the Bank). The firm operates through the commercial banking segment. The Bank is a state chartered bank engaged in commercial and retail banking. The Bank's services include checking accounts, savings accounts, time deposit accounts, commercial, mortgage and installment loans, night depository, automated teller services, safe deposit boxes and other miscellaneous services. The Bank provides brokerage and investment services through an arrangement with Investment Professionals, Inc. Under this arrangement, financial advisors offer customers a range of investment products and services, such as estate planning, annuities, life insurance, fixed income, and equity securities and equity research and recommendations. The Bank, through Investment Professionals, Inc., also offers asset management services to customers.",Mr. James Gasior,Banks - Regional,28.47,USD,0,https://images.financialmodelingprep.com/symbol/CLDB.png,7221,12.29805615550756,0.389999,206,16296000,8263000,"[{'period': '2020', 'revenue': 30.78, 'unit': 'M', 'net_profit': 8.26}, {'period': '2019', 'revenue': 29.11, 'unit': 'M', 'net_profit': 7.28}, {'period': '2018', 'revenue': 29.06, 'unit': 'M', 'net_profit': 8.84}, {'period': '2017', 'revenue': 25.47, 'unit': 'M', 'net_profit': 4.35}]","[{'period': ""Q2 '21"", 'revenue': 7.68, 'unit': 'M', 'net_profit': 2.0}, {'period': ""Q1 '21"", 'revenue': 8.18, 'unit': 'M', 'net_profit': 2.77}, {'period': ""Q4 '20"", 'revenue': 8.53, 'unit': 'M', 'net_profit': 2.8}, {'period': ""Q3 '20"", 'revenue': 7.77, 'unit': 'M', 'net_profit': 2.16}, {'period': ""Q2 '20"", 'revenue': 7.33, 'unit': 'M', 'net_profit': 1.93}, {'period': ""Q1 '20"", 'revenue': 7.16, 'unit': 'M', 'net_profit': 1.37}]",1.97,1.97,821305000,9728000,203983000,740300000,0,167875000,5155000,36108000,9512000,-0.008638520501277528,0.13471573743477067,0.17261904761904764,"[0.15, 0.29135]","['2021-08-06', '1999-12-08']",__nan__,0.9013703800658708
114,CLDX,Celldex Therapeutics Inc.,"Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.",Mr. Anthony S. Marucci M.B.A.,Biotechnology,18.94,USD,1257309361,https://images.financialmodelingprep.com/symbol/CLDX.png,814411,-7.73,0.64,541848,-191901000,-157863000,"[{'period': '2024', 'revenue': 7.02, 'unit': 'M', 'net_profit': -157.86}, {'period': '2023', 'revenue': 6.88, 'unit': 'M', 'net_profit': -141.43}, {'period': '2022', 'revenue': 2.36, 'unit': 'M', 'net_profit': -122.78}, {'period': '2021', 'revenue': 4.65, 'unit': 'M', 'net_profit': -70.51}]","[{'period': ""Q4 '24"", 'revenue': 1.18, 'unit': 'M', 'net_profit': -47.09}, {'period': ""Q3 '24"", 'revenue': 3.19, 'unit': 'M', 'net_profit': -42.12}, {'period': ""Q2 '24"", 'revenue': 2.5, 'unit': 'M', 'net_profit': -35.84}, {'period': ""Q1 '24"", 'revenue': 0.156, 'unit': 'M', 'net_profit': -32.81}, {'period': ""Q4 '23"", 'revenue': 4.13, 'unit': 'M', 'net_profit': -43.31}, {'period': ""Q3 '23"", 'revenue': 1.52, 'unit': 'M', 'net_profit': -38.26}]",-2.45,-2.45,792340000,747159000,725281000,45335000,700000,0,39501000,28356000,-157778000,-0.38024511989872983,-0.11619964787985491,0.16095890410958896,__nan__,__nan__,__nan__,0.057216598934800716
115,CLEU,China Liberal Education Holdings Limited Ordinary Shares,"China Liberal Education Holdings Limited provides educational services and products under the China Liberal brand name in the People's Republic of China. The company offers Sino-foreign jointly managed academic programs, including undergraduate and postgraduate education; and diploma and non-degree higher education, and senior secondary education programs in the areas of languages, liberal arts, and businesses. It also provides overseas study consulting and technological consulting services for Chinese universities to enhance their campus information and data management system, as well as to optimize their teaching, operating, and management environment. The company's consulting services include campus intranet solution buildout, school management software customization, smart devices, installation and testing, and school management data collection and analysis. In addition, it sells textbooks and other course materials, and AI-space products to students enrolled under the Sino-foreign Jointly Managed Academic Programs, as well as offers job readiness training to graduating students. The company was founded in 2011 and is headquartered in Beijing, the People's Republic of China.",Ms. Ngai Ngai  Lam,Education & Training Services,1.64,USD,5521167,https://images.financialmodelingprep.com/symbol/CLEU.png,20364547,,0.07,27423,-3458636,-4958744,"[{'period': '2023', 'revenue': 2.89, 'unit': 'M', 'net_profit': -4.96}, {'period': '2022', 'revenue': 11.6, 'unit': 'M', 'net_profit': -1.69}, {'period': '2021', 'revenue': 3.91, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 5.02, 'unit': 'M', 'net_profit': 1.21}]","[{'period': ""Q2 '24"", 'revenue': 0.8857999999999999, 'unit': 'M', 'net_profit': -4.72}, {'period': ""Q2 '23"", 'revenue': 9020.0, 'unit': 'K', 'net_profit': 376.21}, {'period': ""Q4 '22"", 'revenue': 8.87, 'unit': 'M', 'net_profit': -3.19}, {'period': ""Q2 '22"", 'revenue': 2.74, 'unit': 'M', 'net_profit': 1.5}, {'period': ""Q4 '21"", 'revenue': 2.06, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q2 '21"", 'revenue': 1850.0, 'unit': 'K', 'net_profit': 226.02}]",-1.65,-2.14,72801367,65594477,20337847,6264432,41453230,0,6231907,20337847,-3784615,-1.158676621299936,-1.9360738893826348,-0.14583333333333331,__nan__,__nan__,__nan__,0.08604827434078265
116,CLFD,Clearfield Inc. Common Stock,"Clearfield, Inc. manufactures, markets, and sells standard and custom passive connectivity products to the fiber-to-the-premises, enterprises, and original equipment manufacturers markets in the United States and internationally. The company offers FieldSmart, a series of panels, cabinets, wall boxes, and other enclosures. It also provides WaveSmart, which are optical components integrated for signal coupling, splitting, termination, multiplexing, demultiplexing, and attenuation for integration within its fiber management platform; and outdoor cabinet and fiber active cabinet products. The company offers StreetSmart, a portfolio of fiber management products; FieldShield, a fiber pathway and protection method for reducing the cost of broadband deployment; and YOURx platform that consists of hardened terminals, test access points, and various drop cable options for portions of the access network across various fiber drop cable media. It also provides CraftSmart, a line of optical protection field enclosures, including CraftSmart Fiber Protection Pedestals and CraftSmart Fiber Protection Vaults integrated solutions optimized to house FieldSmart products at the last mile access point of the network in above-grade or below-grade installations. The company offers fiber and copper assemblies with an industry-standard or customer-specified configuration; and designs and manufactures custom solutions for in-the-box and network connectivity assemblies specific to that customer's product line. It provides its fiber to anywhere platform for various incumbent local exchange carriers, competitive local exchange carriers, wireless operators, and multiple systems operators and cable TV companies, as well as the utility/municipality, enterprise, and data center markets. The company was formerly known as APA Enterprises, Inc. and changed its name to Clearfield, Inc. in January 2008. Clearfield, Inc. was founded in 1979 and is headquartered in Minneapolis, Minnesota.",Ms. Cheryl P. Beranek,Communication Equipment,25.97,USD,366996016,https://images.financialmodelingprep.com/symbol/CLFD.png,129465,-41.22,-0.54,95887,-8339000,-12453000,"[{'period': '2024', 'revenue': 166.71, 'unit': 'M', 'net_profit': -12.45}, {'period': '2023', 'revenue': 268.72, 'unit': 'M', 'net_profit': 32.53}, {'period': '2022', 'revenue': 270.88, 'unit': 'M', 'net_profit': 49.36}, {'period': '2021', 'revenue': 140.76, 'unit': 'M', 'net_profit': 20.33}]","[{'period': ""Q1 '25"", 'revenue': 35.48, 'unit': 'M', 'net_profit': -1.91}, {'period': ""Q4 '24"", 'revenue': 46770.0, 'unit': 'K', 'net_profit': -827.0}, {'period': ""Q3 '24"", 'revenue': 48790.0, 'unit': 'K', 'net_profit': -447.0}, {'period': ""Q2 '24"", 'revenue': 36.91, 'unit': 'M', 'net_profit': -5.91}, {'period': ""Q1 '24"", 'revenue': 34.23, 'unit': 'M', 'net_profit': -5.27}, {'period': ""Q4 '23"", 'revenue': 49.69, 'unit': 'M', 'net_profit': 2.7}]",-0.85,-0.85,315275000,229595000,130992000,39512000,21309000,24505000,24352000,16167000,12656000,-1.1924044207563278,-1.3827805612762425,-1.391705069124424,__nan__,__nan__,__nan__,0.1253255094758544
117,CLGN,CollPlant Biotechnologies Ltd American Depositary Shares,"CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.",Mr. Yehiel  Tal,Biotechnology,2.35,USD,26918103,https://images.financialmodelingprep.com/symbol/CLGN.png,7827,-1.62,-0.09,4821,-16213000,-16609000,"[{'period': '2024', 'revenue': 0.515, 'unit': 'M', 'net_profit': -16.61}, {'period': '2023', 'revenue': 10.96, 'unit': 'M', 'net_profit': -7.02}, {'period': '2022', 'revenue': 0.299, 'unit': 'M', 'net_profit': -16.75}, {'period': '2021', 'revenue': 15640.0, 'unit': 'K', 'net_profit': 409.0}]","[{'period': ""Q4 '24"", 'revenue': 0.164, 'unit': 'M', 'net_profit': -3.88}, {'period': ""Q3 '24"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -4.33}, {'period': ""Q2 '24"", 'revenue': 0.249, 'unit': 'M', 'net_profit': -4.21}, {'period': ""Q1 '24"", 'revenue': 0.098, 'unit': 'M', 'net_profit': -4.2}, {'period': ""Q4 '23"", 'revenue': 0.299, 'unit': 'M', 'net_profit': -4.69}, {'period': ""Q3 '23"", 'revenue': 0.043000000000000003, 'unit': 'M', 'net_profit': -4.38}]",-1.45,-1.45,18710000,13180000,11909000,5245000,583000,0,2970000,11909000,-14576000,-1.5293291731669267,-1.366291494514888,-1.3387096774193548,__nan__,__nan__,__nan__,0.28033137359700694
118,CLIR,ClearSign Technologies Corporation Common Stock,"ClearSign Technologies Corporation designs and develops products and technologies to enhance operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States and the People's Republic of China. Its ClearSign Core Burner Technology consists of an industrial burner body and a downstream porous ceramic structure or metal flame stabilizing device; ClearSign Core Plug & Play technology provides direct burner replacement for traditional refinery process heaters; and ClearSign Eye Flame Sensor, an electrical flame sensor for industrial applications. The company also provides ClearSign Core Boiler Burner; and ClearSign Core Flaring Burners technologies. It serves energy, institutional, commercial and industrial boiler, chemical, and petrochemical industries. The company was formerly known as ClearSign Combustion Corporation and changed its name ClearSign Technologies Corporation in November 2019. ClearSign Technologies Corporation was incorporated in 2008 and is headquartered in Tulsa, Oklahoma.",Dr. Colin James Deller Ph.D.,Industrial - Pollution & Treatment Controls,0.5899,USD,30921838,https://images.financialmodelingprep.com/symbol/CLIR.png,88860,-5.36,-0.0081,20349,-5552000,-5299000,"[{'period': '2024', 'revenue': 3.6, 'unit': 'M', 'net_profit': -5.3}, {'period': '2023', 'revenue': 2.4, 'unit': 'M', 'net_profit': -5.19}, {'period': '2022', 'revenue': 0.374, 'unit': 'M', 'net_profit': -5.4}, {'period': '2021', 'revenue': 0.607, 'unit': 'M', 'net_profit': -7.89}]","[{'period': ""Q4 '24"", 'revenue': 0.59, 'unit': 'M', 'net_profit': -1.16}, {'period': ""Q3 '24"", 'revenue': 1.86, 'unit': 'M', 'net_profit': -1.16}, {'period': ""Q2 '24"", 'revenue': 0.045, 'unit': 'M', 'net_profit': -1.87}, {'period': ""Q1 '24"", 'revenue': 1.1, 'unit': 'M', 'net_profit': -1.11}, {'period': ""Q4 '23"", 'revenue': 1270.0, 'unit': 'K', 'net_profit': -955.0}, {'period': ""Q3 '23"", 'revenue': 0.085, 'unit': 'M', 'net_profit': -1.33}]",-0.11,-0.11,15916000,14848000,14035000,2152000,359000,0,2039000,14035000,-4373000,0.02287926786342837,-0.02021563342318059,0.15384615384615388,__nan__,__nan__,__nan__,0.13520985172153807
119,CLLS,Cellectis S.A. American Depositary Shares,"Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leukemia. It is also developing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. The company has strategic alliances with Allogene Therapeutics, Inc.; Les Laboratoires Servier; The University of Texas M.D. Anderson Cancer Center; and Iovance Biotherapeutics, as well as a strategic research and development collaboration with Cytovia Therapeutics, Inc. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.",Dr. Andre  Choulika Ph.D.,Biotechnology,1.38,USD,138400200,https://images.financialmodelingprep.com/symbol/CLLS.png,357063,-3.37,-0.07,25768,-9462000,-36761000,"[{'period': '2024', 'revenue': 41.51, 'unit': 'M', 'net_profit': -36.76}, {'period': '2023', 'revenue': 0.755, 'unit': 'M', 'net_profit': -101.06}, {'period': '2022', 'revenue': 19.17, 'unit': 'M', 'net_profit': -98.69}, {'period': '2021', 'revenue': 73.95, 'unit': 'M', 'net_profit': -86.28}]","[{'period': ""Q4 '24"", 'revenue': 12.72, 'unit': 'M', 'net_profit': 5.92}, {'period': ""Q3 '24"", 'revenue': 16.2, 'unit': 'M', 'net_profit': -23.06}, {'period': ""Q2 '24"", 'revenue': 8.06, 'unit': 'M', 'net_profit': -25.27}, {'period': ""Q1 '24"", 'revenue': 4.53, 'unit': 'M', 'net_profit': 5.64}, {'period': ""Q4 '23"", 'revenue': 0.28300000000000003, 'unit': 'M', 'net_profit': -42.86}, {'period': ""Q3 '23"", 'revenue': 0.155, 'unit': 'M', 'net_profit': -17.48}]",-0.37,-0.37,383544000,287069000,260306000,252511000,23037000,7521000,166269000,143251000,19146000,0.8978582840364437,0.6362421951533263,0.7909604519774011,__nan__,__nan__,__nan__,0.6583625346765951
120,CLMT,Calumet Specialty Products Partners L.P. Common Units,"Calumet, Inc. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.",Mr. Louis Todd Borgmann,Oil & Gas Exploration & Production,9.22,USD,794829600,https://images.financialmodelingprep.com/symbol/CLMT.png,1402113,-3.45,-0.54,611728,164500000,-222000000,"[{'period': '2024', 'revenue': 4190.0, 'unit': 'M', 'net_profit': -222.0}, {'period': '2023', 'revenue': 4180.0, 'unit': 'M', 'net_profit': 48.1}, {'period': '2022', 'revenue': 4690.0, 'unit': 'M', 'net_profit': -171.8}, {'period': '2021', 'revenue': 3150.0, 'unit': 'M', 'net_profit': -260.1}]","[{'period': ""Q4 '24"", 'revenue': 949.5, 'unit': 'M', 'net_profit': -40.7}, {'period': ""Q3 '24"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': -100.6}, {'period': ""Q2 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': -38.3}, {'period': ""Q1 '24"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': -40.8}, {'period': ""Q4 '23"", 'revenue': 976.5, 'unit': 'M', 'net_profit': -47.0}, {'period': ""Q3 '23"", 'revenue': 2040.0, 'unit': 'M', 'net_profit': 103.1}]",-2.67,-2.67,2758200000,766000000,38100000,3224500000,278100000,0,863600000,38100000,-123100000,-0.606647537063606,-5.615384615384615,-5.525423728813559,"[0.685, 0.3]","['2016-01-29', '2006-04-28']",__nan__,1.1690595315785657
121,CLNE,Clean Energy Fuels Corp. Common Stock,"Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets and related fueling solutions, primarily in the United States and Canada. It supplies renewable natural gas (RNG), compressed natural gas (CNG), and liquefied natural gas (LNG) for medium and heavy-duty vehicles; and offers operation and maintenance services for public and private vehicle fleet customer stations. The company also designs, builds, operates, and maintains fueling stations; and sells and services compressors and other equipment that are used in RNG production and fueling stations. In addition, it transports and sells CNG, RNG, and LNG through virtual natural gas pipelines and interconnects; sells U.S. federal, state, and local government credits, such as RNG as a vehicle fuel, including Renewable Identification Numbers and Low Carbon Fuel Standards credits; and obtains federal, state, and local credits, grants, and incentives. Further, the company focuses on developing, owning, and operating dairy and other livestock waste RNG projects. It serves heavy-duty trucking, airports, refuse, public transit, industrial, and institutional energy users, as well as government fleets. As of December 31, 2021, the company served approximately 1,000 fleet customers operating approximately 48,000 vehicles; and owned, operated, or supplied approximately 548 fueling stations in 42 states in the United States and 25 fueling stations in Canada. Clean Energy Fuels Corp. was incorporated in 2001 and is headquartered in Newport Beach, California.",Mr. Andrew J. Littlefair,Oil & Gas Refining & Marketing,1.34,USD,300111251,https://images.financialmodelingprep.com/symbol/CLNE.png,2926816,-3.62,-0.06,2296831,-4081000,-83070000,"[{'period': '2024', 'revenue': 415.87, 'unit': 'M', 'net_profit': -83.07}, {'period': '2023', 'revenue': 425.16, 'unit': 'M', 'net_profit': -99.5}, {'period': '2022', 'revenue': 420.16, 'unit': 'M', 'net_profit': -59.59}, {'period': '2021', 'revenue': 255.65, 'unit': 'M', 'net_profit': -94.16}]","[{'period': ""Q4 '24"", 'revenue': 109.33, 'unit': 'M', 'net_profit': -30.16}, {'period': ""Q3 '24"", 'revenue': 104.88, 'unit': 'M', 'net_profit': -18.18}, {'period': ""Q2 '24"", 'revenue': 97.89, 'unit': 'M', 'net_profit': -16.29}, {'period': ""Q1 '24"", 'revenue': 102.09, 'unit': 'M', 'net_profit': -18.44}, {'period': ""Q4 '23"", 'revenue': 106.71, 'unit': 'M', 'net_profit': -18.69}, {'period': ""Q3 '23"", 'revenue': 95.57, 'unit': 'M', 'net_profit': -25.81}]",-0.37,-0.37,1243891000,413768000,219532000,524360000,122313000,265268000,154722000,89512000,-418000,0.8749157075619355,0.16510045529010925,0.1777777777777778,__nan__,__nan__,__nan__,0.42154819031571095
122,CLNN,Clene Inc. Common Stock,"Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.",Mr. Robert  Etherington MBA,Biotechnology,3.02,USD,26066749,https://images.financialmodelingprep.com/symbol/CLNN.png,48645,-0.53,0.02,60088,-33691000,-39400000,"[{'period': '2024', 'revenue': 0.342, 'unit': 'M', 'net_profit': -39.4}, {'period': '2023', 'revenue': 0.654, 'unit': 'M', 'net_profit': -49.5}, {'period': '2022', 'revenue': 0.47300000000000003, 'unit': 'M', 'net_profit': -15.28}, {'period': '2021', 'revenue': 0.723, 'unit': 'M', 'net_profit': -9.74}]","[{'period': ""Q4 '24"", 'revenue': 0.091, 'unit': 'M', 'net_profit': -13.55}, {'period': ""Q3 '24"", 'revenue': 0.08700000000000001, 'unit': 'M', 'net_profit': -7.99}, {'period': ""Q2 '24"", 'revenue': 0.091, 'unit': 'M', 'net_profit': -6.79}, {'period': ""Q1 '24"", 'revenue': 0.073, 'unit': 'M', 'net_profit': -11.08}, {'period': ""Q4 '23"", 'revenue': 0.17, 'unit': 'M', 'net_profit': -10.17}, {'period': ""Q3 '23"", 'revenue': 0.108, 'unit': 'M', 'net_profit': -2.42}]",-5.67,-5.67,27337000,16157000,12155000,36194000,391000,0,10291000,12155000,-21341000,0.22085520686385607,0.20410471881060116,0.3987274655355249,__nan__,__nan__,__nan__,1.323993122873761
123,CLNNW,Clene Inc. Warrant,"Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.",Mr. Robert  Etherington MBA,Biotechnology,0.032,USD,25894123,https://images.financialmodelingprep.com/symbol/CLNNW.png,10745.84,,-0.0034,6691,-33691000,-39400000,"[{'period': '2024', 'revenue': 0.342, 'unit': 'M', 'net_profit': -39.4}, {'period': '2023', 'revenue': 0.654, 'unit': 'M', 'net_profit': -49.5}, {'period': '2022', 'revenue': 0.47300000000000003, 'unit': 'M', 'net_profit': -15.28}, {'period': '2021', 'revenue': 0.723, 'unit': 'M', 'net_profit': -9.74}]","[{'period': ""Q4 '24"", 'revenue': 0.091, 'unit': 'M', 'net_profit': -13.55}, {'period': ""Q3 '24"", 'revenue': 0.08700000000000001, 'unit': 'M', 'net_profit': -7.99}, {'period': ""Q2 '24"", 'revenue': 0.091, 'unit': 'M', 'net_profit': -6.79}, {'period': ""Q1 '24"", 'revenue': 0.073, 'unit': 'M', 'net_profit': -11.08}, {'period': ""Q4 '23"", 'revenue': 0.17, 'unit': 'M', 'net_profit': -10.17}, {'period': ""Q3 '23"", 'revenue': 0.108, 'unit': 'M', 'net_profit': -2.42}]",-5.67,-5.67,27337000,16157000,12155000,36194000,391000,0,10291000,12155000,-21341000,0.22085520686385607,0.20410471881060116,0.3987274655355249,__nan__,__nan__,__nan__,1.323993122873761
124,CLOV,Clover Health Investments Corp. Class A Common Stock,"Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.",Mr. Andrew  Toy,Medical - Healthcare Plans,3.32,USD,1696210234,https://images.financialmodelingprep.com/symbol/CLOV.png,6018391,-36.89,-0.28,5265358,-44935000,-43009000,"[{'period': '2024', 'revenue': 1370.0, 'unit': 'M', 'net_profit': -43.01}, {'period': '2023', 'revenue': 1260.0, 'unit': 'M', 'net_profit': -213.36}, {'period': '2022', 'revenue': 1100.0, 'unit': 'M', 'net_profit': -339.57}, {'period': '2021', 'revenue': 1470.0, 'unit': 'M', 'net_profit': -587.76}]","[{'period': ""Q4 '24"", 'revenue': 336.96, 'unit': 'M', 'net_profit': -22.09}, {'period': ""Q3 '24"", 'revenue': 330.99, 'unit': 'M', 'net_profit': -9.15}, {'period': ""Q2 '24"", 'revenue': 356.26, 'unit': 'M', 'net_profit': 7.41}, {'period': ""Q1 '24"", 'revenue': 346.92, 'unit': 'M', 'net_profit': -19.17}, {'period': ""Q4 '23"", 'revenue': 510.25, 'unit': 'M', 'net_profit': -70.47}, {'period': ""Q3 '23"", 'revenue': 306.03, 'unit': 'M', 'net_profit': -41.47}]",-0.08,-0.08,580742000,343124000,221540000,239599000,0,201719000,213516000,194543000,33289000,0.7835834553440703,0.7984214547175913,0.8222222222222222,__nan__,__nan__,__nan__,0.41257391406166594
125,CLOVW,Clover Health Investments Corp. Warrants,,,,,,,,,,,,-6744840000000,-6744840000000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'T', 'net_profit': -6.74}]","[{'period': ""Q2 '21"", 'revenue': 412.47, 'unit': 'M', 'net_profit': -317.61}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'T', 'net_profit': -6.74}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -2.29}, {'period': ""Q2 '20"", 'revenue': 172.08, 'unit': 'M', 'net_profit': 5.4}]",-0.32,-0.32,856420161000000,28302906000000,856120495000000,62913978000000,0,828117255000000,33933978000000,28003240000000,-2227118000000,0,0,0,__nan__,__nan__,__nan__,0.07346157980043162
126,CLPS,CLPS Incorporation Common Stock,"CLPS Incorporation provides information technology, consulting, and solutions to institutions operating in banking, insurance, and financial sectors in the People's Republic of China and internationally. It offers IT consulting services in credit card business areas, such as credit card application, account setup, authorization and activation, settlement, collection, promotion, point system, anti-fraud, statement, reporting, and risk management. The company also provides banking services, including business analysis, system design, development, testing, system maintenance, and operation support; and services in loans, deposit, general ledger, wealth management, debit card, anti-money-laundering, statement and reporting, and risk management, as well as architecture consulting services for banking systems, and online and mobile banking. In addition, it offers solutions in the field of wealth management; e-commerce solutions in online platforms, cross-border e-commerce, logistics, and back-end technology, such as big data analysis and intelligent decision-making among others; and driving, automatic control, and other AI-driven technology solutions for the automotive industry. Further, the company provides IT consulting services to its clients in the banking, wealth management, e-commerce, and automotive industries, among others; and software project development, maintenance, and testing services. Additionally, it offers CLPS Virtual Banking platform, a training platform for IT talents; recruitment and headhunting, as well as fee-for-service training services; and sells product and third-party software. The company was founded in 2005 and is headquartered in Kwun Tong, Hong Kong.",Mr. Ming Hui  Lin,Information Technology Services,1.05,USD,29232704,https://images.financialmodelingprep.com/symbol/CLPS.png,16273,-21,0.03,2634,-1285922,-2329965,"[{'period': '2024', 'revenue': 142.81, 'unit': 'M', 'net_profit': -2.33}, {'period': '2023', 'revenue': 150360.0, 'unit': 'K', 'net_profit': 192.53}, {'period': '2022', 'revenue': 152.02, 'unit': 'M', 'net_profit': 4.46}, {'period': '2021', 'revenue': 126.06, 'unit': 'M', 'net_profit': 6.82}]","[{'period': ""Q2 '25"", 'revenue': 82780.0, 'unit': 'K', 'net_profit': -389.91}, {'period': ""Q4 '24"", 'revenue': 71040.0, 'unit': 'K', 'net_profit': -842.43}, {'period': ""Q2 '24"", 'revenue': 71.77, 'unit': 'M', 'net_profit': -1.49}, {'period': ""Q4 '23"", 'revenue': 73.6, 'unit': 'M', 'net_profit': -1.07}, {'period': ""Q2 '23"", 'revenue': 76.76, 'unit': 'M', 'net_profit': 1.27}, {'period': ""Q4 '22"", 'revenue': 76.1, 'unit': 'M', 'net_profit': -1.81}]",-0.0924,-0.0924,110029816,78076408,31216431,46110203,42338318,2988105,39795803,29116431,6807952,-1.3495549156627227,-13.101891143671862,-12.132530120481928,"[0.13, 0.05]","['2024-11-04', '2022-12-28']",__nan__,0.4190700727882704
127,CLPT,ClearPoint Neuro Inc. Common Stock,"ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.",Mr. Joseph Michael Burnett,Medical - Devices,11.95,USD,334355742,https://images.financialmodelingprep.com/symbol/CLPT.png,240685,-17.07,-0.29,216888,-19746000,-18914000,"[{'period': '2024', 'revenue': 31.39, 'unit': 'M', 'net_profit': -18.91}, {'period': '2023', 'revenue': 23.95, 'unit': 'M', 'net_profit': -22.09}, {'period': '2022', 'revenue': 20.55, 'unit': 'M', 'net_profit': -16.54}, {'period': '2021', 'revenue': 16.3, 'unit': 'M', 'net_profit': -15.32}]","[{'period': ""Q4 '24"", 'revenue': 7.77, 'unit': 'M', 'net_profit': -5.39}, {'period': ""Q3 '24"", 'revenue': 8.12, 'unit': 'M', 'net_profit': -4.97}, {'period': ""Q2 '24"", 'revenue': 7.86, 'unit': 'M', 'net_profit': -4.41}, {'period': ""Q1 '24"", 'revenue': 7.64, 'unit': 'M', 'net_profit': -4.15}, {'period': ""Q4 '23"", 'revenue': 6.81, 'unit': 'M', 'net_profit': -4.62}, {'period': ""Q3 '23"", 'revenue': 5.76, 'unit': 'M', 'net_profit': -4.81}]",-0.7,-0.7,39189000,33363000,20104000,13800000,4713000,0,10353000,20104000,-9225000,0.05922149697460575,0.14373670152564624,0.2222222222222223,__nan__,__nan__,__nan__,0.3521396310189084
128,CLRB,Cellectar Biosciences Inc.  Common Stock,"Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.",Mr. James V. Caruso,Biotechnology,0.2902,USD,13372380,https://images.financialmodelingprep.com/symbol/CLRB.png,1166440,-0.21,-0.0088,893768,-51777698,-44581446,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -44.58}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.98}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.6}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.97}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.36}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.66}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -919.37}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.58}, {'period': ""Q4 '23"", 'revenue': 0.33037, 'unit': 'M', 'net_profit': -7.45}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.73}]",-1.22,-1.2,25474047,24250272,23288607,11179366,0,0,9387757,23288607,-47687196,-0.33556902774196673,-0.17370570628885768,0.6077170418006431,__nan__,__nan__,__nan__,0.4388531590602781
129,CLRM,Clarim Acquisition Corp. Class A Common Stock,"Clarim Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on the consumer-facing e-commerce sector. The company was incorporated in 2020 and is based in New York, New York.",Mr. James F. McCann,Shell Companies,10.07,USD,0,https://images.financialmodelingprep.com/symbol/CLRM.png,92853,38.73076923076923,0.01,7200,-2360223,7291007,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.29}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.96}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.45}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -583.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.74}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.13}]",0.2,0.2,288120,499.625,107.125,20636,0,0,1281.21,107.125,-1504523,0,0,0,__nan__,__nan__,__nan__,0.07162293488824101
130,CLRMU,Clarim Acquisition Corp. Unit,"Clarim Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on the consumer-facing e-commerce sector. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.15,USD,0,https://images.financialmodelingprep.com/symbol/CLRMU.png,14466,70,0.09,257,-2360223,7291007,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.29}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.96}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.45}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -583.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.74}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.13}]",0.2,0.2,288120,499.625,107.125,20636,0,0,1281.21,107.125,-1504523,0,0,0,__nan__,__nan__,__nan__,0.07162293488824101
131,CLRMW,Clarim Acquisition Corp. Warrant,"Clarim Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in New York, New York.",Mr. James F. McCann,Shell Companies,0.0009,USD,0,https://images.financialmodelingprep.com/symbol/CLRMW.png,0,0,-0.0017,3790,-2360223,7291007,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.29}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.96}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.45}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -583.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.74}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.13}]",0.2,0.2,288120,499.625,107.125,20636,0,0,1281.21,107.125,-1504523,0,0,0,__nan__,__nan__,__nan__,0.07162293488824101
132,CLRO,ClearOne Inc. (DE) Common Stock,"ClearOne, Inc., together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers a range of audio conferencing products, including professional audio conferencing and sound-reinforcement products for use in enterprise, healthcare, education and distance learning, government, legal, and finance organizations; mid-tier premium conferencing products for smaller rooms, and small and medium businesses, which interface with video and Web conferencing systems; USB-based personal and group speakerphones that could be used with PCs, laptops, tablets, smartphones, and other portable devices; and traditional tabletop conferencing phones used in conference rooms and offices. It also provides video products, such as video conferencing and collaboration solutions; and AV networking, which deliver the IP A/V experience by streaming time sensitive high definition audio and video, and control over TCP/IP networks. In addition, the company offers professional microphones consisting of beamforming microphones, ceiling microphones, and wireless microphones. ClearOne, Inc. sells its commercial products to a network of independent professional audiovisual, information technology, and telecommunications distributors, as well as systems integrators, dealers, value-added resellers, and end-users. The company was incorporated in 1983 and is headquartered in Salt Lake City, Utah.",Mr. Derek L. Graham,Communication Equipment,0.4925,USD,12801550,https://images.financialmodelingprep.com/symbol/CLRO.png,728004,-1.33,-0.0038,23417,-9211000,-8983000,"[{'period': '2024', 'revenue': 11.39, 'unit': 'M', 'net_profit': -8.98}, {'period': '2023', 'revenue': 18700.0, 'unit': 'K', 'net_profit': -560.0}, {'period': '2022', 'revenue': 25.2, 'unit': 'M', 'net_profit': 20.56}, {'period': '2021', 'revenue': 28.97, 'unit': 'M', 'net_profit': -7.69}]","[{'period': ""Q4 '24"", 'revenue': 2.96, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q3 '24"", 'revenue': 2.5, 'unit': 'M', 'net_profit': -2.06}, {'period': ""Q2 '24"", 'revenue': 2.3, 'unit': 'M', 'net_profit': -2.82}, {'period': ""Q1 '24"", 'revenue': 3.62, 'unit': 'M', 'net_profit': -1.9}, {'period': ""Q4 '23"", 'revenue': 4.15, 'unit': 'M', 'net_profit': 2.64}, {'period': ""Q3 '23"", 'revenue': 4.89, 'unit': 'M', 'net_profit': -1.35}]",-0.37,-0.37,26544000,18753000,1417000,5213000,2208000,0,3545000,1417000,-6312000,-6.893154190658989,-15.041071428571428,-14.811965811965813,"[0.5, 0.1]","['2024-04-11', '2014-12-10']",__nan__,0.19639089813140445
133,CLSD,Clearside Biomedical Inc. Common Stock,"Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.","Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.",Biotechnology,0.8,USD,61823432,https://images.financialmodelingprep.com/symbol/CLSD.png,211291,-1.7,-0.06,187765,-24347000,-34352000,"[{'period': '2024', 'revenue': 1.66, 'unit': 'M', 'net_profit': -34.35}, {'period': '2023', 'revenue': 8.23, 'unit': 'M', 'net_profit': -32.48}, {'period': '2022', 'revenue': 1.33, 'unit': 'M', 'net_profit': -34.07}, {'period': '2021', 'revenue': 29570.0, 'unit': 'K', 'net_profit': 376.0}]","[{'period': ""Q4 '24"", 'revenue': 0.306, 'unit': 'M', 'net_profit': -7.31}, {'period': ""Q3 '24"", 'revenue': 1.04, 'unit': 'M', 'net_profit': -7.69}, {'period': ""Q2 '24"", 'revenue': 0.09, 'unit': 'M', 'net_profit': -7.59}, {'period': ""Q1 '24"", 'revenue': 0.23, 'unit': 'M', 'net_profit': -11.76}, {'period': ""Q4 '23"", 'revenue': 6.34, 'unit': 'M', 'net_profit': -4.83}, {'period': ""Q3 '23"", 'revenue': 0.859, 'unit': 'M', 'net_profit': -9.27}]",-0.47,-0.47,25126000,21274000,20020000,63981000,507000,0,4794000,20020000,-24698000,-0.055902506722178856,-0.0574726796983223,0.11320754716981142,__nan__,__nan__,__nan__,2.5464061131895246
134,CLSK,CleanSpark Inc. Common Stock,"CleanSpark, Inc. provides bitcoin mining and energy technology solutions worldwide. It operates in two segments, Digital Currency Mining and Energy. The Digital Currency Mining segment engages in mining of bitcoin. The energy segment provides engineering, design and software, custom hardware, open automated demand response, solar, and energy storage solutions for microgrids and distributed energy systems to military, commercial, and residential customers; and develops platforms that enables designing, building, operating, and managing of energy assets. This segment also offers microgrid energy modeling, energy market communications, and energy management solutions comprising mPulse and mVoult, which are control platforms that enables integration and optimization of multiple energy sources; Canvas, a middleware for grid operators and aggregators to administrate load shifting programs; Plaid, a middleware for controls and Internet-of-Things products companies to participate in load shifting programs; and mVSO, an energy modeling software for internal microgrid design, as well as owns gasification energy technologies for various applications, such as feedstock for the generation of di-methyl ether. In addition, it provides design, software development, and other technology-based consulting services; data center services, including rack space, power, and equipment; and various cloud services, such as virtual, virtual storage, and data backup services. The company was formerly known as Stratean Inc. and changed its name to CleanSpark, Inc. in November 2016. CleanSpark, Inc. was incorporated in 1987 and is headquartered in Henderson, Nevada.",Mr. Zachary K. Bradford CPA,Software - Application,7.47,USD,2097632921,https://images.financialmodelingprep.com/symbol/CLSK.png,24694496,-10.83,-0.04,23559528,6299000,-145777000,"[{'period': '2024', 'revenue': 378.97, 'unit': 'M', 'net_profit': -145.78}, {'period': '2023', 'revenue': 168.41, 'unit': 'M', 'net_profit': -136.59}, {'period': '2022', 'revenue': 131.53, 'unit': 'M', 'net_profit': -57.66}, {'period': '2021', 'revenue': 39.29, 'unit': 'M', 'net_profit': -21.81}]","[{'period': ""Q1 '25"", 'revenue': 162.31, 'unit': 'M', 'net_profit': 246.79}, {'period': ""Q4 '24"", 'revenue': 89.28, 'unit': 'M', 'net_profit': -62.18}, {'period': ""Q3 '24"", 'revenue': 104.11, 'unit': 'M', 'net_profit': -236.24}, {'period': ""Q2 '24"", 'revenue': 111.8, 'unit': 'M', 'net_profit': 126.73}, {'period': ""Q1 '24"", 'revenue': 73.79, 'unit': 'M', 'net_profit': 25.91}, {'period': ""Q4 '23"", 'revenue': 53.12, 'unit': 'M', 'net_profit': -74.88}]",-0.67,-0.66,1962662000,705430000,553801000,201821000,138746000,0,187887000,121222000,-1040058000,1.8290339563042906,-0.06726749591841218,0.49624060150375937,"[0.12, 0.12]","['2021-06-21', '2021-06-21']",__nan__,0.1028302377077663
135,CLSN,Celsion Corporation Common Stock,"Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.",Michael Tardugno,Biotechnology,1.9466,USD,14471628,https://images.financialmodelingprep.com/symbol/CLSN.png,0,-0.49057459677419357,-0.013400078,56809,-19132446000,-18620242000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'B', 'net_profit': -18.62}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.51}, {'period': '2022', 'revenue': 0.5, 'unit': 'M', 'net_profit': -35.9}, {'period': '2021', 'revenue': 0.5, 'unit': 'M', 'net_profit': -20.77}]","[{'period': ""Q4 '24"", 'revenue': 0.72716, 'unit': 'M', 'net_profit': -4.06}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -4.85}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.79}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.93}, {'period': ""Q4 '23"", 'revenue': 7.05, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.48}]",-1618,-1618,9717364,8008959,5872767,5473066,0,0,4786131000,5872767,-18884511000,-961.4800014125972,-953.1513679467827,-748.074074074074,__nan__,__nan__,__nan__,0.563225376758553
136,CLVR,Clever Leaves Holdings Inc. Common Shares,"Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.",Mr. Andres  Fajardo,Drug Manufacturers - Specialty & Generic,0.0002,USD,351,https://images.financialmodelingprep.com/symbol/CLVR.png,791,,5.00000000712604e-12,116,-16835000,-17899000,"[{'period': '2023', 'revenue': 17.42, 'unit': 'M', 'net_profit': -17.9}, {'period': '2022', 'revenue': 17.8, 'unit': 'M', 'net_profit': -66.1}, {'period': '2021', 'revenue': 15.37, 'unit': 'M', 'net_profit': -45.63}, {'period': '2020', 'revenue': 12.12, 'unit': 'M', 'net_profit': -41.41}]","[{'period': ""Q4 '23"", 'revenue': 4.64, 'unit': 'M', 'net_profit': -5.08}, {'period': ""Q3 '23"", 'revenue': 3.82, 'unit': 'M', 'net_profit': -5.14}, {'period': ""Q2 '23"", 'revenue': 4.98, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q1 '23"", 'revenue': 3.98, 'unit': 'M', 'net_profit': -4.08}, {'period': ""Q4 '22"", 'revenue': 4.61, 'unit': 'M', 'net_profit': -28.82}, {'period': ""Q3 '22"", 'revenue': 2.87, 'unit': 'M', 'net_profit': -20.16}]",-11.42,-11.42,31243000,13940000,6831000,7026000,2079000,0,5811000,6831000,-11539000,0.5298011395374819,0.7292174097214869,0.7788964181994191,__nan__,__nan__,__nan__,0.22488237365169797
137,CLVRW,Clever Leaves Holdings Inc. Warrant,"Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.",Mr. Andres  Fajardo,Drug Manufacturers - Specialty & Generic,0.025,USD,175,https://images.financialmodelingprep.com/symbol/CLVRW.png,0,-0.013736263736263736,0,1100,-16835000,-17899000,"[{'period': '2023', 'revenue': 17.42, 'unit': 'M', 'net_profit': -17.9}, {'period': '2022', 'revenue': 17.8, 'unit': 'M', 'net_profit': -66.1}, {'period': '2021', 'revenue': 15.37, 'unit': 'M', 'net_profit': -45.63}, {'period': '2020', 'revenue': 12.12, 'unit': 'M', 'net_profit': -41.41}]","[{'period': ""Q4 '23"", 'revenue': 4.64, 'unit': 'M', 'net_profit': -5.08}, {'period': ""Q3 '23"", 'revenue': 3.82, 'unit': 'M', 'net_profit': -5.14}, {'period': ""Q2 '23"", 'revenue': 4.98, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q1 '23"", 'revenue': 3.98, 'unit': 'M', 'net_profit': -4.08}, {'period': ""Q4 '22"", 'revenue': 4.61, 'unit': 'M', 'net_profit': -28.82}, {'period': ""Q3 '22"", 'revenue': 2.87, 'unit': 'M', 'net_profit': -20.16}]",-11.42,-11.42,31243000,13940000,6831000,7026000,2079000,0,5811000,6831000,-11539000,0.5298011395374819,0.7292174097214869,0.7788964181994191,__nan__,__nan__,__nan__,0.22488237365169797
138,CLVS,Clovis Oncology Inc. Common Stock,"Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the company offers Rubraca for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is also developing lucitanib, an investigational angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through 3 (VEGFR 1-3), platelet-derived growth factor receptors alpha and beta (PDGFRa/ß), and fibroblast growth factor receptors 1 through 3 (FGFR 1-3);and FAP-2286, an investigational peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein. In addition, the company sells its Rubraca through a limited number of specialty distributor and specialty pharmacy providers, who subsequently sells Rubraca to patients and health care providers. Clovis Oncology, Inc. has license agreements with Pfizer Inc., AstraZeneca UK Limited, Advenchen Laboratories LLC, and 3B Pharmaceuticals GmbH, a clinical collaboration with Bristol Myers Squibb Company; and a partnership with Foundation Medicine, Inc. Clovis Oncology, Inc. was incorporated in 2009 and is headquartered in Boulder, Colorado. On December 11, 2022, Clovis Oncology, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.",Mr. Patrick Mahaffy,Biotechnology,0.0812,USD,0,https://images.financialmodelingprep.com/symbol/CLVS.png,5971191,-0.038963531669865645,0,24212259,-114354000,-264524000,"[{'period': '2021', 'revenue': 148.76, 'unit': 'M', 'net_profit': -264.52}, {'period': '2020', 'revenue': 164.52, 'unit': 'M', 'net_profit': -369.21}, {'period': '2019', 'revenue': 143.01, 'unit': 'M', 'net_profit': -400.42}, {'period': '2018', 'revenue': 95.39, 'unit': 'M', 'net_profit': -368.01}]","[{'period': ""Q3 '22"", 'revenue': 1.34, 'unit': 'M', 'net_profit': -56.01}, {'period': ""Q2 '22"", 'revenue': 32.14, 'unit': 'M', 'net_profit': -71.33}, {'period': ""Q1 '22"", 'revenue': 34.25, 'unit': 'M', 'net_profit': -60.17}, {'period': ""Q4 '21"", 'revenue': 35.97, 'unit': 'M', 'net_profit': -64.39}, {'period': ""Q3 '21"", 'revenue': 37.92, 'unit': 'M', 'net_profit': -67.41}, {'period': ""Q2 '21"", 'revenue': 36.82, 'unit': 'M', 'net_profit': -66.45}]",-2.18,-2.18,472833000,198087000,143428000,751673000,26868000,0,125214000,143428000,-196369000,0.6617446091046233,0.28354441350768667,0.502283105022831,__nan__,__nan__,__nan__,1.5897219525709922
139,CLWT,Euro Tech Holdings Company Limited Common Stock,"Euro Tech Holdings Company Limited primarily distributes water treatment equipment, laboratory instruments, analyzers, test kits and related supplies, and power generation equipment to commercial customers, and governmental agencies in Hong Kong and the People's Republic of China. The company operates in two segments, Trading and Manufacturing, and Engineering. It sells analytical instruments, such as spectrophotometers, colorimeters, chromatographs, mass spectrometers, flow injector analyzers, automated sample preparation workstations, and atomic spectrometers; environmental monitoring instruments comprising air and water quality monitoring instruments; sample pre-treatment equipment; and general-purpose laboratory instruments consisting of water quality monitoring and analysis equipment. The company also distributes general testing and measuring equipment comprising multi-channel digital and analogue recorders, signal amplifiers, and calibration equipment for energy conservation, renewable energy equipment, power quality analyzers, and continuous emissions monitoring systems; and air pollution control systems to power plants, railway and aero-space industries, utilities, educational institutions, and telecommunications companies. In addition, it offers process control systems, including sensors, temperature and pressure gauges, power and energy consumption meters, flow meters, valves, temperature and pressure transmitters and control devices, and temperature and pressure calibrators, as well as moisture, power, energy, and harmonic analyzers; systems engineering services; and maintenance, installation assistance, and calibration services. Further, the company distributes programmable logic controllers, telemetry units, and supervisory control and data acquisition systems and software; and designs, operates, and manages various wastewater, water, and power generation projects. The company was founded in 1971 and is headquartered in Hong Kong, Hong Kong.",Mr. Y. L.  Leung,Industrial - Pollution & Treatment Controls,1.205,USD,9298140,https://images.financialmodelingprep.com/symbol/CLWT.png,15321,4.3,0.03,10558,1717000,1828000,"[{'period': '2023', 'revenue': 17.94, 'unit': 'M', 'net_profit': 1.83}, {'period': '2022', 'revenue': 14950.0, 'unit': 'K', 'net_profit': 539.0}, {'period': '2021', 'revenue': 21.39, 'unit': 'M', 'net_profit': 1.37}, {'period': '2020', 'revenue': 13360.0, 'unit': 'K', 'net_profit': 402.0}]","[{'period': ""Q2 '24"", 'revenue': 7260.0, 'unit': 'K', 'net_profit': 44.0}, {'period': ""Q4 '23"", 'revenue': 9.98, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q2 '23"", 'revenue': 7960.0, 'unit': 'K', 'net_profit': -255.0}, {'period': ""Q4 '22"", 'revenue': 8220.0, 'unit': 'K', 'net_profit': 553.0}, {'period': ""Q2 '22"", 'revenue': 6730.0, 'unit': 'K', 'net_profit': -184.0}, {'period': ""Q4 '21"", 'revenue': 11330.0, 'unit': 'K', 'net_profit': 499.0}]",0.24,0.24,22120000,10545000,5453000,5640000,3068000,9856000,5596000,5453000,-85000,9.664596273291925,2.391465677179963,2.443328550932568,"[0.08, 0.42]","['2024-06-13', '2018-06-14']",__nan__,0.2549728752260398
140,CLXT,Calyxt Inc. Common Stock,"Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.",Mr. Michael Allen Carr,Packaged Foods,6.3,USD,31334247,https://images.financialmodelingprep.com/symbol/CLXT.png,22518,-1.6449086161879896,0.33,254088,-22370000,-9803000,"[{'period': '2022', 'revenue': 0.157, 'unit': 'M', 'net_profit': -9.8}, {'period': '2021', 'revenue': 25.99, 'unit': 'M', 'net_profit': -29.09}, {'period': '2020', 'revenue': 23.85, 'unit': 'M', 'net_profit': -46.4}, {'period': '2019', 'revenue': 7.3, 'unit': 'M', 'net_profit': -41.1}]","[{'period': ""Q3 '23"", 'revenue': 0.47500000000000003, 'unit': 'M', 'net_profit': -26.43}, {'period': ""Q2 '23"", 'revenue': 0.197, 'unit': 'M', 'net_profit': -18.69}, {'period': ""Q1 '23"", 'revenue': 0.042, 'unit': 'M', 'net_profit': -6.33}, {'period': ""Q4 '22"", 'revenue': 0.042, 'unit': 'M', 'net_profit': -1.98}, {'period': ""Q3 '22"", 'revenue': 0.042, 'unit': 'M', 'net_profit': -5.7}, {'period': ""Q2 '22"", 'revenue': 0.041, 'unit': 'M', 'net_profit': -2.48}]",-10.66,-10.66,22421000,4132000,3427000,15188000,0,0,1662000,3427000,-20884000,0.2156931491480261,0.6629534124118962,0.7253285235763979,__nan__,__nan__,__nan__,0.6774006511752375
141,CMBM,Cambium Networks Corporation Ordinary Shares,"Cambium Networks Corporation, through its subsidiaries, provides wireless broadband networking infrastructure products and solutions for commercial and government network operators. Its wireless fabric includes intelligent radios, smart antennas, radio frequency (RF) algorithms, wireless-aware switches, and cloud-based network management software. The company offers point-to-point backhaul, point-to-multipoint distribution, Wi-Fi access, cnMatrix ethernet enterprise switching, cnReach IIoT, cnVision video surveillance transport, and cnMaestro and network management tools and solutions. It also offers point-to-point solutions that are connected to high-speed, high-bandwidth wireline networks; and wireless broadband backhaul to facilities or point-to-multipoint access points deployed throughout a network over distances of approximately 100 kilometers and at 2 gigabytes per second. The company also offers cnPilot and Xirrus Wi-Fi solution provides distributed access to individual users in indoor settings, such as office complexes, and outdoor settings, such as athletic stadiums and outdoor public Wi-Fi spots; cnReach solutions offer narrow-band connectivity for sensors and devices; embedded proprietary RF technology and software enables automated optimization of data flow at the outermost points in the network; cnMatrix cloud-managed wireless-aware switching solution provides the interface between wireless and wired networks; and cnVision solutions for video surveillance and CCTV deployments. It serves medium-sized wireless Internet service providers, mobile network operators, enterprises, and government agencies in North America, Europe, the Middle East, Africa, Caribbean and Latin America, and the Asia Pacific. The company was formerly known as Vector Cambium Holdings (Cayman), Ltd. and changed its name to Cambium Networks Corporation in 2018. The was founded in 2011 and is headquartered in Rolling Meadows, Illinois.",Mr. Morgan C. S. Kurk,Communication Equipment,0.3798,USD,10726999,https://images.financialmodelingprep.com/symbol/CMBM.png,251196,-0.11,-0.0053,72867,-52100000,-77420000,"[{'period': '2023', 'revenue': 220.19, 'unit': 'M', 'net_profit': -77.42}, {'period': '2022', 'revenue': 296.9, 'unit': 'M', 'net_profit': 20.2}, {'period': '2021', 'revenue': 335.85, 'unit': 'M', 'net_profit': 37.42}, {'period': '2020', 'revenue': 278.46, 'unit': 'M', 'net_profit': 18.57}]","[{'period': ""Q3 '24"", 'revenue': 43.73, 'unit': 'M', 'net_profit': -9.68}, {'period': ""Q2 '24"", 'revenue': 45.95, 'unit': 'M', 'net_profit': -9.14}, {'period': ""Q1 '24"", 'revenue': 42.34, 'unit': 'M', 'net_profit': -26.45}, {'period': ""Q4 '23"", 'revenue': 40.21, 'unit': 'M', 'net_profit': -39.01}, {'period': ""Q3 '23"", 'revenue': 43.05, 'unit': 'M', 'net_profit': -26.2}, {'period': ""Q2 '23"", 'revenue': 59.54, 'unit': 'M', 'net_profit': -2.64}]",-2.81,-2.81,217875000,162571000,18710000,136941000,64325000,0,96328000,18710000,-28177000,-2.8883653497644075,-4.832673267326733,-4.746666666666667,__nan__,__nan__,__nan__,0.6285301204819277
142,CMCO,Columbus McKinnon Corporation Common Stock,"Columbus McKinnon Corporation designs, manufactures, and markets intelligent motion solutions to ergonomically move, lift, position, and secure materials worldwide. The company offers electric, air-powered, lever, and hand hoists; hoist trolleys, explosion-protected and custom engineered hoists, and winches; crane systems, such as crane components and kits, enclosed track rail systems, mobile and jib cranes, and fall protection systems, as well as material handling solutions; rigging equipment comprising below-the-hook lifting devices, shackles, chains and chains accessories, forestry and hand tools, lifting slings, lashing systems, and tie-downs and load binders; rotary unions and swivel joints; and mechanical and electromechanical actuators. It also provides power and motion technology products, including AC motor controls and line regenerative systems, automation and diagnostics, brakes, cable and festoon systems, collision avoidance systems, conductor bar systems, DC motor and magnet control systems, elevator drives, inverter duty motors, mining drives, pendant pushbutton stations, radio controls, and wind inverters; power delivery subsystems; overhead aluminum light rail workstations; and low profile, flexible chain, large scale, sanitary, and vertical elevation conveyor systems, as well as pallet system conveyors and accumulation systems. The company serves market verticals, including general industries, transportation, energy and utilities, process industries, industrial automation, construction and infrastructure, food and beverage, entertainment, life sciences, consumer packaged goods, and e-commerce/supply chain/warehousing. It offers its products to end users directly, as well as through distributors, independent crane builders, material handling specialists and integrators, government agencies, original equipment manufacturers, and engineering procurement and construction firms. The company was founded in 1875 and is headquartered in Buffalo, New York.",Mr. David J. Wilson,Agricultural - Machinery,12.98,USD,371390639,https://images.financialmodelingprep.com/symbol/CMCO.png,692532,40.56,-0.15,391783,145429000,46625000,"[{'period': '2023', 'revenue': 1010.0, 'unit': 'M', 'net_profit': 46.62}, {'period': '2022', 'revenue': 936.24, 'unit': 'M', 'net_profit': 48.43}, {'period': '2021', 'revenue': 906.55, 'unit': 'M', 'net_profit': 29.66}, {'period': '2020', 'revenue': 649.64, 'unit': 'M', 'net_profit': 9.11}]","[{'period': ""Q3 '24"", 'revenue': 234.14, 'unit': 'M', 'net_profit': 3.96}, {'period': ""Q2 '24"", 'revenue': 242.27, 'unit': 'M', 'net_profit': -15.04}, {'period': ""Q1 '24"", 'revenue': 239.73, 'unit': 'M', 'net_profit': 8.63}, {'period': ""Q4 '23"", 'revenue': 265.5, 'unit': 'M', 'net_profit': 11.81}, {'period': ""Q3 '23"", 'revenue': 254.14, 'unit': 'M', 'net_profit': 9.73}, {'period': ""Q2 '23"", 'revenue': 258.4, 'unit': 'M', 'net_profit': 15.81}]",1.62,1.61,1825945000,514155000,114126000,943882000,171186000,11447000,261761000,114126000,42385000,-0.008792317286786306,-0.037250407813500176,-0.04142011834319517,"[0.07, 0.06]","['2025-05-02', '1996-04-08']",__nan__,0.5169279468987291
143,CMCSA,Comcast Corporation Class A Common Stock,"Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Media, Studios, Theme Parks, and Sky segments. The Cable Communications segment offers broadband, video, voice, wireless, and other services to residential and business customers under the Xfinity brand; and advertising services. The Media segment operates NBCUniversal's television and streaming platforms, including national, regional, and international cable networks, the NBC and Telemundo broadcast, and Peacock networks. The Studios segment operates NBCUniversal's film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida; Hollywood, California; Osaka, Japan; and Beijing, China. The Sky segment offers direct-to-consumer services, such as video, broadband, voice and wireless phone services, and content business operates entertainment networks, the Sky News broadcast network, and Sky Sports networks. The company also owns the Philadelphia Flyers, as well as the Wells Fargo Center arena in Philadelphia, Pennsylvania; and provides streaming service, such as Peacock. Comcast Corporation was founded in 1963 and is headquartered in Philadelphia, Pennsylvania.",Mr. Brian L. Roberts,Telecommunications Services,33.6,USD,126725024160,https://images.financialmodelingprep.com/symbol/CMCSA.png,28451875,8.12,-0.41,22476491,29340000000,16192000000,"[{'period': '2024', 'revenue': 123.73, 'unit': 'B', 'net_profit': 16.19}, {'period': '2023', 'revenue': 121.57, 'unit': 'B', 'net_profit': 15.39}, {'period': '2022', 'revenue': 121.43, 'unit': 'B', 'net_profit': 5.37}, {'period': '2021', 'revenue': 116.39, 'unit': 'B', 'net_profit': 14.16}]","[{'period': ""Q4 '24"", 'revenue': 31.91, 'unit': 'B', 'net_profit': 4.78}, {'period': ""Q3 '24"", 'revenue': 32.07, 'unit': 'B', 'net_profit': 3.63}, {'period': ""Q2 '24"", 'revenue': 29.69, 'unit': 'B', 'net_profit': 3.93}, {'period': ""Q1 '24"", 'revenue': 30.06, 'unit': 'B', 'net_profit': 3.86}, {'period': ""Q4 '23"", 'revenue': 31.25, 'unit': 'B', 'net_profit': 3.26}, {'period': ""Q3 '23"", 'revenue': 30.11, 'unit': 'B', 'net_profit': 4.05}]",4.14,4.14,266211000000,26801000000,7322000000,179937000000,13661000000,8647000000,39581000000,7322000000,15492000000,-0.2457777435027377,0.05224850532882766,0.10991957104557633,"[0.33, 0.1822]","['2025-04-02', '1986-03-03']",__nan__,0.6759187261232631
144,CMCT,CIM Commercial Trust Corporation Common stock,"Creative Media & Community Trust Corporation is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States (including improving and developing such assets). Its properties are primarily located in Los Angeles and the San Francisco Bay Area. Creative Media & Community Trust Corporation is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities.",Mr. David A. Thompson CPA,REIT - Office,4.16,USD,3139165,https://images.financialmodelingprep.com/symbol/CMCT.png,34409,-0.01,-0.33,27298,39652000,-25175000,"[{'period': '2024', 'revenue': 124.51, 'unit': 'M', 'net_profit': -25.18}, {'period': '2023', 'revenue': 119.26, 'unit': 'M', 'net_profit': -48.48}, {'period': '2022', 'revenue': 101.91, 'unit': 'M', 'net_profit': 5.92}, {'period': '2021', 'revenue': 90930.0, 'unit': 'K', 'net_profit': -851.0}]","[{'period': ""Q4 '24"", 'revenue': 27.46, 'unit': 'M', 'net_profit': -10.27}, {'period': ""Q3 '24"", 'revenue': 28.62, 'unit': 'M', 'net_profit': -10.38}, {'period': ""Q2 '24"", 'revenue': 34440.0, 'unit': 'K', 'net_profit': -796.0}, {'period': ""Q1 '24"", 'revenue': 34.0, 'unit': 'M', 'net_profit': -3.73}, {'period': ""Q4 '23"", 'revenue': 33.46, 'unit': 'M', 'net_profit': -8.4}, {'period': ""Q3 '23"", 'revenue': 28.12, 'unit': 'M', 'net_profit': -15.77}]",-17.21,-17.21,889555000,96368000,20262000,562492000,76106000,33677000,74129000,20262000,-6236000,0.05628812701457151,0.48076724760235123,-4.168168168168168,"[0.04, 0.024]","['2024-09-25', '1994-04-25']",__nan__,0.6323296479700524
145,CME,CME Group Inc. Class A Common Stock,"CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.",Mr. Terrence A. Duffy,Financial - Data & Stock Exchanges,260.33,USD,93817725400,https://images.financialmodelingprep.com/symbol/CME.png,2499724,26.95,-2.2,1977763,5039100000,3525800000,"[{'period': '2024', 'revenue': 6.13, 'unit': 'B', 'net_profit': 3.53}, {'period': '2023', 'revenue': 5.58, 'unit': 'B', 'net_profit': 3.23}, {'period': '2022', 'revenue': 5.02, 'unit': 'B', 'net_profit': 2.69}, {'period': '2021', 'revenue': 4.69, 'unit': 'B', 'net_profit': 2.64}]","[{'period': ""Q4 '24"", 'revenue': 1530.0, 'unit': 'M', 'net_profit': 874.6}, {'period': ""Q3 '24"", 'revenue': 1580.0, 'unit': 'M', 'net_profit': 879.4}, {'period': ""Q2 '24"", 'revenue': 1530.0, 'unit': 'M', 'net_profit': 883.2}, {'period': ""Q1 '24"", 'revenue': 1490.0, 'unit': 'M', 'net_profit': 855.2}, {'period': ""Q4 '23"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 814.6}, {'period': ""Q3 '23"", 'revenue': 1340.0, 'unit': 'M', 'net_profit': 750.2}]",9.93,9.92,137447000000,103033500000,3005600000,110960100000,573100000,0,102313900000,2892400000,3690500000,0.3301744845973128,0.09286467051019776,0.11950394588500571,"[1.25, 0.14]","['2025-03-07', '2003-03-06']",__nan__,0.8072937204886247
146,CMII,CM Life Sciences II Inc. Class A Common Stock,"CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.",Mr. Eli Decatur Casdin,Shell Companies,10.63,USD,1993401380,https://images.financialmodelingprep.com/symbol/CMII.png,66038,0,-0.6700001,121382,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
147,CMIIU,CM Life Sciences II Inc. Unit,"CM Life Sciences II Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,11.22,USD,0,https://images.financialmodelingprep.com/symbol/CMIIU.png,118536,0,-0.6399994,33735,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
148,CMIIW,CM Life Sciences II Inc. Warrant,"CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.",Mr. Eli Decatur Casdin,Shell Companies,2.68,USD,496268038,https://images.financialmodelingprep.com/symbol/CMIIW.png,0,0,0.13,16179,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
149,CMLF,CM Life Sciences Inc. Class A Common Stock,"CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Eli Decatur Casdin,Shell Companies,11.6,USD,0,https://images.financialmodelingprep.com/symbol/CMLF.png,723143,-1288.888888888889,-0.87999916,489110,-192244,-192244,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -192.24}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.01}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -192.24}]",-0.0035,-0.0035,444135663,1371712,443858632,15593370,0,0,97120,1094681,,0,0,0,__nan__,__nan__,__nan__,0.03510947509747714
150,CMLFU,CM Life Sciences Inc. Unit,"CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Eli Decatur Casdin,Shell Companies,13,USD,10311794688,https://images.financialmodelingprep.com/symbol/CMLFU.png,10023,-1444.4444444444443,-0.62,1314,-192244,-192244,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -192.24}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.01}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -192.24}]",-0.0035,-0.0035,444135663,1371712,443858632,15593370,0,0,97120,1094681,,0,0,0,__nan__,__nan__,__nan__,0.03510947509747714
151,CMLFW,CM Life Sciences Inc. Warrant,,,,,,,,,,,,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.01}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.47}]",,,444135663,1371712,1094681,15593370,0,0,97120,1094681,,,,,__nan__,__nan__,__nan__,0.03510947509747714
152,CMLS,Cumulus Media Inc. Class A Common Stock,"Cumulus Media Inc., an audio-first media company, owns and operates radio stations in the United States. It owns and operates 406 stations in 86 markets, as well as approximately 9,500 affiliated stations through Westwood One. The company's content portfolio includes sports, news, talk, and entertainment programming from various brands, including the NFL, the NCAA, the Masters, CNN, the AP, the Academy of Country Music Awards, and other partners. It also provides digital marketing services, such as email marketing, geo-targeted display and video solutions, website and microsite building, hosting, social media management, reputation management, and search engine marketing and optimization. The company serves advertisers through broadcast and on-demand digital, mobile, social, and voice-activated platforms. Cumulus Media Inc. was incorporated in 2002 and is based in Atlanta, Georgia.",Ms. Mary G. Berner,Broadcasting,0.2526,USD,4273420,https://images.financialmodelingprep.com/symbol/CMLS.png,327636,-0.02,0.0026,64682,-162860000,-283254000,"[{'period': '2024', 'revenue': 827.08, 'unit': 'M', 'net_profit': -283.25}, {'period': '2023', 'revenue': 844.55, 'unit': 'M', 'net_profit': -117.88}, {'period': '2022', 'revenue': 953.51, 'unit': 'M', 'net_profit': 16.23}, {'period': '2021', 'revenue': 916.47, 'unit': 'M', 'net_profit': 17.28}]","[{'period': ""Q4 '24"", 'revenue': 218.58, 'unit': 'M', 'net_profit': -231.08}, {'period': ""Q3 '24"", 'revenue': 203.6, 'unit': 'M', 'net_profit': -10.32}, {'period': ""Q2 '24"", 'revenue': 204.85, 'unit': 'M', 'net_profit': -27.7}, {'period': ""Q1 '24"", 'revenue': 200.05, 'unit': 'M', 'net_profit': -14.15}, {'period': ""Q4 '23"", 'revenue': 221.3, 'unit': 'M', 'net_profit': -98.07}, {'period': ""Q3 '23"", 'revenue': 207.42, 'unit': 'M', 'net_profit': 2.72}]",-16.79,-16.79,1118649000,248051000,63836000,1111698000,161986000,0,133778000,63836000,-22583000,-5.542944141899192,-1.4029216399867661,-1.4582723279648608,__nan__,__nan__,__nan__,0.9937862546696953
153,CMLTU,CM Life Sciences III Inc. Unit,"CM Life Sciences III Inc. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.",Mr. Eli Decatur Casdin,Shell Companies,8.87,USD,0,https://images.financialmodelingprep.com/symbol/CMLTU.png,68320,0,-0.6199999,11702,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
154,CMMB,Chemomab Therapeutics Ltd. American Depositary Share,"Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.",Dr. Adi Mor George Ph.D.,Biotechnology,1.16,USD,1093683,https://images.financialmodelingprep.com/symbol/CMMB.png,365895,-1.49,0.04,78746,-14672,-13945,"[{'period': '2024', 'revenue': 0.0, 'unit': 'K', 'net_profit': -13.95}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.22}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.65}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.55}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.96}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.48}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.91}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.45}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.07}]",-0.0009,-0.0009,16964000,16040000,14266000,3427000,263000,0,3218000,6071000,-15386000,0.9994221802142407,0.9994242599397217,0.9912621359223301,__nan__,__nan__,__nan__,0.20201603395425607
155,CMPI,Checkmate Pharmaceuticals Inc. Common Stock,"Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.",Mr. Barry A. Labinger,Biotechnology,10.5,USD,0,https://images.financialmodelingprep.com/symbol/CMPI.png,233019,-3.8489736070381233,0,63651,-61339000,-61405000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -61.41}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.91}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.29}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.81}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.89}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.34}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.97}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.97}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.13}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.93}]",-6.42,-6.42,78838000,73962000,50675000,9379000,0,0,9379000,50675000,-53715000,-0.6704520697167756,-0.663731440338138,-0.6632124352331606,__nan__,__nan__,__nan__,0.11896547350262564
156,CMPR,Cimpress plc Ordinary Shares (Ireland),"Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. The company operates through five segments: Vistaprint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. It offers printed and digital marketing products; internet-based canvas-print wall décor, business signage, and other printed products; business cards; and marketing materials, such as flyers and postcards, digital and marketing services, writing instruments, decorated apparel, promotional products and gifts, packaging, design services, textiles, and magazines and catalogs. The company also manufactures and markets custom writing instruments and promotional products, apparels, and gifts; and provides professional desktop publishing skill sets for local printers, print resellers, graphic artists, advertising agencies, and other customers. In addition, it offers graphic design services, do-it-yourself (DIY) design services, website services, and corporate solutions under the VistaPrint, VistaCreate, 99designs by Vista, Vista Corporate Solutions, and Vista x Wix brand names; and online printing solutions. Further, the company provides promotional and packaging products, logo apparel, books and magazines, wall decors, photo merchandise, invitations and announcements, and other categories; and website design and hosting, and email marketing services, as well as order referral and other third-party offerings. The company serves various businesses, graphic designers, resellers, and printers, as well as teams, associations, groups, consumers, and families. Cimpress plc was founded in 1994 and is based in Dundalk, Ireland.",Mr. Robert S. Keane,Advertising Agencies,41.42,USD,1028066891,https://images.financialmodelingprep.com/symbol/CMPR.png,245098,6.93,-0.69,224301,400032000,173682000,"[{'period': '2024', 'revenue': 3290.0, 'unit': 'M', 'net_profit': 173.68}, {'period': '2023', 'revenue': 3080.0, 'unit': 'M', 'net_profit': -185.98}, {'period': '2022', 'revenue': 2890.0, 'unit': 'M', 'net_profit': -50.57}, {'period': '2021', 'revenue': 2590.0, 'unit': 'M', 'net_profit': -74.94}]","[{'period': ""Q2 '25"", 'revenue': 939.16, 'unit': 'M', 'net_profit': 61.06}, {'period': ""Q1 '25"", 'revenue': 804.97, 'unit': 'M', 'net_profit': -12.55}, {'period': ""Q4 '24"", 'revenue': 832.61, 'unit': 'M', 'net_profit': 115.0}, {'period': ""Q3 '24"", 'revenue': 780.59, 'unit': 'M', 'net_profit': -3.98}, {'period': ""Q2 '24"", 'revenue': 921.36, 'unit': 'M', 'net_profit': 58.1}, {'period': ""Q1 '24"", 'revenue': 757.29, 'unit': 'M', 'net_profit': 4.55}]",6.64,6.43,1892157000,457979000,208275000,2409063000,64576000,0,663963000,203775000,237488000,0.6327903379197466,1.933884653023476,1.9378531073446326,__nan__,__nan__,__nan__,1.273183462048868
157,CMPS,COMPASS Pathways Plc American Depository Shares,"COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.","Mr. Kabir Kumar Nath M.A., M.B.A.",Medical - Care Facilities,3.38,USD,231706487,https://images.financialmodelingprep.com/symbol/CMPS.png,1076586,-1.47,0.25,1015243,-178205000,-155122000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -155.12}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -118.46}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -91.5}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -71.74}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.33}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.5}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.1}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.19}, {'period': ""Q4 '23"", 'revenue': 3.68, 'unit': 'M', 'net_profit': -32.81}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.39}]",-2.3,-2.3,213666000,201291000,165081000,58971000,0,0,34016000,165081000,-119186000,-0.4394355503142114,-0.30944421934089683,0.008620689655172422,__nan__,__nan__,__nan__,0.2759961809553228
158,CMRX,Chimerix Inc. Common Stock,"Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.",Mr. Michael T. Andriole M.B.A.,Biotechnology,8.54,USD,801084879,https://images.financialmodelingprep.com/symbol/CMRX.png,4057565,-8.63,-0.01,755560,-96567000,-88387000,"[{'period': '2024', 'revenue': 0.212, 'unit': 'M', 'net_profit': -88.39}, {'period': '2023', 'revenue': 0.324, 'unit': 'M', 'net_profit': -82.09}, {'period': '2022', 'revenue': 33.82, 'unit': 'M', 'net_profit': 172.17}, {'period': '2021', 'revenue': 1.98, 'unit': 'M', 'net_profit': -255.79}]","[{'period': ""Q4 '24"", 'revenue': 0.057, 'unit': 'M', 'net_profit': -22.95}, {'period': ""Q3 '24"", 'revenue': 0.026000000000000002, 'unit': 'M', 'net_profit': -22.88}, {'period': ""Q2 '24"", 'revenue': 0.129, 'unit': 'M', 'net_profit': -20.68}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.87}, {'period': ""Q4 '23"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -18.16}, {'period': ""Q3 '23"", 'revenue': 0.011, 'unit': 'M', 'net_profit': -23.99}]",-0.99,-0.99,146008000,135951000,31049000,24329000,812000,8475000,23871000,31049000,-75264000,-0.03864521264009293,-0.07664291369754553,-0.064516129032258,__nan__,__nan__,__nan__,0.16662785600788999
159,CMTL,Comtech Telecommunications Corp. Common Stock,"Comtech Telecommunications Corp., together with its subsidiaries, designs, develops, produces, and markets products, systems, and services for communications solutions in the United States and internationally. It operates in two segments, Commercial Solutions and Government Solutions. The Commercial Solutions segment offers satellite ground station technologies, including single channel per carrier and time division multiple access modems, amplifiers, frequency converters, and network software to modulate, demodulate, and amplify signals, as well as to carry voice, video, and/or data over networks; and public safety and location technologies, such as 911 call handling and mapping solutions that allow cellular carriers and voice over the Internet carriers to deliver emergency calls to public safety emergency call centers. The Government Solutions segment provides tactical satellite-based networks, such as satellite modems, ruggedized routers, and solid-state drives; sustainment services for the secret Internet Protocol router and non-classified Internet Protocol router access point; and small aperture terminals. This segment also offers high-performance transmission technologies that are used in communication systems comprising electronic warfare, radar, and identification friend or foe (IFF); troposcatter technologies for satellite communication; and high-power radio frequency microwave amplifiers and related switching control technologies that are used in electronic warfare, communications, radar, IFF, and medical applications. The company serves satellite systems integrators, wireless and other communication service providers, satellite broadcasters, prime contractors and system suppliers, medical equipment companies, aviation industry system integrators, oil companies, and domestic and international defense and government customers, as well as end-customers. Comtech Telecommunications Corp. was founded in 1967 and is headquartered in Melville, New York.","Mr. Kenneth H. Traub B.A., M.B.A.",Communication Equipment,1.25,USD,36683250,https://images.financialmodelingprep.com/symbol/CMTL.png,360447,-0.13,-0.07,137066,-44814000,-99985000,"[{'period': '2024', 'revenue': 540.4, 'unit': 'M', 'net_profit': -99.98}, {'period': '2023', 'revenue': 549.99, 'unit': 'M', 'net_profit': -26.9}, {'period': '2022', 'revenue': 486.24, 'unit': 'M', 'net_profit': -33.05}, {'period': '2021', 'revenue': 581.7, 'unit': 'M', 'net_profit': -73.48}]","[{'period': ""Q2 '25"", 'revenue': 126.57, 'unit': 'M', 'net_profit': -48.74}, {'period': ""Q1 '25"", 'revenue': 115.8, 'unit': 'M', 'net_profit': -155.86}, {'period': ""Q4 '24"", 'revenue': 126.19, 'unit': 'M', 'net_profit': -77.14}, {'period': ""Q3 '24"", 'revenue': 128.08, 'unit': 'M', 'net_profit': 2.79}, {'period': ""Q2 '24"", 'revenue': 134.22, 'unit': 'M', 'net_profit': -10.56}, {'period': ""Q1 '24"", 'revenue': 151.91, 'unit': 'M', 'net_profit': -1.44}]",-4.7,-4.7,912434000,336551000,32433000,426105000,195595000,0,183547000,32433000,-77872000,-3.4018651516775646,-2.7170526785382356,-3.8958333333333335,"[0.1, 0.25]","['2023-01-17', '2010-10-20']",__nan__,0.4669981609628751
160,CNBKA,Century Bancorp Inc. Class A Common Stock,"Century Bancorp, Inc. operates as a bank holding company for Century Bank and Trust Company that provides banking products and services. The company accepts savings accounts, NOW accounts, demand deposits, time deposits, and money market accounts, as well as cash management accounts. It offers single-family and multi-family residential loans, commercial and residential real estate loans, municipal loans, and various consumer loans, as well as provides loans for the construction of residential homes, multi-family properties, commercial real estate properties, and land development. The company also provides automated lockbox collection, cash management, and account reconciliation services to corporate and institutional customers, as well as to the municipal market; and securities brokerage services. It serves commercial enterprises, state and local governments and agencies, non-profit organizations, and individuals in Massachusetts, New Hampshire, Rhode Island, Connecticut, and New York. As of March 31, 2020, the company operated 27 banking offices in 20 cities and towns in Massachusetts. Century Bancorp, Inc. was founded in 1969 and is headquartered in Medford, Massachusetts.",Mr. Barry Sloane,Banks - Regional,115.29,USD,0,https://images.financialmodelingprep.com/symbol/CNBKA.png,8905,14.288015863180071,0.0699997,11374,87753000,42209000,"[{'period': '2020', 'revenue': 124.22, 'unit': 'M', 'net_profit': 42.21}, {'period': '2019', 'revenue': 114.19, 'unit': 'M', 'net_profit': 39.7}, {'period': '2018', 'revenue': 108.82, 'unit': 'M', 'net_profit': 36.21}, {'period': '2017', 'revenue': 102.17, 'unit': 'M', 'net_profit': 22.3}]","[{'period': ""Q3 '21"", 'revenue': 34.55, 'unit': 'M', 'net_profit': 11.73}, {'period': ""Q2 '21"", 'revenue': 34.1, 'unit': 'M', 'net_profit': 10.82}, {'period': ""Q1 '21"", 'revenue': 32.77, 'unit': 'M', 'net_profit': 10.77}, {'period': ""Q4 '20"", 'revenue': 33.35, 'unit': 'M', 'net_profit': 11.6}, {'period': ""Q3 '20"", 'revenue': 31.5, 'unit': 'M', 'net_profit': 10.89}, {'period': ""Q2 '20"", 'revenue': 29.86, 'unit': 'M', 'net_profit': 10.06}]",7.58,7.58,6358834000,136735000,419183000,5988425000,13283000,2793204000,0,136735000,35999000,-0.13779144600450002,0.06322577394896597,-0.12166859791425268,"[0.18, 0.071]","['2021-09-30', '1987-07-27']",__nan__,0.9417489118288038
161,CNCE,Concert Pharmaceuticals Inc. Common Stock,"Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.",Dr. Roger D. Tung Ph.D.,Biotechnology,8.37,USD,0,https://images.financialmodelingprep.com/symbol/CNCE.png,2542039,-2.640378548895899,0,0,-73486000,-82594000,"[{'period': '2021', 'revenue': 32.58, 'unit': 'M', 'net_profit': -82.59}, {'period': '2020', 'revenue': 7.9, 'unit': 'M', 'net_profit': -74.77}, {'period': '2019', 'revenue': 1.08, 'unit': 'M', 'net_profit': -77.33}, {'period': '2018', 'revenue': 10.51, 'unit': 'M', 'net_profit': -56.02}]","[{'period': ""Q3 '22"", 'revenue': 0.008, 'unit': 'M', 'net_profit': -28.2}, {'period': ""Q2 '22"", 'revenue': 0.021, 'unit': 'M', 'net_profit': -21.41}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.43}, {'period': ""Q4 '21"", 'revenue': 0.02758, 'unit': 'M', 'net_profit': 22.59}, {'period': ""Q3 '21"", 'revenue': 0.543, 'unit': 'M', 'net_profit': -26.68}, {'period': ""Q2 '21"", 'revenue': 32.02, 'unit': 'M', 'net_profit': 5.42}]",-2.4,-2.4,165316000,150329000,143099000,53091000,218000,0,16120000,141636000,-55409000,-0.06752084604433597,-0.10469999732498729,0,__nan__,__nan__,__nan__,0.32114858815843594
162,CNDT,Conduent Incorporated Common Stock ,"Conduent Incorporated provides business process services with capabilities in transaction-intensive processing, analytics, and automation in the United States, Europe, and internationally. It operates through three segments: Commercial Industries, Government Services, and Transportation. The Commercial Industries segment offers business process services and customized solutions to clients in various industries; and end-user customer experience management, transaction processing services, healthcare and human resource, and learning services. The Government Services segment provides government-centric business process services to the United States federal, state, local, and foreign governments for public assistance, program administration, transaction processing, and payment services; medical management and fiscal agent care management services; and government healthcare, payment solutions, child support, and federal services. The Transportation segment offers systems and support comprising mission-critical mobility and payment solutions to government clients. This segment also provides electronic tolling, urban congestion management, and mileage-based user solutions; transit solutions; citation and permit administration, parking enforcement, and curbside demand management solutions; and computer-aided dispatch/automatic vehicle location solutions. Conduent Incorporated was founded in 2016 and is headquartered in Florham Park, New Jersey.",Mr. Clifford A. Skelton,Information Technology Services,1.97,USD,318805376,https://images.financialmodelingprep.com/symbol/CNDT.png,1149914,0.88,-0.08,1201000,783000000,426000000,"[{'period': '2024', 'revenue': 3360.0, 'unit': 'M', 'net_profit': 426.0}, {'period': '2023', 'revenue': 3720.0, 'unit': 'M', 'net_profit': -296.0}, {'period': '2022', 'revenue': 3860.0, 'unit': 'M', 'net_profit': -182.0}, {'period': '2021', 'revenue': 4140.0, 'unit': 'M', 'net_profit': -28.0}]","[{'period': ""Q4 '24"", 'revenue': 800.0, 'unit': 'M', 'net_profit': -12.0}, {'period': ""Q3 '24"", 'revenue': 807.0, 'unit': 'M', 'net_profit': 123.0}, {'period': ""Q2 '24"", 'revenue': 828.0, 'unit': 'M', 'net_profit': 216.0}, {'period': ""Q1 '24"", 'revenue': 921.0, 'unit': 'M', 'net_profit': 99.0}, {'period': ""Q4 '23"", 'revenue': 953.0, 'unit': 'M', 'net_profit': 6.0}, {'period': ""Q3 '23"", 'revenue': 932.0, 'unit': 'M', 'net_profit': -289.0}]",2.7,2.55,2599000000,1252000000,366000000,1756000000,493000000,0,744000000,366000000,-50000000,17.209302325581394,2.439189189189189,2.914893617021277,__nan__,__nan__,__nan__,0.6756444786456329
163,CNET,ZW Data Action Technologies Inc. Common Stock,"ZW Data Action Technologies Inc., through its subsidiaries, provides omni-channel advertising, precision marketing, and data analysis management systems in the People's Republic of China. It offers Internet advertising, precision marketing, and related data services through its Internet portals, including 28.com and liansuo.com that provide advertisers with tools to build sales channels in the form of franchisees, sales agents, distributors, and/or resellers. The company also develops and operates blockchain technology-based products and services. In addition, it provides other e-commerce online to offline advertising and marketing and related value-added technical services, as well as strategic corporation management services. The company was formerly known as ChinaNet Online Holdings, Inc. and changed its name to ZW Data Action Technologies Inc. in October 2020. ZW Data Action Technologies Inc. was founded in 2003 and is headquartered in Beijing, the People's Republic of China.",Mr. Handong  Cheng,Advertising Agencies,1.55,USD,3566868,https://images.financialmodelingprep.com/symbol/CNET.png,13032,-0.57,0.06,1112,-3757000,-3761000,"[{'period': '2024', 'revenue': 15.44, 'unit': 'M', 'net_profit': -3.76}, {'period': '2023', 'revenue': 30.59, 'unit': 'M', 'net_profit': -5.97}, {'period': '2022', 'revenue': 26.23, 'unit': 'M', 'net_profit': -9.79}, {'period': '2021', 'revenue': 47.33, 'unit': 'M', 'net_profit': -2.69}]","[{'period': ""Q3 '24"", 'revenue': 3.24, 'unit': 'M', 'net_profit': -1.91}, {'period': ""Q2 '24"", 'revenue': 6420.0, 'unit': 'K', 'net_profit': -216.0}, {'period': ""Q1 '24"", 'revenue': 3530.0, 'unit': 'K', 'net_profit': -850.0}, {'period': ""Q4 '23"", 'revenue': 5.27, 'unit': 'M', 'net_profit': -1.91}, {'period': ""Q3 '23"", 'revenue': 9.18, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q2 '23"", 'revenue': 9.82, 'unit': 'M', 'net_profit': -1.4}]",-1.86,-1.86,1334000,1249000,24000,3663000,34000,0,3663000,24000,-2058000,-0.2007031000319591,0.37043856712420486,0.43975903614457823,__nan__,__nan__,__nan__,2.7458770614692654
164,CNEY,CN Energy Group Inc. Ordinary Shares,"CN Energy Group. Inc. manufactures and supplies wood-based activated carbon in China. The company's activated carbon is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production. It also produces biomass electricity for State Grid Heilongjiang, a subsidiary of State Grid Corporation of China in Heilongjiang Province. The company was incorporated in 2018 and is based in Lishui, China.",Mr. Wenhua  Liu,Chemicals - Specialty,0.1155,USD,786816,https://images.financialmodelingprep.com/symbol/CNEY.png,3067647,-0.03,-0.0043,266127,-11100885,-14040769,"[{'period': '2024', 'revenue': 50.96, 'unit': 'M', 'net_profit': -14.04}, {'period': '2023', 'revenue': 57.9, 'unit': 'M', 'net_profit': -5.63}, {'period': '2022', 'revenue': 40.21, 'unit': 'M', 'net_profit': 2.23}, {'period': '2021', 'revenue': 19.85, 'unit': 'M', 'net_profit': 1.3}]","[{'period': ""Q4 '24"", 'revenue': 9.84, 'unit': 'M', 'net_profit': -5.54}, {'period': ""Q3 '24"", 'revenue': 9.84, 'unit': 'M', 'net_profit': -5.54}, {'period': ""Q2 '24"", 'revenue': 15.64, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q1 '24"", 'revenue': 15.64, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q4 '23"", 'revenue': 17610.0, 'unit': 'K', 'net_profit': -727.28}, {'period': ""Q3 '23"", 'revenue': 17610.0, 'unit': 'K', 'net_profit': -727.28}]",-7.79,-7.79,98362506,61498560,317323,1450089,30499709,0,1450089,317323,-2371172,-3.6730415623384562,-1.495808373653955,-1.4967948717948718,__nan__,__nan__,__nan__,0.01474229418270413
165,CNFR,Conifer Holdings Inc. Common Stock,"Conifer Holdings, Inc., an insurance holding company, engages in the sale of property and casualty insurance products. It offers insurance coverage in specialty commercial and personal product lines. The company underwrites various specialty insurance products, including property, general liability, liquor liability, automobile, and homeowners and dwelling policies. It serves the commercial insurance needs of owner-operated businesses in the markets, such as hospitality, which includes restaurants, bars, taverns, and bowling centers, as well as small grocery and convenience stores; artisan contractors comprising plumbers, painters, carpenters, electricians, and other independent contractors; and security service providers, including companies that provide security guard services, security alarm products and services, and private investigative services. The company also offers specialty homeowners insurance products, such as low- value dwelling insurance tailored for owners of lower valued homes in Illinois, Indiana, Louisiana, and Texas; and wholesale agency services comprising commercial and personal lines insurance products for its insurance company subsidiaries, as well as third party insurers. Conifer Holdings, Inc. markets and sells its insurance products through a network of approximately 4,600 independent agents in 50 states in the United States. The company was incorporated in 2009 and is headquartered in Birmingham, Michigan.","Mr. Brian Joseph Roney B.A., B.S., M.B.A.",Insurance - Property & Casualty,0.6037,USD,7378953,https://images.financialmodelingprep.com/symbol/CNFR.png,15837,-0.21,0.0017,3150,-29526000,24347000,"[{'period': '2024', 'revenue': 66.3, 'unit': 'M', 'net_profit': 24.35}, {'period': '2023', 'revenue': 98.76, 'unit': 'M', 'net_profit': -25.9}, {'period': '2022', 'revenue': 104.89, 'unit': 'M', 'net_profit': -10.68}, {'period': '2021', 'revenue': 115.96, 'unit': 'M', 'net_profit': -1.09}]","[{'period': ""Q4 '24"", 'revenue': 13.75, 'unit': 'M', 'net_profit': -25.38}, {'period': ""Q3 '24"", 'revenue': 16.02, 'unit': 'M', 'net_profit': 53.29}, {'period': ""Q2 '24"", 'revenue': 26.85, 'unit': 'M', 'net_profit': -3.79}, {'period': ""Q1 '24"", 'revenue': 23080.0, 'unit': 'K', 'net_profit': 231.0}, {'period': ""Q4 '23"", 'revenue': 21.14, 'unit': 'M', 'net_profit': -19.46}, {'period': ""Q3 '23"", 'revenue': 28.12, 'unit': 'M', 'net_profit': -2.71}]",0.002,0.002,281656000,37555000,27654000,260131000,9901000,128419000,1000,27654000,-32679000,-0.34865025350568674,1.9398934527486102,1.000943396226415,__nan__,__nan__,__nan__,0.9235769875308888
166,CNFRL,Conifer Holdings Inc. 6.75% Senior Unsecured Notes due 2023,,None,,24.05,USD,0,https://images.financialmodelingprep.com/symbol/CNFRL.png,3988,0,-0.73,596,-29526000,24347000,"[{'period': '2024', 'revenue': 66.3, 'unit': 'M', 'net_profit': 24.35}, {'period': '2023', 'revenue': 98.76, 'unit': 'M', 'net_profit': -25.9}, {'period': '2022', 'revenue': 104.89, 'unit': 'M', 'net_profit': -10.68}, {'period': '2021', 'revenue': 115.96, 'unit': 'M', 'net_profit': -1.09}]","[{'period': ""Q4 '24"", 'revenue': 13.75, 'unit': 'M', 'net_profit': -25.38}, {'period': ""Q3 '24"", 'revenue': 16.02, 'unit': 'M', 'net_profit': 53.29}, {'period': ""Q2 '24"", 'revenue': 26.85, 'unit': 'M', 'net_profit': -3.79}, {'period': ""Q1 '24"", 'revenue': 23080.0, 'unit': 'K', 'net_profit': 231.0}, {'period': ""Q4 '23"", 'revenue': 21.14, 'unit': 'M', 'net_profit': -19.46}, {'period': ""Q3 '23"", 'revenue': 28.12, 'unit': 'M', 'net_profit': -2.71}]",0.002,0.002,281656000,37555000,27654000,260131000,9901000,128419000,1000,27654000,-32679000,-0.34865025350568674,1.9398934527486102,1.000943396226415,"[0.42188, 0.422]","['2023-09-14', '2019-03-14']",__nan__,0.9235769875308888
167,CNNB,Cincinnati Bancorp Inc. Common Stock,"Cincinnati Bancorp, Inc. operates as the holding company for Cincinnati Federal that provides various banking and financial services to individuals and businesses in the United States. The company offers various deposit accounts, including demand accounts, checking accounts, savings accounts, certificate of deposit accounts, and individual retirement accounts. Its loan portfolio comprises one- to four-family residential real estate loans; nonresidential real estate and multi-family loans; home equity loans and lines of credit; construction and land loans; commercial business loans; and consumer loans. The company also invests in securities, primarily mortgage-backed securities. It operates full-service branch offices in Miami Heights, Anderson, and Price Hill, as well as in Covington and Florence in Northern Kentucky. The company was formerly known as CF Bancorp and changed its name to Cincinnati Bancorp in March 2015. Cincinnati Bancorp was founded in 1922 and is based in Cincinnati, Ohio.",Mr. Robert A. Bedinghaus,Banks - Regional,13.1925,USD,0,https://images.financialmodelingprep.com/symbol/CNNB.png,2315,42.556451612903224,0.0425,100,3870002,1416818,"[{'period': '2022', 'revenue': 12.85, 'unit': 'M', 'net_profit': 1.42}, {'period': '2021', 'revenue': 15.44, 'unit': 'M', 'net_profit': 1.65}, {'period': '2020', 'revenue': 15.44, 'unit': 'M', 'net_profit': 3.16}, {'period': '2019', 'revenue': 8350.0, 'unit': 'K', 'net_profit': 798.47}]","[{'period': ""Q2 '23"", 'revenue': 2370.0, 'unit': 'K', 'net_profit': -434.79}, {'period': ""Q1 '23"", 'revenue': 2920.0, 'unit': 'K', 'net_profit': 287.61}, {'period': ""Q4 '22"", 'revenue': 2670.0, 'unit': 'K', 'net_profit': 134.19}, {'period': ""Q3 '22"", 'revenue': 3980.0, 'unit': 'K', 'net_profit': 867.56}, {'period': ""Q2 '22"", 'revenue': 2890.0, 'unit': 'K', 'net_profit': 66.25}, {'period': ""Q1 '22"", 'revenue': 3320.0, 'unit': 'K', 'net_profit': 348.82}]",0.52,0.51,303155338,24677364,21491260,263322318,3186104,6366581,79550,15124679,6295335,0.6602852257000008,-0.14056403711396237,-0.11864406779661009,"[1, 1]","['2022-04-29', '2022-04-29']",__nan__,0.8686052494975365
168,CNOB,ConnectOne Bancorp Inc. Common Stock,"ConnectOne Bancorp, Inc. operates as the bank holding company for ConnectOne Bank that provides commercial banking products and services for small and mid-sized businesses, local professionals, and individuals in the Northern New Jersey and New York Metropolitan area, and South Florida market. The company offers personal and business checking, retirement, money market, and time and savings accounts. It also provides consumer and commercial business loans on a secured and unsecured basis; revolving lines of credit; commercial mortgage loans; residential mortgages on primary and secondary residences; home equity loans; bridge loans; other personal purpose loans; and commercial construction and real estate loans. In addition, the company offers check cards, ATM cards, credit cards, wire transfers, access to automated teller services, Internet banking, treasury direct, automated clearing house origination, mobile banking by phone, safe deposit boxes, and remote deposit capture services. It operates through a network of eight banking offices in Bergen County, five banking offices in Union County, one banking office in Morris County, one office in Essex County, one office in Hudson County, one office in Monmouth County, one banking office in Manhattan in New York City, one office in Nassau County on Long Island, one in Astoria, and five branches in the Hudson Valley, as well as one financial center in West Palm Beach in Palm Beach County. The company was formerly known as Center Bancorp, Inc. and changed its name to ConnectOne Bancorp, Inc. in July 2014. ConnectOne Bancorp, Inc. was incorporated in 1982 and is headquartered in Englewood Cliffs, New Jersey.",Mr. Frank S. Sorrentino III,Banks - Regional,21.38,USD,822488066,https://images.financialmodelingprep.com/symbol/CNOB.png,202039,12.15,-0.18,199244,0,73793000,"[{'period': '2024', 'revenue': 517.89, 'unit': 'M', 'net_profit': 73.79}, {'period': '2023', 'revenue': 269.11, 'unit': 'M', 'net_profit': 87.0}, {'period': '2022', 'revenue': 315.36, 'unit': 'M', 'net_profit': 125.21}, {'period': '2021', 'revenue': 277.89, 'unit': 'M', 'net_profit': 130.35}]","[{'period': ""Q4 '24"", 'revenue': 68.45, 'unit': 'M', 'net_profit': 20.37}, {'period': ""Q3 '24"", 'revenue': 65.62, 'unit': 'M', 'net_profit': 17.16}, {'period': ""Q2 '24"", 'revenue': 134.41, 'unit': 'M', 'net_profit': 19.06}, {'period': ""Q1 '24"", 'revenue': 133.46, 'unit': 'M', 'net_profit': 17.2}, {'period': ""Q4 '23"", 'revenue': 133.17, 'unit': 'M', 'net_profit': 19.27}, {'period': ""Q3 '23"", 'revenue': 65.92, 'unit': 'M', 'net_profit': 21.41}]",1.77,1.76,9879600000,8908286000,670663000,8637896000,8237623000,0,15498000,57816000,60700000,-1,-0.15183384480994908,-0.14492753623188398,"[0.18, 0.3]","['2025-02-18', '1994-04-12']",__nan__,0.8743163690837685
169,CNSL,Consolidated Communications Holdings Inc. Common Stock,"Consolidated Communications Holdings, Inc., together with its subsidiaries, provides broadband and business communication solutions for consumer, commercial, and carrier channels in the United States. It offers high-speed broadband Internet access and voice over Internet protocol (VoIP) phone services; commercial data connectivity services in various markets, including Ethernet services, private line data services, software defined wide area network, and multi-protocol label switching services; networking services; cloud-based services; data center and disaster recovery solutions; and wholesale services to regional and national interexchange, and wireless carriers comprising cellular backhaul and other fiber transport solutions. The company also provides voice services, such as local phone and long-distance services; and sells business equipment, as well as offers related hardware and maintenance support, video, and other miscellaneous services. In addition, it offers video services, which consist of high-definition television, digital video recorders (DVR), and/or a whole home DVR; and on-demand streaming TV services that provide endless entertainment options. Further, the company provides network access services that include interstate and intrastate switched access, network special access, and end user access; and telephone directory publishing, video advertising, billing and support, and other miscellaneous services. Consolidated Communications Holdings, Inc. was founded in 1894 and is headquartered in Mattoon, Illinois.",Mr. C. Robert Udell Jr.,Telecommunications Services,4.64,USD,549691520,https://images.financialmodelingprep.com/symbol/CNSL.png,461661,-2.2745098039215685,-0.01,324699,175458000,-250514000,"[{'period': '2023', 'revenue': 1110.0, 'unit': 'M', 'net_profit': -250.51}, {'period': '2022', 'revenue': 1190.0, 'unit': 'M', 'net_profit': -177.7}, {'period': '2021', 'revenue': 1280.0, 'unit': 'M', 'net_profit': -106.69}, {'period': '2020', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 36.98}]","[{'period': ""Q3 '24"", 'revenue': 271.09, 'unit': 'M', 'net_profit': -49.07}, {'period': ""Q2 '24"", 'revenue': 268.71, 'unit': 'M', 'net_profit': -54.97}, {'period': ""Q1 '24"", 'revenue': 274.68, 'unit': 'M', 'net_profit': -35.5}, {'period': ""Q4 '23"", 'revenue': 275.18, 'unit': 'M', 'net_profit': -47.3}, {'period': ""Q3 '23"", 'revenue': 283.65, 'unit': 'M', 'net_profit': -69.16}, {'period': ""Q2 '23"", 'revenue': 275.16, 'unit': 'M', 'net_profit': -108.25}]",-2.6,-2.6,3628426000,256154999,4765000,2849062001,124074000,6027000,317245000,4765000,-400448000,-0.5069299251365752,-0.40972628640885966,-0.6352201257861635,"[0.38738, 0.4089]","['2019-04-12', '2005-10-12']",__nan__,0.7852060372734624
170,CNSP,CNS Pharmaceuticals Inc. Common Stock,"CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.","Mr. John Michael Climaco Esq., J.D.",Biotechnology,0.8989,USD,2646704,https://images.financialmodelingprep.com/symbol/CNSP.png,543358,,0.0789,178424,-14901943,-14857801,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.86}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.85}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.27}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.5}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.18}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.61}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.53}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.54}, {'period': ""Q4 '23"", 'revenue': 0.00636, 'unit': 'M', 'net_profit': -5.38}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.52}]",-38.87,-38.87,8700943,8658508,6461378,2524332,882539,0,2524332,6461378,-17117487,0.20990596774058434,0.21183900718181406,0.8453550825542072,__nan__,__nan__,__nan__,0.29012165692845016
171,CNST,Constellation Pharmaceuticals Inc. Common Stock,"Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Its lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib; and CPI-1205 that is in Phase Ib/II clinical trials for metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors. The company is also developing CPI-0209 that is in Phase I dose escalation portion of a Phase I/II clinical trial to treat solid tumors. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.",Mr. Jigar Raythatha,Biotechnology,33.99,USD,0,https://images.financialmodelingprep.com/symbol/CNST.png,1573175,0,0,1269201,-122812000,-126357000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -126.36}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -85.55}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -59.92}, {'period': '2017', 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.38}]","[{'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.07}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.38}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.78}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.75}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.44}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.21}]",-4.49,-4.49,441854000,428609000,421448000,31130000,0,257755000,30548000,163693000,-112370000,-0.48587468089482533,-0.4769959088252484,-0.4769736842105264,__nan__,__nan__,__nan__,0.07045313610378089
172,CNTB,Connect Biopharma Holdings Limited American Depositary Shares,"Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.",Dr. Barry D. Quart Pharm.D.,Biotechnology,0.745,USD,41235154,https://images.financialmodelingprep.com/symbol/CNTB.png,98119,-2.66,-0.0286,96366,-22452000,-15628000,"[{'period': '2024', 'revenue': 26.03, 'unit': 'M', 'net_profit': -15.63}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -59.5}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -116.42}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -205.21}]","[{'period': ""Q2 '24"", 'revenue': 24.12, 'unit': 'M', 'net_profit': 7.65}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.92}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.58}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -56.68}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -59.74}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -56.65}]",-0.28,-0.28,101284000,96961000,93708000,9118000,1051000,0,8462000,78232000,-24362000,0.6153635304598095,0.7373577802799859,0.7407407407407407,__nan__,__nan__,__nan__,0.09002409067572371
173,CNTG,Centogene N.V. Common Shares,"Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.",Ms. Kim  Stratton,Medical - Diagnostics & Research,0.325,USD,9425033,https://images.financialmodelingprep.com/symbol/CNTG.png,220749,-0.23381294964028776,0,7229138,-19434000,-35532000,"[{'period': '2023', 'revenue': 48.54, 'unit': 'M', 'net_profit': -35.53}, {'period': '2022', 'revenue': 47.47, 'unit': 'M', 'net_profit': -31.84}, {'period': '2021', 'revenue': 42.23, 'unit': 'M', 'net_profit': -46.25}, {'period': '2020', 'revenue': 38.45, 'unit': 'M', 'net_profit': -21.38}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '23"", 'revenue': 12.31, 'unit': 'M', 'net_profit': -12.23}, {'period': ""Q1 '23"", 'revenue': 12.31, 'unit': 'M', 'net_profit': -12.23}, {'period': ""Q4 '22"", 'revenue': 13.04, 'unit': 'M', 'net_profit': -7.82}, {'period': ""Q3 '22"", 'revenue': 13.04, 'unit': 'M', 'net_profit': -7.82}, {'period': ""Q2 '22"", 'revenue': 11.2, 'unit': 'M', 'net_profit': -10.35}]",-1.27,-1.26,77155000,44019000,18174000,102437000,19415000,2784000,43366000,18174000,-34028000,0.21150647137582668,-0.11591972613925441,-0.14414414414414406,__nan__,__nan__,__nan__,1.3276780506772081
174,CNTY,Century Casinos Inc. Common Stock,"Century Casinos, Inc. operates as a casino entertainment company in the United States, Canada, and Poland. The company develops and operates gaming establishments, as well as related lodging, restaurant, horse racing, and entertainment facilities. As of March 8, 2022, it operated two ship-based casinos. The company was founded in 1992 and is based in Colorado Springs, Colorado.",Dr. Erwin  Haitzmann,"Gambling, Resorts & Casinos",1.35,USD,41421515,https://images.financialmodelingprep.com/symbol/CNTY.png,92954,-0.32,0.01,57923,65838000,-128170000,"[{'period': '2024', 'revenue': 575.92, 'unit': 'M', 'net_profit': -128.17}, {'period': '2023', 'revenue': 550.21, 'unit': 'M', 'net_profit': -28.2}, {'period': '2022', 'revenue': 430.53, 'unit': 'M', 'net_profit': 13.67}, {'period': '2021', 'revenue': 388.51, 'unit': 'M', 'net_profit': 20.62}]","[{'period': ""Q4 '24"", 'revenue': 137.77, 'unit': 'M', 'net_profit': -64.89}, {'period': ""Q3 '24"", 'revenue': 155.7, 'unit': 'M', 'net_profit': -8.12}, {'period': ""Q2 '24"", 'revenue': 146.44, 'unit': 'M', 'net_profit': -41.61}, {'period': ""Q1 '24"", 'revenue': 136.02, 'unit': 'M', 'net_profit': -13.54}, {'period': ""Q4 '23"", 'revenue': 143.76, 'unit': 'M', 'net_profit': -10.82}, {'period': ""Q3 '23"", 'revenue': 161.18, 'unit': 'M', 'net_profit': -14.18}]",-4.19,-4.19,1226312000,135549000,98769000,1144308000,11097000,0,86044000,98769000,-62534000,-0.42928224687933425,-3.5453578267962267,-3.5053763440860215,__nan__,__nan__,__nan__,0.9331295787695137
175,CNXC,Concentrix Corporation Common Stock,"Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; digital transformation; and voice of the customer and analytics solutions. The company's clients include consumer electronics, technology, e-commerce, and health insurance companies, as well as global IPOs, social brands, and banks. Concentrix Corporation was incorporated in 2009 and is based in Fremont, California.",Mr. Christopher A. Caldwell,Information Technology Services,46.87,USD,2994218520,https://images.financialmodelingprep.com/symbol/CNXC.png,967362,11.75,-0.46,590172,596387000,251217000,"[{'period': '2024', 'revenue': 9620.0, 'unit': 'M', 'net_profit': 251.22}, {'period': '2023', 'revenue': 7110.0, 'unit': 'M', 'net_profit': 313.84}, {'period': '2022', 'revenue': 6320.0, 'unit': 'M', 'net_profit': 435.05}, {'period': '2021', 'revenue': 5590.0, 'unit': 'M', 'net_profit': 405.58}]","[{'period': ""Q1 '25"", 'revenue': 2370.0, 'unit': 'M', 'net_profit': 70.26}, {'period': ""Q4 '24"", 'revenue': 2450.0, 'unit': 'M', 'net_profit': 115.65}, {'period': ""Q3 '24"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': 16.63}, {'period': ""Q2 '24"", 'revenue': 2380.0, 'unit': 'M', 'net_profit': 66.83}, {'period': ""Q1 '24"", 'revenue': 2400.0, 'unit': 'M', 'net_profit': 52.1}, {'period': ""Q4 '23"", 'revenue': 2230.0, 'unit': 'M', 'net_profit': 69.49}]",3.72,3.71,11991438000,2842424000,240571000,7951714000,1926737000,0,1995813000,240571000,428730000,-0.3864148210183226,-0.1995430821878525,-0.3496503496503496,"[0.33275, 0.25]","['2025-04-25', '2021-10-21']",__nan__,0.663115966575485
176,CNXN,PC Connection Inc. Common Stock,"PC Connection, Inc., together with its subsidiaries, provides various information technology (IT) solutions. The company operates through three segments: Business Solutions, Enterprise Solutions, and Public Sector Solutions. It offers IT products, including computer systems, data center solutions, software and peripheral equipment, networking communications, and other products and accessories, as well as provides services related to design, configuration, and implementation of IT solutions. The company markets its products and services through its websites comprising connection.com, connection.com/enterprise, connection.com/publicsector, and macconnection.com. It serves small to medium-sized businesses (SMBs) that include small office/home office customers; government and educational institutions; and medium-to-large corporate accounts through outbound telemarketing and field sales, and marketing programs targeted to specific customer populations, as well as through digital, web, and print media advertising. The company was founded in 1982 and is headquartered in Merrimack, New Hampshire.",Mr. Timothy J. McGrath,Technology Distributors,58.9,USD,1524008050,https://images.financialmodelingprep.com/symbol/CNXN.png,136427,17.9,-1.19,74024,97062000,87095000,"[{'period': '2024', 'revenue': 2800.0, 'unit': 'M', 'net_profit': 87.09}, {'period': '2023', 'revenue': 2850.0, 'unit': 'M', 'net_profit': 83.27}, {'period': '2022', 'revenue': 3120.0, 'unit': 'M', 'net_profit': 89.22}, {'period': '2021', 'revenue': 2890.0, 'unit': 'M', 'net_profit': 69.91}]","[{'period': ""Q4 '24"", 'revenue': 708.9, 'unit': 'M', 'net_profit': 20.72}, {'period': ""Q3 '24"", 'revenue': 724.72, 'unit': 'M', 'net_profit': 27.06}, {'period': ""Q2 '24"", 'revenue': 736.48, 'unit': 'M', 'net_profit': 26.16}, {'period': ""Q1 '24"", 'revenue': 632.02, 'unit': 'M', 'net_profit': 13.15}, {'period': ""Q4 '23"", 'revenue': 696.47, 'unit': 'M', 'net_profit': 23.78}, {'period': ""Q3 '23"", 'revenue': 693.09, 'unit': 'M', 'net_profit': 25.6}]",3.31,3.29,1299354000,1166850000,442613000,388364000,611433000,0,371205000,178318000,173868000,-0.17899224347208242,0.04592234991773847,0.04416403785488963,"[0.15, 0.4]","['2025-02-25', '2011-11-22']",__nan__,0.29889006383171945
177,COCP,Cocrystal Pharma Inc. Common Stock,"Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington.",Dr. Sam  Lee Ph.D.,Biotechnology,1.3354,USD,13586079,https://images.financialmodelingprep.com/symbol/COCP.png,21540,-0.78,0.0254,20917,-17878000,-17504000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.5}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.98}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.84}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.19}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.27}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.94}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.34}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.96}, {'period': ""Q4 '23"", 'revenue': 0.14400000000000002, 'unit': 'M', 'net_profit': -4.46}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.17}]",-1.72,-1.72,13456000,11580000,9860000,3933000,1215000,0,2428000,9860000,-16493000,0.07712161883130292,0.026690391459074734,-904.2631578947369,__nan__,__nan__,__nan__,0.2922859690844233
178,CODA,Coda Octopus Group Inc. Common stock,"Coda Octopus Group, Inc., together with its subsidiaries, develops and sells underwater technologies and equipment for 3D imaging, mapping, defense, and survey applications in the Americas, Europe, Australia, Asia, the Middle East, and Africa. The company operates through two segments, Marine Engineering Business and Marine Technology Business. It sells technology solutions to the subsea and underwater markets. The company's solutions include geophysical systems, a geophysical data acquisition systems, processing, and analysis software that are used primarily by survey companies, offshore renewable companies, research institutions, and salvage companies; GNSS-aided navigation systems; Echoscope and Echoscope PIPE used for real time monitoring of cable installations for offshore wind projects; and diver augmented vision display system. It offers CodaOctopus GeoSurvey products, such as hardware and software solutions for field acquisition of sidescan sonar and sub-bottom profiler; and CodaOctopus DA4G productivity suite of software that automates the tasks of analyzing, annotating, and mosaicing complex data sets. It markets its products under the CodaOctopus brand name. Coda Octopus Group, Inc. was founded in 1994 and is headquartered in Orlando, Florida.","Ms. Annmarie  Gayle LL.B, LLM",Aerospace & Defense,6.27,USD,70413655,https://images.financialmodelingprep.com/symbol/CODA.png,25563,18.44,-0.03,5360,4443048,3645996,"[{'period': '2024', 'revenue': 20.32, 'unit': 'M', 'net_profit': 3.65}, {'period': '2023', 'revenue': 19.35, 'unit': 'M', 'net_profit': 3.12}, {'period': '2022', 'revenue': 22.23, 'unit': 'M', 'net_profit': 4.3}, {'period': '2021', 'revenue': 21.33, 'unit': 'M', 'net_profit': 4.95}]","[{'period': ""Q1 '25"", 'revenue': 5210.0, 'unit': 'K', 'net_profit': 912.98}, {'period': ""Q4 '24"", 'revenue': 5060.0, 'unit': 'K', 'net_profit': 326.21}, {'period': ""Q3 '24"", 'revenue': 5.48, 'unit': 'M', 'net_profit': 1.27}, {'period': ""Q2 '24"", 'revenue': 5.32, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q1 '24"", 'revenue': 4460.0, 'unit': 'K', 'net_profit': 629.89}, {'period': ""Q4 '23"", 'revenue': 3560.0, 'unit': 'K', 'net_profit': -320.96}]",0.33,0.32,57544544,42982015,22479072,4416021,5926495,0,3897016,2451675,367928,0.08664872154456532,0.16703652738713806,0.17857142857142852,__nan__,__nan__,__nan__,0.07674091569828062
179,CODX,Co-Diagnostics Inc. Common Stock,"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.",Mr. Dwight H. Egan,Medical - Devices,0.3552,USD,11925003,https://images.financialmodelingprep.com/symbol/CODX.png,192157,-0.29,0.0078,14757,-38704044,-37639008,"[{'period': '2024', 'revenue': 3.92, 'unit': 'M', 'net_profit': -37.64}, {'period': '2023', 'revenue': 6.81, 'unit': 'M', 'net_profit': -35.33}, {'period': '2022', 'revenue': 34.22, 'unit': 'M', 'net_profit': -14.24}, {'period': '2021', 'revenue': 97.89, 'unit': 'M', 'net_profit': 36.66}]","[{'period': ""Q4 '24"", 'revenue': 0.14932, 'unit': 'M', 'net_profit': -11.03}, {'period': ""Q3 '24"", 'revenue': 0.64114, 'unit': 'M', 'net_profit': -9.7}, {'period': ""Q2 '24"", 'revenue': 0.1611, 'unit': 'M', 'net_profit': -7.6}, {'period': ""Q1 '24"", 'revenue': 0.25275000000000003, 'unit': 'M', 'net_profit': -9.31}, {'period': ""Q4 '23"", 'revenue': 3.56, 'unit': 'M', 'net_profit': -14.68}, {'period': ""Q3 '23"", 'revenue': 2.46, 'unit': 'M', 'net_profit': -5.98}]",-1.24,-1.24,63999919,32291698,29747642,9688001,132570,0,7315718,2936544,-29903397,0.06682737097523951,-0.06526906323616836,-0.03333333333333337,__nan__,__nan__,__nan__,0.15137520720924663
180,COFS,ChoiceOne Financial Services Inc. Common Stock,"ChoiceOne Financial Services, Inc. operates as the bank holding company for ChoiceOne Bank that provides community banking services to corporations, partnerships, and individuals in Michigan. The company offers various deposit products, including time, savings, and demand deposits, safe deposit, and automated transaction machine services. It also provides commercial loans, such as business, industry, agricultural, construction, inventory, and real estate loans; and consumer loans comprising direct and indirect loans to consumers and purchasers of residential and real properties. In addition, the company offers safe deposit and automated transaction machine services; and alternative investment products, including annuities and mutual funds, as well as sells insurance policies, such as life and health for commercial and consumer clients. It operates 32 full-service offices in Kent, Muskegon, Newaygo, and Ottawa, Lapeer, Macomb, and St. Clair counties, Michigan. The company also operates three loan production offices. ChoiceOne Financial Services, Inc. was founded in 1898 and is headquartered in Sparta, Michigan.",Mr. Kelly J. Potes CFP,Banks - Regional,26.25,USD,393093750,https://images.financialmodelingprep.com/symbol/COFS.png,48622,8.08,-0.14,71080,0,26727000,"[{'period': '2024', 'revenue': 121.1, 'unit': 'M', 'net_profit': 26.73}, {'period': '2023', 'revenue': 80.79, 'unit': 'M', 'net_profit': 21.26}, {'period': '2022', 'revenue': 81.39, 'unit': 'M', 'net_profit': 23.64}, {'period': '2021', 'revenue': 79.83, 'unit': 'M', 'net_profit': 22.04}]","[{'period': ""Q4 '24"", 'revenue': 24.34, 'unit': 'M', 'net_profit': 7.16}, {'period': ""Q3 '24"", 'revenue': 25.11, 'unit': 'M', 'net_profit': 7.35}, {'period': ""Q2 '24"", 'revenue': 22.45, 'unit': 'M', 'net_profit': 6.59}, {'period': ""Q1 '24"", 'revenue': 20.52, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q4 '23"", 'revenue': 20.6, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q3 '23"", 'revenue': 19.93, 'unit': 'M', 'net_profit': 5.12}]",3.09,3.13,2723243000,575518000,575518000,2462828000,0,0,155000000,96401000,48646000,0,0.25709044729786934,0.09574468085106384,"[0.28, 0.17001]","['2025-03-14', '2001-09-11']",__nan__,0.90437320503532
181,COGT,Cogent Biosciences Inc. Common Stock,"Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.",Mr. Andrew R. Robbins M.B.A.,Biotechnology,4.3,USD,489555387,https://images.financialmodelingprep.com/symbol/COGT.png,1420878,-2.22,-0.07,923651,-275939000,-255859000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -255.86}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -192.41}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -132.64}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -71.81}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -67.93}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -70.63}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.95}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.35}, {'period': ""Q4 '23"", 'revenue': 5.59, 'unit': 'M', 'net_profit': -54.37}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.38}]",-3.49,-3.49,327898000,296472000,287077000,71612000,0,0,55710000,98165000,-207791000,-0.3404206742446323,-0.32975936801621536,-0.44214876033057865,__nan__,__nan__,__nan__,0.21839718449029882
182,COHR,Coherent Inc. Common Stock,"Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a range of commercial, industrial, and scientific research applications. It operates in two segments, Original Equipment Manufacturers (OEM) Laser Sources and Industrial Lasers & Systems. The company designs, manufactures, markets, and services lasers, laser tools, precision optics, and related accessories; and laser measurement and control products. Its products are used for applications in microelectronics, materials processing, OEM components and instrumentation, and scientific research and government programs. The company markets its products through a direct sales force in the United States, as well as through direct sales personnel and independent representatives internationally. Coherent, Inc. was founded in 1966 and is headquartered in Santa Clara, California. As of July 1, 2022, Coherent, Inc. operates as a subsidiary of II-VI Incorporated.",Mr. James Robert Anderson,"Hardware, Equipment & Parts",52.12,USD,8076880457,https://images.financialmodelingprep.com/symbol/COHR.png,4475916,-130.3,-3.17,2726412,682936000,-279511000,"[{'period': '2024', 'revenue': 4710.0, 'unit': 'M', 'net_profit': -279.51}, {'period': '2023', 'revenue': 5160.0, 'unit': 'M', 'net_profit': -259.46}, {'period': '2022', 'revenue': 3320.0, 'unit': 'M', 'net_profit': 234.76}, {'period': '2021', 'revenue': 3110.0, 'unit': 'M', 'net_profit': 297.55}]","[{'period': ""Q2 '25"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 103.39}, {'period': ""Q1 '25"", 'revenue': 1350.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '24"", 'revenue': 1310.0, 'unit': 'M', 'net_profit': -79.85}, {'period': ""Q3 '24"", 'revenue': 1210.0, 'unit': 'M', 'net_profit': -13.19}, {'period': ""Q2 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': -26.99}, {'period': ""Q1 '24"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': -67.53}]",-1.84,-1.84,14488634000,3660099000,926033000,6542355000,875451000,0,1343767000,926033000,198915000,0.11408627392124972,-0.07728803891188554,0.3720136518771331,"[1, 1]","['2012-12-17', '2012-12-17']",__nan__,0.4515508501353544
183,COHU,Cohu Inc. Common Stock,"Cohu, Inc., through its subsidiaries, provides semiconductor test equipment and services in China, the United States, Taiwan, Malaysia, the Philippines, and internationally. The company supplies semiconductor test and inspection handlers, micro-electromechanical system (MEMS) test modules, test contactors, thermal sub-systems, and semiconductor automated test equipment for semiconductor and electronics manufacturers, and test subcontractors. It also provides semiconductor automated test equipment for wafer level and device package testing; various test handlers, including pick-and-place, turret, gravity, strip, and MEMS and thermal sub-systems; interface products comprising test contactors, and probe heads and pins; spares and kits; various parts and labor warranties on test and handling systems, and instruments; and training on the maintenance and operation of its systems, as well as application, data management software, and consulting services on its products. In addition, the company offers data analytics product that includes DI-Core, a software suite used to optimize Cohu equipment performance, which provides real-time online performance monitoring and process control. It markets its products through direct sales force and independent sales representatives. The company was formerly known as Cohu Electronics, Inc. and changed its name to Cohu, Inc. in 1972. Cohu, Inc. was incorporated in 1947 and is headquartered in Poway, California.",Dr. Luis Antonio Muller Ph.D.,Semiconductors,14.3,USD,665522501,https://images.financialmodelingprep.com/symbol/COHU.png,567632,-9.6,0.24,509852,-11841000,-69818000,"[{'period': '2024', 'revenue': 401.78, 'unit': 'M', 'net_profit': -69.82}, {'period': '2023', 'revenue': 636.32, 'unit': 'M', 'net_profit': 28.16}, {'period': '2022', 'revenue': 812.77, 'unit': 'M', 'net_profit': 96.85}, {'period': '2021', 'revenue': 887.21, 'unit': 'M', 'net_profit': 167.32}]","[{'period': ""Q4 '24"", 'revenue': 94.12, 'unit': 'M', 'net_profit': -21.36}, {'period': ""Q3 '24"", 'revenue': 95.34, 'unit': 'M', 'net_profit': -18.06}, {'period': ""Q2 '24"", 'revenue': 104.7, 'unit': 'M', 'net_profit': -15.77}, {'period': ""Q1 '24"", 'revenue': 107.61, 'unit': 'M', 'net_profit': -14.63}, {'period': ""Q4 '23"", 'revenue': 137.23, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q3 '23"", 'revenue': 150.8, 'unit': 'M', 'net_profit': 3.92}]",-1.49,-1.49,999415000,534307000,262092000,142524000,91619000,0,85184000,206407000,-7856000,-1.1196761739200745,-3.479684614291803,-3.5254237288135597,"[0.06, 0.4032]","['2020-02-24', '1984-11-29']",__nan__,0.14260742534382614
184,COIN,Coinbase Global Inc. Class A Common Stock,"Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. The company offers the primary financial account in the cryptoeconomy for retailers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable ecosystem partners to build crypto-based applications and securely accept crypto assets as payment. Coinbase Global, Inc. was founded in 2012 and is based in Wilmington, Delaware.",Mr. Brian  Armstrong,Software - Application,175,USD,44428907425,https://images.financialmodelingprep.com/symbol/COIN.png,9324070,18.44,-0.03,5039197,3150807000,2579066000,"[{'period': '2024', 'revenue': 6.56, 'unit': 'B', 'net_profit': 2.58}, {'period': '2023', 'revenue': 3110.0, 'unit': 'M', 'net_profit': 94.87}, {'period': '2022', 'revenue': 3.19, 'unit': 'B', 'net_profit': -2.62}, {'period': '2021', 'revenue': 7.84, 'unit': 'B', 'net_profit': 3.62}]","[{'period': ""Q4 '24"", 'revenue': 2.27, 'unit': 'B', 'net_profit': 1.29}, {'period': ""Q3 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': 75.5}, {'period': ""Q2 '24"", 'revenue': 1380.0, 'unit': 'M', 'net_profit': 36.15}, {'period': ""Q1 '24"", 'revenue': 1.45, 'unit': 'B', 'net_profit': 1.18}, {'period': ""Q4 '23"", 'revenue': 953.79, 'unit': 'M', 'net_profit': 273.44}, {'period': ""Q3 '23"", 'revenue': 674.15, 'unit': 'M', 'net_profit': -2.27}]",10.42,9.43,22541951000,18112653000,9824230000,12265109000,265251000,0,7941320000,8582422000,2556844000,123.97251308900523,26.184977495757398,25.049999999999997,__nan__,__nan__,__nan__,0.5441014843834946
185,COKE,Coca-Cola Consolidated Inc. Common Stock,"Coca-Cola Consolidated, Inc., together with its subsidiaries, manufactures, markets, and distributes nonalcoholic beverages primarily products of The Coca-Cola Company in the United States. The company offers sparkling beverages, such as carbonated beverages; and still beverages, including energy products, as well as noncarbonated beverages comprising bottled water, ready to drink coffee and tea, enhanced water, juices, and sports drinks. It also sells its products to other Coca-Cola bottlers; and post-mix products that are dispensed through equipment, which mixes the fountain syrup with carbonated or still water enabling fountain retailers to sell finished products to consumers in cups or glasses. In addition, the company distributes products for various other beverage brands that include Dr Pepper and Monster Energy. It sells and distributes its products directly to grocery stores, mass merchandise stores, club stores, convenience stores, and drug stores; and restaurants, schools, amusement parks, and recreational facilities, as well as through vending machine outlets. The company was formerly known as Coca-Cola Bottling Co. Consolidated and changed its name to Coca-Cola Consolidated, Inc. in January 2019. Coca-Cola Consolidated, Inc. was incorporated in 1980 and is headquartered in Charlotte, North Carolina.",Mr. J. Frank Harrison III,Beverages - Non-Alcoholic,1364.11,USD,11892016332,https://images.financialmodelingprep.com/symbol/COKE.png,47531,19.5,-51.89,50442,1052293000,633125000,"[{'period': '2024', 'revenue': 6900.0, 'unit': 'M', 'net_profit': 633.12}, {'period': '2023', 'revenue': 6650.0, 'unit': 'M', 'net_profit': 408.38}, {'period': '2022', 'revenue': 6200.0, 'unit': 'M', 'net_profit': 430.16}, {'period': '2021', 'revenue': 5560.0, 'unit': 'M', 'net_profit': 189.58}]","[{'period': ""Q4 '24"", 'revenue': 1750.0, 'unit': 'M', 'net_profit': 178.95}, {'period': ""Q3 '24"", 'revenue': 1770.0, 'unit': 'M', 'net_profit': 115.62}, {'period': ""Q2 '24"", 'revenue': 1800.0, 'unit': 'M', 'net_profit': 172.81}, {'period': ""Q1 '24"", 'revenue': 1590.0, 'unit': 'M', 'net_profit': 165.74}, {'period': ""Q4 '23"", 'revenue': 1630.0, 'unit': 'M', 'net_profit': 75.84}, {'period': ""Q3 '23"", 'revenue': 1710.0, 'unit': 'M', 'net_profit': 92.09}]",78.8,69.94,5313139000,2547302000,1437034000,3895528000,567653000,0,1313169000,1135824000,505342000,0.17100868998164967,0.5503520048974594,0.8089990817263543,"[2.5, 0.14]","['2025-04-25', '1985-02-25']",__nan__,0.7331876692855203
186,COLB,Columbia Banking System Inc. Common Stock,"Columbia Banking System, Inc. operates as the bank holding company for Columbia State Bank that provides a range of banking services to small and medium-sized businesses, professionals, and individuals in the United States. It offers personal banking products and services, including noninterest and interest-bearing checking, savings, money market, and certificate of deposit accounts; home mortgages for purchases and refinances, home equity loans and lines of credit, and other personal loans; debit and credit cards; and digital banking services. The company also provides business banking products and services, such as checking, savings, interest-bearing money market, and certificate of deposit accounts; agricultural, asset-based, builder, and other commercial real estate loans, as well as loans guaranteed by the small business administration; and professional banking, treasury management, merchant card, and international banking services. In addition, it offers wealth management solutions that include financial planning services, such as asset allocation, net worth analysis, estate planning and preservation, education funding, and wealth transfer; long-term care, and life and disability insurance solutions; individual retirement solutions comprising retirement planning, retirement income strategies, and traditional and Roth individual retirement accounts; and business solutions, which comprise business retirement plans, key person insurance, business succession planning, and deferred compensation plans to individuals, families, and professional businesses. Further, the company provides fiduciary, investment, and administrative trust services, such as personal and special needs trusts, estate settlement, and investment agency and charitable management. It operates a network of 153 branch locations, including 68 in the state of Washington, 59 in Oregon, 15 in Idaho, and 11 in California. The company was founded in 1993 and is headquartered in Tacoma, Washington.",Mr. Clint E. Stein CPA,Banks - Regional,22.06,USD,4635130282,https://images.financialmodelingprep.com/symbol/COLB.png,1606914,8.65,-0.12,1160268,0,533675000,"[{'period': '2024', 'revenue': 2760.0, 'unit': 'M', 'net_profit': 533.67}, {'period': '2023', 'revenue': 1780.0, 'unit': 'M', 'net_profit': 348.71}, {'period': '2022', 'revenue': 547.56, 'unit': 'M', 'net_profit': 336.75}, {'period': '2021', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 420.3}]","[{'period': ""Q4 '24"", 'revenue': 487.12, 'unit': 'M', 'net_profit': 143.27}, {'period': ""Q3 '24"", 'revenue': 698.9, 'unit': 'M', 'net_profit': 146.18}, {'period': ""Q2 '24"", 'revenue': 743.48, 'unit': 'M', 'net_profit': 120.14}, {'period': ""Q1 '24"", 'revenue': 733.34, 'unit': 'M', 'net_profit': 124.08}, {'period': ""Q4 '23"", 'revenue': 757.17, 'unit': 'M', 'net_profit': 93.53}, {'period': ""Q3 '23"", 'revenue': 524.86, 'unit': 'M', 'net_profit': 135.84}]",2.56,2.55,51576397000,496666000,496666000,46458173000,0,0,0,496666000,658866000,0,0.5304044850379249,0.4301675977653631,"[0.36, 0.05]","['2025-02-28', '2003-05-05']",__nan__,0.9007642197263217
187,COLI,Colicity Inc. Class A Common Stock,"Colicity Inc. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus its search on identifying a prospective target business in the technology, media, and telecommunications industries in the United States and other developed countries. Colicity Inc. was incorporated in 2020 and is based in Kirkland, Washington.",Mr. Craig O. McCaw,Shell Companies,10.07,USD,0,https://images.financialmodelingprep.com/symbol/COLI.png,158484,22.886363636363637,-0.005,7445,5648973,12442392,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.44}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.58}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.62}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 10.29}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.26}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -438.53}]",0.29,0.29,1.0434040000000024,1.012239,0.732368,22.613736,0,345.031165,0.315861,0.732368,-1300181,0,0,0,__nan__,__nan__,__nan__,21.673039397970438
188,COLIU,Colicity Inc. Units,"Colicity Inc. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus its search on identifying a prospective target business in the technology, media, and telecommunications industries in the United States and other developed countries. Colicity Inc. was incorporated in 2020 and is based in Kirkland, Washington.",Mr. Craig O. McCaw,Shell Companies,10.055,USD,0,https://images.financialmodelingprep.com/symbol/COLIU.png,39004,31.226708074534162,-0.0051,3165,5648973,12442392,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.44}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.58}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.62}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 10.29}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.26}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -438.53}]",0.29,0.29,1.0434040000000024,1.012239,0.732368,22.613736,0,345.031165,0.315861,0.732368,-1300181,0,0,0,__nan__,__nan__,__nan__,21.673039397970438
189,COLIW,Colicity Inc. Warrant,,,Shell Companies,0.001,USD,0,https://images.financialmodelingprep.com/symbol/COLIW.png,0,0,0,21647,5648973,12442392,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.44}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.58}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.62}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 10.29}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.26}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -438.53}]",0.29,0.29,1.0434040000000024,1.012239,0.732368,22.613736,0,345.031165,0.315861,0.732368,-1300181,0,0,0,__nan__,__nan__,__nan__,21.673039397970438
190,COLL,Collegium Pharmaceutical Inc. Common Stock,"Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.",Mr. Vikram  Karnani,Drug Manufacturers - Specialty & Generic,26.91,USD,864666684,https://images.financialmodelingprep.com/symbol/COLL.png,406070,14.47,-0.1,340776,169895000,69190000,"[{'period': '2024', 'revenue': 631.45, 'unit': 'M', 'net_profit': 69.19}, {'period': '2023', 'revenue': 566.77, 'unit': 'M', 'net_profit': 48.16}, {'period': '2022', 'revenue': 463.93, 'unit': 'M', 'net_profit': -25.0}, {'period': '2021', 'revenue': 276.87, 'unit': 'M', 'net_profit': 71.52}]","[{'period': ""Q4 '24"", 'revenue': 181.95, 'unit': 'M', 'net_profit': 12.54}, {'period': ""Q3 '24"", 'revenue': 159.3, 'unit': 'M', 'net_profit': 9.34}, {'period': ""Q2 '24"", 'revenue': 145.28, 'unit': 'M', 'net_profit': 19.61}, {'period': ""Q1 '24"", 'revenue': 144.92, 'unit': 'M', 'net_profit': 27.71}, {'period': ""Q4 '23"", 'revenue': 149.75, 'unit': 'M', 'net_profit': 31.94}, {'period': ""Q3 '23"", 'revenue': 136.71, 'unit': 'M', 'net_profit': 20.63}]",2.14,1.71,1663591000,482257000,162763000,1434749000,228540000,0,509510000,70565000,203328000,-0.44897965802651724,0.43681860658290933,0.3375,__nan__,__nan__,__nan__,0.8624409485264106
191,COLM,Columbia Sportswear Company Common Stock,"Columbia Sportswear Company, together with its subsidiaries, designs, sources, markets, and distributes outdoor, active, and everyday lifestyle apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada. The company provides apparel, accessories, and equipment that are used in various activities, such as skiing, snowboarding, hiking, climbing, mountaineering, camping, hunting, fishing, trail running, water sports, yoga, golf, and adventure travel. It also offers footwear products that include lightweight hiking boots, trail running shoes, rugged cold weather boots for activities on snow and ice, sandals and shoes for use in water activities, and function-first fashion footwear and casual shoes for everyday use. The company sells its products under the Columbia, Mountain Hardwear, SOREL, and prAna brand names through the company owned network of branded and outlet retail stores, brand-specific e-commerce sites, and concession-based arrangements with third-parties at branded outlet and shop-in-shop retail locations, as well as through independently operated specialty outdoor and sporting goods stores, sporting goods chains, department store chains, Internet retailers, and international distributors. As of December 31, 2021, it operated approximately 455 retail stores. The company was founded in 1938 and is headquartered in Portland, Oregon.",Mr. Timothy P. Boyle,Apparel - Manufacturers,63.08,USD,3491025527,https://images.financialmodelingprep.com/symbol/COLM.png,887367,16.51,-2.44,1041847,270741000,223273000,"[{'period': '2024', 'revenue': 3370.0, 'unit': 'M', 'net_profit': 223.27}, {'period': '2023', 'revenue': 3490.0, 'unit': 'M', 'net_profit': 251.4}, {'period': '2022', 'revenue': 3460.0, 'unit': 'M', 'net_profit': 311.44}, {'period': '2021', 'revenue': 3130.0, 'unit': 'M', 'net_profit': 354.11}]","[{'period': ""Q4 '24"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 102.56}, {'period': ""Q3 '24"", 'revenue': 931.77, 'unit': 'M', 'net_profit': 90.16}, {'period': ""Q2 '24"", 'revenue': 570.3, 'unit': 'M', 'net_profit': -11.74}, {'period': ""Q1 '24"", 'revenue': 770.26, 'unit': 'M', 'net_profit': 42.3}, {'period': ""Q4 '23"", 'revenue': 1060.0, 'unit': 'M', 'net_profit': 93.34}, {'period': ""Q3 '23"", 'revenue': 985.68, 'unit': 'M', 'net_profit': 103.51}]",3.83,3.82,2975265000,2008582000,815477000,1195226000,417539000,0,766545000,531869000,431237000,-0.414406405730897,-0.11188146380270485,-0.06812652068126526,"[0.3, 0.14]","['2025-03-10', '2006-11-14']",__nan__,0.4017208551171072
192,COMM,CommScope Holding Company Inc. Common Stock,"CommScope Holding Company, Inc. provides infrastructure solutions for communications and entertainment networks. It operates through four segments: Broadband Networks (Broadband), Outdoor Wireless Networks (OWN), Venue and Campus Networks (VCN), and Home Networks (Home). The Broadband segment provides converged cable access platforms, passive optical networking products, video systems, access technologies, fiber and coaxial cables, fiber and copper connectivity products, and hardened closures to the telco and cable provider broadband market. The OWN segment provides base station antennas, radio frequency filters, tower connectivity, microwave antennas, metro cell products, cabinets, steel towers, accessories, Spectrum Access System, and Comsearch products to the macro and metro cell markets. The VCN segment offers Wi-Fi and switching, distributed antenna systems, licensed and unlicensed small cells, enterprise fiber, and copper infrastructures for campuses, venues, data centers, and buildings. The Home segment provides devices and related software, and management solutions that offer residential connectivity and services to subscribers, such as digital subscriber lines, cable modems, and telephony and data gateways; and set top boxes and software that support cable, satellite, and Internet protocol television content delivery, which include digital video recorders, high definition set top boxes, and hybrid set top devices. It offers its products and services through specialized resellers and distributors, satellite video distributors, and system integrators, as well as directly to customers in the United States, Europe, the Middle East, Africa, the Asia Pacific, the Caribbean, Latin America, and Canada. The company was formerly known as Cedar I Holding Company, Inc. and changed its name to CommScope Holding Company, Inc. in January 2011. CommScope Holding Company, Inc. was founded in 1976 and is headquartered in Hickory, North Carolina.",Mr. Charles L. Treadway,Communication Equipment,3.02,USD,654012891,https://images.financialmodelingprep.com/symbol/COMM.png,5600391,-1.23,-0.31,3990729,648100000,-380700000,"[{'period': '2024', 'revenue': 4210.0, 'unit': 'M', 'net_profit': -380.7}, {'period': '2023', 'revenue': 5.79, 'unit': 'B', 'net_profit': -1.45}, {'period': '2022', 'revenue': 9.23, 'unit': 'B', 'net_profit': -1.29}, {'period': '2021', 'revenue': 8590.0, 'unit': 'M', 'net_profit': -462.6}]","[{'period': ""Q4 '24"", 'revenue': 1170.0, 'unit': 'M', 'net_profit': 32.3}, {'period': ""Q3 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': -33.0}, {'period': ""Q2 '24"", 'revenue': 1390.0, 'unit': 'M', 'net_profit': 44.4}, {'period': ""Q1 '24"", 'revenue': 1170.0, 'unit': 'M', 'net_profit': -359.2}, {'period': ""Q4 '23"", 'revenue': 1190.0, 'unit': 'M', 'net_profit': -525.1}, {'period': ""Q3 '23"", 'revenue': 1600.0, 'unit': 'M', 'net_profit': -828.7}]",-1.78,-1.78,8747500000,3484500000,564900000,10976300000,685900000,0,1229700000,564900000,247800000,0.24850703140050087,0.7376111379143979,0.7517433751743374,__nan__,__nan__,__nan__,1.2547927979422693
193,COMS,ComSovereign Holding Corp. Common Stock,"COMSovereign Holding Corp. provides technologically-advanced telecom solutions for network operators, mobile device carriers, governmental units, and other enterprises worldwide. The company offers packet microwave solutions that transmit broadband voice, video, and data, as well as enable service providers, government agencies, enterprises, and other organizations; and in-band full-duplex technologies that alleviate the performance limitations of the principal transmission technologies. It also provides tethered drones and aerostats for use in intelligence, surveillance, and reconnaissance, as well as communication applications for national defense and security customers; and edge compute capable small cell 4G LTE and 5G access radios. In addition, the company offers maintenance and support services, as well as other professional services, such as engineering, designing, and developing a range of network systems and system components. The company was formerly known as Drone Aviation Holding Corp. and changed its name to COMSovereign Holding Corp. in November 2019. COMSovereign Holding Corp. was incorporated in 2014 and is based in Tucson, Arizona.",Mr. David A. Knight,Telecommunications Services,0.001,USD,2695,https://images.financialmodelingprep.com/symbol/COMS.png,611,,0,2,-74474000,-79713000,"[{'period': '2022', 'revenue': 9.88, 'unit': 'M', 'net_profit': -79.71}, {'period': '2021', 'revenue': 12.64, 'unit': 'M', 'net_profit': -155.78}, {'period': '2020', 'revenue': 9.43, 'unit': 'M', 'net_profit': -37.08}, {'period': '2019', 'revenue': 4.71, 'unit': 'M', 'net_profit': -27.55}]","[{'period': ""Q3 '23"", 'revenue': 0.25, 'unit': 'M', 'net_profit': -1.42}, {'period': ""Q2 '23"", 'revenue': 3500.0, 'unit': 'K', 'net_profit': 638.0}, {'period': ""Q1 '23"", 'revenue': 0.483, 'unit': 'M', 'net_profit': -4.93}, {'period': ""Q4 '22"", 'revenue': 1.94, 'unit': 'M', 'net_profit': -40.14}, {'period': ""Q3 '22"", 'revenue': 3.8, 'unit': 'M', 'net_profit': -3.33}, {'period': ""Q2 '22"", 'revenue': 2.09, 'unit': 'M', 'net_profit': -39.73}]",-72.04,-72.04,24918000,11982000,1868000,39919000,1776000,0,27916000,1868000,-9694000,0.4009636189602889,0.4883008839332139,0.6741893175342589,__nan__,__nan__,__nan__,1.6020146079139579
194,COMSW,ComSovereign Holding Corp. Warrants,"ComSovereign Holding Corp. designs, develops, markets, and sells technologically-advanced products for telecom network operators, mobile device carriers, and other enterprises worldwide. The company designs, manufactures, and sells microwave packet radio equipment, such as backhaul telecom radios that transmit broadband voice, video, and data, as well as enable service providers, government agencies, enterprises, and other organizations to meet their increasing bandwidth requirements rapidly and affordably; and in-band full-duplex and transpositional modulation technologies that alleviate the performance limitations of the principal transmission technologies. It also offers intelligent batteries and back-up power solutions for use in cellular towers and other radio access network infrastructures, as well as automotive, aerospace, and marine vehicles; and tethered drones and aerostats for use in intelligence, surveillance, and reconnaissance, as well as communications applications for national defense and security customers. In addition, the company is developing silicon photonic devices used in data interconnects, communication networks, and computing systems. Further, it provides maintenance and support services, as well as other professional services, such as engineering, designing, and developing a range of next-generation network systems and system components. ComSovereign Holding Corp. is based in Dallas, Texas.",Mr. David A. Knight,Telecommunications Services,0.0001,USD,257,https://images.financialmodelingprep.com/symbol/COMSW.png,0,0,-0.002,9392,-74474000,-79713000,"[{'period': '2022', 'revenue': 9.88, 'unit': 'M', 'net_profit': -79.71}, {'period': '2021', 'revenue': 12.64, 'unit': 'M', 'net_profit': -155.78}, {'period': '2020', 'revenue': 9.43, 'unit': 'M', 'net_profit': -37.08}, {'period': '2019', 'revenue': 4.71, 'unit': 'M', 'net_profit': -27.55}]","[{'period': ""Q3 '23"", 'revenue': 0.25, 'unit': 'M', 'net_profit': -1.42}, {'period': ""Q2 '23"", 'revenue': 3500.0, 'unit': 'K', 'net_profit': 638.0}, {'period': ""Q1 '23"", 'revenue': 0.483, 'unit': 'M', 'net_profit': -4.93}, {'period': ""Q4 '22"", 'revenue': 1.94, 'unit': 'M', 'net_profit': -40.14}, {'period': ""Q3 '22"", 'revenue': 3.8, 'unit': 'M', 'net_profit': -3.33}, {'period': ""Q2 '22"", 'revenue': 2.09, 'unit': 'M', 'net_profit': -39.73}]",-72.04,-72.04,24918000,11982000,1868000,39919000,1776000,0,27916000,1868000,-9694000,0.4009636189602889,0.4883008839332139,0.6741893175342589,__nan__,__nan__,__nan__,1.6020146079139579
195,CONE,CyrusOne Inc Common Stock,"CyrusOne (NASDAQ: CONE) is a premier global REIT specializing in design, construction and operation of more than 50 high-performance data centers worldwide. The Company provides mission-critical facilities that ensure the continued operation of IT infrastructure for approximately 1,000 customers, including approximately 200 Fortune 1000 companies. A leader in hybrid-cloud and multi-cloud deployments, CyrusOne offers colocation, hyperscale, and build-to-suit environments that help customers enhance the strategic connection of their essential data infrastructure and support achievement of sustainability goals. CyrusOne data centers offer world-class flexibility, enabling clients to modernize, simplify, and rapidly respond to changing demand. Combining exceptional financial strength with a broad global footprint, CyrusOne provides customers with long-term stability and strategic advantage at scale.",Mr. Venkatesh Durvasula,REIT - Industrial,90.36,USD,0,https://images.financialmodelingprep.com/symbol/CONE.png,2696655,451.8,0,1325394,584200000,25300000,"[{'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': 25.3}, {'period': '2020', 'revenue': 1030.0, 'unit': 'M', 'net_profit': 41.4}, {'period': '2019', 'revenue': 981.3, 'unit': 'M', 'net_profit': 41.4}, {'period': '2018', 'revenue': 821.4, 'unit': 'M', 'net_profit': 1.2}]","[{'period': ""Q4 '21"", 'revenue': 318.4, 'unit': 'M', 'net_profit': -24.4}, {'period': ""Q3 '21"", 'revenue': 304.1, 'unit': 'M', 'net_profit': 6.7}, {'period': ""Q2 '21"", 'revenue': 284.6, 'unit': 'M', 'net_profit': 7.4}, {'period': ""Q1 '21"", 'revenue': 298.6, 'unit': 'M', 'net_profit': 18.2}, {'period': ""Q4 '20"", 'revenue': 268.4, 'unit': 'M', 'net_profit': 19.0}, {'period': ""Q3 '20"", 'revenue': 262.8, 'unit': 'M', 'net_profit': -37.3}]",0.2,0.2,7452000000,981200000,346300000,4528300000,420400000,30300000,625600000,346300000,477600000,0.07212332538080382,-0.3888888888888889,-0.4285714285714285,"[0.52, 0.16]","['2022-03-25', '2013-03-29']",__nan__,0.6076623725174449
196,CONN,Conn's Inc. Common Stock,"Conn's, Inc. operates as a specialty retailer of durable consumer goods and related services in the United States. It operates through two segments, Retail and Credit. The company's stores offer furniture and mattress, including furniture and related accessories for the living room, dining room, and bedroom, as well as flat and other mattresses; and home appliances, such as refrigerators, freezers, washers, dryers, dishwashers, and ranges. Its stores also provide consumer electronics comprising LED, OLED, QLED, 4K Ultra HD, 8K televisions, gaming products, video game consoles, and home theater and portable audio equipment; and home office products, including computers, tablets, monitors, and accessories. In addition, the company offers short- and medium-term financing to its retail customers; and product support services, which comprise next-day delivery and installation services, credit insurance products, product repair services, and repair service agreements. As of July 27, 2022, it operated approximately 160 retail locations in Alabama, Arizona, Colorado, Florida, Georgia, Louisiana, Mississippi, Nevada, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, and Virginia. Conn's, Inc. was founded in 1890 and is headquartered in The Woodlands, Texas.",Mr. Norman L. Miller,Specialty Retail,0.0975,USD,2426385,https://images.financialmodelingprep.com/symbol/CONN.png,504248,-0.030757097791798107,-0.0844,2348765,-36152000,-76893000,"[{'period': '2024', 'revenue': 1240.0, 'unit': 'M', 'net_profit': -76.89}, {'period': '2023', 'revenue': 1340.0, 'unit': 'M', 'net_profit': -59.29}, {'period': '2022', 'revenue': 1590.0, 'unit': 'M', 'net_profit': 108.2}, {'period': '2021', 'revenue': 1390.0, 'unit': 'M', 'net_profit': -3.14}]","[{'period': ""Q4 '24"", 'revenue': 366.08, 'unit': 'M', 'net_profit': 43.3}, {'period': ""Q3 '24"", 'revenue': 280.13, 'unit': 'M', 'net_profit': -51.3}, {'period': ""Q2 '24"", 'revenue': 306.91, 'unit': 'M', 'net_profit': -33.52}, {'period': ""Q1 '24"", 'revenue': 284.57, 'unit': 'M', 'net_profit': -35.38}, {'period': ""Q4 '23"", 'revenue': 334.88, 'unit': 'M', 'net_profit': -42.8}, {'period': ""Q3 '23"", 'revenue': 321.2, 'unit': 'M', 'net_profit': -24.84}]",-3.17,-3.17,2444042000,1204096000,70753000,1946544000,780702000,402361000,466523000,70753000,-102288000,-1.638006494423267,-0.2968528637927545,-0.2886178861788618,__nan__,__nan__,__nan__,0.7964445782846612
197,CONX,CONX Corp. Class A Common Stock,"CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including wireless communications industry. CONX Corp. was incorporated in 2020 and is based in Littleton, Colorado.",Mr. Kyle Jason Kiser,Shell Companies,8.79,USD,183449937,https://images.financialmodelingprep.com/symbol/CONX.png,3363,-35.16,-0.41,7394,0,-5994501,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.99}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 24.19}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 19.36}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.12}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.37}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.17}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -920.21}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -926.47}]",-0.25,-0.25,21983432,17328,8162.000000000001,40046956,0,21966104,3991456,8162.000000000001,-1789134,1,-1.2477604025666724,-1.8620689655172415,__nan__,__nan__,__nan__,1.8216880785493366
198,CONXU,CONX Corp. Unit,"CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including wireless communications industry. CONX Corp. was incorporated in 2020 and is based in Littleton, Colorado.",Mr. Kyle Jason Kiser,Shell Companies,9.01,USD,183449934,https://images.financialmodelingprep.com/symbol/CONXU.png,0,36.04,-1.71,1214,0,-5994501,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.99}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 24.19}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 19.36}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.12}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.37}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.17}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -920.21}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -926.47}]",-0.25,-0.25,21983432,17328,8162.000000000001,40046956,0,21966104,3991456,8162.000000000001,-1789134,1,-1.2477604025666724,-1.8620689655172415,__nan__,__nan__,__nan__,1.8216880785493366
199,CONXW,CONX Corp. Warrant,"CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including wireless communications industry. The company was incorporated in 2020 and is based in Littleton, Colorado.",Mr. Kyle Jason Kiser,Shell Companies,0.1881,USD,221235635,https://images.financialmodelingprep.com/symbol/CONXW.png,0,0,0.0284,262090,0,-5994501,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.99}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 24.19}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 19.36}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.12}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.37}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.17}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -920.21}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -926.47}]",-0.25,-0.25,21983432,17328,8162.000000000001,40046956,0,21966104,3991456,8162.000000000001,-1789134,1,-1.2477604025666724,-1.8620689655172415,__nan__,__nan__,__nan__,1.8216880785493366
200,COOL,Corner Growth Acquisition Corp. Class A Ordinary Shares,"Corner Growth Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Palo Alto, California.",Mr. Marvin  Tien,Shell Companies,11.1,USD,111994560,https://images.financialmodelingprep.com/symbol/COOL.png,568,-31.714285714285715,-0.1,6233,-3129840,-3489963,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.49}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 37.34}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.55}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.13}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.51}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -380.48}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 681.55}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.31}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.11}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.31}]",-0.32,-0.32,4653117,99600,21631,12682079,0,4553517,4384213,21631,-9916.00000000004,0.8552242591416561,-1.0934626995784547,-1.4210526315789473,__nan__,__nan__,__nan__,2.72550185176947
201,COOLU,Corner Growth Acquisition Corp. Unit,"Corner Growth Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Palo Alto, California.",Mr. Marvin  Tien,Shell Companies,11.4,USD,111994558,https://images.financialmodelingprep.com/symbol/COOLU.png,509,43.67816091954023,-0.1,501,-3129840,-3489963,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.49}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 37.34}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.55}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.13}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.51}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -380.48}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 681.55}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.31}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.11}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.31}]",-0.32,-0.32,4653117,99600,21631,12682079,0,4553517,4384213,21631,-9916.00000000004,0.8552242591416561,-1.0934626995784547,-1.4210526315789473,__nan__,__nan__,__nan__,2.72550185176947
202,COOLW,Corner Growth Acquisition Corp. Warrant,"Corner Growth Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Palo Alto, California.",Mr. Marvin  Tien,Shell Companies,0.2001,USD,2154177,https://images.financialmodelingprep.com/symbol/COOLW.png,23520,0,-0.0099,7400,-3129840,-3489963,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.49}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 37.34}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.55}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.13}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.51}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -380.48}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 681.55}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.31}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.11}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.31}]",-0.32,-0.32,4653117,99600,21631,12682079,0,4553517,4384213,21631,-9916.00000000004,0.8552242591416561,-1.0934626995784547,-1.4210526315789473,__nan__,__nan__,__nan__,2.72550185176947
203,COOP,Mr. Cooper Group Inc. Common Stock,"Mr. Cooper Group Inc. provides servicing, origination, and transaction-based services related to single-family residences in the United States. The company operates through two segments: Servicing and Originations. The Servicing segment performs activities for underlying mortgages, including collecting and disbursing borrower payments, investor reporting, customer service, and modifying loans. The Originations segment originates residential mortgage loans through its direct-to-consumer channel, as well as originates and purchases loans from mortgage bankers and brokers. It operates primarily under the Mr. Cooper and Xome brands. The company was formerly known as WMIH Corp. and changed its name to Mr. Cooper Group Inc. in October 2018. Mr. Cooper Group Inc. was incorporated in 2015 and is based in Coppell, Texas.",Mr. Jesse K. Bray CPA,Financial - Mortgages,107.26,USD,6862856266,https://images.financialmodelingprep.com/symbol/COOP.png,963921,10.31,-3.95,636634,964000000,669000000,"[{'period': '2024', 'revenue': 2230.0, 'unit': 'M', 'net_profit': 669.0}, {'period': '2023', 'revenue': 1790.0, 'unit': 'M', 'net_profit': 500.0}, {'period': '2022', 'revenue': 2460.0, 'unit': 'M', 'net_profit': 923.0}, {'period': '2021', 'revenue': 3.32, 'unit': 'B', 'net_profit': 1.45}]","[{'period': ""Q4 '24"", 'revenue': 870.0, 'unit': 'M', 'net_profit': 204.0}, {'period': ""Q3 '24"", 'revenue': 424.0, 'unit': 'M', 'net_profit': 80.0}, {'period': ""Q2 '24"", 'revenue': 572.0, 'unit': 'M', 'net_profit': 204.0}, {'period': ""Q1 '24"", 'revenue': 722.0, 'unit': 'M', 'net_profit': 181.0}, {'period': ""Q4 '23"", 'revenue': 404.0, 'unit': 'M', 'net_profit': 46.0}, {'period': ""Q3 '23"", 'revenue': 574.0, 'unit': 'M', 'net_profit': 275.0}]",10.41,10.4,18939000000,4529000000,753000000,14126000000,1345000000,0,8817000000,753000000,-762000000,0.3791130185979971,0.338,0.3973154362416107,__nan__,__nan__,__nan__,0.7458683140609325
204,CORE,Core Mark Holding Co Inc Common Stock,,,,,,,,,,,,160400000,63200000,"[{'period': '2020', 'revenue': 16960.0, 'unit': 'M', 'net_profit': 63.2}, {'period': '2019', 'revenue': 16670.0, 'unit': 'M', 'net_profit': 57.7}, {'period': '2018', 'revenue': 16400.0, 'unit': 'M', 'net_profit': 45.5}, {'period': '2017', 'revenue': 15690.0, 'unit': 'M', 'net_profit': 33.5}]","[{'period': ""Q2 '21"", 'revenue': 4500.0, 'unit': 'M', 'net_profit': 15.5}, {'period': ""Q1 '21"", 'revenue': 3930.0, 'unit': 'M', 'net_profit': 8.5}, {'period': ""Q4 '20"", 'revenue': 4250.0, 'unit': 'M', 'net_profit': 19.0}, {'period': ""Q3 '20"", 'revenue': 4500.0, 'unit': 'M', 'net_profit': 23.0}, {'period': ""Q2 '20"", 'revenue': 4260.0, 'unit': 'M', 'net_profit': 16.9}, {'period': ""Q1 '20"", 'revenue': 3940.0, 'unit': 'M', 'net_profit': 4.3}]",1.4,1.4,1954700000,1337200000,22800000,1322800000,468100000,0,745800000,22800000,117100000,0.15979754157628345,0.09532062391681109,0.11999999999999993,__nan__,__nan__,__nan__,0.6767278866322198
205,CORT,Corcept Therapeutics Incorporated Common Stock,"Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.",Dr. Joseph K. Belanoff M.D.,Biotechnology,62.9,USD,6636165747,https://images.financialmodelingprep.com/symbol/CORT.png,1544083,51.14,0.66,1197849,136951000,139733000,"[{'period': '2024', 'revenue': 675.04, 'unit': 'M', 'net_profit': 139.73}, {'period': '2023', 'revenue': 482.38, 'unit': 'M', 'net_profit': 106.14}, {'period': '2022', 'revenue': 401.86, 'unit': 'M', 'net_profit': 101.42}, {'period': '2021', 'revenue': 365.98, 'unit': 'M', 'net_profit': 112.51}]","[{'period': ""Q4 '24"", 'revenue': 181.89, 'unit': 'M', 'net_profit': 30.75}, {'period': ""Q3 '24"", 'revenue': 182.55, 'unit': 'M', 'net_profit': 46.69}, {'period': ""Q2 '24"", 'revenue': 163.8, 'unit': 'M', 'net_profit': 35.49}, {'period': ""Q1 '24"", 'revenue': 146.81, 'unit': 'M', 'net_profit': 27.76}, {'period': ""Q4 '23"", 'revenue': 135.41, 'unit': 'M', 'net_profit': 31.36}, {'period': ""Q3 '23"", 'revenue': 123.6, 'unit': 'M', 'net_profit': 31.38}]",1.35,1.23,840553000,471602000,383334000,160964000,53976000,0,140773000,127665000,195895000,0.2642719988183597,0.31649707932918786,0.32352941176470595,__nan__,__nan__,__nan__,0.1914977401781922
206,COST,Costco Wholesale Corporation Common Stock,"Costco Wholesale Corporation, together with its subsidiaries, engages in the operation of membership warehouses in the United States, Puerto Rico, Canada, the United Kingdom, Mexico, Japan, Korea, Australia, Spain, France, Iceland, China, and Taiwan. It offers branded and private-label products in a range of merchandise categories. The company offers sundries, dry groceries, candies, coolers, freezers, liquor, and tobacco and deli products; appliances, electronics, health and beauty aids, hardware, garden and patio products, sporting goods, tires, toys and seasonal products, office supplies, automotive care products, postages, tickets, apparel, small appliances, furniture, domestics, housewares, special order kiosks, and jewelry; and meat, produce, service deli, and bakery products. It also operates pharmacies, opticals, food courts, hearing-aid centers, and tire installation centers, as well as 636 gas stations; and offers business delivery, travel, same-day grocery, and various other services online in various countries. As of August 29, 2021, the company operated 815 membership warehouses, including 564 in the United States and Puerto Rico, 105 in Canada, 39 in Mexico, 30 in Japan, 29 in the United Kingdom, 16 in South Korea, 14 in Taiwan, 12 in Australia, 3 in Spain, 1 in Iceland, 1 in France, and 1 in China. It also operates e-commerce websites in the United States, Canada, the United Kingdom, Mexico, South Korea, Taiwan, Japan, and Australia. The company was formerly known as Costco Companies, Inc. and changed its name to Costco Wholesale Corporation in August 1999. Costco Wholesale Corporation was founded in 1976 and is based in Issaquah, Washington.",Mr. Ron M. Vachris,Discount Stores,957.77,USD,424946602130,https://images.financialmodelingprep.com/symbol/COST.png,2459509,55.98,-36.73,2482260,12146000000,7367000000,"[{'period': '2024', 'revenue': 254.45, 'unit': 'B', 'net_profit': 7.37}, {'period': '2023', 'revenue': 242.29, 'unit': 'B', 'net_profit': 6.29}, {'period': '2022', 'revenue': 226.95, 'unit': 'B', 'net_profit': 5.84}, {'period': '2021', 'revenue': 195.93, 'unit': 'B', 'net_profit': 5.01}]","[{'period': ""Q2 '25"", 'revenue': 63.72, 'unit': 'B', 'net_profit': 1.79}, {'period': ""Q1 '25"", 'revenue': 62.15, 'unit': 'B', 'net_profit': 1.8}, {'period': ""Q4 '24"", 'revenue': 79.7, 'unit': 'B', 'net_profit': 2.35}, {'period': ""Q3 '24"", 'revenue': 58.52, 'unit': 'B', 'net_profit': 1.68}, {'period': ""Q2 '24"", 'revenue': 58.44, 'unit': 'B', 'net_profit': 1.74}, {'period': ""Q1 '24"", 'revenue': 57.8, 'unit': 'B', 'net_profit': 1.59}]",16.6,16.56,69831000000,34246000000,11144000000,46209000000,2721000000,0,35464000000,9906000000,6629000000,0.09069683908045977,0.17085187539732993,0.17066290550070534,"[1.3, 0.1]","['2025-05-02', '2004-05-06']",__nan__,0.6617261674614426
207,COUP,Coupa Software Incorporated Common Stock,"Coupa Software Incorporated provides cloud-based business spend management platform that connects its customers with suppliers worldwide. The company provides visibility into and control over how companies spend money, optimize supply chains, and manage liquidity, as well as enables businesses to achieve savings that drive profitability. Its platform offers procurement, invoicing, expense management, and payment solutions that form the transactional engine for managing a company's business spend; and specialized solutions, including strategic sourcing, contract management, contingent workforce, supplier risk management, supply chain design and planning, treasury management, and spend analysis. It serves businesses in various industries, including healthcare and pharmaceuticals, retail, financial services, manufacturing, and technology. The company markets its platform primarily through a direct sales force. Coupa Software Incorporated was incorporated in 2006 and is headquartered in San Mateo, California.",Mr. Robert  Bernshteyn,Software - Application,80.97,USD,6116578737,https://images.financialmodelingprep.com/symbol/COUP.png,2287176,-17.993333333333332,0,5078184,-102575000,-369106000,"[{'period': '2022', 'revenue': 725.29, 'unit': 'M', 'net_profit': -369.11}, {'period': '2021', 'revenue': 541.64, 'unit': 'M', 'net_profit': -180.12}, {'period': '2020', 'revenue': 389.72, 'unit': 'M', 'net_profit': -90.83}, {'period': '2019', 'revenue': 260.37, 'unit': 'M', 'net_profit': -55.52}]","[{'period': ""Q3 '23"", 'revenue': 217.34, 'unit': 'M', 'net_profit': -84.1}, {'period': ""Q2 '23"", 'revenue': 211.1, 'unit': 'M', 'net_profit': -70.6}, {'period': ""Q1 '23"", 'revenue': 196.37, 'unit': 'M', 'net_profit': -81.2}, {'period': ""Q4 '22"", 'revenue': 193.3, 'unit': 'M', 'net_profit': -93.96}, {'period': ""Q3 '22"", 'revenue': 185.82, 'unit': 'M', 'net_profit': -91.2}, {'period': ""Q2 '22"", 'revenue': 179.25, 'unit': 'M', 'net_profit': -91.47}]",-5,-5,3193179000,1015048000,729491000,2287517000,226191000,223032000,566952000,506459000,170538000,-0.2643756086136551,-1.0492568719221396,-0.9011406844106464,__nan__,__nan__,__nan__,0.7163760628514718
208,COVA,COVA Acquisition Corp. Class A Ordinary Share,"COVA Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the technology industry in Southeast Asia or the United States. The company was incorporated in 2020 and is based in San Francisco, California.",Mr. Jun Hong  Heng,Shell Companies,10.55,USD,0,https://images.financialmodelingprep.com/symbol/COVA.png,53664,527.5,0.33,38785,11607395000,23216621161,"[{'period': '2021', 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.22}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.21}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.53}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 14.41}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.2}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.6}]",619.11,619.11,0.9253540000000058,0.795742,0.007181,22.772544000000003,0,300.053996,0.524694,0.007181,-2170645000000,0,0,0,__nan__,__nan__,__nan__,24.6095483458221
209,COVAU,COVA Acquisition Corp. Unit,"As of December 20, 2022, COVA Acquisition Corp. was acquired by ECARX Holdings, Inc., in a reverse merger transaction. COVA Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the technology industry in Southeast Asia or the United States. The company was incorporated in 2020 and is based in San Francisco, California.",Mr. Jun Hong  Heng,Shell Companies,10.5,USD,0,https://images.financialmodelingprep.com/symbol/COVAU.png,6104,18.197573656845755,0.4,4260,11607395000,23216621161,"[{'period': '2021', 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.22}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.21}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.53}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 14.41}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.2}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.6}]",619.11,619.11,0.9253540000000058,0.795742,0.007181,22.772544000000003,0,300.053996,0.524694,0.007181,-2170645000000,0,0,0,__nan__,__nan__,__nan__,24.6095483458221
210,COVAW,COVA Acquisition Corp. Warrants to purchase Class A ordinary shares,"COVA Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in San Francisco, California.",Mr. Jun Hong  Heng,Shell Companies,0.1,USD,0,https://images.financialmodelingprep.com/symbol/COVAW.png,0,0,0.02,22819,11607395000,23216621161,"[{'period': '2021', 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.22}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.21}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.53}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 14.41}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.2}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.6}]",619.11,619.11,0.9253540000000058,0.795742,0.007181,22.772544000000003,0,300.053996,0.524694,0.007181,-2170645000000,0,0,0,__nan__,__nan__,__nan__,24.6095483458221
211,COWN,Cowen Inc. Class A Common Stock,"Cowen Inc., together with its subsidiaries, provides investment banking, research, sales and trading, prime brokerage, global clearing, securities financing, commission management, and investment management services in the United States and internationally. It operates in two segments, Operating Company (Op Co) and Asset Company (Asset Co). The company offers public and private capital raising, and strategic advisory services for public and private companies. It also trades common stocks, listed options, equity-linked securities, and other financial instruments on behalf of institutional investor clients. In addition, the company offers investment products and solutions in the liquidity spectrum to institutional and private clients, as well as provides investment research services. Further, it is involved in the private investment, private real estate investment, and other legacy investment activities. The company was founded in 1918 and is headquartered in New York, New York.",Mr. Jeffrey Marc Solomon,Financial - Capital Markets,38.99,USD,1099182296,https://images.financialmodelingprep.com/symbol/COWN.png,608823,17.642533936651585,0,949372,98989000,76458000,"[{'period': '2022', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 76.46}, {'period': '2021', 'revenue': 2110.0, 'unit': 'M', 'net_profit': 295.61}, {'period': '2020', 'revenue': 1620.0, 'unit': 'M', 'net_profit': 216.36}, {'period': '2019', 'revenue': 1050.0, 'unit': 'M', 'net_profit': 55.87}]","[{'period': ""Q4 '22"", 'revenue': 413.93, 'unit': 'M', 'net_profit': 19.22}, {'period': ""Q3 '22"", 'revenue': 410.79, 'unit': 'M', 'net_profit': -7.7}, {'period': ""Q2 '22"", 'revenue': 302410.0, 'unit': 'K', 'net_profit': -818.0}, {'period': ""Q1 '22"", 'revenue': 410.59, 'unit': 'M', 'net_profit': 55.15}, {'period': ""Q4 '21"", 'revenue': 494.28, 'unit': 'M', 'net_profit': 59.98}, {'period': ""Q3 '21"", 'revenue': 412.24, 'unit': 'M', 'net_profit': 37.8}]",2.47,2.21,8828774000,4383085000,1139682000,7480929000,2815923000,3992836000,4371617000,1139682000,159057000,-0.7477588816577395,-0.7413560388483513,-0.7629558541266794,"[0.12, 0.04]","['2023-02-28', '2020-02-28']",__nan__,0.8473349753884288
212,COWNL,Cowen Inc. 7.75% Senior Notes due 2033,,None,,25.22,USD,0,https://images.financialmodelingprep.com/symbol/COWNL.png,7813,0,0,16479,335767000,65855000,"[{'period': '2022', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 65.86}, {'period': '2021', 'revenue': 2110.0, 'unit': 'M', 'net_profit': 303.99}, {'period': '2020', 'revenue': 1620.0, 'unit': 'M', 'net_profit': 207.06}, {'period': '2019', 'revenue': 1050.0, 'unit': 'M', 'net_profit': 24.63}]","[{'period': ""Q4 '22"", 'revenue': 413.93, 'unit': 'M', 'net_profit': 19.22}, {'period': ""Q3 '22"", 'revenue': 410.79, 'unit': 'M', 'net_profit': -7.7}, {'period': ""Q2 '22"", 'revenue': 302410.0, 'unit': 'K', 'net_profit': -818.0}, {'period': ""Q1 '22"", 'revenue': 410.59, 'unit': 'M', 'net_profit': 55.15}, {'period': ""Q4 '21"", 'revenue': 1240.0, 'unit': 'M', 'net_profit': 212.05}, {'period': ""Q3 '21"", 'revenue': 412.24, 'unit': 'M', 'net_profit': 32.87}]",2.3,2.3,8828774000,3229660000,1364835000,7480929000,1864825000,49832000,859298000,1139652000,159057000,-0.4561746761103112,-0.7833652969989243,-0.7836312323612419,"[0.4844, 0.484]","['2023-02-28', '2019-08-29']",__nan__,0.8473349753884288
213,CPARU,Catalyst Partners Acquisition Corp. Unit,"Catalyst Partners Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the software companies. The company was incorporated in 2021 and is based in Cambridge, Massachusetts.",Dr. James Ireland Cash Jr.,Shell Companies,10,USD,0,https://images.financialmodelingprep.com/symbol/CPARU.png,9141,0,-0.02,270,,,[],"[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 32.88}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.96}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.65}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.83}]",,,347513577,3861462,2969044,28616378,0,0,720159,2969044,,,,,__nan__,__nan__,__nan__,0.08234607190613448
214,CPHC,Canterbury Park Holding Corporation 'New' Common Stock,"Canterbury Park Holding Corporation, through its subsidiaries, engages in horse racing, card casino, food and beverage, and real estate development businesses. The company's Horse Racing segment operates year-round simulcasting of horse races, as well as wagering on live thoroughbred and quarter horse races on a seasonal basis. Its Card Casino segment offers unbanked card games, such as poker and table games. The company's Food and Beverage segment operates concession stands, restaurants and buffets, bars, and other food venues, as well as café style restaurants and full-service bars within the Card Casino and simulcast area. This segment also provides lounge services along with a buffet restaurant; various concession style food and beverages during live racing; and catering and events services. Its Development segment engages in various development opportunities, such as residential development, office, restaurants, hotel, entertainment, and retail operations. The company is also involved in the provision of related services and activities, such as parking, advertising signage, publication sales, and other entertainment events and activities. Canterbury Park Holding Corporation was founded in 1994 and is based in Shakopee, Minnesota.",Mr. Randall D. Sampson CPA,"Gambling, Resorts & Casinos",17,USD,85665635,https://images.financialmodelingprep.com/symbol/CPHC.png,1790,40.48,-0.2,789,8370747,2112842,"[{'period': '2024', 'revenue': 61.56, 'unit': 'M', 'net_profit': 2.11}, {'period': '2023', 'revenue': 61.44, 'unit': 'M', 'net_profit': 10.56}, {'period': '2022', 'revenue': 66.82, 'unit': 'M', 'net_profit': 7.51}, {'period': '2021', 'revenue': 60.4, 'unit': 'M', 'net_profit': 11.8}]","[{'period': ""Q4 '24"", 'revenue': 11.98, 'unit': 'M', 'net_profit': -1.25}, {'period': ""Q3 '24"", 'revenue': 19.28, 'unit': 'M', 'net_profit': 2.02}, {'period': ""Q2 '24"", 'revenue': 16200.0, 'unit': 'K', 'net_profit': 338.29}, {'period': ""Q1 '24"", 'revenue': 14100.0, 'unit': 'K', 'net_profit': 998.15}, {'period': ""Q4 '23"", 'revenue': 12.53, 'unit': 'M', 'net_profit': 1.36}, {'period': ""Q3 '23"", 'revenue': 19.27, 'unit': 'M', 'net_profit': 1.14}]",0.42,0.42,109922782,24412677,15075642,25834108,3625586,6976091,10673728,10075642,6487814,0.006896323592651155,-0.7999818048405373,-0.8046511627906977,"[0.07, 0.25]","['2025-03-31', '2012-06-26']",__nan__,0.235020507395819
215,CPIX,Cumberland Pharmaceuticals Inc. Common Stock,"Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.",Mr. A. J. Kazimi MBA,Drug Manufacturers - Specialty & Generic,4.49,USD,62718089,https://images.financialmodelingprep.com/symbol/CPIX.png,1478921,-9.76,-0.27,30188,-6432409,-6479770,"[{'period': '2024', 'revenue': 37.87, 'unit': 'M', 'net_profit': -6.48}, {'period': '2023', 'revenue': 39.55, 'unit': 'M', 'net_profit': -6.28}, {'period': '2022', 'revenue': 42.01, 'unit': 'M', 'net_profit': -5.65}, {'period': '2021', 'revenue': 35.99, 'unit': 'M', 'net_profit': -5.6}]","[{'period': ""Q4 '24"", 'revenue': 10.44, 'unit': 'M', 'net_profit': -1.9}, {'period': ""Q3 '24"", 'revenue': 9.09, 'unit': 'M', 'net_profit': -1.54}, {'period': ""Q2 '24"", 'revenue': 9.85, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q1 '24"", 'revenue': 8.5, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q4 '23"", 'revenue': 9.35, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q3 '23"", 'revenue': 10.09, 'unit': 'M', 'net_profit': -1.05}]",-0.46,-0.46,75583410000000,36452158000000,17964184000000,53037433000000,11701466000000,0,31621729000000,17964184000000,-678647000000,-42.954962593841515,-0.03192224635788589,-0.0454545454545455,__nan__,__nan__,__nan__,0.7017073323365538
216,CPLP,Capital Product Partners L.P. Common Units,"Capital Product Partners L.P., a shipping company, provides marine transportation services in Greece. Its vessels transport a range of cargoes, including liquefied natural gas, containerized goods, and dry bulk cargo under short-term voyage charters, and medium to long-term time charters. As of April 27, 2022, the company owned 21 vessels, including 11 Neo-Panamax container vessels, three Panamax container vessels, one cape-size bulk carrier, and six LNG carriers. Capital GP L.L.C. serves as the general partner of the company. The company was incorporated in 2007 and is headquartered in Piraeus, Greece.",Mr. Gerasimos G. Kalogiratos,Marine Shipping,16.77,USD,979155021,https://images.financialmodelingprep.com/symbol/CPLP.png,18401,6.628458498023716,0.35,9356,247423000,47208000,"[{'period': '2023', 'revenue': 360.59, 'unit': 'M', 'net_profit': 47.21}, {'period': '2022', 'revenue': 299.07, 'unit': 'M', 'net_profit': 172.7}, {'period': '2021', 'revenue': 184.66, 'unit': 'M', 'net_profit': 77.8}, {'period': '2020', 'revenue': 140.87, 'unit': 'M', 'net_profit': 13.76}]","[{'period': ""Q2 '24"", 'revenue': 97.67, 'unit': 'M', 'net_profit': 34.18}, {'period': ""Q1 '24"", 'revenue': 104.49, 'unit': 'M', 'net_profit': 33.9}, {'period': ""Q4 '23"", 'revenue': 95.51, 'unit': 'M', 'net_profit': 12.73}, {'period': ""Q3 '23"", 'revenue': 95.53, 'unit': 'M', 'net_profit': 17.04}, {'period': ""Q2 '23"", 'revenue': 88.53, 'unit': 'M', 'net_profit': 7.41}, {'period': ""Q1 '23"", 'revenue': 81.02, 'unit': 'M', 'net_profit': -15.81}]",2.15,2.15,3140299000,225504000,192422000,1965366000,4433000,11721000,183930000,192422000,-278257000,-0.05608414338252125,-0.7266410339556214,-0.7595078299776286,"[0.15, 0.3626]","['2024-08-06', '2007-08-02']",__nan__,0.6258531432834898
217,CPRT,Copart Inc. (DE) Common Stock,"Copart, Inc. provides online auctions and vehicle remarketing services in the United States, Canada, the United Kingdom, Brazil, the Republic of Ireland, Germany, Finland, the United Arab Emirates, Oman, Bahrain, and Spain. It offers a range of services for processing and selling vehicles over the internet through its virtual bidding third generation internet auction-style sales technology to vehicle sellers, insurance companies, banks and finance companies, charities, fleet operators, dealers, vehicle rental companies, and individuals. The company's services include online seller access, salvage estimation, estimating, end-of-life vehicle processing, virtual insured exchange, transportation, vehicle inspection stations, on-demand reporting, title processing and procurement, loan payoff, flexible vehicle processing programs, buy it now, member network, sales process, and dealer services. Its services also comprise services to sell vehicles through CashForCars.com; U-Pull-It service that allows buyer to remove valuable parts and sell the remaining parts and car body; copart 360, an online technology for posting vehicle images; membership tiers for those registering to buy vehicles through Copart.com; and virtual queue to secure a place in line while visiting one of its locations. The company sells its products principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, and exporters, as well as to the public. The company was incorporated in 1982 and is headquartered in Dallas, Texas.",Mr. Jeffrey  Liaw,Auto - Dealerships,58.73,USD,56738639541,https://images.financialmodelingprep.com/symbol/CPRT.png,4933018,39.42,-0.95,3550144,1762279000,1363020000,"[{'period': '2024', 'revenue': 4.24, 'unit': 'B', 'net_profit': 1.36}, {'period': '2023', 'revenue': 3.87, 'unit': 'B', 'net_profit': 1.24}, {'period': '2022', 'revenue': 3.5, 'unit': 'B', 'net_profit': 1.09}, {'period': '2021', 'revenue': 2690.0, 'unit': 'M', 'net_profit': 936.5}]","[{'period': ""Q2 '25"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': 387.4}, {'period': ""Q1 '25"", 'revenue': 1150.0, 'unit': 'M', 'net_profit': 362.09}, {'period': ""Q4 '24"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 322.57}, {'period': ""Q3 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': 382.29}, {'period': ""Q2 '24"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 325.63}, {'period': ""Q1 '24"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 332.53}]",1.42,1.4,8427763999,4418184000,3422158000,879209000,785877000,0,628567000,1514111000,961574000,0.18546734124013078,0.10121584402552715,0.09230769230769222,__nan__,__nan__,__nan__,0.10432292599844074
218,CPRX,Catalyst Pharmaceuticals Inc. Common Stock,"Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.",Mr. Richard John  Daly M.B.A.,Biotechnology,22.02,USD,2685541034,https://images.financialmodelingprep.com/symbol/CPRX.png,1277906,16.81,-0.5,706165,195124000,163889000,"[{'period': '2024', 'revenue': 491.73, 'unit': 'M', 'net_profit': 163.89}, {'period': '2023', 'revenue': 398.2, 'unit': 'M', 'net_profit': 71.41}, {'period': '2022', 'revenue': 214.2, 'unit': 'M', 'net_profit': 83.08}, {'period': '2021', 'revenue': 140.83, 'unit': 'M', 'net_profit': 39.48}]","[{'period': ""Q4 '24"", 'revenue': 141.82, 'unit': 'M', 'net_profit': 55.94}, {'period': ""Q3 '24"", 'revenue': 128.69, 'unit': 'M', 'net_profit': 43.88}, {'period': ""Q2 '24"", 'revenue': 122.71, 'unit': 'M', 'net_profit': 40.79}, {'period': ""Q1 '24"", 'revenue': 98.51, 'unit': 'M', 'net_profit': 23.27}, {'period': ""Q4 '23"", 'revenue': 110.57, 'unit': 'M', 'net_profit': 34.84}, {'period': ""Q3 '23"", 'revenue': 102.69, 'unit': 'M', 'net_profit': -30.76}]",1.38,1.31,851411000,623609000,517553000,123779000,65476000,21564000,120678000,517553000,143369000,0.6302039384090966,1.2950427111048872,1.0597014925373132,__nan__,__nan__,__nan__,0.14538102044723406
219,CPSH,CPS Technologies Corp. Common Stock,"CPS Technologies Corporation produces and sells advanced material solutions to the transportation, automotive, energy, computing/internet, telecommunication, aerospace, defense, and oil and gas markets. It primarily offers metal matrix composites that are a combination of metal and ceramic, such as baseplates for various applications, including motor controllers used in electric trains, subway cars, wind turbines, and hybrid and electric vehicles; hermetic packages for use in radar, satellite, and avionics applications; baseplates and housings used in modules built with wide band gap semiconductors; and lids and heatspreaders used with integrated circuits for use in internet switches and routers. The company also assembles housings and packages for hybrid circuits. It primarily sells its products to microelectronics systems companies in the United States, Europe, and Asia. The company was formerly known as Ceramics Process Systems Corporation and changed its name to CPS Technologies Corporation in March 2007. CPS Technologies Corporation was incorporated in 1984 and is headquartered in Norton, Massachusetts.",Mr. Brian  Mackey,"Hardware, Equipment & Parts",1.46,USD,21207902,https://images.financialmodelingprep.com/symbol/CPSH.png,58800,-6.64,0,6527,-3833776,-3135449,"[{'period': '2024', 'revenue': 21.12, 'unit': 'M', 'net_profit': -3.14}, {'period': '2023', 'revenue': 27.55, 'unit': 'M', 'net_profit': 1.37}, {'period': '2022', 'revenue': 26.59, 'unit': 'M', 'net_profit': 2.13}, {'period': '2021', 'revenue': 22.45, 'unit': 'M', 'net_profit': 3.22}]","[{'period': ""Q4 '24"", 'revenue': 5930.0, 'unit': 'K', 'net_profit': -995.15}, {'period': ""Q3 '24"", 'revenue': 4.25, 'unit': 'M', 'net_profit': -1.04}, {'period': ""Q2 '24"", 'revenue': 5030.0, 'unit': 'K', 'net_profit': -954.3}, {'period': ""Q1 '24"", 'revenue': 5910.0, 'unit': 'K', 'net_profit': -143.15}, {'period': ""Q4 '23"", 'revenue': 6750.0, 'unit': 'K', 'net_profit': 139.51}, {'period': ""Q3 '23"", 'revenue': 6290.0, 'unit': 'K', 'net_profit': 171.08}]",-0.22,-0.22,18876946,14159016,4311688,4364827,5035276,0,4307550000000,3280687,-4470682000000,-2.7518097151155194,-3.288154530116121,-3.328042328042328,__nan__,__nan__,__nan__,0.23122527341022217
220,CPSI,Computer Programs and Systems Inc. Common Stock,"Computer Programs and Systems, Inc. provides healthcare information technology solutions and services in the United States and the Caribbean nation of St. Maarten. Its software systems include patient management software that enables a hospital to identify a patient at various points in the healthcare delivery system, as well as to collect and maintain patient information throughout the process of patient care; and financial accounting software, which offers business office applications to track and coordinate information needed for managerial decision-making. The company also provides clinical software that automates record keeping and reporting for various clinical functions, including laboratory, radiology, physical therapy, respiratory care, and pharmacy; patient care applications; and enterprise applications that support its products for use in various areas of the hospital, and provide software applications. In addition, it offers Centriq, an intuitive user interface to centralize data from various care areas that provide the end user with a tool to view past and present patient information. Further, the company provides software solutions that promote data-driven clinical and financial outcomes for customers in the post-acute care industry; software application support, hardware maintenance, and education and related services; post-acute care support and maintenance services; revenue cycle management products and services, consulting and business management services, and managed information technology services; patient engagement, and encoder solutions. It serves community hospitals and physician clinics, skilled nursing, and assisted living facilities. Computer Programs and Systems, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.",Mr. Christopher L. Fowler,Medical - Healthcare Information Services,9.19,USD,133705310,https://images.financialmodelingprep.com/symbol/CPSI.png,206653,-183.8,0.33,534996,43829000,15867000,"[{'period': '2022', 'revenue': 326.65, 'unit': 'M', 'net_profit': 15.87}, {'period': '2021', 'revenue': 280.63, 'unit': 'M', 'net_profit': 18.43}, {'period': '2020', 'revenue': 264.49, 'unit': 'M', 'net_profit': 14.25}, {'period': '2019', 'revenue': 274.63, 'unit': 'M', 'net_profit': 20.47}]","[{'period': ""Q3 '23"", 'revenue': 82.71, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q2 '23"", 'revenue': 84.62, 'unit': 'M', 'net_profit': -2.84}, {'period': ""Q1 '23"", 'revenue': 86.23, 'unit': 'M', 'net_profit': 3.08}, {'period': ""Q4 '22"", 'revenue': 83.22, 'unit': 'M', 'net_profit': 2.52}, {'period': ""Q3 '22"", 'revenue': 82.83, 'unit': 'M', 'net_profit': 2.16}, {'period': ""Q2 '22"", 'revenue': 82.73, 'unit': 'M', 'net_profit': 3.08}]",1.11,1.11,430963000,74559000,6951000,199252000,55785000,3312000,44455000,6951000,13008000,0.01670184880187432,-0.13906673901247965,-0.11904761904761897,"[0.1, 0.085]","['2020-08-14', '2003-05-07']",__nan__,0.46234131468362716
221,CPSS,Consumer Portfolio Services Inc. Common Stock,"Consumer Portfolio Services, Inc. operates as a specialty finance company in the United States. It is involved in the purchase and service of retail automobile contracts originated by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans. The company, through its automobile contract purchases, offers indirect financing to the customers of dealers with limited credit histories or past credit problems. It serves as an alternative source of financing for dealers, facilitating sales to customers who are not able to obtain financing from commercial banks, credit unions, and the captive finance companies. The company also acquires installment purchase contracts in four merger and acquisition transactions; purchases immaterial amounts of vehicle purchase money loans from non-affiliated lenders. and offers financing directly to sub-prime consumers to facilitate their purchase of a new or used automobile, light truck, or passenger van. It services its automobile contracts through its branches in California, Nevada, Virginia, Florida, and Illinois. The company was founded in 1991 and is based in Las Vegas, Nevada.",Mr. Charles E. Bradley Jr.,Financial - Credit Services,8.09,USD,173475464,https://images.financialmodelingprep.com/symbol/CPSS.png,23365,10.24,-0.23,14226,0,19203000,"[{'period': '2024', 'revenue': 393.51, 'unit': 'M', 'net_profit': 19.2}, {'period': '2023', 'revenue': 214.6, 'unit': 'M', 'net_profit': 45.34}, {'period': '2022', 'revenue': 242.19, 'unit': 'M', 'net_profit': 85.98}, {'period': '2021', 'revenue': 192.57, 'unit': 'M', 'net_profit': 47.52}]","[{'period': ""Q4 '24"", 'revenue': 52.78, 'unit': 'M', 'net_profit': 5.14}, {'period': ""Q3 '24"", 'revenue': 100.58, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q2 '24"", 'revenue': 90.38, 'unit': 'M', 'net_profit': 4.67}, {'period': ""Q1 '24"", 'revenue': 86.74, 'unit': 'M', 'net_profit': 4.59}, {'period': ""Q4 '23"", 'revenue': 85.98, 'unit': 'M', 'net_profit': 7.19}, {'period': ""Q3 '23"", 'revenue': 54.19, 'unit': 'M', 'net_profit': 10.38}]",0.9,0.79,3493868000,11713000,11713000,3201098000,0,0,410898000,11713000,233755000,0,-0.5764947180380654,-0.5852534562211982,__nan__,__nan__,__nan__,0.9162046190640287
222,CPTA,Capitala Finance Corp. Common Stock,"Capitala Finance Corp. is an externally managed non-diversified, closed-end management investment company. The Company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The Company invests in first lien loans, which have a first priority security interest in all or some of the borrower’s assets. In addition, its first lien loans may include positions in stretch senior secured loans, also referred to as unitranche loans, which combine characteristics of traditional first lien senior secured loans and second lien loans. It also may invest in second lien loans, which have a second priority security interest in all or substantially all of the borrower’s assets. It also provides capital to lower and traditional middle-market companies in the United States. The Company’s investment advisor is Capitala Investment Advisors, LLC.",Mr. Joseph Alala,Asset Management,25.4,USD,68861178,https://images.financialmodelingprep.com/symbol/CPTA.png,28256,0,0.539999,19991,-20303000,-35447000,"[{'period': '2020', 'revenue': -30.79, 'unit': 'M', 'net_profit': -35.45}, {'period': '2019', 'revenue': -22.61, 'unit': 'M', 'net_profit': -27.65}, {'period': '2018', 'revenue': -13.25, 'unit': 'M', 'net_profit': -16.03}, {'period': '2017', 'revenue': -0.043000000000000003, 'unit': 'M', 'net_profit': -6.98}]","[{'period': ""Q2 '21"", 'revenue': -5.73, 'unit': 'M', 'net_profit': -7.55}, {'period': ""Q1 '21"", 'revenue': 13.63, 'unit': 'M', 'net_profit': 12.35}, {'period': ""Q4 '20"", 'revenue': 1830.0, 'unit': 'K', 'net_profit': 538.0}, {'period': ""Q3 '20"", 'revenue': 4.16, 'unit': 'M', 'net_profit': 3.35}, {'period': ""Q2 '20"", 'revenue': 4.16, 'unit': 'M', 'net_profit': 3.1}, {'period': ""Q1 '20"", 'revenue': -40.94, 'unit': 'M', 'net_profit': -42.44}]",-13.08,-13.08,327997000,52228000,49942000,219050000,2286000,274692000,1716000,49942000,53113000,-1.0512224691856942,-0.2821282598473614,-0.27113702623906716,"[0.0139, 0.0783]","['2020-03-20', '2013-12-06']",__nan__,0.6678414741598246
223,CPTAG,Capitala Finance Corp. 5.75% Convertible Notes Due 2022,,None,Asset Management,25,USD,0,https://images.financialmodelingprep.com/symbol/CPTAG.png,4114,-24.9500998003992,0.04000092,89443,-20303000,-35447000,"[{'period': '2020', 'revenue': -30.79, 'unit': 'M', 'net_profit': -35.45}, {'period': '2019', 'revenue': -22.61, 'unit': 'M', 'net_profit': -27.65}, {'period': '2018', 'revenue': -13.25, 'unit': 'M', 'net_profit': -16.03}, {'period': '2017', 'revenue': -0.043000000000000003, 'unit': 'M', 'net_profit': -6.98}]","[{'period': ""Q2 '21"", 'revenue': -5.73, 'unit': 'M', 'net_profit': -7.55}, {'period': ""Q1 '21"", 'revenue': 13.63, 'unit': 'M', 'net_profit': 12.35}, {'period': ""Q4 '20"", 'revenue': 1830.0, 'unit': 'K', 'net_profit': 538.0}, {'period': ""Q3 '20"", 'revenue': 4.16, 'unit': 'M', 'net_profit': 3.35}, {'period': ""Q2 '20"", 'revenue': 4.16, 'unit': 'M', 'net_profit': 3.1}, {'period': ""Q1 '20"", 'revenue': -40.94, 'unit': 'M', 'net_profit': -42.44}]",-13.08,-13.08,327997000,52228000,49942000,219050000,2286000,274692000,1716000,49942000,53113000,-1.0512224691856942,-0.2821282598473614,-0.27113702623906716,"[0.359, 0.359]","['2022-05-12', '2017-08-11']",__nan__,0.6678414741598246
224,CPTAL,Capitala Finance Corp. 6% Notes Due 2022,,None,Asset Management,25,USD,0,https://images.financialmodelingprep.com/symbol/CPTAL.png,5744,-316.45569620253167,0.04000092,4022,-20303000,-35447000,"[{'period': '2020', 'revenue': -30.79, 'unit': 'M', 'net_profit': -35.45}, {'period': '2019', 'revenue': -22.61, 'unit': 'M', 'net_profit': -27.65}, {'period': '2018', 'revenue': -13.25, 'unit': 'M', 'net_profit': -16.03}, {'period': '2017', 'revenue': -0.043000000000000003, 'unit': 'M', 'net_profit': -6.98}]","[{'period': ""Q2 '21"", 'revenue': -5.73, 'unit': 'M', 'net_profit': -7.55}, {'period': ""Q1 '21"", 'revenue': 13.63, 'unit': 'M', 'net_profit': 12.35}, {'period': ""Q4 '20"", 'revenue': 1830.0, 'unit': 'K', 'net_profit': 538.0}, {'period': ""Q3 '20"", 'revenue': 4.16, 'unit': 'M', 'net_profit': 3.35}, {'period': ""Q2 '20"", 'revenue': 4.16, 'unit': 'M', 'net_profit': 3.1}, {'period': ""Q1 '20"", 'revenue': -40.94, 'unit': 'M', 'net_profit': -42.44}]",-13.08,-13.08,327997000,52228000,49942000,219050000,2286000,274692000,1716000,49942000,53113000,-1.0512224691856942,-0.2821282598473614,-0.27113702623906716,"[0.375, 0.375]","['2022-05-12', '2017-08-11']",__nan__,0.6678414741598246
225,CPZ,Calamos Long/Short Equity & Dynamic Income Trust Common Stock,"Calamos Long/Short Equity & Dynamic Income Trust is a diversified and closed-end management investment company, which engages in the business of seeking to provide current income and risk-managed capital appreciation. The firm is also involved in providing hedged market exposure through time-tested global long and short equity strategy. The company was founded on September 21, 2017 and is headquartered in Naperville, IL.",John Peter Calamos,Asset Management,14.936,USD,293226539,https://images.financialmodelingprep.com/symbol/CPZ.png,72836,5.59,-0.194,81036,52414939,52414939,"[{'period': '2024', 'revenue': 55.87, 'unit': 'M', 'net_profit': 52.41}, {'period': '2023', 'revenue': 13.88, 'unit': 'M', 'net_profit': 11.01}, {'period': '2022', 'revenue': -38.8, 'unit': 'M', 'net_profit': -42.75}, {'period': '2021', 'revenue': 113.72, 'unit': 'M', 'net_profit': 110.64}]",[],2.67,2.67,725428851,2656931,0,381218930,2652696,0,2310347,0,60426377,0.8193919464590319,3.7599186503846354,3.7678571428571423,"[0.14, 0.0422]","['2025-04-11', '2019-12-30']",__nan__,0.525508365809399
226,CRAI,CRA International Inc. Common Stock,"CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services in the United States, the United Kingdom, and internationally. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guides corporations through business strategy and performance-related issues. The company also offers consulting services, including research and analysis, expert testimony, and support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. In addition, it offers management consulting services comprising strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, new product pricing strategies, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries, including communications and media; consumer, health, and wellness products; energy; entertainment and leisure; financial services; healthcare; life sciences; manufacturing and industries; natural resources; retail and distribution; technology; and transportation. CRA International, Inc. was incorporated in 1965 and is headquartered in Boston, Massachusetts.",Mr. Paul A. Maleh,Consulting Services,161.01,USD,1093508593,https://images.financialmodelingprep.com/symbol/CRAI.png,40650,23.85,-1.73,40307,97483000,46653000,"[{'period': '2024', 'revenue': 687.41, 'unit': 'M', 'net_profit': 46.65}, {'period': '2023', 'revenue': 623.98, 'unit': 'M', 'net_profit': 38.48}, {'period': '2022', 'revenue': 590.9, 'unit': 'M', 'net_profit': 43.62}, {'period': '2021', 'revenue': 565.93, 'unit': 'M', 'net_profit': 41.68}]","[{'period': ""Q4 '24"", 'revenue': 176.44, 'unit': 'M', 'net_profit': 14.99}, {'period': ""Q3 '24"", 'revenue': 167.75, 'unit': 'M', 'net_profit': 11.44}, {'period': ""Q2 '24"", 'revenue': 171.44, 'unit': 'M', 'net_profit': 6.54}, {'period': ""Q1 '24"", 'revenue': 171.79, 'unit': 'M', 'net_profit': 13.69}, {'period': ""Q4 '23"", 'revenue': 161.61, 'unit': 'M', 'net_profit': 11.46}, {'period': ""Q3 '23"", 'revenue': 147.55, 'unit': 'M', 'net_profit': 8.6}]",6.82,6.74,571439000,269363000,26711000,359366000,162293000,0,251309000,26711000,33112000,0.1897311348963228,0.21236454354096826,0.24680073126142607,"[0.49, 0.14]","['2025-03-04', '2016-11-16']",__nan__,0.628879022957831
227,CRBP,Corbus Pharmaceuticals Holdings Inc. Common Stock,"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the activation of transforming growth factor ß (TGFß); and CRB-602, an anti-avß6/avß8 mAb that blocks the activation of TGFß for the treatment of fibrotic diseases. The company is also developing cannabinoid receptor type 1 inverse agonist program for the treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; fibrotic diseases, including lung, cardiac, renal disease, and liver fibrosis; and other diseases comprising ascites, cognitive defects, Prader-Willi syndrome, and smoking cessation. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.",Dr. Yuval  Cohen Ph.D.,Biotechnology,6.3,USD,77063036,https://images.financialmodelingprep.com/symbol/CRBP.png,239372,-1.71,0.27,106527,0,-40209000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.21}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -44.6}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.83}, {'period': '2021', 'revenue': 0.8817100000000001, 'unit': 'M', 'net_profit': -45.55}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.53}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.78}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.0}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.9}, {'period': ""Q4 '23"", 'revenue': 1.35, 'unit': 'M', 'net_profit': -8.02}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.05}]",-3.68,-3.68,155879000,152976000,149062000,13451000,0,0,11818000,17198000,-41794000,1,0.09851993963856857,0.6430649854510184,__nan__,__nan__,__nan__,0.08629129003906877
228,CRCT,Cricut Inc. Class A Common Stock,"Cricut, Inc. designs and markets a creativity platform that enables users to turn ideas into professional-looking handmade goods. It operates in three segments: Connected Machines, Subscriptions, and Accessories and Materials. The company offers connected machines, design apps, and accessories and materials for users to create personalized birthday cards, mugs, T-shirts, and large-scale interior decorations. Its connected machines include Cricut Joy, Cricut Explore, and Cricut Maker to cut, write, score, and create decorative effects using various materials, such as paper, vinyl, leather, and others; and design apps comprise Design Space app and Cricut Joy-specific app. The company also provides Cricut Access and Cricut Access Premium subscription offerings, and in-app purchases; and a software that integrates its connected machines and design apps. In addition, it offers a range of accessories and materials, such as Cricut EasyPress, Cricut Mug Press, various hand tools, machine replacement tools and blades, and project materials. The company offers its products through its third-party brick-and-mortar and online retail partners; and its website cricut.com, as well as through a network of distributors. It operates in the United States, the United Kingdom, Ireland, Australia, New Zealand, and Western Europe, as well as the Middle East, Latin America, South Africa, and Asia. The company was formerly known as Provo Craft & Novelty, Inc. and changed its name to Cricut, Inc. in March 2018. The company was incorporated in 1969 and is headquartered in South Jordan, Utah.",Mr. Ashish  Arora,Computer Hardware,4.15,USD,879006607,https://images.financialmodelingprep.com/symbol/CRCT.png,362331,14.31,0.03,404719,118209000,62830000,"[{'period': '2024', 'revenue': 712.54, 'unit': 'M', 'net_profit': 62.83}, {'period': '2023', 'revenue': 765.15, 'unit': 'M', 'net_profit': 53.64}, {'period': '2022', 'revenue': 886.3, 'unit': 'M', 'net_profit': 60.67}, {'period': '2021', 'revenue': 1310.0, 'unit': 'M', 'net_profit': 140.47}]","[{'period': ""Q4 '24"", 'revenue': 209.31, 'unit': 'M', 'net_profit': 11.93}, {'period': ""Q3 '24"", 'revenue': 167.89, 'unit': 'M', 'net_profit': 11.49}, {'period': ""Q2 '24"", 'revenue': 167.95, 'unit': 'M', 'net_profit': 19.77}, {'period': ""Q1 '24"", 'revenue': 167.39, 'unit': 'M', 'net_profit': 19.65}, {'period': ""Q4 '23"", 'revenue': 231.25, 'unit': 'M', 'net_profit': 11.29}, {'period': ""Q3 '23"", 'revenue': 174.91, 'unit': 'M', 'net_profit': 17.23}]",0.29,0.29,693035000,580214000,336914000,226274000,101980000,0,203374000,232140000,246634000,0.07554637599403126,0.1714147214557387,0.15999999999999992,"[0.1, 0.35]","['2025-01-07', '2023-01-31']",__nan__,0.3264972187551855
229,CRDF,Cardiff Oncology Inc. Common Stock,"Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.",Dr. Mark  Erlander Ph.D.,Biotechnology,2.82,USD,187598495,https://images.financialmodelingprep.com/symbol/CRDF.png,1218988,-2.97,-0.03,863203,-48651000,-45431000,"[{'period': '2024', 'revenue': 0.683, 'unit': 'M', 'net_profit': -45.43}, {'period': '2023', 'revenue': 0.488, 'unit': 'M', 'net_profit': -41.44}, {'period': '2022', 'revenue': 0.386, 'unit': 'M', 'net_profit': -37.51}, {'period': '2021', 'revenue': 0.359, 'unit': 'M', 'net_profit': -27.74}]","[{'period': ""Q4 '24"", 'revenue': 0.151, 'unit': 'M', 'net_profit': -11.79}, {'period': ""Q3 '24"", 'revenue': 0.165, 'unit': 'M', 'net_profit': -11.86}, {'period': ""Q2 '24"", 'revenue': 0.163, 'unit': 'M', 'net_profit': -11.78}, {'period': ""Q1 '24"", 'revenue': 0.20500000000000002, 'unit': 'M', 'net_profit': -10.01}, {'period': ""Q4 '23"", 'revenue': 0.156, 'unit': 'M', 'net_profit': -9.34}, {'period': ""Q3 '23"", 'revenue': 0.14100000000000001, 'unit': 'M', 'net_profit': -9.73}]",-0.95,-0.95,97190000,95054000,91746000,14241000,773000,0,13428000,51470000,-37773000,-0.08079708535122407,-0.09628146038946937,-0.02150537634408592,__nan__,__nan__,__nan__,0.14652742051651405
230,CREE,Cree Inc. Common Stock,"Wolfspeed, Inc. provides lighting-class light emitting diode (LED) and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, and internationally. It operates in two segments, Wolfspeed and LED Products. The Wolfspeed segment offers silicon carbide (SiC) materials for RF, power switching, gemstones, and other applications. It also provides SiC power device products, including SiC Schottky diodes, metal oxide semiconductor field effect transistors (MOSFETs), power modules, and gate driver boards for electric vehicles, including charging infrastructure, server power supplies, solar inverters, uninterruptible power supplies, industrial power supplies, and other applications. In addition, this segment offers gallium nitride (GaN) die, high-electron mobility transistors (HEMTs), monolithic microwave integrated circuits (MMICs), and laterally diffused MOSFET (LDMOS) power transistors for telecommunications infrastructure, military, and other commercial applications; and custom die manufacturing services for GaN HEMTs and MMICs. The LED Products segment provides blue and green LED chip products for video screens, gaming displays, function indicator lights and automotive backlights, headlamps, and directional indicators. It also offers XLamp LED components and LED modules for lighting applications; and surface mount and through-hole packaged LED products for video, signage, general illumination, transportation, gaming, and specialty lighting applications. The company was founded in 1987 and is headquartered in Durham, North Carolina.",Mr. Gregg Lowe,Semiconductors,79.12,USD,9843873040,https://images.financialmodelingprep.com/symbol/CREE.png,1398932,0,0,1325405,-356500000,-523900000,"[{'period': '2021', 'revenue': 525.6, 'unit': 'M', 'net_profit': -523.9}, {'period': '2020', 'revenue': 903.9, 'unit': 'M', 'net_profit': -191.7}, {'period': '2019', 'revenue': 1080.0, 'unit': 'M', 'net_profit': -375.1}, {'period': '2018', 'revenue': 924.9, 'unit': 'M', 'net_profit': -280.0}]","[{'period': ""Q3 '21"", 'revenue': 156.6, 'unit': 'M', 'net_profit': -70.1}, {'period': ""Q2 '21"", 'revenue': 145.8, 'unit': 'M', 'net_profit': -147.6}, {'period': ""Q1 '21"", 'revenue': 137.3, 'unit': 'M', 'net_profit': -108.9}, {'period': ""Q4 '20"", 'revenue': 127.0, 'unit': 'M', 'net_profit': -83.0}, {'period': ""Q3 '20"", 'revenue': 216.6, 'unit': 'M', 'net_profit': -184.4}, {'period': ""Q2 '20"", 'revenue': 205.7, 'unit': 'M', 'net_profit': -39.5}]",-4.66,-4.66,3446800000,1478700000,1154600000,1330300000,102300000,0,448800000,379000000,-701900000,-9.902140672782874,-1.7329160146061555,-1.6179775280898876,__nan__,__nan__,__nan__,0.38595218753626553
231,CREG,China Recycling Energy Corporation Common Stock,"Smart Powerr Corp. engages in the recycling energy business in China. The company designs, finances, constructs, installs, operates, and transfers waste energy recycling projects to mid- to large-size enterprises involved in high energy-consuming businesses. It provides waste pressure-to-energy solutions, including the Blast Furnace Top Gas Recovery Turbine Unit, a system that utilizes high pressure gas emitted from the blast furnace top to drive turbine units and generate electricity; and waste heat-to-energy solutions, such as heat power generation projects for applications in cement, steel, coking coal, and nonferrous metal industries, which collect the residual heat from various manufacturing processes. The company also offers waste gas-to-energy solutions comprising the Waste Gas Power Generation system that utilizes flammable waste gas from coal mining, petroleum exploitation, refinery processing, or other sources as a fuel source to generate electricity; and the Combined Cycle Power Plant, which employs power generating cycle to utilize the waste gas that generates electricity by burning the flammable waste gas in a gas turbine, as well as uses the waste heat from burning the gas to make steam to generate additional electricity through a steam turbine. In addition, it provides project investment, investment management, economic information consulting, technical, financial leasing, and financial leasing transactions consulting services; purchases, repairs, and disposes financial leasing assets; and sells and leases energy saving systems and equipment. The company was formerly known as China Recycling Energy Corporation and changed its name to Smart Powerr Corp. in March 2022. Smart Powerr Corp. was incorporated in 1980 and is headquartered in Xi'an, China.",Mr. Guohua  Ku,Renewable Utilities,0.6517,USD,5970366,https://images.financialmodelingprep.com/symbol/CREG.png,61739,-3.62,0.0208,18644,-1093468,-1559012,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.56}, {'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': -746.79}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.46}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.23}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -606.73}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -262.73}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -409.76}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -279.8}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -228.72}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -180.72}]",-0.18,-0.18,121234786,121115843,25341,16503705,49747,0,13096541,25341,-10764096,-0.37045127831064223,-1.0876288521745185,-0.8769551616266944,__nan__,__nan__,__nan__,0.1361301120290673
232,CRESY,Cresud S.A.C.I.F. y A. American Depositary Shares,"Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces basic agricultural commodities in Brazil and other Latin American countries. It operates through Agricultural Business, and Urban Properties and Investment Business segments. The Agricultural Business segment is involved in the planting, harvesting, and sale of crops, such as wheat, corn, soybeans, cotton, and sunflower, as well as sugarcane; sale of grain derivatives, including flour and oil; breeding, purchasing, and/or fattening of cattle for sale to meat processors and local livestock auction markets; provision of agricultural services; leasing of farms to third parties; disposal and development of farmlands; and brokerage activities. The Urban Properties and Investment Business segment leases, rents, and services commercial and other spaces in shopping malls; leases offices and other rental spaces; develops, maintains, and sells undeveloped parcels of land and/or trading properties; and operates hotels, as well as engages in the entertainment activities. The company was incorporated in 1936 and is headquartered in Buenos Aires, Argentina.",Mr. Alejandro  Gustavo Elsztain,Conglomerates,11.6,USD,69443632,https://images.financialmodelingprep.com/symbol/CRESY.png,242724,-9.28,-0.79,134152,103585000000,78460000000,"[{'period': '2024', 'revenue': 711.37, 'unit': 'B', 'net_profit': 78.46}, {'period': '2023', 'revenue': 707.41, 'unit': 'B', 'net_profit': 162.99}, {'period': '2022', 'revenue': 767.7, 'unit': 'B', 'net_profit': 297.05}, {'period': '2021', 'revenue': 149.93, 'unit': 'B', 'net_profit': -44.43}]","[{'period': ""Q2 '25"", 'revenue': 204.47, 'unit': 'B', 'net_profit': -18.8}, {'period': ""Q1 '25"", 'revenue': 226.51, 'unit': 'B', 'net_profit': -39.56}, {'period': ""Q4 '24"", 'revenue': 260.56, 'unit': 'B', 'net_profit': 56.12}, {'period': ""Q3 '24"", 'revenue': 140.38, 'unit': 'B', 'net_profit': -51.65}, {'period': ""Q2 '24"", 'revenue': 101.24, 'unit': 'B', 'net_profit': -13.71}, {'period': ""Q1 '24"", 'revenue': 208.65, 'unit': 'B', 'net_profit': 126.01}]",132.44,111.77,3473111000000,706400000000,260738000000,1909201000000,263962000000,147907000000,657605000000,114635000000,-11926000000,-0.08913842528270695,-0.5186207742806307,-0.5108402585410896,"[0.58955, 0.03]","['2024-12-02', '1998-12-21']",__nan__,0.5497091800406033
233,CREX,Creative Realities Inc. Common Stock,"Creative Realities, Inc., together with its subsidiaries, provides digital marketing technology and solutions to retail companies, individual retail brands, enterprises, and organizations in the United States and internationally. Its technology and solutions include digital merchandising systems and omni-channel customer engagement systems; interactive digital shopping assistants; advisors and kiosks; and other interactive marketing technologies, such as mobile, social media, point-of-sale transactions, beaconing, and Web-based media that enables its customers to engage with their consumers. The company also provides system hardware; professional and implementation services; software design and development; and software licensing, deployment, and maintenance and support services, as well as media management and distribution software platforms and networks; device and product management; and customized software service layers, systems, experiences, workflows, and integrated solutions. The company sells its solutions to the automotive, apparel and accessories, banking, baby/children, beauty, CPG, department stores, digital out-of-home, electronics, fashion, fitness, foodservice/quick service restaurant, financial services, gaming, luxury, mass merchants, mobile operators, and pharmacy retail industries. Creative Realities, Inc. is headquartered in Louisville, Kentucky.",Mr. Richard C. Mills,Software - Application,1.28,USD,13371724,https://images.financialmodelingprep.com/symbol/CREX.png,52716,-3.76,-0.08,25404,2451000,-3508000,"[{'period': '2024', 'revenue': 50.85, 'unit': 'M', 'net_profit': -3.51}, {'period': '2023', 'revenue': 45.17, 'unit': 'M', 'net_profit': -2.94}, {'period': '2022', 'revenue': 43.35, 'unit': 'M', 'net_profit': 1.88}, {'period': '2021', 'revenue': 18440.0, 'unit': 'K', 'net_profit': 232.0}]","[{'period': ""Q4 '24"", 'revenue': 11.01, 'unit': 'M', 'net_profit': -3.22}, {'period': ""Q3 '24"", 'revenue': 14440.0, 'unit': 'K', 'net_profit': 438.0}, {'period': ""Q2 '24"", 'revenue': 13120.0, 'unit': 'K', 'net_profit': -615.0}, {'period': ""Q1 '24"", 'revenue': 12290.0, 'unit': 'K', 'net_profit': -109.0}, {'period': ""Q4 '23"", 'revenue': 14.46, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q3 '23"", 'revenue': 11.57, 'unit': 'M', 'net_profit': -1.93}]",-0.34,-0.34,65210000,14496000,1037000,39750000,10605000,0,26163000,1037000,580000,-0.2703185471866627,-0.1944160708205652,0.02857142857142844,__nan__,__nan__,__nan__,0.6095690844962429
234,CREXW,Creative Realities Inc. Warrant,,None,Software - Application,0.0046,USD,0,https://images.financialmodelingprep.com/symbol/CREXW.png,0,0,0.0003,5020,2451000,-3508000,"[{'period': '2024', 'revenue': 50.85, 'unit': 'M', 'net_profit': -3.51}, {'period': '2023', 'revenue': 45.17, 'unit': 'M', 'net_profit': -2.94}, {'period': '2022', 'revenue': 43.35, 'unit': 'M', 'net_profit': 1.88}, {'period': '2021', 'revenue': 18440.0, 'unit': 'K', 'net_profit': 232.0}]","[{'period': ""Q4 '24"", 'revenue': 11.01, 'unit': 'M', 'net_profit': -3.22}, {'period': ""Q3 '24"", 'revenue': 14440.0, 'unit': 'K', 'net_profit': 438.0}, {'period': ""Q2 '24"", 'revenue': 13120.0, 'unit': 'K', 'net_profit': -615.0}, {'period': ""Q1 '24"", 'revenue': 12290.0, 'unit': 'K', 'net_profit': -109.0}, {'period': ""Q4 '23"", 'revenue': 14.46, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q3 '23"", 'revenue': 11.57, 'unit': 'M', 'net_profit': -1.93}]",-0.34,-0.34,65210000,14496000,1037000,39750000,10605000,0,26163000,1037000,580000,-0.2703185471866627,-0.1944160708205652,0.02857142857142844,__nan__,__nan__,__nan__,0.6095690844962429
235,CRIS,Curis Inc. Common Stock,"Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.",Mr. James E. Dentzer,Biotechnology,1.3,USD,13600925,https://images.financialmodelingprep.com/symbol/CRIS.png,53581,-0.19,-0.01,40846,-42571000,-43389000,"[{'period': '2024', 'revenue': 10.91, 'unit': 'M', 'net_profit': -43.39}, {'period': '2023', 'revenue': 10.02, 'unit': 'M', 'net_profit': -47.41}, {'period': '2022', 'revenue': 10.16, 'unit': 'M', 'net_profit': -60.32}, {'period': '2021', 'revenue': 10.65, 'unit': 'M', 'net_profit': -50.64}]","[{'period': ""Q4 '24"", 'revenue': 3.35, 'unit': 'M', 'net_profit': -9.62}, {'period': ""Q3 '24"", 'revenue': 2.93, 'unit': 'M', 'net_profit': -10.09}, {'period': ""Q2 '24"", 'revenue': 2.55, 'unit': 'M', 'net_profit': -11.8}, {'period': ""Q1 '24"", 'revenue': 2.09, 'unit': 'M', 'net_profit': -11.88}, {'period': ""Q4 '23"", 'revenue': 2.7, 'unit': 'M', 'net_profit': -11.78}, {'period': ""Q3 '23"", 'revenue': 2.83, 'unit': 'M', 'net_profit': -12.18}]",-6.88,-6.88,41265000,26385000,19997000,47263000,3349000,0,19027000,19997000,-39563000,0.05689093688384767,0.08487123784616034,0.23214285714285723,__nan__,__nan__,__nan__,1.1453532048951895
236,CRKN,Crown Electrokinetics Corp. Common Stock,"Crown Electrokinetics Corp. develops and sells optical switching films. The company also focuses on commercializing electrokinetic technology for use in the smart glass market. It offers electrokinetic film technology for smart or dynamic glass. The company was formerly known as 3D Nanocolor Corp. and changed its name to Crown ElectroKinetics Corp. in October 2017. Crown ElectroKinetics Corp. was incorporated in 2015 and is based in Corvallis, Oregon.",Mr. Douglas B. Croxall,Chemicals - Specialty,2,USD,3475900,https://images.financialmodelingprep.com/symbol/CRKN.png,148579,,0.25,4630,-18336000,-28984000,"[{'period': '2023', 'revenue': 0.153, 'unit': 'M', 'net_profit': -28.98}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.37}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.16}, {'period': '2020', 'revenue': 0.1, 'unit': 'M', 'net_profit': -40.76}]","[{'period': ""Q3 '24"", 'revenue': 8.04, 'unit': 'M', 'net_profit': -5.86}, {'period': ""Q2 '24"", 'revenue': 4.65, 'unit': 'M', 'net_profit': -5.03}, {'period': ""Q1 '24"", 'revenue': 0.682, 'unit': 'M', 'net_profit': -4.61}, {'period': ""Q4 '23"", 'revenue': 0.094, 'unit': 'M', 'net_profit': -9.31}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.14}, {'period': ""Q2 '23"", 'revenue': 0.037, 'unit': 'M', 'net_profit': -14.62}]",-819.45,-819.45,9527000,1870000,1059000,4850000,83000,0,3776000,1059000,-18333000,-0.25546045874700446,-1.0169798190675017,-14.141352549889136,__nan__,__nan__,__nan__,0.5090794583814422
237,CRMD,CorMedix Inc. Common Stock,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",Mr. Joseph  Todisco MBA,Biotechnology,8.14,USD,530579608,https://images.financialmodelingprep.com/symbol/CRMD.png,1427849,-27.13,0.47,1136261,-22356389000,-17930020,"[{'period': '2024', 'revenue': 43.47, 'unit': 'M', 'net_profit': -17.93}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -46.34}, {'period': '2022', 'revenue': 0.06541, 'unit': 'M', 'net_profit': -29.7}, {'period': '2021', 'revenue': 0.19094, 'unit': 'M', 'net_profit': -28.21}]","[{'period': ""Q4 '24"", 'revenue': 31.21, 'unit': 'M', 'net_profit': 13.46}, {'period': ""Q3 '24"", 'revenue': 11.46, 'unit': 'M', 'net_profit': -2.78}, {'period': ""Q2 '24"", 'revenue': 0.8061200000000001, 'unit': 'M', 'net_profit': -14.15}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.47}, {'period': ""Q4 '23"", 'revenue': 0.30411000000000005, 'unit': 'M', 'net_profit': -14.75}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.74}]",-0.3,-0.3,118845673000,114575436000,51687627000,34188723000,51653583000,0,33839632000,40650770,-50614653000,-456.3071350024453,0.6130703690849224,0.6703296703296704,__nan__,__nan__,__nan__,0.2876732668256252
238,CRMT,America's Car-Mart Inc Common Stock,"America's Car-Mart, Inc., through its subsidiaries, operates as an automotive retailer in the United States. It primarily sells older model used vehicles and provides financing for its customers. As of April 30, 2022, the company operated 154 dealerships in the South-Central United States. The company was founded in 1981 and is based in Rogers, Arkansas.",Mr. Douglas  Campbell,Auto - Dealerships,46.42,USD,383515959,https://images.financialmodelingprep.com/symbol/CRMT.png,96863,45.96,-1.63,44969,32084000,-31393000,"[{'period': '2023', 'revenue': 1390.0, 'unit': 'M', 'net_profit': -31.39}, {'period': '2022', 'revenue': 1410.0, 'unit': 'M', 'net_profit': 20.43}, {'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': 95.01}, {'period': '2020', 'revenue': 918.61, 'unit': 'M', 'net_profit': 104.82}]","[{'period': ""Q3 '24"", 'revenue': 325.73, 'unit': 'M', 'net_profit': 3.16}, {'period': ""Q2 '24"", 'revenue': 347.27, 'unit': 'M', 'net_profit': 4.12}, {'period': ""Q1 '24"", 'revenue': 347760.0, 'unit': 'K', 'net_profit': -964.0}, {'period': ""Q4 '23"", 'revenue': 364670.0, 'unit': 'K', 'net_profit': 426.0}, {'period': ""Q3 '23"", 'revenue': 299.61, 'unit': 'M', 'net_profit': -8.54}, {'period': ""Q2 '23"", 'revenue': 361.58, 'unit': 'M', 'net_profit': -27.46}]",-4.92,-4.92,1477644000,1310373000,5522000,1006494000,1108456000,0,353799000,5522000,-80044000,-0.5397371894187181,-2.5364624119028973,-2.5375,__nan__,__nan__,__nan__,0.6811478272168398
239,CRNC,Cerence Inc. Common Stock,"Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts.",Mr. Brian Matthew Krzanich,Software - Application,7.1,USD,306712857,https://images.financialmodelingprep.com/symbol/CRNC.png,1991145,-0.46,-0.49,955025,-561427000,-588078000,"[{'period': '2024', 'revenue': 331.5, 'unit': 'M', 'net_profit': -588.08}, {'period': '2023', 'revenue': 294.48, 'unit': 'M', 'net_profit': -56.25}, {'period': '2022', 'revenue': 327.89, 'unit': 'M', 'net_profit': -310.83}, {'period': '2021', 'revenue': 387.18, 'unit': 'M', 'net_profit': 45.89}]","[{'period': ""Q1 '25"", 'revenue': 50.9, 'unit': 'M', 'net_profit': -24.29}, {'period': ""Q4 '24"", 'revenue': 54.8, 'unit': 'M', 'net_profit': -20.42}, {'period': ""Q3 '24"", 'revenue': 70.54, 'unit': 'M', 'net_profit': -313.54}, {'period': ""Q2 '24"", 'revenue': 67.83, 'unit': 'M', 'net_profit': -277.98}, {'period': ""Q1 '24"", 'revenue': 138.34, 'unit': 'M', 'net_profit': 23.86}, {'period': ""Q4 '23"", 'revenue': 80.76, 'unit': 'M', 'net_profit': -11.55}]",-14.12,-14.12,702358000,265509000,126987000,561261000,62755000,0,216808000,121485000,12200000,-99.57810820494447,-9.45397660610801,-9.085714285714285,__nan__,__nan__,__nan__,0.7991095709025882
240,CRNT,Ceragon Networks Ltd. Ordinary Shares,"Ceragon Networks Ltd. provides wireless backhaul and fronthaul solutions that enable cellular operators and other wireless service providers. Its solutions use microwave and millimeter wave radio technology to transfer telecommunication traffic between base stations, small/distributed cells, and the core of the service provider's network. The company also uses microwave technology for ultra-high speed, ultra-low latency communication for wireless 5G and 4G, 3G, and other cellular base stations. In addition, it provides IP-20 all-outdoor solutions, such as IP-20C, IP-20C-HP, IP-20S, IP-20E, and IP-20V; IP-20 split-mount/all-indoor solutions comprising IP-20N/IP-20A, IP-20F, and IP-20G; and IP-50 disaggregated solutions, including IP-50E, IP-50C, IP-50S, and IP-50FX for various short-haul, long-haul, fronthaul, and enterprise access applications. Further, the company offers network management system; and network and radio planning, site survey, solutions development, installation, network auditing and optimization, maintenance, training, and other services. It provides its services to oil and gas companies; public safety organizations; business and public institutions; broadcasters; energy utilities; and private communications networks. The company sells its products through direct sales, original equipment manufacturers, distributors, and system integrators. It operates in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. The company was formerly known as Giganet Ltd. and changed its name to Ceragon Networks Ltd. in September 2000. Ceragon Networks Ltd. was incorporated in 1996 and is headquartered in Rosh HaAyin, Israel.",Mr. Doron  Arazi,Communication Equipment,2.01,USD,178566551,https://images.financialmodelingprep.com/symbol/CRNT.png,1744555,7.44,-0.04,633535,53915000,24063000,"[{'period': '2024', 'revenue': 394.19, 'unit': 'M', 'net_profit': 24.06}, {'period': '2023', 'revenue': 347.18, 'unit': 'M', 'net_profit': 6.22}, {'period': '2022', 'revenue': 295.17, 'unit': 'M', 'net_profit': -7.4}, {'period': '2021', 'revenue': 290.77, 'unit': 'M', 'net_profit': -14.83}]","[{'period': ""Q4 '24"", 'revenue': 106.93, 'unit': 'M', 'net_profit': 3.61}, {'period': ""Q3 '24"", 'revenue': 102.67, 'unit': 'M', 'net_profit': 12.22}, {'period': ""Q2 '24"", 'revenue': 96.09, 'unit': 'M', 'net_profit': 7.83}, {'period': ""Q1 '24"", 'revenue': 88500.0, 'unit': 'K', 'net_profit': 403.0}, {'period': ""Q4 '23"", 'revenue': 90.36, 'unit': 'M', 'net_profit': -1.2}, {'period': ""Q3 '23"", 'revenue': 87.26, 'unit': 'M', 'net_profit': 3.37}]",0.27,0.27,344996000,261038000,35311000,178671000,149619000,0,151448000,35311000,9734000,0.7824908255364168,2.8686495176848874,2.673469387755102,__nan__,__nan__,__nan__,0.5178929610778096
241,CRNX,Crinetics Pharmaceuticals Inc. Common Stock,"Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.",Dr. R. Scott Struthers Ph.D.,Biotechnology,30.15,USD,2805413481,https://images.financialmodelingprep.com/symbol/CRNX.png,1002826,-8.17,-0.27,649200,-338854000,-298408000,"[{'period': '2024', 'revenue': 1.04, 'unit': 'M', 'net_profit': -298.41}, {'period': '2023', 'revenue': 4.01, 'unit': 'M', 'net_profit': -214.53}, {'period': '2022', 'revenue': 4.74, 'unit': 'M', 'net_profit': -159.95}, {'period': '2021', 'revenue': 1.08, 'unit': 'M', 'net_profit': -106.72}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -80.59}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -76.83}, {'period': ""Q2 '24"", 'revenue': 0.399, 'unit': 'M', 'net_profit': -74.06}, {'period': ""Q1 '24"", 'revenue': 0.64, 'unit': 'M', 'net_profit': -66.93}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -60.1}, {'period': ""Q3 '23"", 'revenue': 0.34600000000000003, 'unit': 'M', 'net_profit': -57.46}]",-3.69,-3.69,1434592000,1375388000,1354069000,109787000,0,0,59684000,264545000,-229814000,-0.5297458354024649,-0.39099142773238116,0,__nan__,__nan__,__nan__,0.07652837880038366
242,CRON,Cronos Group Inc. Common Share,"Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",Mr. Michael Ryan Gorenstein J.D.,Drug Manufacturers - Specialty & Generic,1.74,USD,665603592,https://images.financialmodelingprep.com/symbol/CRON.png,1624700,15.82,-0.03,1448801,-50213000,41080000,"[{'period': '2024', 'revenue': 117.61, 'unit': 'M', 'net_profit': 41.08}, {'period': '2023', 'revenue': 87.24, 'unit': 'M', 'net_profit': -73.96}, {'period': '2022', 'revenue': 91.9, 'unit': 'M', 'net_profit': -168.73}, {'period': '2021', 'revenue': 74.44, 'unit': 'M', 'net_profit': -396.7}]","[{'period': ""Q4 '24"", 'revenue': 41.18, 'unit': 'M', 'net_profit': 43.73}, {'period': ""Q3 '24"", 'revenue': 34.26, 'unit': 'M', 'net_profit': 8.35}, {'period': ""Q2 '24"", 'revenue': 27.76, 'unit': 'M', 'net_profit': -8.76}, {'period': ""Q1 '24"", 'revenue': 25.18, 'unit': 'M', 'net_profit': -2.23}, {'period': ""Q4 '23"", 'revenue': 24.58, 'unit': 'M', 'net_profit': -46.04}, {'period': ""Q3 '23"", 'revenue': 33.91, 'unit': 'M', 'net_profit': -1.64}]",0.11,0.11,1166312000,936113000,858805000,55330000,29770000,2813000,49700000,858805000,6432000,0.30065459610027856,1.5554128415559132,1.5789473684210527,__nan__,__nan__,__nan__,0.04744013608708476
243,CROX,Crocs Inc. Common Stock,"Crocs, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for men, women, and children. It offers various footwear products, including clogs, sandals, slides, flip-flops, boots, flats, wedges, platforms, socks, shoe charms, loafers, sneakers, and slippers under the Crocs brand name. The company sells its products in approximately 85 countries through wholesalers, retail stores, e-commerce sites, and third-party marketplaces. As of December 31, 2021, it had 193 outlet stores, 107 retail stores, 373 company-operated stores, 73 kiosks and store-in-stores, and 14 company-operated e-commerce sites. The company serves in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Crocs, Inc. was founded in 1999 and is headquartered in Broomfield, Colorado.",Mr. Andrew  Rees,Apparel - Footwear & Accessories,89.46,USD,5014784074,https://images.financialmodelingprep.com/symbol/CROX.png,1961242,5.63,-1.26,1579097,1021911000,950071000,"[{'period': '2024', 'revenue': 4100.0, 'unit': 'M', 'net_profit': 950.07}, {'period': '2023', 'revenue': 3960.0, 'unit': 'M', 'net_profit': 792.57}, {'period': '2022', 'revenue': 3550.0, 'unit': 'M', 'net_profit': 540.16}, {'period': '2021', 'revenue': 2310.0, 'unit': 'M', 'net_profit': 725.69}]","[{'period': ""Q4 '24"", 'revenue': 989.77, 'unit': 'M', 'net_profit': 368.91}, {'period': ""Q3 '24"", 'revenue': 1060.0, 'unit': 'M', 'net_profit': 199.8}, {'period': ""Q2 '24"", 'revenue': 1110.0, 'unit': 'M', 'net_profit': 228.91}, {'period': ""Q1 '24"", 'revenue': 938.63, 'unit': 'M', 'net_profit': 152.45}, {'period': ""Q4 '23"", 'revenue': 960.1, 'unit': 'M', 'net_profit': 253.59}, {'period': ""Q3 '23"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': 177.03}]",16,15.88,4812153000,872269000,180485000,2976421000,283907000,0,740208000,180485000,923139000,-0.06412150262792293,0.19872792928286098,0.23934934159566226,__nan__,__nan__,__nan__,0.6185216887326733
244,CRSA,Crescent Acquisition Corp Class A Common Stock,"Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was formerly known as Crescent Funding Inc. and changed its name to Crescent Acquisition Corp. in October 2018. The company was founded in 2017 and is based in Los Angeles, California.",Mr. Todd M. Purdy,Shell Companies,8.81,USD,817654338,https://images.financialmodelingprep.com/symbol/CRSA.png,381656,0,-0.30999947,216454,-28622000,-37475000,"[{'period': '2022', 'revenue': 136.03, 'unit': 'M', 'net_profit': -37.48}, {'period': '2021', 'revenue': 119.23, 'unit': 'M', 'net_profit': -103.19}, {'period': '2020', 'revenue': 102.55, 'unit': 'M', 'net_profit': -4.64}, {'period': '2019', 'revenue': 92.75, 'unit': 'M', 'net_profit': -6.91}]","[{'period': ""Q3 '23"", 'revenue': 35.35, 'unit': 'M', 'net_profit': -5.75}, {'period': ""Q2 '23"", 'revenue': 35.38, 'unit': 'M', 'net_profit': -4.39}, {'period': ""Q1 '23"", 'revenue': 36.87, 'unit': 'M', 'net_profit': -8.47}, {'period': ""Q4 '22"", 'revenue': 35.69, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q3 '22"", 'revenue': 35.25, 'unit': 'M', 'net_profit': -7.77}, {'period': ""Q2 '22"", 'revenue': 32.99, 'unit': 'M', 'net_profit': -10.78}]",-0.41,-0.41,178155000,98753000,68924000,80920000,21447000,-48133818,22352000,20742000,-24750000,0.695377771155504,0.6368490416109464,0.682170542635659,__nan__,__nan__,__nan__,0.45421122056636076
245,CRSAU,Crescent Acquisition Corp Unit,"Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was formerly known as Crescent Funding Inc. and changed its name to Crescent Acquisition Corp. in October 2018. The company was founded in 2017 and is based in Los Angeles, California.",Mr. Todd M. Purdy,Shell Companies,10.15,USD,937847891,https://images.financialmodelingprep.com/symbol/CRSAU.png,403,-27.211796246648795,0,20,-28622000,-37475000,"[{'period': '2022', 'revenue': 136.03, 'unit': 'M', 'net_profit': -37.48}, {'period': '2021', 'revenue': 119.23, 'unit': 'M', 'net_profit': -103.19}, {'period': '2020', 'revenue': 102.55, 'unit': 'M', 'net_profit': -4.64}, {'period': '2019', 'revenue': 92.75, 'unit': 'M', 'net_profit': -6.91}]","[{'period': ""Q3 '23"", 'revenue': 35.35, 'unit': 'M', 'net_profit': -5.75}, {'period': ""Q2 '23"", 'revenue': 35.38, 'unit': 'M', 'net_profit': -4.39}, {'period': ""Q1 '23"", 'revenue': 36.87, 'unit': 'M', 'net_profit': -8.47}, {'period': ""Q4 '22"", 'revenue': 35.69, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q3 '22"", 'revenue': 35.25, 'unit': 'M', 'net_profit': -7.77}, {'period': ""Q2 '22"", 'revenue': 32.99, 'unit': 'M', 'net_profit': -10.78}]",-0.41,-0.41,178155000,98753000,68924000,80920000,21447000,-48133818,22352000,20742000,-24750000,0.695377771155504,0.6368490416109464,0.682170542635659,__nan__,__nan__,__nan__,0.45421122056636076
246,CRSAW,Crescent Acquisition Corp Warrant,,None,Shell Companies,1.5982,USD,0,https://images.financialmodelingprep.com/symbol/CRSAW.png,0,-1598.2,-0.05180001,742415,-28622000,-37475000,"[{'period': '2022', 'revenue': 136.03, 'unit': 'M', 'net_profit': -37.48}, {'period': '2021', 'revenue': 119.23, 'unit': 'M', 'net_profit': -103.19}, {'period': '2020', 'revenue': 102.55, 'unit': 'M', 'net_profit': -4.64}, {'period': '2019', 'revenue': 92.75, 'unit': 'M', 'net_profit': -6.91}]","[{'period': ""Q3 '23"", 'revenue': 35.35, 'unit': 'M', 'net_profit': -5.75}, {'period': ""Q2 '23"", 'revenue': 35.38, 'unit': 'M', 'net_profit': -4.39}, {'period': ""Q1 '23"", 'revenue': 36.87, 'unit': 'M', 'net_profit': -8.47}, {'period': ""Q4 '22"", 'revenue': 35.69, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q3 '22"", 'revenue': 35.25, 'unit': 'M', 'net_profit': -7.77}, {'period': ""Q2 '22"", 'revenue': 32.99, 'unit': 'M', 'net_profit': -10.78}]",-0.41,-0.41,178155000,98753000,68924000,80920000,21447000,-48133818,22352000,20742000,-24750000,0.695377771155504,0.6368490416109464,0.682170542635659,__nan__,__nan__,__nan__,0.45421122056636076
247,CRSP,CRISPR Therapeutics AG Common Shares,"CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta-thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. It also develops CTX110, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting cluster of differentiation 19 positive malignancies; CTX120, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting B-cell maturation antigen for the treatment of relapsed or refractory multiple myeloma; and CTX130, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting Cluster of Differentiation 70 to treat various solid tumors and hematologic malignancies. In addition, the company develops VCTX210, a gene-edited immune-evasive stem cell-derived product candidate for the treatment of treatment of type 1 diabetes; and pursues various in vivo gene-editing programs that target the liver, lung, muscle, and central nervous system diseases. It has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, ViaCyte, Inc., Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.",Dr. Samarth  Kulkarni Ph.D.,Biotechnology,37.82,USD,3259633942,https://images.financialmodelingprep.com/symbol/CRSP.png,2260070,-8.71,0.05,1652623,-466566000,-366252000,"[{'period': '2024', 'revenue': 35.0, 'unit': 'M', 'net_profit': -366.25}, {'period': '2023', 'revenue': 371.21, 'unit': 'M', 'net_profit': -153.61}, {'period': '2022', 'revenue': 0.436, 'unit': 'M', 'net_profit': -650.17}, {'period': '2021', 'revenue': 913.08, 'unit': 'M', 'net_profit': 377.66}]","[{'period': ""Q4 '24"", 'revenue': 35.0, 'unit': 'M', 'net_profit': -37.31}, {'period': ""Q3 '24"", 'revenue': 0.602, 'unit': 'M', 'net_profit': -85.94}, {'period': ""Q2 '24"", 'revenue': 0.517, 'unit': 'M', 'net_profit': -126.41}, {'period': ""Q1 '24"", 'revenue': 0.504, 'unit': 'M', 'net_profit': -116.59}, {'period': ""Q4 '23"", 'revenue': 200.0, 'unit': 'M', 'net_profit': 89.35}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -112.15}]",-4.34,-4.34,2242034000,1937132000,1903826000,309954000,25000000,0,87782000,298257000,-144675000,-1.3017449346574512,-1.384297897272313,-1.2371134020618557,__nan__,__nan__,__nan__,0.13824678840731228
248,CRSR,Corsair Gaming Inc. Common Stock,"Corsair Gaming, Inc., together with its subsidiaries, designs, markets, and distributes gaming and streaming peripherals, components and systems in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers gamer and creator peripherals, including gaming keyboards, mice, headsets, and controllers, as well as capture cards, stream decks, USB microphones, studio accessories, and EpocCam software. It also provides gaming components and systems comprising power supply units, cooling solutions, computer cases, and DRAM modules, as well as prebuilt and custom-built gaming PCs, and others; and PC gaming software comprising iCUE for gamers and Elgato's streaming suite for streamers and content creators. In addition, the company offers coaching and training, and other services. It sells its products through a network of distributors and retailers, including online retailers, as well as directly to consumers through its website. The company was incorporated in 1994 and is headquartered in Fremont, California. Corsair Gaming, Inc. is a subsidiary of Corsair Group (Cayman), LP.",Mr. Andrew J. Paul,Computer Hardware,5.79,USD,607111608,https://images.financialmodelingprep.com/symbol/CRSR.png,1193760,-6.09,-0.24,1093662,-49954000,-85181000,"[{'period': '2024', 'revenue': 1320.0, 'unit': 'M', 'net_profit': -85.18}, {'period': '2023', 'revenue': 1460.0, 'unit': 'M', 'net_profit': -2.59}, {'period': '2022', 'revenue': 1380.0, 'unit': 'M', 'net_profit': -53.95}, {'period': '2021', 'revenue': 1900.0, 'unit': 'M', 'net_profit': 100.96}]","[{'period': ""Q4 '24"", 'revenue': 413.62, 'unit': 'M', 'net_profit': 2.29}, {'period': ""Q3 '24"", 'revenue': 304.2, 'unit': 'M', 'net_profit': -51.71}, {'period': ""Q2 '24"", 'revenue': 261.3, 'unit': 'M', 'net_profit': -29.58}, {'period': ""Q1 '24"", 'revenue': 337.26, 'unit': 'M', 'net_profit': -12.54}, {'period': ""Q4 '23"", 'revenue': 417.29, 'unit': 'M', 'net_profit': 6.98}, {'period': ""Q3 '23"", 'revenue': 363.19, 'unit': 'M', 'net_profit': -3.08}]",-0.82,-0.82,1235829000,623388000,107011000,616377000,218648000,0,396313000,107011000,26028000,-1.7728151735020654,-31.88841698841699,-27.366559485530548,__nan__,__nan__,__nan__,0.49875589583995844
249,CRTD,Creatd Inc. Common Stock,"Creatd, Inc., a technology company, provides economic opportunities for creators. The company operated in three segments: Creatd Labs, Creatd Partners, and Creatd Ventures. Its flagship product is Vocal, a content distribution platform that delivers a digital publishing platform organized into niche-communities capable of hosting various rich media content. The company's Vocal platform enhances the visibility of content and maximizes viewership, and provides advertisers access to target markets that closely match their interests. It also offers Vocal for Brands, an internal content marketing studio that pairs leading brands with vocal creators to produce marketing campaigns; WHE Agency that focuses on representation and management of family and lifestyle-focused influencers and digital creators; and Seller's Choice, a marketing agency for direct-to-consumer and e-commerce clients, which provides design, development, strategy, and sales optimization services. In addition, the company builds, develops, and scales e-commerce brands, such as Camp and Dune Glow Remedy. Further, its Creatd studios elevates creators' stories to TV, film, books, podcasts, videos, and others. The company was formerly known as Jerrick Media Holdings, Inc. and changed its name to Creatd Inc. in September 2020. Creatd, Inc. is headquartered in New York, New York.",Mr. Jeremy Phillip Frommer,Internet Content & Information,0.38,USD,3917757,https://images.financialmodelingprep.com/symbol/CRTD.png,8529,,0,2,-14568474,-24233681,"[{'period': '2023', 'revenue': 1.92, 'unit': 'M', 'net_profit': -24.23}, {'period': '2022', 'revenue': 4.8, 'unit': 'M', 'net_profit': -36.66}, {'period': '2021', 'revenue': 4.3, 'unit': 'M', 'net_profit': -41.34}, {'period': '2020', 'revenue': 1.21, 'unit': 'M', 'net_profit': -30.28}]","[{'period': ""Q2 '24"", 'revenue': 0.37854000000000004, 'unit': 'M', 'net_profit': -3.88}, {'period': ""Q1 '24"", 'revenue': 0.42847, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q3 '23"", 'revenue': 0.43786, 'unit': 'M', 'net_profit': -2.92}, {'period': ""Q2 '23"", 'revenue': 0.69936, 'unit': 'M', 'net_profit': -4.45}, {'period': ""Q1 '23"", 'revenue': 0.98614, 'unit': 'M', 'net_profit': -15.91}, {'period': ""Q4 '22"", 'revenue': 0.79898, 'unit': 'M', 'net_profit': -11.69}]",-0.47,-0.47,2164127,73255,71105,23052635,0,0,21448447,71105,-3401763,0.49817719693272516,0.3389719129467413,0.9890595903165735,__nan__,__nan__,__nan__,10.652163666919732
250,CRTDW,Creatd Inc. Warrant,"Creatd, Inc., a technology company, provides economic opportunities for creators in the United States. It operates in four segments: Creatd Labs, Creatd Partners, Creatd Ventures, and Creatd Studios. The company's flagship product is Vocal that delivers a digital publishing platform organized into niche-communities capable of hosting various rich media content. Its Vocal platform enhances the visibility of content and maximizes viewership; and provides advertisers access to target markets that closely match its interests. The company also offers Vocal for Brands, a content marketing that fosters relationships between brands and creators through its suite of agency services; Seller's Choice, performance marketing initiatives; and WHE Agency, an influencer marketing. In addition, it builds, develops, and scales e-commerce brands, such as Camp and Dune Glow Remedy. Further, the company's Creatd studios elevates creators to develop their content for television, film, prints, and podcasts. It serves businesses and consumers. The company was formerly known as Jerrick Media Holdings, Inc. and changed its name to Creatd Inc. in September 2020. Creatd, Inc. is headquartered in New York, New York.",Mr. Jeremy Phillip Frommer,Internet Content & Information,0.0018,USD,2651114,https://images.financialmodelingprep.com/symbol/CRTDW.png,11846,0,-0.0012,10999,-14568474,-24233681,"[{'period': '2023', 'revenue': 1.92, 'unit': 'M', 'net_profit': -24.23}, {'period': '2022', 'revenue': 4.8, 'unit': 'M', 'net_profit': -36.66}, {'period': '2021', 'revenue': 4.3, 'unit': 'M', 'net_profit': -41.34}, {'period': '2020', 'revenue': 1.21, 'unit': 'M', 'net_profit': -30.28}]","[{'period': ""Q2 '24"", 'revenue': 0.37854000000000004, 'unit': 'M', 'net_profit': -3.88}, {'period': ""Q1 '24"", 'revenue': 0.42847, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q3 '23"", 'revenue': 0.43786, 'unit': 'M', 'net_profit': -2.92}, {'period': ""Q2 '23"", 'revenue': 0.69936, 'unit': 'M', 'net_profit': -4.45}, {'period': ""Q1 '23"", 'revenue': 0.98614, 'unit': 'M', 'net_profit': -15.91}, {'period': ""Q4 '22"", 'revenue': 0.79898, 'unit': 'M', 'net_profit': -11.69}]",-0.47,-0.47,2164127,73255,71105,23052635,0,0,21448447,71105,-3401763,0.49817719693272516,0.3389719129467413,0.9890595903165735,__nan__,__nan__,__nan__,10.652163666919732
251,CRTO,Criteo S.A. American Depositary Shares,"Criteo S.A., a technology company, provides marketing and monetization services on the open Internet in North and South America, Europe, the Middle East, and Africa, and the Asia-Pacific. The company's Criteo Shopper Graph, which derives clients' proprietary commerce data, such as transaction activity on their digital properties. Its Criteo AI Engine solutions include lookalike finder, recommendation, and predictive bidding algorithms; bidding engine that executes campaigns based on certain objectives set by its clients; dynamic creative optimization+, which assembles customized creative advertising content by optimizing each individual creative component in the advertisement; software systems and processes, which enable data synchronization, storage, and analysis of distributed computing infrastructure in various geographies; and experimentation platform, an offline/online testing platform to enhance the capabilities and effectiveness of prediction models. The company also provides Criteo Marketing Solutions that allow commerce companies to address various marketing goals by engaging their consumers with personalized ads across the web, mobile, and offline store environments; and Criteo Retail Media solutions, which allows retailers to generate advertising revenues from consumer brands, and/or to drive sales for themselves, by monetizing their data and audiences through personalized ads, either on their own digital property or on the open Internet. In addition, it offers real-time access to advertising inventory through its publisher partners; consulting services to companies in distance sales; and business intelligence and analytics services. It serves companies in digital retail, travel, and classifieds industries. Criteo S.A. was incorporated in 2005 and is headquartered in Paris, France.",Mr. Michael  Komasinski,Advertising Agencies,29.6,USD,1606611691,https://images.financialmodelingprep.com/symbol/CRTO.png,420832,15.58,-0.3,275212,245842000,111571000,"[{'period': '2024', 'revenue': 1930.0, 'unit': 'M', 'net_profit': 111.57}, {'period': '2023', 'revenue': 1950.0, 'unit': 'M', 'net_profit': 53.26}, {'period': '2022', 'revenue': 2020.0, 'unit': 'M', 'net_profit': 8.95}, {'period': '2021', 'revenue': 2250.0, 'unit': 'M', 'net_profit': 134.46}]","[{'period': ""Q4 '24"", 'revenue': 553.03, 'unit': 'M', 'net_profit': 71.09}, {'period': ""Q3 '24"", 'revenue': 458.89, 'unit': 'M', 'net_profit': 6.26}, {'period': ""Q2 '24"", 'revenue': 470.87, 'unit': 'M', 'net_profit': 26.99}, {'period': ""Q1 '24"", 'revenue': 449.0, 'unit': 'M', 'net_profit': 7.24}, {'period': ""Q4 '23"", 'revenue': 570.95, 'unit': 'M', 'net_profit': 61.02}, {'period': ""Q3 '23"", 'revenue': 469.19, 'unit': 'M', 'net_profit': 6.93}]",2.04,1.9,2266449000,1224114000,290693000,1185352000,800859000,19916000,1046600000,290693000,180049000,0.5902119704780817,1.0948759834018664,1.1473684210526318,__nan__,__nan__,__nan__,0.5229996351120189
252,CRTX,Cortexyme Inc. Common Stock,"Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.",Ms. Casey Lynch,Biotechnology,1.95,USD,70454085,https://images.financialmodelingprep.com/symbol/CRTX.png,0,-0.6581167735403307,0.05000007,272208,-90318000,-89945000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -89.94}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -76.85}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.98}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.48}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.56}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.71}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -89.94}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.71}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.75}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.09}]",-3.02,-3.02,133228000,111673000,106802000,14642000,0,19933000,14222000,69724000,-63112000,-0.14481639689199297,-0.17041210685890512,-0.14828897338403046,__nan__,__nan__,__nan__,0.10990182243972739
253,CRUS,Cirrus Logic Inc. Common Stock,"Cirrus Logic, Inc., a fabless semiconductor company, provides low-power and high-precision mixed-signal processing solutions in the United States and internationally. It offers portable products, including codecs components that integrate analog-to-digital converters (ADCs) and digital-to-analog converters (DACs) into a single integrated circuit (IC); smart codecs, a codec with digital signal processer; boosted amplifiers; digital signal processors; and SoundClear technology, which consists of a portfolio of tools, software, and algorithms that helps to enhance user experience with features, such as louder, high-fidelity sound, audio playback, voice capture, hearing augmentation, and active noise cancellation. The company's audio products are used in smartphones, tablets, wireless headsets, laptops, AR/VR headsets, home theater systems, automotive entertainment systems, and professional audio systems. It also provides high-performance mixed-signal products, such as haptic driver and sensing solutions, camera controllers, power conversion, and control ICs and fast-charging ICs used in various industrial and energy applications comprising digital utility meters, power supplies, energy control, energy measurement, and energy exploration. The company markets and sells its products through direct sales force, external sales representatives, and distributors. Cirrus Logic, Inc. was incorporated in 1984 and is headquartered in Austin, Texas.",Mr. John M. Forsyth,Semiconductors,85.78,USD,4558771924,https://images.financialmodelingprep.com/symbol/CRUS.png,757334,15.6,0.2,698005,401951000,274572000,"[{'period': '2024', 'revenue': 1790.0, 'unit': 'M', 'net_profit': 274.57}, {'period': '2023', 'revenue': 1900.0, 'unit': 'M', 'net_profit': 176.7}, {'period': '2022', 'revenue': 1780.0, 'unit': 'M', 'net_profit': 326.36}, {'period': '2021', 'revenue': 1370.0, 'unit': 'M', 'net_profit': 217.34}]","[{'period': ""Q3 '25"", 'revenue': 555.74, 'unit': 'M', 'net_profit': 116.0}, {'period': ""Q2 '25"", 'revenue': 541.86, 'unit': 'M', 'net_profit': 102.14}, {'period': ""Q1 '25"", 'revenue': 374.03, 'unit': 'M', 'net_profit': 42.09}, {'period': ""Q4 '24"", 'revenue': 371.83, 'unit': 'M', 'net_profit': 44.84}, {'period': ""Q3 '24"", 'revenue': 618.98, 'unit': 'M', 'net_profit': 138.72}, {'period': ""Q2 '24"", 'revenue': 481.06, 'unit': 'M', 'net_profit': 75.41}]",5.06,4.9,2231576000,1106192000,526542000,414562000,162478000,173374000,186393000,502764000,383329000,0.27024020579135816,0.5538615643197908,0.5911949685534589,__nan__,__nan__,__nan__,0.18577095290503215
254,CRVL,CorVel Corp. Common Stock,"CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.",Mr. Michael G. Combs,Insurance - Brokers,110.17,USD,5658236454,https://images.financialmodelingprep.com/symbol/CRVL.png,112037,64.81,-4.92,113892,121353000,76252000,"[{'period': '2024', 'revenue': 795.31, 'unit': 'M', 'net_profit': 76.25}, {'period': '2023', 'revenue': 718.56, 'unit': 'M', 'net_profit': 66.36}, {'period': '2022', 'revenue': 646.23, 'unit': 'M', 'net_profit': 66.41}, {'period': '2021', 'revenue': 552.64, 'unit': 'M', 'net_profit': 46.36}]","[{'period': ""Q3 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.41}, {'period': ""Q2 '25"", 'revenue': 224.38, 'unit': 'M', 'net_profit': 23.4}, {'period': ""Q1 '25"", 'revenue': 211.72, 'unit': 'M', 'net_profit': 21.58}, {'period': ""Q4 '24"", 'revenue': 207.23, 'unit': 'M', 'net_profit': 19.45}, {'period': ""Q3 '24"", 'revenue': 202.3, 'unit': 'M', 'net_profit': 17.09}, {'period': ""Q2 '24"", 'revenue': 195.52, 'unit': 'M', 'net_profit': 19.9}]",1.335,1.32,454679000,302231000,105563000,207032000,97108000,0,184499000,105563000,69997000,0.10647823113745156,0.1489791305658103,0.16187989556135765,__nan__,__nan__,__nan__,0.4553366221004269
255,CRVS,Corvus Pharmaceuticals Inc. Common Stock,"Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with either advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was incorporated in 2014 and is based in Burlingame, California.",Dr. Richard A. Miller M.D.,Biotechnology,3.22,USD,219397263,https://images.financialmodelingprep.com/symbol/CRVS.png,651390,-3.16,-0.02,1270221,-27548000,-62293000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -62.29}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.03}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -50.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.2}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.11}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.22}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.26}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.7}, {'period': ""Q4 '23"", 'revenue': 0.246, 'unit': 'M', 'net_profit': -6.65}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.0}]",-1.02,-1.02,68907000,54407000,51964000,36339000,216000,0,35402000,8740000,-25424000,-0.024927449959074335,-1.3046727588886011,-0.8214285714285713,__nan__,__nan__,__nan__,0.527362967477905
256,CRWD,CrowdStrike Holdings Inc. Class A Common Stock,"CrowdStrike Holdings, Inc. provides cloud-delivered protection across endpoints and cloud workloads, identity, and data. It offers threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. The company primarily sells subscriptions to its Falcon platform and cloud modules through its direct sales team that leverages its network of channel partners. It serves customers worldwide. The company was incorporated in 2011 and is based in Austin, Texas.",Mr. George R. Kurtz,Software - Infrastructure,362.69,USD,89901207073,https://images.financialmodelingprep.com/symbol/CRWD.png,4372877,-4533.62,-12.93,2878767,294801000,-19271000,"[{'period': '2025', 'revenue': 3950.0, 'unit': 'M', 'net_profit': -19.27}, {'period': '2024', 'revenue': 3060.0, 'unit': 'M', 'net_profit': 89.33}, {'period': '2023', 'revenue': 2240.0, 'unit': 'M', 'net_profit': -182.28}, {'period': '2022', 'revenue': 1450.0, 'unit': 'M', 'net_profit': -232.38}]","[{'period': ""Q4 '25"", 'revenue': 1060.0, 'unit': 'M', 'net_profit': -92.28}, {'period': ""Q3 '25"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': -16.82}, {'period': ""Q2 '25"", 'revenue': 963.87, 'unit': 'M', 'net_profit': 47.01}, {'period': ""Q1 '25"", 'revenue': 921.04, 'unit': 'M', 'net_profit': 42.82}, {'period': ""Q4 '24"", 'revenue': 845.34, 'unit': 'M', 'net_profit': 53.7}, {'period': ""Q3 '24"", 'revenue': 786.01, 'unit': 'M', 'net_profit': 26.66}]",-0.0787,-0.0787,8701578000,6113345000,4323295000,5382661000,1128564000,72544000,3461050000,4323295000,1126875000,0.0033148757602262558,-1.2157354439307264,-1.2127027027027026,__nan__,__nan__,__nan__,0.6185844682424269
257,CRWS,Crown Crafts Inc Common Stock,"Crown Crafts, Inc., through its subsidiaries, operates in the consumer products industry in the United States and internationally. It provides infant, toddler, and juvenile products, including infant and toddler beddings; blankets and swaddle blankets; nursery and toddler accessories; room décors; reusable and disposable bibs; burp cloths; hooded bath towels and washcloths; reusable and disposable placemats, and floor mats; disposable toilet seat covers and changing mats; developmental toys; feeding and care goods; and other infant, toddler, and juvenile soft goods. The company sells its products primarily to mass merchants, large chain stores, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs and internet-based retailers through a network of sales force and independent commissioned sales representatives. Crown Crafts, Inc. was incorporated in 1957 and is headquartered in Gonzales, Louisiana.",Ms. Olivia W. Elliott CPA,"Furnishings, Fixtures & Appliances",2.8,USD,29102360,https://images.financialmodelingprep.com/symbol/CRWS.png,19862,11.67,-0.1,18109,13095000,4894000,"[{'period': '2024', 'revenue': 87.63, 'unit': 'M', 'net_profit': 4.89}, {'period': '2023', 'revenue': 75.05, 'unit': 'M', 'net_profit': 5.65}, {'period': '2022', 'revenue': 87.36, 'unit': 'M', 'net_profit': 9.92}, {'period': '2021', 'revenue': 79.16, 'unit': 'M', 'net_profit': 6.08}]","[{'period': ""Q3 '25"", 'revenue': 23350.0, 'unit': 'K', 'net_profit': 893.0}, {'period': ""Q2 '25"", 'revenue': 24460.0, 'unit': 'K', 'net_profit': 860.0}, {'period': ""Q1 '25"", 'revenue': 16210.0, 'unit': 'K', 'net_profit': -322.0}, {'period': ""Q4 '24"", 'revenue': 22.58, 'unit': 'M', 'net_profit': 1.0}, {'period': ""Q3 '24"", 'revenue': 23.8, 'unit': 'M', 'net_profit': 1.7}, {'period': ""Q2 '24"", 'revenue': 24.13, 'unit': 'M', 'net_profit': 1.82}]",0.48,0.48,82706000,54824000,829000,31105000,22403000,0,10461000,829000,6298000,0.5175570749797196,-0.13380530973451327,-0.14285714285714296,"[0.08, 0.0454]","['2025-03-14', '1989-01-12']",__nan__,0.37609121466399054
258,CRZNU,Corazon Capital V838 Monoceros Corp Unit,"Corazon Capital V838 Monoceros Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the education, social media and dating, and ecommerce sectors. The company was incorporated in 2021 and is based in Chicago, Illinois.",Mr. Sam  Yagan,Shell Companies,10.22,USD,263230858,https://images.financialmodelingprep.com/symbol/CRZNU.png,8057,31.349693251533743,0,100,9708074,-1096536,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.1}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.38}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.62}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.66}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.13}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -327.29}]",-0.053804779999999996,-0.053804779999999996,207688104,934801,852101,8029701,0,206753303,667536,852101,-521329,1.3141024495021547,-1.1169262739267127,-1.1461582008382978,__nan__,__nan__,__nan__,0.038662305858403904
259,CRZNW,Corazon Capital V838 Monoceros Corp Warrant,"Corazon Capital V838 Monoceros Corp is a blank check company. The company was incorporated in 2021 and is based in Chicago, Illinois.",Mr. Sam  Yagan,Shell Companies,0.0007,USD,260480863,https://images.financialmodelingprep.com/symbol/CRZNW.png,0,0,0,16400,9708074,-1096536,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.1}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.38}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.62}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.66}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.13}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -327.29}]",-0.053804779999999996,-0.053804779999999996,207688104,934801,852101,8029701,0,206753303,667536,852101,-521329,1.3141024495021547,-1.1169262739267127,-1.1461582008382978,__nan__,__nan__,__nan__,0.038662305858403904
260,CSBR,Champions Oncology Inc. Common Stock,"Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.",Dr. Ronnie  Morris M.D.,Biotechnology,7.92,USD,109509080,https://images.financialmodelingprep.com/symbol/CSBR.png,44372,17.6,-0.05,16624,-5054000,-7276000,"[{'period': '2024', 'revenue': 50.16, 'unit': 'M', 'net_profit': -7.28}, {'period': '2023', 'revenue': 53.87, 'unit': 'M', 'net_profit': -5.33}, {'period': '2022', 'revenue': 49110.0, 'unit': 'K', 'net_profit': 548.0}, {'period': '2021', 'revenue': 41040.0, 'unit': 'K', 'net_profit': 362.0}]","[{'period': ""Q3 '25"", 'revenue': 17.04, 'unit': 'M', 'net_profit': 4.5}, {'period': ""Q2 '25"", 'revenue': 13490.0, 'unit': 'K', 'net_profit': 728.0}, {'period': ""Q1 '25"", 'revenue': 14.06, 'unit': 'M', 'net_profit': 1.31}, {'period': ""Q4 '24"", 'revenue': 14000.0, 'unit': 'K', 'net_profit': -109.0}, {'period': ""Q3 '24"", 'revenue': 12.02, 'unit': 'M', 'net_profit': -2.53}, {'period': ""Q2 '24"", 'revenue': 11.57, 'unit': 'M', 'net_profit': -2.07}]",-0.54,-0.54,26132000,13639000,2618000,28035000,9526000,0,21541000,2618000,-6973000,-1.4427259545674238,-0.36382380506091844,-0.38461538461538464,__nan__,__nan__,__nan__,1.0728225929894382
261,CSCO,Cisco Systems Inc. Common Stock (DE),"Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol based networking and other products related to the communications and information technology industry in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China. The company also offers switching portfolio encompasses campus switching as well as data center switching; enterprise routing portfolio interconnects public and private wireline and mobile networks, delivering highly secure, and reliable connectivity to campus, data center and branch networks; and wireless products include indoor and outdoor wireless coverage designed for seamless roaming use of voice, video, and data applications. In addition, it provides security, which comprising network security, identity and access management, secure access service edge, and threat intelligence, detection, and response offerings; collaboration products, such as Webex Suite, collaboration devices, contact center, and communication platform as a service; end-to-end collaboration solutions that can be delivered from the cloud, on-premise or within hybrid cloud environments allowing customers to transition their collaboration solutions from on-premise to the cloud; and observability offers network assurance, monitoring and analytics and observability suite. Further, the company offers a range of service and support options for its customers, including technical support and advanced services and advisory services. It serves businesses of various sizes, public institutions, governments, and service providers. The company sells its products and services directly, as well as through systems integrators, service providers, other resellers, and distributors. Cisco Systems, Inc. has strategic alliances with other companies. Cisco Systems, Inc. was incorporated in 1984 and is headquartered in San Jose, California.",Mr. Charles H. Robbins,Communication Equipment,54.37,USD,216299763225,https://images.financialmodelingprep.com/symbol/CSCO.png,23548473,23.85,-1.39,15402990,15747000000,10320000000,"[{'period': '2024', 'revenue': 53.8, 'unit': 'B', 'net_profit': 10.32}, {'period': '2023', 'revenue': 57.0, 'unit': 'B', 'net_profit': 12.61}, {'period': '2022', 'revenue': 51.56, 'unit': 'B', 'net_profit': 11.81}, {'period': '2021', 'revenue': 49.82, 'unit': 'B', 'net_profit': 10.59}]","[{'period': ""Q2 '25"", 'revenue': 13.99, 'unit': 'B', 'net_profit': 2.43}, {'period': ""Q1 '25"", 'revenue': 13.84, 'unit': 'B', 'net_profit': 2.71}, {'period': ""Q4 '24"", 'revenue': 13.64, 'unit': 'B', 'net_profit': 2.16}, {'period': ""Q3 '24"", 'revenue': 12.7, 'unit': 'B', 'net_profit': 1.89}, {'period': ""Q2 '24"", 'revenue': 12.79, 'unit': 'B', 'net_profit': 2.63}, {'period': ""Q1 '24"", 'revenue': 14.67, 'unit': 'B', 'net_profit': 3.64}]",2.55,2.54,124413000000,36862000000,17854000000,78956000000,10023000000,0,40584000000,7508000000,10210000000,-0.09867780894053002,-0.18179655910568462,-0.17207792207792216,"[0.41, 0.06]","['2025-04-03', '2011-03-29']",__nan__,0.6346282140933825
262,CSCW,Color Star Technology Co. Ltd. Ordinary Shares,"Color Star Technology Co., Ltd., an entertainment and education company, provides online entertainment performances and music education services in the United States and China. The company operates Color World, an online platform of curriculum that includes music, sports, animation, painting and calligraphy, film and television, life skills, etc. Its Color World platform provides celebrity lectures, celebrity concert videos, celebrity peripheral products, and artist interactive communication services. The company was formerly known as Huitao Technology Co., Ltd. and changed its name to Color Star Technology Co., Ltd. in May 2020. Color Star Technology Co., Ltd. was founded in 2002 and is based in New York, New York.",Mr. Louis  Luo,Entertainment,1.08,USD,10335276,https://images.financialmodelingprep.com/symbol/CSCW.png,1004847,-8.925619834710744,-0.04,312697,-22411458,-26864340,"[{'period': '2023', 'revenue': 2.83, 'unit': 'M', 'net_profit': -26.86}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.85}, {'period': '2021', 'revenue': 16.52, 'unit': 'M', 'net_profit': -77.21}, {'period': '2020', 'revenue': 6.78, 'unit': 'M', 'net_profit': -8.24}]","[{'period': ""Q4 '23"", 'revenue': 0.885, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q3 '23"", 'revenue': 0.885, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q2 '23"", 'revenue': 0.53022, 'unit': 'M', 'net_profit': -10.56}, {'period': ""Q1 '23"", 'revenue': 0.53022, 'unit': 'M', 'net_profit': -10.56}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.84}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.84}]",-70.54,-70.54,27591648,10473112,20218,9065904,1605000,0,9057321,20218,-2780452,0.009502806734394707,0.2902357259965181,0.8291513272621585,__nan__,__nan__,__nan__,0.3285742120224207
263,CSGP,CoStar Group Inc. Common Stock,"CoStar Group, Inc. provides information, analytics, and online marketplace services to the commercial real estate, hospitality, residential, and related professionals industries in the United States, Canada, Europe, the Asia Pacific, and Latin America. It offers CoStar Property that provides inventory of office, industrial, retail, multifamily, hospitality, and student housing properties and land; CoStar COMPS, a robust database of comparable commercial real estate sales transactions; CoStar Market Analytics to view and report on aggregated market and submarket trends; and CoStar Tenant, an online business-to-business prospecting and analytical tool that provides tenant information. The company also provides Lease Comps and Analysis, a tool to capture, manage, and maintain lease data; CoStar Lease Analysis; Public Record, a searchable database of commercially-zoned parcels; CoStar Real Estate Manager, a real estate lease administration, portfolio management, and lease accounting compliance software solution; and CoStar Risk Analytics and CoStar Investment. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. CoStar Group, Inc. was founded in 1987 and is headquartered in Washington, the District of Columbia.",Mr. Andrew C. Florance,Real Estate - Services,77.81,USD,32817379030,https://images.financialmodelingprep.com/symbol/CSGP.png,3480070,228.85,-1.89,3029620,4700000,138700000,"[{'period': '2024', 'revenue': 2740.0, 'unit': 'M', 'net_profit': 138.7}, {'period': '2023', 'revenue': 2460.0, 'unit': 'M', 'net_profit': 374.7}, {'period': '2022', 'revenue': 2180.0, 'unit': 'M', 'net_profit': 369.5}, {'period': '2021', 'revenue': 1940.0, 'unit': 'M', 'net_profit': 292.6}]","[{'period': ""Q4 '24"", 'revenue': 709.4, 'unit': 'M', 'net_profit': 59.8}, {'period': ""Q3 '24"", 'revenue': 692.6, 'unit': 'M', 'net_profit': 53.0}, {'period': ""Q2 '24"", 'revenue': 677.8, 'unit': 'M', 'net_profit': 19.2}, {'period': ""Q1 '24"", 'revenue': 656.4, 'unit': 'M', 'net_profit': 6.7}, {'period': ""Q4 '23"", 'revenue': 640.1, 'unit': 'M', 'net_profit': 96.47}, {'period': ""Q3 '23"", 'revenue': 624.67, 'unit': 'M', 'net_profit': 90.57}]",0.34,0.34,9256800000,4950200000,4681000000,1703300000,187900000,0,552300000,4681000000,392600000,-0.9879425346331452,-0.6298372030958099,-0.6304347826086957,__nan__,__nan__,__nan__,0.18400527180019013
264,CSGS,CSG Systems International Inc. Common Stock,"CSG Systems International, Inc. provides revenue management and digital monetization, customer engagement, and payment solutions primarily to the communications industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers Advanced Convergent Platform, a private SaaS based platform; related solutions, including field force automation, analytics, electronic bill presentment, ACH, etc. to the North American cable and satellite markets. The company also provides managed services; and professional services to implement, configure, and maintain its solutions, as well as licenses various solutions, such as mediation, partner management, rating, and charging. It serves retail, financial services, healthcare, insurance, and government entities. The company was incorporated in 1994 and is headquartered in Greenwood Village, Colorado.",Mr. Brian A. Shepherd,Software - Infrastructure,59.07,USD,1699639540,https://images.financialmodelingprep.com/symbol/CSGS.png,344019,19.5,-1.37,239661,215249000,86852000,"[{'period': '2024', 'revenue': 1200.0, 'unit': 'M', 'net_profit': 86.85}, {'period': '2023', 'revenue': 1170.0, 'unit': 'M', 'net_profit': 66.25}, {'period': '2022', 'revenue': 1090.0, 'unit': 'M', 'net_profit': 44.06}, {'period': '2021', 'revenue': 1050.0, 'unit': 'M', 'net_profit': 72.33}]","[{'period': ""Q4 '24"", 'revenue': 316.65, 'unit': 'M', 'net_profit': 34.47}, {'period': ""Q3 '24"", 'revenue': 295.14, 'unit': 'M', 'net_profit': 19.09}, {'period': ""Q2 '24"", 'revenue': 290.32, 'unit': 'M', 'net_profit': 13.83}, {'period': ""Q1 '24"", 'revenue': 295.13, 'unit': 'M', 'net_profit': 19.47}, {'period': ""Q4 '23"", 'revenue': 297.32, 'unit': 'M', 'net_profit': 12.67}, {'period': ""Q3 '23"", 'revenue': 286.87, 'unit': 'M', 'net_profit': 18.69}]",3.06,3.03,1500687000,900882000,161789000,1218118000,349676000,0,615209000,161789000,113296000,0.10509346490124706,0.31105274280711287,0.38461538461538464,"[0.32, 0.15]","['2025-03-19', '2013-07-08']",__nan__,0.8117069049042205
265,CSII,Cardiovascular Systems Inc. Common Stock,"Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.","Mr. Scott Raymond Ward B.Sc., M.S., MS",Medical - Devices,20,USD,843960000,https://images.financialmodelingprep.com/symbol/CSII.png,677842,-20.833333333333332,0.03,387776,-34464000,-36933000,"[{'period': '2022', 'revenue': 236.22, 'unit': 'M', 'net_profit': -36.93}, {'period': '2021', 'revenue': 258.97, 'unit': 'M', 'net_profit': -13.42}, {'period': '2020', 'revenue': 236.54, 'unit': 'M', 'net_profit': -27.24}, {'period': '2019', 'revenue': 248020.0, 'unit': 'K', 'net_profit': -255.0}]","[{'period': ""Q2 '23"", 'revenue': 61.45, 'unit': 'M', 'net_profit': -7.89}, {'period': ""Q1 '23"", 'revenue': 59.67, 'unit': 'M', 'net_profit': -10.63}, {'period': ""Q4 '22"", 'revenue': 62.5, 'unit': 'M', 'net_profit': -9.69}, {'period': ""Q3 '22"", 'revenue': 56.22, 'unit': 'M', 'net_profit': -9.66}, {'period': ""Q2 '22"", 'revenue': 59.13, 'unit': 'M', 'net_profit': -8.97}, {'period': ""Q1 '22"", 'revenue': 58.37, 'unit': 'M', 'net_profit': -8.62}]",-0.94,-0.94,322677000,241846000,159833000,73197000,39678000,33425000,39954000,66424000,-28492000,-2.2158253242511896,-1.7518813799269801,-1.6857142857142857,__nan__,__nan__,__nan__,0.22684294201322064
266,CSIQ,Canadian Solar Inc. Common Shares (BC),"Canadian Solar Inc., together with its subsidiaries, designs, develops, manufactures, and sells solar ingots, wafers, cells, modules, and other solar power and battery storage products in Asia, the Americas, Europe, and internationally. The company operates through two segments, Canadian Solar Inc. (CSI) Solar and Global Energy. The CSI Solar segment offers standard solar modules and battery storage solutions, as well as solar system kits that are a ready-to-install packages comprising inverters, racking systems, and other accessories; and engineering, procurement, and construction (EPC) services. The Global Energy segment engages in the development, construction, maintenance, and sale of solar and battery storage projects; operation of solar power plants; and sale of electricity. This segment also provides operation and maintenance (O&M) services, including monitoring, inspections, repair, and replacement of plant equipment; and site management and administrative support services for solar projects, as well as asset management services. As of January 31, 2021, this segment had a fleet of solar power plants in operation with an aggregate capacity of approximately 445 MWp. The company serves distributors, system integrators, project developers, and installers/EPC companies. It sells its products primarily under its Canadian Solar brand name; and on an OEM basis. The company was incorporated in 2001 and is headquartered in Guelph, Canada.",Dr. Xiaohua  Qu Ph.D.,Solar,7.32,USD,484400414,https://images.financialmodelingprep.com/symbol/CSIQ.png,1882467,13.56,-0.14,954390,829664000,274187000,"[{'period': '2023', 'revenue': 7610.0, 'unit': 'M', 'net_profit': 274.19}, {'period': '2022', 'revenue': 7470.0, 'unit': 'M', 'net_profit': 239.97}, {'period': '2021', 'revenue': 5280.0, 'unit': 'M', 'net_profit': 95.25}, {'period': '2020', 'revenue': 3480.0, 'unit': 'M', 'net_profit': 146.7}]","[{'period': ""Q3 '24"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': -14.03}, {'period': ""Q2 '24"", 'revenue': 1640.0, 'unit': 'M', 'net_profit': 3.82}, {'period': ""Q1 '24"", 'revenue': 1330.0, 'unit': 'M', 'net_profit': 12.35}, {'period': ""Q4 '23"", 'revenue': 1700.0, 'unit': 'M', 'net_profit': -1.39}, {'period': ""Q3 '23"", 'revenue': 1850.0, 'unit': 'M', 'net_profit': 21.89}, {'period': ""Q2 '23"", 'revenue': 2360.0, 'unit': 'M', 'net_profit': 169.97}]",4.27,3.87,11895760000,6095453000,1958013000,8190516000,1209697000,277051000,5864391000,1938689000,-840845000,0.22885695200036732,0.14259817975730096,0.1447721179624664,__nan__,__nan__,__nan__,0.6885239782914249
267,CSOD,Cornerstone OnDemand Inc. Common Stock,"Cornerstone OnDemand, Inc., together with its subsidiaries, provides learning and people development solutions through software-as-a-service model worldwide. Its enterprise people development solution comprises four product suites, such as Recruiting Suite that helps organizations to attract, hire, and onboard the right employees; Learning Suite, which provides robust, a modern learning management software to supports compliance, knowledge sharing, and employee-driven development training; Performance Suite that provides tools to manage goal setting, performance reviews, competency assessments, development plans, continuous feedback, compensation management, and succession planning; and HR Suite, which provides an aggregated view of all employee data with workforce planning, self-service management, and compliance reporting capabilities. The company also offers professional services, including application configuration, system integration, business process re-engineering, change management, and training. Cornerstone OnDemand, Inc. sells its software, content, and services directly through its sales force and indirectly through its domestic and international network of distributors. It serves business services, financial services, healthcare, pharmaceuticals, insurance, manufacturing, retail, and technology industries. Cornerstone OnDemand, Inc. was founded in 1999 and is headquartered in Santa Monica, California.",Mr. Adam Miller,Software - Application,57.49,USD,0,https://images.financialmodelingprep.com/symbol/CSOD.png,1328149,0,0,3739087,93258000,-39982000,"[{'period': '2020', 'revenue': 740.92, 'unit': 'M', 'net_profit': -39.98}, {'period': '2019', 'revenue': 576.52, 'unit': 'M', 'net_profit': -4.05}, {'period': '2018', 'revenue': 537.89, 'unit': 'M', 'net_profit': -33.84}, {'period': '2017', 'revenue': 481.99, 'unit': 'M', 'net_profit': -61.34}]","[{'period': ""Q2 '21"", 'revenue': 214340.0, 'unit': 'K', 'net_profit': -371.0}, {'period': ""Q1 '21"", 'revenue': 209.27, 'unit': 'M', 'net_profit': -12.45}, {'period': ""Q4 '20"", 'revenue': 206.92, 'unit': 'M', 'net_profit': 1.56}, {'period': ""Q3 '20"", 'revenue': 199.5, 'unit': 'M', 'net_profit': -15.78}, {'period': ""Q2 '20"", 'revenue': 184.36, 'unit': 'M', 'net_profit': -11.99}, {'period': ""Q1 '20"", 'revenue': 150.14, 'unit': 'M', 'net_profit': -13.78}]",-0.6,-0.6,2134569000,451013000,161716000,1865695000,221461000,8565000,597671000,153151000,64074000,0.5091756481211768,-8.86235816477553,-7.888888888888888,__nan__,__nan__,__nan__,0.874038271894701
268,CSPI,CSP Inc. Common Stock,"CSP Inc. develops and markets IT integration solutions, security products, managed IT services, purpose built network adapters, and cluster computer systems for commercial and defense customers worldwide. It operates in two segments, Technology Solutions and High Performance Products. The Technology Solutions segment provides third-party computer hardware and software as a value added reseller to various customers in Web and infrastructure hosting, education, telecommunications, healthcare services, distribution, financial and professional services, and manufacturing industries. This segment also offers professional IT consulting services, such as planning, designing, assessment, implementation, migration, optimization, and project management; storage and virtualization solutions; enterprise security intrusion prevention, network access control, and unified threat management services; and IT security compliance services. In addition, this segment provides unified communications, wireless, and routing and switching solutions; custom software applications and solutions development and support services; optimization, maintenance, and technical support services; and managed IT services, such as monitoring, reporting, and management of alerts for the resolution and preventive general IT, as well as IT security support tasks. Further, this segment offers managed and cloud services, such as proactive monitoring and remote management of IT infrastructure, managed and hosted unified communication services, security, and backup and replication. The High Performance Products segment offers ARIA Software-Defined Security, a cybersecurity solution; Myricom network adapters; and multicomputer products for digital signal processing applications in the defense markets. CSP Inc. was incorporated in 1968 and is headquartered in Lowell, Massachusetts.",Mr. Victor J. Dellovo,Information Technology Services,14.62,USD,144451638,https://images.financialmodelingprep.com/symbol/CSPI.png,32096,731,-0.83,8193,610000,-326000,"[{'period': '2024', 'revenue': 55220.0, 'unit': 'K', 'net_profit': -326.0}, {'period': '2023', 'revenue': 64.65, 'unit': 'M', 'net_profit': 5.2}, {'period': '2022', 'revenue': 54.36, 'unit': 'M', 'net_profit': 1.89}, {'period': '2021', 'revenue': 49210.0, 'unit': 'K', 'net_profit': 234.0}]","[{'period': ""Q1 '25"", 'revenue': 15670.0, 'unit': 'K', 'net_profit': 438.0}, {'period': ""Q4 '24"", 'revenue': 13.03, 'unit': 'M', 'net_profit': -1.66}, {'period': ""Q3 '24"", 'revenue': 13110.0, 'unit': 'K', 'net_profit': -185.0}, {'period': ""Q2 '24"", 'revenue': 13.71, 'unit': 'M', 'net_profit': 1.59}, {'period': ""Q1 '24"", 'revenue': 15380.0, 'unit': 'K', 'net_profit': -73.0}, {'period': ""Q4 '23"", 'revenue': 15.33, 'unit': 'M', 'net_profit': 1.41}]",-0.0361,-0.0361,69436000,54849000,30585000,22166000,18878000,0,18682000,30585000,4017000,-0.8970985155195681,-1.0626441199077632,-1.0644642857142856,"[0.03, 0.1]","['2025-02-24', '2012-01-25']",__nan__,0.319229218272942
269,CSQ,Calamos Strategic Total Return Common Stock,"Calamos Strategic Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The fund is managed by Calamos Advisors LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in common and preferred stocks of companies across all market capitalizations, convertible securities, and high yield corporate bonds with an average credit rating of BB as rated by S&P. The fund employs both fundamental and quantitative analysis with a combination of bottom-up and top-down security picking approaches to create its portfolio. Calamos Strategic Total Return Fund was formed on December 31, 2003 and is domiciled in the United States.",Mr. John Peter Calamos Sr.,Asset Management,14.64,USD,2321720707,https://images.financialmodelingprep.com/symbol/CSQ.png,254896,2.73,-0.32,460472,0,861928337,"[{'period': '2024', 'revenue': 863.77, 'unit': 'M', 'net_profit': 861.93}, {'period': '2023', 'revenue': 274.34, 'unit': 'M', 'net_profit': 169.64}, {'period': '2022', 'revenue': -601.24, 'unit': 'M', 'net_profit': -602.97}, {'period': '2021', 'revenue': 1.01, 'unit': 'B', 'net_profit': 1.01}]","[{'period': ""Q2 '24"", 'revenue': 12.4, 'unit': 'M', 'net_profit': 499.07}, {'period': ""Q4 '23"", 'revenue': 202.97, 'unit': 'M', 'net_profit': -13.5}, {'period': ""Q2 '23"", 'revenue': 71.37, 'unit': 'M', 'net_profit': 183.14}, {'period': ""Q4 '22"", 'revenue': 103.44, 'unit': 'M', 'net_profit': -213.88}, {'period': ""Q2 '22"", 'revenue': 127.15, 'unit': 'M', 'net_profit': -389.09}, {'period': ""Q4 '21"", 'revenue': 114.8, 'unit': 'M', 'net_profit': 280.59}]",5.37,5.37,4167608290,0,0,1352322903,25869634,3985572163,0,0,137289263,-1,4.080932167311394,4.018691588785046,"[0.1025, 0.075]","['2025-04-11', '2004-06-09']",__nan__,0.32448416667296726
270,CSSE,Chicken Soup for the Soul Entertainment Inc. Class A Common Stock,"Chicken Soup for the Soul Entertainment, Inc. operates as a streaming video-on-demand (VOD) company in the United States and internationally. It owns and operates various ad-supported and subscription-based VOD networks, including Crackle, Chicken Soup for the Soul, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix, and FrightPix. The company distributes and exhibits VOD content directly to consumers through various digital platforms, such as connected TVs, smartphones, tablets, gaming consoles, and the web through its owned and operated AVOD or FAST channel networks. It also produces and licenses movies, television series, and programs; and produces long and short-form original content. The company was founded in 2014 and is headquartered in Cos Cob, Connecticut. Chicken Soup for the Soul Entertainment, Inc. is a subsidiary of Chicken Soup for the Soul Productions, LLC.",Mr. William J. Rouhana Jr.,Entertainment,0.1055,USD,3424414,https://images.financialmodelingprep.com/symbol/CSSE.png,6240673,-0.00496938294865756,0,22111163,-423022877,-622515636,"[{'period': '2023', 'revenue': 294.41, 'unit': 'M', 'net_profit': -622.52}, {'period': '2022', 'revenue': 252.81, 'unit': 'M', 'net_profit': -101.95}, {'period': '2021', 'revenue': 110.4, 'unit': 'M', 'net_profit': -50.48}, {'period': '2020', 'revenue': 66.36, 'unit': 'M', 'net_profit': -40.59}]","[{'period': ""Q1 '24"", 'revenue': 27.4, 'unit': 'M', 'net_profit': -48.7}, {'period': ""Q4 '23"", 'revenue': 39.17, 'unit': 'M', 'net_profit': -96.75}, {'period': ""Q3 '23"", 'revenue': 65.72, 'unit': 'M', 'net_profit': -429.79}, {'period': ""Q2 '23"", 'revenue': 79.91, 'unit': 'M', 'net_profit': -40.41}, {'period': ""Q1 '23"", 'revenue': 109.6, 'unit': 'M', 'net_profit': -55.69}, {'period': ""Q4 '22"", 'revenue': 113.57, 'unit': 'M', 'net_profit': -53.75}]",-22.36,-22.36,422300625,155795159,3316652,925862510,142088225,0,377861168,23915,-29966885,-26.180552897081423,-5.10615257547221,-2.7834179357021993,"[0.203, 0.45]","['2020-08-28', '2018-08-03']",__nan__,2.1924251473698386
271,CSSEN,Chicken Soup for the Soul Entertainment Inc. 9.50% Notes due 2025,"Chicken Soup for the Soul Entertainment, Inc. is an advertising-supported video-on-demand (AVOD) company. It creates, acquires, and distributes films and TV series through its Screen Media and Chicken Soup for the Soul TV Group subsidiaries. Its flagship streaming services are Redbox, Crackle, and Chicken Soup for the Soul. The company was founded on May 4, 2016 and is headquartered in Cos Cob, CT.",William J. Rouhana,Entertainment,0.8666,USD,3424413,https://images.financialmodelingprep.com/symbol/CSSEN.png,37742,0,0,1037146,-423022877,-622515636,"[{'period': '2023', 'revenue': 294.41, 'unit': 'M', 'net_profit': -622.52}, {'period': '2022', 'revenue': 252.81, 'unit': 'M', 'net_profit': -101.95}, {'period': '2021', 'revenue': 110.4, 'unit': 'M', 'net_profit': -50.48}, {'period': '2020', 'revenue': 66.36, 'unit': 'M', 'net_profit': -40.59}]","[{'period': ""Q1 '24"", 'revenue': 27.4, 'unit': 'M', 'net_profit': -48.7}, {'period': ""Q4 '23"", 'revenue': 39.17, 'unit': 'M', 'net_profit': -96.75}, {'period': ""Q3 '23"", 'revenue': 65.72, 'unit': 'M', 'net_profit': -429.79}, {'period': ""Q2 '23"", 'revenue': 79.91, 'unit': 'M', 'net_profit': -40.41}, {'period': ""Q1 '23"", 'revenue': 109.6, 'unit': 'M', 'net_profit': -55.69}, {'period': ""Q4 '22"", 'revenue': 113.57, 'unit': 'M', 'net_profit': -53.75}]",-22.36,-22.36,422300625,155795159,3316652,925862510,142088225,0,377861168,23915,-29966885,-26.180552897081423,-5.10615257547221,-2.7834179357021993,"[0.59375, 0.48]","['2025-06-13', '2020-09-14']",__nan__,2.1924251473698386
272,CSSEP,Chicken Soup for the Soul Entertainment Inc. 9.75% Series A Cumulative Redeemable Perpetual Preferred Stock,"Chicken Soup for the Soul Entertainment, Inc. operates as a streaming video-on-demand (VOD) company in the United States and internationally. It owns and operates various ad-supported and subscription-based VOD networks, including Crackle, Chicken Soup for the Soul, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix, and FrightPix. The company distributes and exhibits VOD content directly to consumers through various digital platforms, such as connected TVs, smartphones, tablets, gaming consoles, and the web through its owned and operated AVOD or FAST channel networks. It also produces and licenses movies, television series, and programs; and produces long and short-form original content. The company was founded in 2014 and is headquartered in Cos Cob, Connecticut. Chicken Soup for the Soul Entertainment, Inc. is a subsidiary of Chicken Soup for the Soul Productions, LLC.",Mr. William J. Rouhana Jr.,Entertainment,0.4,USD,1404104,https://images.financialmodelingprep.com/symbol/CSSEP.png,163696,-0.09585430146177809,0,2460666,-423022877,-622515636,"[{'period': '2023', 'revenue': 294.41, 'unit': 'M', 'net_profit': -622.52}, {'period': '2022', 'revenue': 252.81, 'unit': 'M', 'net_profit': -101.95}, {'period': '2021', 'revenue': 110.4, 'unit': 'M', 'net_profit': -50.48}, {'period': '2020', 'revenue': 66.36, 'unit': 'M', 'net_profit': -40.59}]","[{'period': ""Q1 '24"", 'revenue': 27.4, 'unit': 'M', 'net_profit': -48.7}, {'period': ""Q4 '23"", 'revenue': 39.17, 'unit': 'M', 'net_profit': -96.75}, {'period': ""Q3 '23"", 'revenue': 65.72, 'unit': 'M', 'net_profit': -429.79}, {'period': ""Q2 '23"", 'revenue': 79.91, 'unit': 'M', 'net_profit': -40.41}, {'period': ""Q1 '23"", 'revenue': 109.6, 'unit': 'M', 'net_profit': -55.69}, {'period': ""Q4 '22"", 'revenue': 113.57, 'unit': 'M', 'net_profit': -53.75}]",-22.36,-22.36,422300625,155795159,3316652,925862510,142088225,0,377861168,23915,-29966885,-26.180552897081423,-5.10615257547221,-2.7834179357021993,"[0.2031, 0.2031]","['2023-12-28', '2018-06-28']",__nan__,2.1924251473698386
273,CSTE,Caesarstone Ltd. Ordinary Shares,"Caesarstone Ltd., together with its subsidiaries, develops, manufactures, and markets engineered quartz and other surfaces under the Caesarstone brand in the United States, Australia, Canada, Latin America, Asia, Israel, Europe, the Middle East, and Africa. The company's engineered quartz slabs are primarily used as indoor and outdoor kitchen countertops in the renovation and remodeling construction end markets. Its products are also used in other applications, such as vanity tops, wall panels, back splashes, floor tiles, stairs, furniture, and other interior and exterior surfaces that are used in various residential and non-residential applications. The company also offers porcelain products under the Lioli brand for flooring and cladding applications, as well as resells natural stones, various ancillary fabrication tools, and installation accessories; and sells sinks and materials. It sells its products directly to fabricators, sub-distributors, and resellers; and through direct sales force and indirect network of independent distributors. The company was formerly known as Caesarstone Sdot Yam Ltd. and changed its name to Caesarstone Ltd. in June 2016. Caesarstone Ltd. was founded in 1987 and is headquartered in Menashe, Israel.",Mr. Yosef  Shiran,Construction,3.05,USD,105395282,https://images.financialmodelingprep.com/symbol/CSTE.png,73886,-2.7,0.04,78661,-20615000,-42832000,"[{'period': '2024', 'revenue': 443.22, 'unit': 'M', 'net_profit': -42.83}, {'period': '2023', 'revenue': 565.23, 'unit': 'M', 'net_profit': -107.66}, {'period': '2022', 'revenue': 690.81, 'unit': 'M', 'net_profit': -56.37}, {'period': '2021', 'revenue': 643.89, 'unit': 'M', 'net_profit': 18.97}]","[{'period': ""Q4 '24"", 'revenue': 97.86, 'unit': 'M', 'net_profit': -24.34}, {'period': ""Q3 '24"", 'revenue': 107.63, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q2 '24"", 'revenue': 119.43, 'unit': 'M', 'net_profit': -9.18}, {'period': ""Q1 '24"", 'revenue': 118.29, 'unit': 'M', 'net_profit': -5.09}, {'period': ""Q4 '23"", 'revenue': 128.53, 'unit': 'M', 'net_profit': -50.52}, {'period': ""Q3 '23"", 'revenue': 142390.0, 'unit': 'K', 'net_profit': -887.0}]",-1.13,-1.13,549041000,348476000,106336000,275256000,87067000,0,151688000,57336000,21453000,0.6006238133984269,0.6021401501077506,0.6378205128205129,"[0.199, 0.58]","['2022-08-16', '2013-11-25']",__nan__,0.5013396085173967
274,CSTL,Castle Biosciences Inc. Common Stock,"Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.",Mr. Derek J. Maetzold,Medical - Diagnostics & Research,21.14,USD,609781947,https://images.financialmodelingprep.com/symbol/CSTL.png,406326,34.1,-0.37,542239,38138000,18245000,"[{'period': '2024', 'revenue': 332.07, 'unit': 'M', 'net_profit': 18.25}, {'period': '2023', 'revenue': 219.79, 'unit': 'M', 'net_profit': -57.47}, {'period': '2022', 'revenue': 137.04, 'unit': 'M', 'net_profit': -67.14}, {'period': '2021', 'revenue': 94.08, 'unit': 'M', 'net_profit': -31.29}]","[{'period': ""Q4 '24"", 'revenue': 86.31, 'unit': 'M', 'net_profit': 9.59}, {'period': ""Q3 '24"", 'revenue': 85.78, 'unit': 'M', 'net_profit': 2.27}, {'period': ""Q2 '24"", 'revenue': 87.0, 'unit': 'M', 'net_profit': 8.92}, {'period': ""Q1 '24"", 'revenue': 72.97, 'unit': 'M', 'net_profit': -2.53}, {'period': ""Q4 '23"", 'revenue': 66.12, 'unit': 'M', 'net_profit': -2.58}, {'period': ""Q3 '23"", 'revenue': 61.49, 'unit': 'M', 'net_profit': -6.91}]",0.66,0.62,531235000,360154000,293130000,75400000,51218000,0,49392000,119709000,36540000,1.8470593461265103,1.3174920822747365,1.3084112149532712,__nan__,__nan__,__nan__,0.14193341929654485
275,CSTR,CapStar Financial Holdings Inc. Common Stock,"CapStar Financial Holdings, Inc. operates as the bank holding company for CapStar Bank that provides banking services to consumer and corporate customers located primarily in Tennessee, the United States. Its deposit products and services include demand deposits, interest-bearing transaction accounts, money market accounts, time and savings deposits, certificates of deposit, and CDARS reciprocal products. The company also provides commercial and consumer real estate, construction and land development, commercial and industrial, consumer, PPP, and other loans. In addition, it offers mortgage banking products and services; private banking and wealth management services for the owners and operators of business clients and other high net worth individuals; and correspondent banking services to community banks. Further, the company provides telephone and online banking, direct deposit, mobile banking, safe deposit box, remote deposit, and cash management services for individuals, and small and medium sized businesses. CapStar Financial Holdings, Inc. was founded in 2007 and is headquartered in Nashville, Tennessee.",Mr. Timothy K. Schools,Banks - Regional,20.11,USD,418561496,https://images.financialmodelingprep.com/symbol/CSTR.png,98498,14.26241134751773,0.01,115390,36199000,29804000,"[{'period': '2023', 'revenue': 181.16, 'unit': 'M', 'net_profit': 29.8}, {'period': '2022', 'revenue': 120.61, 'unit': 'M', 'net_profit': 39.02}, {'period': '2021', 'revenue': 133.85, 'unit': 'M', 'net_profit': 48.68}, {'period': '2020', 'revenue': 119.57, 'unit': 'M', 'net_profit': 24.7}]","[{'period': ""Q4 '23"", 'revenue': 49.38, 'unit': 'M', 'net_profit': 6.63}, {'period': ""Q3 '23"", 'revenue': 26.65, 'unit': 'M', 'net_profit': 8.93}, {'period': ""Q2 '23"", 'revenue': 28.78, 'unit': 'M', 'net_profit': 7.8}, {'period': ""Q1 '23"", 'revenue': 29.49, 'unit': 'M', 'net_profit': 6.45}, {'period': ""Q4 '22"", 'revenue': 31.24, 'unit': 'M', 'net_profit': 10.33}, {'period': ""Q3 '22"", 'revenue': 28.82, 'unit': 'M', 'net_profit': 8.19}]",1.41,1.41,3142175000,272210000,385072000,2780617000,12588000,269742000,1403064000,249611000,24315000,-0.47828781436909995,-0.23612784171002382,-0.20338983050847462,"[0.11, 0.04]","['2024-02-06', '2018-07-30']",__nan__,0.8849338435955986
276,CSWC,Capital Southwest Corporation Common Stock,"Capital Southwest Corporation is a business development company specializing in credit and private equity and venture capital investments in middle market companies, mezzanine, later stage, mature, late venture, emerging growth, buyouts, recapitalizations and growth capital investments. It does not invest in startups, publicly traded companies, real estate developments, project finance opportunities, oil and gas exploration businesses, troubled companies, turnarounds, and companies in which significant senior management is departing. In lower middle market, the firm typically invests in growth financing, bolt-on acquisitions, new platform acquisitions, refinancing, dividend recapitalizations, sponsor-led buyouts, and management buyouts situations. The investment structures are Unitranche debt, subordinated debt, senior debt, first and second lien debt, and preferred and common equity. The firm makes equity co-investments alongside debt investments, up to 20% of total check and only makes non-control investments. It prefers to invest in Industrial manufacturing and services, value-added distribution, healthcare products and services, business services, specialty chemicals, food and beverage, tech-enabled services and SaaS models. The firm seeks to invest in energy services and products, industrial technologies, and specialty chemicals and products. Within energy services and products, the firm seeks to invest in each segment of the industry, including upstream, midstream and downstream, excluding exploration and production with a focus on differentiated products and services, equipment and tool rental, consumable products, and drilling and completion chemicals. Within industrial technologies, it seeks to invest in automation and process controls, handling and packaging equipment, industrial filtration and fluid handling, measurement, monitoring and testing, professional tools, and sensors and instrumentation. Within and specialty chemicals and products, the firm seeks to invest in businesses that develop and manufacture highly differentiated chemicals and products including adhesives, coatings and sealants, catalysts and absorbents, cosmeceuticals, fine chemicals, flavors and fragrances, performance lubricants, polymers, plastics and composites, chemical dispensing and filtration equipment, professional and industrial trade consumables and tools, engineered solutions for HVAC, plumbing, and electrical installations, specified high performance materials for fire protection and oilfield applications. It may also invest in exceptional opportunities in building products. The firm seeks to invest in the United States. The firm seeks to make investments ranging from $5 to $25 million in securities. It seeks to make equity investments ranging from $5 million to $50 million and debt investments between $5 million and $20 million and co-invest in transaction size up to $40 million. It prefers to invest in companies with revenues approaching above $10 million, profitable operations, historical growth rate of at least 15 percent per year. Within the lower middle market, it seeks to invest in with less than $15 million in EBITDA and also opportunistically invests in the upper middle market, generally defined as companies with EBITDA in excess of $50 million. In addition to making direct investments, the firm allocates capital to syndicated first and second lien term loans in the upper middle market. Criteria for Upper Middle Market Syndicated 1st Lien is EBITDA Size more than $30 million, Closing Leverage greater than 4 times, investment hold size between $5 million and $7 million, investment yield greater than 6.5%. Criteria for Upper Middle Market Syndicated 2nd Lien is EBITDA Size more than $50 million, Closing Leverage greater than 6 times, investment hold size between $5 million and $7 million, investment yield greater than 9%. It prefers to take a majority and minority stake. The firm has the flexibility to hold investments for very long period in its portfolio companies. It may also invest through warrants. The firm prefers to take Board participation in its portfolio companies. Capital Southwest Corporation was founded on April 19, 1961 and is based in Dallas, Texas.","Mr. Michael Scott Sarner CPA, CPA",Asset Management,19.36,USD,979263648,https://images.financialmodelingprep.com/symbol/CSWC.png,623196,13.83,-0.32,346613,158341000,83389000,"[{'period': '2024', 'revenue': 109.06, 'unit': 'M', 'net_profit': 83.39}, {'period': '2023', 'revenue': 61.45, 'unit': 'M', 'net_profit': 33.09}, {'period': '2022', 'revenue': 83.0, 'unit': 'M', 'net_profit': 42.81}, {'period': '2021', 'revenue': 72.58, 'unit': 'M', 'net_profit': 50.88}]","[{'period': ""Q3 '25"", 'revenue': 26.61, 'unit': 'M', 'net_profit': 16.27}, {'period': ""Q2 '25"", 'revenue': 38.42, 'unit': 'M', 'net_profit': 22.68}, {'period': ""Q1 '25"", 'revenue': 52.06, 'unit': 'M', 'net_profit': 14.04}, {'period': ""Q4 '24"", 'revenue': 26.77, 'unit': 'M', 'net_profit': 13.47}, {'period': ""Q3 '24"", 'revenue': 48.57, 'unit': 'M', 'net_profit': 23.48}, {'period': ""Q2 '24"", 'revenue': 42.78, 'unit': 'M', 'net_profit': 22.62}]",2.05,2.05,1556758000,62829000,32273000,801082000,30204000,1476561000,562000,32273000,-188509000,1.2087210032222517,1.5198380322122502,0.8636363636363633,"[0.64, 0.16]","['2025-03-14', '1985-05-09']",__nan__,0.5145835126590003
277,CSWI,CSW Industrials Inc. Common Stock,"CSW Industrials, Inc. operates as a diversified industrial company in the United States and internationally. It operates through three segments: Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The Contractor Solutions segment provides cements, diffusers, grilles, registers, solvents, thread sealants, traps, and vents for use in HVAC/R, plumbing, general industrial, architecturally, and specified building products. The Engineered Building Solutions segment offers architectural railings and associated services; fire and smoke protection solutions; and pre-engineered and custom architectural building components for use in architecturally specified building products. The Specialized Reliability Solutions segment provides compounds, lubricants, lubricant management products, and sealants; and contamination control, industrial maintenance and repair, and operations solutions for use in energy, general industrial, mining, and railing markets. The company was incorporated in 2014 and is headquartered in Dallas, Texas.",Mr. Joseph Brooks Armes J.D.,Industrial - Machinery,291.18,USD,4886897234,https://images.financialmodelingprep.com/symbol/CSWI.png,137047,34.96,-7.25,91269,192031000,101648000,"[{'period': '2024', 'revenue': 792.84, 'unit': 'M', 'net_profit': 101.65}, {'period': '2023', 'revenue': 757.9, 'unit': 'M', 'net_profit': 96.44}, {'period': '2022', 'revenue': 626.43, 'unit': 'M', 'net_profit': 66.39}, {'period': '2021', 'revenue': 419.2, 'unit': 'M', 'net_profit': 40.1}]","[{'period': ""Q3 '25"", 'revenue': 193.65, 'unit': 'M', 'net_profit': 26.95}, {'period': ""Q2 '25"", 'revenue': 227.93, 'unit': 'M', 'net_profit': 36.05}, {'period': ""Q1 '25"", 'revenue': 226.18, 'unit': 'M', 'net_profit': 38.59}, {'period': ""Q4 '24"", 'revenue': 210.86, 'unit': 'M', 'net_profit': 31.76}, {'period': ""Q3 '24"", 'revenue': 174.97, 'unit': 'M', 'net_profit': 9.22}, {'period': ""Q2 '24"", 'revenue': 203.65, 'unit': 'M', 'net_profit': 30.05}]",6.54,6.52,1043326000,331410000,22156000,408248000,142665000,1230000,115836000,22156000,147757000,0.0990093343482267,0.05405713693161197,0.05144694533762063,"[0.27, 0.135]","['2025-04-25', '2019-05-07']",__nan__,0.3912947630941815
278,CSX,CSX Corporation Common Stock,"CSX Corporation, together with its subsidiaries, provides rail-based freight transportation services. The company offers rail services; and transportation of intermodal containers and trailers, as well as other transportation services, such as rail-to-truck transfers and bulk commodity operations. It transports chemicals, agricultural and food products, automotive, minerals, forest products, fertilizers, and metals and equipment; and coal, coke, and iron ore to electricity-generating power plants, steel manufacturers, and industrial plants, as well as exports coal to deep-water port facilities. The company also offers intermodal transportation services through a network of approximately 30 terminals transporting manufactured consumer goods in containers; and drayage services, including the pickup and delivery of intermodal shipments. It serves the automotive industry with distribution centers and storage locations, as well as connects non-rail served customers through transferring products, such as plastics and ethanol from rail to trucks. The company operates approximately 19,500 route mile rail network, which serves various population centers in 23 states east of the Mississippi River, the District of Columbia, and the Canadian provinces of Ontario and Quebec, as well as owns and leases approximately 3,500 locomotives. It also serves production and distribution facilities through track connections. CSX Corporation was incorporated in 1978 and is headquartered in Jacksonville, Florida.",Mr. Joseph R. Hinrichs,Railroads,27.46,USD,52026265200,https://images.financialmodelingprep.com/symbol/CSX.png,16204203,16.35,-0.22,24822372,7045000000,3470000000,"[{'period': '2024', 'revenue': 14.54, 'unit': 'B', 'net_profit': 3.47}, {'period': '2023', 'revenue': 14.66, 'unit': 'B', 'net_profit': 3.71}, {'period': '2022', 'revenue': 14.85, 'unit': 'B', 'net_profit': 4.17}, {'period': '2021', 'revenue': 12.52, 'unit': 'B', 'net_profit': 3.78}]","[{'period': ""Q1 '25"", 'revenue': 3420.0, 'unit': 'M', 'net_profit': 646.0}, {'period': ""Q4 '24"", 'revenue': 3540.0, 'unit': 'M', 'net_profit': 733.0}, {'period': ""Q3 '24"", 'revenue': 3620.0, 'unit': 'M', 'net_profit': 894.0}, {'period': ""Q2 '24"", 'revenue': 3700.0, 'unit': 'M', 'net_profit': 963.0}, {'period': ""Q1 '24"", 'revenue': 3680.0, 'unit': 'M', 'net_profit': 893.0}, {'period': ""Q4 '23"", 'revenue': 3680.0, 'unit': 'M', 'net_profit': 886.0}]",1.79,1.79,42764000000,2820000000,1005000000,30257000000,1326000000,2520000000,3276000000,933000000,5549000000,-0.040190735694822885,-0.06594885598923284,-0.03243243243243246,"[0.13, 0.64]","['2025-02-28', '1981-02-17']",__nan__,0.7075343747076981
279,CTAQ,Carney Technology Acquisition Corp. II Class A Common Stock,"Carney Technology Acquisition Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses on searching for a potential business combination target in the technology industry. Carney Technology Acquisition Corp. II was incorporated in 2020 and is based in Palo Alto, California.",Mr. David E. Roberson,Shell Companies,10.18,USD,0,https://images.financialmodelingprep.com/symbol/CTAQ.png,68671,56.55555555555556,0.01,344122,-9721703,7116098,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.8}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.46}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.86}]",0.14,0.14,402967373,398452,73952,24867999,0,0,265999,73952,-802930,0,0,0,__nan__,__nan__,__nan__,0.06171218978564798
280,CTAQU,Carney Technology Acquisition Corp. II Units,"Carney Technology Acquisition Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses on searching for a potential business combination target in the technology industry. Carney Technology Acquisition Corp. II was incorporated in 2020 and is based in Palo Alto, California.",Mr. David E. Roberson,Shell Companies,10.19,USD,0,https://images.financialmodelingprep.com/symbol/CTAQU.png,3100,96.13207547169812,0.04,1300,-9721703,7116098,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.8}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.46}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.86}]",0.14,0.14,402967373,398452,73952,24867999,0,0,265999,73952,-802930,0,0,0,__nan__,__nan__,__nan__,0.06171218978564798
281,CTAQW,Carney Technology Acquisition Corp. II Warrant,"Carney Technology Acquisition Corp. II intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology industry. The company was founded in 2020 and is based in Burlingame, California.",Mr. David E. Roberson,Shell Companies,0.0004,USD,0,https://images.financialmodelingprep.com/symbol/CTAQW.png,30147,0,0.0001,91522,-9721703,7116098,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.8}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.46}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.86}]",0.14,0.14,402967373,398452,73952,24867999,0,0,265999,73952,-802930,0,0,0,__nan__,__nan__,__nan__,0.06171218978564798
282,CTAS,Cintas Corporation Common Stock,"Cintas Corporation provides corporate identity uniforms and related business services primarily in the United States, Canada, and Latin America. It operates through Uniform Rental and Facility Services, First Aid and Safety Services, and All Other segments. The company rents and services uniforms and other garments, including flame resistant clothing, mats, mops and shop towels, and other ancillary items; and provides restroom cleaning services and supplies, as well as sells uniforms. It also offers first aid and safety services, and fire protection products and services. The company provides its products and services through its distribution network and local delivery routes, or local representatives to small service and manufacturing companies, as well as major corporations. Cintas Corporation was founded in 1968 and is headquartered in Cincinnati, Ohio.",Mr. Todd M. Schneider,Specialty Business Services,200.41,USD,80922944654,https://images.financialmodelingprep.com/symbol/CTAS.png,1932188,46.61,-5.35,1405106,2523857000,1571592000,"[{'period': '2024', 'revenue': 9.6, 'unit': 'B', 'net_profit': 1.57}, {'period': '2023', 'revenue': 8.82, 'unit': 'B', 'net_profit': 1.35}, {'period': '2022', 'revenue': 7.85, 'unit': 'B', 'net_profit': 1.24}, {'period': '2021', 'revenue': 7.12, 'unit': 'B', 'net_profit': 1.11}]","[{'period': ""Q3 '25"", 'revenue': 2610.0, 'unit': 'M', 'net_profit': 463.5}, {'period': ""Q2 '25"", 'revenue': 2560.0, 'unit': 'M', 'net_profit': 448.5}, {'period': ""Q1 '25"", 'revenue': 2500.0, 'unit': 'M', 'net_profit': 452.03}, {'period': ""Q4 '24"", 'revenue': 2470.0, 'unit': 'M', 'net_profit': 414.31}, {'period': ""Q3 '24"", 'revenue': 2410.0, 'unit': 'M', 'net_profit': 397.58}, {'period': ""Q2 '24"", 'revenue': 2380.0, 'unit': 'M', 'net_profit': 374.61}]",3.85,3.79,9168817000,3185207000,342015000,4852445000,1244182000,302212000,1828519000,342015000,1670312000,0.1360148824581082,0.16586078738288293,0.16666666666666677,"[0.39, 6.66]","['2025-05-15', '1984-03-06']",__nan__,0.5292334878098233
283,CTBI,Community Trust Bancorp Inc. Common Stock,"Community Trust Bancorp, Inc. operates as the bank holding company for Community Trust Bank, Inc. that provides commercial and personal banking services to small and mid-sized communities. The company accepts time and demand deposits, checking accounts, savings accounts and savings certificates, individual retirement accounts and Keogh plans, and money market accounts. Its loan products include commercial, construction, mortgage, and personal loans; lease-financing, lines of credit, revolving lines of credit, and term loans, as well as other specialized loans, including asset-based financing; residential and commercial real estate loans; and consumer loans. The company also provides cash management, renting safe deposit boxes, and funds transfer services; issues letters of credit; and acts as a trustee of personal trusts, executor of estates, trustee for employee benefit trusts, and paying agent for bond and stock issues, as well as an investment agent and depositor for securities. In addition, it offers securities brokerage, and trust and wealth management services; debit cards; annuity and life insurance products; and repurchase agreements, as well as mobile, internet banking, and e-statement services. The company operates 79 banking locations in eastern, northeastern, central, south central Kentucky, southern West Virginia, and northeastern Tennessee; 4 trust offices across Kentucky; and 1 trust office in northeastern Tennessee. Community Trust Bancorp, Inc. was founded in 1903 and is headquartered in Pikeville, Kentucky.",Mr. Mark A. Gooch CTB,Banks - Regional,47.28,USD,855851449,https://images.financialmodelingprep.com/symbol/CTBI.png,62518,9.87,0.09,73060,0,82813000,"[{'period': '2024', 'revenue': 313.44, 'unit': 'M', 'net_profit': 82.81}, {'period': '2023', 'revenue': 221.32, 'unit': 'M', 'net_profit': 78.0}, {'period': '2022', 'revenue': 227.02, 'unit': 'M', 'net_profit': 81.81}, {'period': '2021', 'revenue': 223.54, 'unit': 'M', 'net_profit': 87.94}]","[{'period': ""Q4 '24"", 'revenue': 65.69, 'unit': 'M', 'net_profit': 22.49}, {'period': ""Q3 '24"", 'revenue': 60.03, 'unit': 'M', 'net_profit': 22.14}, {'period': ""Q2 '24"", 'revenue': 92.06, 'unit': 'M', 'net_profit': 19.5}, {'period': ""Q1 '24"", 'revenue': 90.51, 'unit': 'M', 'net_profit': 18.68}, {'period': ""Q4 '23"", 'revenue': 87.31, 'unit': 'M', 'net_profit': 18.66}, {'period': ""Q3 '23"", 'revenue': 58.64, 'unit': 'M', 'net_profit': 20.63}]",4.61,4.61,6193245000,1153507000,1128749000,5435661000,24758000,0,8378000,73021000,97094000,-1,0.061650684580277934,0.0573394495412844,"[0.47, 0.21]","['2025-03-14', '1988-03-25']",__nan__,0.8776757580234594
284,CTG,Computer Task Group Inc. Common Stock,"Computer Task Group, Incorporated, together with its subsidiaries, offers information and technology services in North America, South America, Western Europe, and India. It operates through three segments: North America IT Solutions and Services, Europe IT Solutions and Services, and Non-Strategic Technology Services. The company offers business process transformation solutions, which include advisory, data strategy, digital workplace, enterprise platforms, information disclosure, and regulatory and compliance services; technology transformation solutions, such as application development, automation, cloud, data management, enterprise platform implementation, and testing services; and operations transformation solutions consisting of application support, IT operations support, cloud, and infrastructure. It also provides staffing services, including managed staffing, staff augmentation, and volume staffing services. The company serves financial services, healthcare, manufacturing, and energy industries, as well as technology service providers. Computer Task Group, Incorporated was incorporated in 1966 and is headquartered in Amherst, New York.",Mr. Filip J. L. Gydé,Information Technology Services,10.5,USD,168993300,https://images.financialmodelingprep.com/symbol/CTG.png,79623,350,0.01,49163,14075000,6609000,"[{'period': '2022', 'revenue': 325.08, 'unit': 'M', 'net_profit': 6.61}, {'period': '2021', 'revenue': 392.29, 'unit': 'M', 'net_profit': 13.73}, {'period': '2020', 'revenue': 366.09, 'unit': 'M', 'net_profit': 7.64}, {'period': '2019', 'revenue': 394.17, 'unit': 'M', 'net_profit': 4.12}]","[{'period': ""Q3 '23"", 'revenue': 71290.0, 'unit': 'K', 'net_profit': -871.0}, {'period': ""Q2 '23"", 'revenue': 74590.0, 'unit': 'K', 'net_profit': -130.0}, {'period': ""Q1 '23"", 'revenue': 78200.0, 'unit': 'K', 'net_profit': 315.0}, {'period': ""Q4 '22"", 'revenue': 77.9, 'unit': 'M', 'net_profit': 1.23}, {'period': ""Q3 '22"", 'revenue': 75.0, 'unit': 'M', 'net_profit': 1.1}, {'period': ""Q2 '22"", 'revenue': 82.76, 'unit': 'M', 'net_profit': 2.04}]",0.46,0.44,181619000,99888000,25140000,75640000,70979000,116000,51933000,25140000,10412000,-0.11555862762347618,-0.5186453022578296,-0.5353535353535354,"[0.06, 0.05]","['2016-09-22', '1981-05-01']",__nan__,0.4164762497315809
285,CTHR,Charles & Colvard Ltd Common Stock,"Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.",Mr. Don  O'Connell,Luxury Goods,0.8601,USD,2682024,https://images.financialmodelingprep.com/symbol/CTHR.png,30985,-0.18,-0.0501,29162,-14605957,-14362957,"[{'period': '2024', 'revenue': 21.96, 'unit': 'M', 'net_profit': -14.36}, {'period': '2023', 'revenue': 29.95, 'unit': 'M', 'net_profit': -19.58}, {'period': '2022', 'revenue': 43.09, 'unit': 'M', 'net_profit': 2.37}, {'period': '2021', 'revenue': 39.24, 'unit': 'M', 'net_profit': 12.81}]","[{'period': ""Q4 '24"", 'revenue': 3.84, 'unit': 'M', 'net_profit': -5.32}, {'period': ""Q3 '24"", 'revenue': 5.26, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q2 '24"", 'revenue': 7.91, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q1 '24"", 'revenue': 4.95, 'unit': 'M', 'net_profit': -2.54}, {'period': ""Q4 '23"", 'revenue': 5.56, 'unit': 'M', 'net_profit': -9.25}, {'period': ""Q3 '23"", 'revenue': 6.64, 'unit': 'M', 'net_profit': -8.4}]",-4.73,-4.73,40980241,18819044,4137055,15330868,1094747,0,14129146,4137055,-8319075,-0.12132691612463793,0.2664772940259726,-6.390625000000001,"[0.08, 0.05]","['2007-05-29', '2005-06-28']",__nan__,0.37410390046266445
286,CTIB,Yunhong CTI Ltd. Common Stock,"Yunhong CTI Ltd. develops, produces, distributes, and sells consumer products in the United States and internationally. It offers novelty products, including foil balloons; latex balloons under the Partyloons name; and toy balloon products, which include punch balls, water bombs, and Animal Twisties, as well as other inflatable toy items. The company also offers packaging films and custom film products for food, and other commercial and packaging applications; and container products, as well as assembles and sells Candy Blossom product line. It primarily serves various retail outlets, including general merchandise stores, discount and drugstore chains, grocery chains, card and gift shops, and party goods stores, as well as florists and balloon decorators. The company sells its products directly, as well as through a network of distributors and wholesalers, retail chains, and independent sales representatives. The company was formerly known as CTI Industries Corporation and changed its name to Yunhong CTI Ltd. in January 2020. Yunhong CTI Ltd. was founded in 1975 and is headquartered in Lake Barrington, Illinois.","Mr. Frank J. Cesario B.S., CPA, M.B.A.",Specialty Retail,2.4,USD,48232320,https://images.financialmodelingprep.com/symbol/CTIB.png,55017,-26.666666666666668,0.43,239336,-399000000,-246000000,"[{'period': '2023', 'revenue': 17800.0, 'unit': 'M', 'net_profit': -246.0}, {'period': '2022', 'revenue': 18.05, 'unit': 'M', 'net_profit': -1.81}, {'period': '2021', 'revenue': 24.09, 'unit': 'M', 'net_profit': -9.03}, {'period': '2020', 'revenue': 26.47, 'unit': 'M', 'net_profit': -2.51}]","[{'period': ""Q3 '23"", 'revenue': 1920.0, 'unit': 'K', 'net_profit': -967.0}, {'period': ""Q2 '23"", 'revenue': 4059.9999999999995, 'unit': 'K', 'net_profit': -149.0}, {'period': ""Q1 '23"", 'revenue': 5050.0, 'unit': 'K', 'net_profit': 638.0}, {'period': ""Q4 '22"", 'revenue': 5570.0, 'unit': 'K', 'net_profit': -78.0}, {'period': ""Q3 '22"", 'revenue': 2.26, 'unit': 'M', 'net_profit': -1.18}, {'period': ""Q2 '22"", 'revenue': 4420.0, 'unit': 'K', 'net_profit': -399.0}]",-0.0126,-0.0126,17247000000,13019000000,921000000,13515000000,3975000000,0,10140000000,921000000,-1338000000,-628.3375394321766,-134.61190738699008,0.9427272727272727,"[0.05, 0.05]","['2011-07-14', '2010-06-16']",__nan__,0.783614541659419
287,CTIC,CTI BioPharma Corp. (DE) Common Stock,"CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.","Dr. Adam R. Craig M.B.A., M.D., Ph.D.",Biotechnology,9.095,USD,1199448600,https://images.financialmodelingprep.com/symbol/CTIC.png,5661603,-16.84259259259259,0.005,5558437,-79853000,-91041000,"[{'period': '2022', 'revenue': 53.95, 'unit': 'M', 'net_profit': -91.04}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -99.64}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.95}, {'period': '2019', 'revenue': 3.35, 'unit': 'M', 'net_profit': -42.32}]","[{'period': ""Q1 '23"", 'revenue': 24.12, 'unit': 'M', 'net_profit': -21.8}, {'period': ""Q4 '22"", 'revenue': 21.08, 'unit': 'M', 'net_profit': -16.93}, {'period': ""Q3 '22"", 'revenue': 18.24, 'unit': 'M', 'net_profit': -15.63}, {'period': ""Q2 '22"", 'revenue': 12.33, 'unit': 'M', 'net_profit': -22.66}, {'period': ""Q1 '22"", 'revenue': 2.29, 'unit': 'M', 'net_profit': -37.19}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.21}]",-0.79,-0.79,125925000,99396000,79939000,143502000,15387000,0,81134000,30420000,-106194000,0.16236940376788486,0.08626400096350717,0.28828828828828834,__nan__,__nan__,__nan__,1.139583085169744
288,CTLP,Cantaloupe Inc. Common Stock,"Cantaloupe, Inc., a digital payment and software services company, provides technology solutions for the unattended retail market. The company offers integrated solutions for payments processing, logistics, and back-office management. It also provides ePort, an integrated payment device that is deployed in self-service, unattended market applications, such as vending, amusement, arcade, commercial laundry, air/vacuum, car wash, and others, which facilitates digital payments; and integrated software services for payment devices in the field for the wireless transfer. The company serves vending machine, car wash, electric vehicle charging, amusement, commercial laundry, micro-market, kiosk, and entertainment companies. It has strategic partnership with Bakkt Holdings, LLC to bring a cashless experience for consumers to spend digital assets at unattended retail devices: and Castles Technology to introduce a next-generation cashless device solution. The company was formerly known as USA Technologies, Inc and changed its name to Cantaloupe, Inc. Cantaloupe Inc. was incorporated in 1992 and is headquartered in Malvern, Pennsylvania.",Mr. Ravi  Venkatesan,Information Technology Services,7.39,USD,539725546,https://images.financialmodelingprep.com/symbol/CTLP.png,505672,38.89,-0.14,235442,28116000,11993000,"[{'period': '2024', 'revenue': 268.6, 'unit': 'M', 'net_profit': 11.99}, {'period': '2023', 'revenue': 243640.0, 'unit': 'K', 'net_profit': 633.0}, {'period': '2022', 'revenue': 195.2, 'unit': 'M', 'net_profit': -1.7}, {'period': '2021', 'revenue': 166.94, 'unit': 'M', 'net_profit': -8.71}]","[{'period': ""Q2 '25"", 'revenue': 73.72, 'unit': 'M', 'net_profit': 4.97}, {'period': ""Q1 '25"", 'revenue': 70.84, 'unit': 'M', 'net_profit': 3.57}, {'period': ""Q4 '24"", 'revenue': 72.66, 'unit': 'M', 'net_profit': 2.21}, {'period': ""Q3 '24"", 'revenue': 67.9, 'unit': 'M', 'net_profit': 4.66}, {'period': ""Q2 '24"", 'revenue': 65.36, 'unit': 'M', 'net_profit': 3.12}, {'period': ""Q1 '24"", 'revenue': 62.68, 'unit': 'M', 'net_profit': 2.01}]",0.16,0.15,335568000,157794000,58920000,151102000,50239000,0,105895000,58920000,12810000,1.3533941575290869,17.946287519747237,17.18181818181818,__nan__,__nan__,__nan__,0.4502872741143375
289,CTMX,CytomX Therapeutics Inc. Common Stock,"CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatment of squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma; BMS-986249, a CTLA-4 Probody therapeutic drug, which is in Phase I/II clinical trials for the treatment of metastatic melanoma; and BMS-986288, an anti-CTLA-4 Probody drug, which is in Phase I clinical trials for the treatment of solid tumors. It also develops CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, as well as CX-904, a conditionally activated epidermal growth factor receptor for the treatment of solid tumor. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.",Dr. Sean A. McCarthy DPHIL,Biotechnology,0.7499,USD,60066908,https://images.financialmodelingprep.com/symbol/CTMX.png,1834549,1.97,0.0939,1737693,24995000,31869000,"[{'period': '2024', 'revenue': 138.1, 'unit': 'M', 'net_profit': 31.87}, {'period': '2023', 'revenue': 101210.0, 'unit': 'K', 'net_profit': -569.0}, {'period': '2022', 'revenue': 53.16, 'unit': 'M', 'net_profit': -97.3}, {'period': '2021', 'revenue': 69.57, 'unit': 'M', 'net_profit': -80.65}]","[{'period': ""Q4 '24"", 'revenue': 38.09, 'unit': 'M', 'net_profit': 18.88}, {'period': ""Q3 '24"", 'revenue': 33.43, 'unit': 'M', 'net_profit': 5.74}, {'period': ""Q2 '24"", 'revenue': 25.11, 'unit': 'M', 'net_profit': -6.53}, {'period': ""Q1 '24"", 'revenue': 41.46, 'unit': 'M', 'net_profit': 13.79}, {'period': ""Q4 '23"", 'revenue': 26610.0, 'unit': 'K', 'net_profit': 837.0}, {'period': ""Q3 '23"", 'revenue': 26.38, 'unit': 'M', 'net_profit': 2.99}]",0.38,0.38,120533000,107305000,100623000,120989000,3103000,0,85772000,38052000,-86541000,6.800649802738454,57.00878734622144,50.35064935064935,__nan__,__nan__,__nan__,1.0037831963030872
290,CTRE,CareTrust REIT Inc. Common Stock,"CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.",Mr. David M. Sedgwick,REIT - Healthcare Facilities,28.06,USD,5265795720,https://images.financialmodelingprep.com/symbol/CTRE.png,1867022,35.07,-0.69,1037209,211540000,125080000,"[{'period': '2024', 'revenue': 296.29, 'unit': 'M', 'net_profit': 125.08}, {'period': '2023', 'revenue': 217.77, 'unit': 'M', 'net_profit': 53.73}, {'period': '2022', 'revenue': 187.51, 'unit': 'M', 'net_profit': 42.87}, {'period': '2021', 'revenue': 190.19, 'unit': 'M', 'net_profit': 48.3}]","[{'period': ""Q4 '24"", 'revenue': 62.2, 'unit': 'M', 'net_profit': 52.13}, {'period': ""Q3 '24"", 'revenue': 77.38, 'unit': 'M', 'net_profit': 33.44}, {'period': ""Q2 '24"", 'revenue': 68.89, 'unit': 'M', 'net_profit': 10.76}, {'period': ""Q1 '24"", 'revenue': 63.07, 'unit': 'M', 'net_profit': 28.75}, {'period': ""Q4 '23"", 'revenue': 53.47, 'unit': 'M', 'net_profit': 26.3}, {'period': ""Q3 '23"", 'revenue': 51.22, 'unit': 'M', 'net_profit': 8.7}]",0.81,0.81,3437016000,368261000,213822000,507633000,97178000,0,110706000,213822000,244251000,0.45085182848207184,1.3277193635433144,0.6200000000000001,"[0.335, 5.88]","['2025-03-31', '2014-10-29']",__nan__,0.1476958501211516
291,CTRM,Castor Maritime Inc. Common Shares,"Castor Maritime Inc. provides shipping services worldwide. The company operates through three segments: Dry Bulk, Aframax/LR2 Tanker, and Handysize Tanker. It offers seaborne transportation services for dry bulk cargo; commodities, such as iron ore, coal, soybeans, etc.; and crude oil and refined petroleum products. As of December 31, 2021, the company owned and operated a fleet of 29 vessels primarily consisting of two Handysize tanker vessels, seven Aframax/LR2 tanker vessels, and 14 dry bulk vessels. Castor Maritime Inc. was incorporated in 2017 and is based in Limassol, Cyprus.",Mr. Petros  Panagiotidis,Marine Shipping,2.12,USD,20484190,https://images.financialmodelingprep.com/symbol/CTRM.png,52432,0.57,-0.06,29515,55705947,38642488,"[{'period': '2023', 'revenue': 97.52, 'unit': 'M', 'net_profit': 38.64}, {'period': '2022', 'revenue': 262.1, 'unit': 'M', 'net_profit': 118.56}, {'period': '2021', 'revenue': 132.05, 'unit': 'M', 'net_profit': 40.5}, {'period': '2020', 'revenue': 12.49, 'unit': 'M', 'net_profit': -1.75}]","[{'period': ""Q3 '24"", 'revenue': 13.41, 'unit': 'M', 'net_profit': 2.84}, {'period': ""Q2 '24"", 'revenue': 16.28, 'unit': 'M', 'net_profit': 22.85}, {'period': ""Q1 '24"", 'revenue': 20.39, 'unit': 'M', 'net_profit': 22.33}, {'period': ""Q4 '23"", 'revenue': 26.36, 'unit': 'M', 'net_profit': 25.01}, {'period': ""Q3 '23"", 'revenue': 21.4, 'unit': 'M', 'net_profit': -5.39}, {'period': ""Q2 '23"", 'revenue': 25.28, 'unit': 'M', 'net_profit': 8.19}]",3.86,1.7,605041979,242276874,188472745,94312238,8565067,117537135,28602396,111383645,41969123,-0.38144171476165667,-0.6740699805306464,-0.6919393455706305,__nan__,__nan__,__nan__,0.15587718087904773
292,CTRN,Citi Trends Inc. Common Stock,"Citi Trends, Inc. operates as a value retailer of fashion apparel, accessories, and home goods. It offers apparel, such as fashion sportswear and footwear for men and ladies, as well as apparel for kids, including newborns, infants, toddlers, boys, and girls; sleepwear, lingerie, and scrubs for ladies; and kids uniforms and accessories. The company also provides accessories and beauty products that include handbags, luggage, hats, belts, sunglasses, jewelry, and watches, as well as undergarments and outerwear for men and women. In addition, it offers home and lifestyle products comprising home products for the bedroom, bathroom, kitchen, and decorative accessories; and food, tech, team sports, and health products, as well as seasonal items, books, and toys. The company provides its products primarily to African American and Latinx families in the United States. As of January 29, 2022, it operated 609 stores in urban and rural markets in 33 states. The company was formerly known as Allied Fashion, Inc. and changed its name to Citi Trends, Inc. in 2001. Citi Trends, Inc. was founded in 1946 and is headquartered in Savannah, Georgia.",Mr. Kenneth Duane Seipel,Apparel - Retail,19.76,USD,163567945,https://images.financialmodelingprep.com/symbol/CTRN.png,92257,-3.81,-0.08,45206,-13930005,-43170000,"[{'period': '2024', 'revenue': 753.08, 'unit': 'M', 'net_profit': -43.17}, {'period': '2023', 'revenue': 747.94, 'unit': 'M', 'net_profit': -11.98}, {'period': '2022', 'revenue': 795.01, 'unit': 'M', 'net_profit': 58.89}, {'period': '2021', 'revenue': 991.6, 'unit': 'M', 'net_profit': 62.24}]","[{'period': ""Q4 '24"", 'revenue': 211.17, 'unit': 'M', 'net_profit': -14.18}, {'period': ""Q3 '24"", 'revenue': 179.07, 'unit': 'M', 'net_profit': -7.15}, {'period': ""Q2 '24"", 'revenue': 176.55, 'unit': 'M', 'net_profit': -18.41}, {'period': ""Q1 '24"", 'revenue': 186.29, 'unit': 'M', 'net_profit': -3.43}, {'period': ""Q4 '23"", 'revenue': 215.18, 'unit': 'M', 'net_profit': 3.55}, {'period': ""Q3 '23"", 'revenue': 179.52, 'unit': 'M', 'net_profit': -3.86}]",-5.19,-5.19,462769000,197060000,61085000,349593000,3119000,0,174391000,61085000,-13957000,-5.085045454545455,-2.6038066616579014,-2.5547945205479454,"[0.08, 0.06]","['2020-03-02', '2015-08-28']",__nan__,0.7554373780439053
293,CTSH,Cognizant Technology Solutions Corporation Class A Common Stock,"Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to information, media and entertainment, and communications and technology companies. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.",Mr. Ravi Kumar Singisetti,Information Technology Services,68.06,USD,33663530930,https://images.financialmodelingprep.com/symbol/CTSH.png,4236768,15.09,-1.38,2211349,3534000000,2240000000,"[{'period': '2024', 'revenue': 19.74, 'unit': 'B', 'net_profit': 2.24}, {'period': '2023', 'revenue': 19.35, 'unit': 'B', 'net_profit': 2.13}, {'period': '2022', 'revenue': 19.43, 'unit': 'B', 'net_profit': 2.29}, {'period': '2021', 'revenue': 18.51, 'unit': 'B', 'net_profit': 2.14}]","[{'period': ""Q4 '24"", 'revenue': 5080.0, 'unit': 'M', 'net_profit': 546.0}, {'period': ""Q3 '24"", 'revenue': 5040.0, 'unit': 'M', 'net_profit': 582.0}, {'period': ""Q2 '24"", 'revenue': 4850.0, 'unit': 'M', 'net_profit': 566.0}, {'period': ""Q1 '24"", 'revenue': 4760.0, 'unit': 'M', 'net_profit': 546.0}, {'period': ""Q4 '23"", 'revenue': 4760.0, 'unit': 'M', 'net_profit': 558.0}, {'period': ""Q3 '23"", 'revenue': 4900.0, 'unit': 'M', 'net_profit': 525.0}]",4.52,4.51,19966000000,7504000000,2243000000,5558000000,4059000000,90000000,3585000000,2231000000,1827000000,0.05587092919031969,0.053621825023518345,0.07363420427553435,"[0.31, 0.15]","['2025-02-18', '2017-05-18']",__nan__,0.2783732344986477
294,CTSO,Cytosorbents Corporation Common Stock,"Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.","Dr. Phillip P. Chan M.D., Ph.D.",Medical - Devices,1.09,USD,68125000,https://images.financialmodelingprep.com/symbol/CTSO.png,103840,-2.87,0.06,143550,-19266562,-20718957,"[{'period': '2024', 'revenue': 25.13, 'unit': 'M', 'net_profit': -20.72}, {'period': '2023', 'revenue': 36.35, 'unit': 'M', 'net_profit': -28.51}, {'period': '2022', 'revenue': 29.36, 'unit': 'M', 'net_profit': -32.81}, {'period': '2021', 'revenue': 40.11, 'unit': 'M', 'net_profit': -24.56}]","[{'period': ""Q4 '24"", 'revenue': 9.15, 'unit': 'M', 'net_profit': -7.88}, {'period': ""Q3 '24"", 'revenue': 8.61, 'unit': 'M', 'net_profit': -2.33}, {'period': ""Q2 '24"", 'revenue': 9.89, 'unit': 'M', 'net_profit': -4.14}, {'period': ""Q1 '24"", 'revenue': 9.79, 'unit': 'M', 'net_profit': -6.36}, {'period': ""Q4 '23"", 'revenue': 8.67, 'unit': 'M', 'net_profit': -5.83}, {'period': ""Q3 '23"", 'revenue': 7.75, 'unit': 'M', 'net_profit': -9.19}]",-0.38,-0.38,47371500,21603242,3279926,36264564,7319597,0,9824243,3279926,-14712152,0.33978967709406005,0.2732076106290179,0.40625,__nan__,__nan__,__nan__,0.7655354801937874
295,CTXR,Citius Pharmaceuticals Inc. Common Stock,"Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.",Mr. Leonard L. Mazur,Biotechnology,0.86,USD,8049888,https://images.financialmodelingprep.com/symbol/CTXR.png,304952,-0.15,-0.108,244087,0,-39425839,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.43}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.54}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.64}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.13}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.77}, {'period': ""Q4 '24"", 'revenue': 0.15593, 'unit': 'M', 'net_profit': -10.79}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.57}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.54}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.23}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.94}]",-0.23,-0.23,116651751,14220646,3251880,42549921,0,0,35814803,3251880,-28201375,1,-0.21150310703602676,-0.0454545454545455,__nan__,__nan__,__nan__,0.36476024264736495
296,CTXRW,Citius Pharmaceuticals Inc. Warrant,"Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. It is developing five proprietary products comprising LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma, which is in Phase 3 clinical trial; Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase 3 clinical trial; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids that is in clinical Phase 2b trial; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. The company was founded in 2007 and is headquartered in Cranford, New Jersey.",None,Biotechnology,0.1441,USD,0,https://images.financialmodelingprep.com/symbol/CTXRW.png,0,0,-0.00590001,5350,-22878727,-23054434,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.05}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.55}, {'period': '2019', 'revenue': 0.09, 'unit': 'M', 'net_profit': -15.56}, {'period': '2018', 'revenue': 0.075, 'unit': 'M', 'net_profit': -12.54}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.92}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.59}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.23}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.96}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.82}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.12}]",-0.66,-0.66,142429059,72814350,70072946,9646326,0,29177000,3982292,70072946,-64257352,-0.3163788155245601,-0.3137863191339682,-0.32000000000000006,__nan__,__nan__,__nan__,0.0677272325445891
297,CTXS,Citrix Systems Inc. Common Stock,"Citrix Systems, Inc., an enterprise software company, provides workspace, app delivery and security, and professional services worldwide. The company offers workspace services, including Citrix Workspace; Citrix Virtual Apps and Desktops; Collaborative Work Management; Citrix Content Collaboration, a cloud-based file sharing, digital transaction, and storage solution, which provides enterprise-class data services on various corporate and personal mobile devices; Citrix Analytics for Security that assesses the behavior of Citrix Virtual Apps and Desktops, and Citrix Workspace users and applies actions to protect sensitive corporate information; Citrix Analytics for Performance, which uses machine learning to quantify user experience; Citrix Secure Workspace Access that provides an end-to-end solution to implement Zero Trust principles; and Citrix Secure Internet Access, which provides a solution that protects direct internet access for branch and remote workers using unsanctioned apps. It also provides Citrix ADC that offers application delivery controller, on-premise, in-cloud, and SaaS deployment option solutions. In addition, the company provides customer services, hardware maintenance, consulting, and product training and certification services. The company serves healthcare, financial services, technology, manufacturing, consumer, and government agencies. It markets and licenses its products through resellers, distributors, systems integrators, independent software vendors, original equipment manufacturers, and service providers. The company was formerly known as Citrus Systems, Inc. and changed its name to Citrix Systems, Inc. in March 2009. Citrix Systems, Inc. was incorporated in 1989 and is headquartered in Fort Lauderdale, Florida. As of September 30, 2022, Citrix Systems, Inc. was taken private.",Mr. David Henshall,Software - Application,103.9,USD,0,https://images.financialmodelingprep.com/symbol/CTXS.png,0,0,0.04,5783859,529320000,307499000,"[{'period': '2021', 'revenue': 3220.0, 'unit': 'M', 'net_profit': 307.5}, {'period': '2020', 'revenue': 3240.0, 'unit': 'M', 'net_profit': 504.45}, {'period': '2019', 'revenue': 3010.0, 'unit': 'M', 'net_profit': 681.81}, {'period': '2018', 'revenue': 2970.0, 'unit': 'M', 'net_profit': 575.67}]","[{'period': ""Q2 '22"", 'revenue': 859.52, 'unit': 'M', 'net_profit': 115.46}, {'period': ""Q1 '22"", 'revenue': 825.34, 'unit': 'M', 'net_profit': 60.23}, {'period': ""Q4 '21"", 'revenue': 850.85, 'unit': 'M', 'net_profit': 102.9}, {'period': ""Q3 '21"", 'revenue': 778.45, 'unit': 'M', 'net_profit': 51.79}, {'period': ""Q2 '21"", 'revenue': 812.11, 'unit': 'M', 'net_profit': 62.77}, {'period': ""Q1 '21"", 'revenue': 775.77, 'unit': 'M', 'net_profit': 90.05}]",2.44,2.44,6975517000,1718985000,527179000,6428260000,885311000,14754000,2354071000,513993000,576090000,-0.3125508943773645,-0.39042236433632144,-0.39,"[0.37, 0.35]","['2021-12-07', '2018-12-07']",__nan__,0.9215460302082269
298,CUBA,Herzfeld Caribbean Basin Fund Inc. (The) Common Stock,"The Herzfeld Caribbean Basin Fund Inc. is a closed-ended equity mutual fund launched by Thomas J. Herzfeld Advisors, Inc. The fund is managed by Herzfeld/Cuba. It invests in the public equity markets of the United States. The fund employing fundamental analysis investing in stocks of companies that are likely to benefit from economic, political, structural and technological developments in the countries in the Caribbean Basin, which consist of Cuba, Jamaica, Trinidad and Tobago, the Bahamas, the Dominican Republic, Barbados, Aruba, Haiti, the Netherlands Antilles, the Commonwealth of Puerto Rico, Mexico, Honduras, Guatemala, Belize, Costa Rica, Panama, Colombia and Venezuela. It invests in stocks of companies operating across diversified sectors. The Herzfeld Caribbean Basin Fund Inc. was formed on March 10, 1992 and is domiciled in the United States.",,Asset Management,2.39,USD,37572944,https://images.financialmodelingprep.com/symbol/CUBA.png,142659,12.58,-0.02,13432,1640201,1640201,"[{'period': '2023', 'revenue': 2.37, 'unit': 'M', 'net_profit': 1.64}, {'period': '2022', 'revenue': 8.45, 'unit': 'M', 'net_profit': 7.84}, {'period': '2021', 'revenue': -6.7, 'unit': 'M', 'net_profit': -7.45}, {'period': '2020', 'revenue': 18.38, 'unit': 'M', 'net_profit': 17.75}]","[{'period': ""Q4 '23"", 'revenue': 2220.0, 'unit': 'K', 'net_profit': -565.74}, {'period': ""Q2 '23"", 'revenue': 0.4233, 'unit': 'M', 'net_profit': 2.21}, {'period': ""Q4 '22"", 'revenue': 1.38, 'unit': 'M', 'net_profit': 5.75}, {'period': ""Q2 '22"", 'revenue': 0.00864, 'unit': 'M', 'net_profit': 2.09}, {'period': ""Q4 '21"", 'revenue': 2.08, 'unit': 'M', 'net_profit': -8.5}, {'period': ""Q2 '21"", 'revenue': 0.6519199999999999, 'unit': 'M', 'net_profit': 1.05}]",0.19,0.19,51313638,0,641709,2267719,43487,51226217,0,641709,0,-0.7907764380890229,-0.7907764380890229,-0.8318584070796461,"[0.2325, 0.0137]","['2024-12-31', '1994-12-23']",__nan__,0.044193300034583397
299,CUE,Cue Biopharma Inc. Common Stock,"Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 a CUE-100 series Immuno-STAT targeting the KRAS G12V mutation, including colorectal carcinoma, lung cancer, and pancreatic cancer; CUE-200 that focuses on cell surface receptors, including CD80 and/or 4-1BBL to address T cell exhaustion associated with chronic infections; and CUE-300 and CUE-400 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences for the development of Immuno-STATs focused on the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.","Mr. Daniel R. Passeri J.D., M.Sc.",Biotechnology,0.7812,USD,58863329,https://images.financialmodelingprep.com/symbol/CUE.png,199218,-1.08,0.0192,131833,-41500000,-40674000,"[{'period': '2024', 'revenue': 9.29, 'unit': 'M', 'net_profit': -40.67}, {'period': '2023', 'revenue': 5.49, 'unit': 'M', 'net_profit': -50.73}, {'period': '2022', 'revenue': 1.25, 'unit': 'M', 'net_profit': -52.8}, {'period': '2021', 'revenue': 14.94, 'unit': 'M', 'net_profit': -44.16}]","[{'period': ""Q4 '24"", 'revenue': 1.58, 'unit': 'M', 'net_profit': -9.5}, {'period': ""Q3 '24"", 'revenue': 3.34, 'unit': 'M', 'net_profit': -8.66}, {'period': ""Q2 '24"", 'revenue': 2.66, 'unit': 'M', 'net_profit': -10.17}, {'period': ""Q1 '24"", 'revenue': 1.72, 'unit': 'M', 'net_profit': -12.35}, {'period': ""Q4 '23"", 'revenue': 1.82, 'unit': 'M', 'net_profit': -13.43}, {'period': ""Q3 '23"", 'revenue': 2.1, 'unit': 'M', 'net_profit': -11.01}]",-0.72,-0.72,32191000,25138000,22459000,14692000,945000,0,13689000,22459000,-36395000,0.09884478415703987,0.1982733132280764,0.3513513513513514,__nan__,__nan__,__nan__,0.4564008573824982
300,CUEN,Cuentas Inc. Common Stock,"Cuentas Inc., together with its subsidiaries, provides mobile banking, online banking, prepaid debit, and digital content services to the unbanked, underbanked, and underserved communities in the United States and internationally. It offers prepaid voice, text, and data mobile phone services; and domestic and international long-distance voice, text, and data telephony services. The company also provides a mobile app and general-purpose reloadable card, which are integrated into a fintech ecosystem that protects customers by depositing their funds in an FDIC insured bank account. In addition, it offers financial services, which include direct ACH deposits, ATM access, retail and online purchases, peer to peer payments, cash reloads at various retailers, prepaid long distance telecom minutes, discounted gift cards for brands, and international and domestic mobile phone recharges. The company has strategic partnerships with Sutton Bank and Interactive Communications International, Inc. Cuentas Inc. is based in Miami, Florida.",Mr. Shalom Arik Maimon,Software - Application,0.0005,USD,1365,https://images.financialmodelingprep.com/symbol/CUEN.png,72,,-2.400000001252095e-11,69,-6094000,-2196000,"[{'period': '2023', 'revenue': 2.35, 'unit': 'M', 'net_profit': -2.2}, {'period': '2022', 'revenue': 2.99, 'unit': 'M', 'net_profit': -21.86}, {'period': '2021', 'revenue': 0.593, 'unit': 'M', 'net_profit': -11.01}, {'period': '2020', 'revenue': 0.558, 'unit': 'M', 'net_profit': -8.61}]","[{'period': ""Q1 '24"", 'revenue': 639.0, 'unit': 'K', 'net_profit': -445.0}, {'period': ""Q4 '23"", 'revenue': 1.35, 'unit': 'M', 'net_profit': 2.1}, {'period': ""Q3 '23"", 'revenue': 0.895, 'unit': 'M', 'net_profit': -1.19}, {'period': ""Q2 '23"", 'revenue': 0.04, 'unit': 'M', 'net_profit': -1.41}, {'period': ""Q1 '23"", 'revenue': 0.064, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q4 '22"", 'revenue': 0.787, 'unit': 'M', 'net_profit': -5.45}]",-0.95,-0.95,4720000,1760000,205000,4790000,1479000,2928000,4689000,205000,-4507000,0.43311627906976746,0.8995195607412492,0.946509009009009,__nan__,__nan__,__nan__,1.0148305084745763
301,CUENW,Cuentas Inc. Warrant,"Cuentas Inc., together with its subsidiaries, provides mobile, prepaid debit, and digital content services to the unbanked, underbanked, and underserved communities in the United States and internationally. It offers prepaid voice, text, and data mobile phone services; and domestic and international long-distance voice, text, and data telephony services. The company also provides a mobile app and general-purpose reloadable card, which are integrated into a fintech ecosystem that protects customers by depositing their funds in an FDIC insured bank account. In addition, it offers financial services, including direct ACH deposits, ATM access, retail and online purchases, peer to peer payments, cash reloads at various retailers, prepaid long distance telecom minutes, discounted gift cards for brands, and international and domestic mobile phone recharges. The company is based in Miami Beach, Florida.",Mr. Shalom Arik Maimon,Software - Application,0.001,USD,2687,https://images.financialmodelingprep.com/symbol/CUENW.png,0,0,0,21923,-6094000,-2196000,"[{'period': '2023', 'revenue': 2.35, 'unit': 'M', 'net_profit': -2.2}, {'period': '2022', 'revenue': 2.99, 'unit': 'M', 'net_profit': -21.86}, {'period': '2021', 'revenue': 0.593, 'unit': 'M', 'net_profit': -11.01}, {'period': '2020', 'revenue': 0.558, 'unit': 'M', 'net_profit': -8.61}]","[{'period': ""Q1 '24"", 'revenue': 639.0, 'unit': 'K', 'net_profit': -445.0}, {'period': ""Q4 '23"", 'revenue': 1.35, 'unit': 'M', 'net_profit': 2.1}, {'period': ""Q3 '23"", 'revenue': 0.895, 'unit': 'M', 'net_profit': -1.19}, {'period': ""Q2 '23"", 'revenue': 0.04, 'unit': 'M', 'net_profit': -1.41}, {'period': ""Q1 '23"", 'revenue': 0.064, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q4 '22"", 'revenue': 0.787, 'unit': 'M', 'net_profit': -5.45}]",-0.95,-0.95,4720000,1760000,205000,4790000,1479000,2928000,4689000,205000,-4507000,0.43311627906976746,0.8995195607412492,0.946509009009009,__nan__,__nan__,__nan__,1.0148305084745763
302,CURI,CuriosityStream Inc. Class A Common Stock,"CuriosityStream Inc. operates as a factual content streaming service and media company. The company provides premium video programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via the distributor's platform or system; and through bundled content licenses for SVoD and linear offerings, partner bulk sales, brand partnerships, and content sales. It offers streaming content through devices, including televisions, set-top boxes, computers, streaming media players, game consoles, and mobile devices. As of December 31, 2021, it had approximately 23 million total paying subscribers, including direct subscribers, partner direct subscribers, and bundled MVPD subscribers. The company was founded in 2015 and is based in Silver Spring, Maryland.",Mr. Clint  Stinchcomb,Broadcasting,3.05,USD,175759263,https://images.financialmodelingprep.com/symbol/CURI.png,292286,-12.71,-0.12,350773,-13333000,-12941000,"[{'period': '2024', 'revenue': 51.13, 'unit': 'M', 'net_profit': -12.94}, {'period': '2023', 'revenue': 56.89, 'unit': 'M', 'net_profit': -48.9}, {'period': '2022', 'revenue': 78.04, 'unit': 'M', 'net_profit': -50.92}, {'period': '2021', 'revenue': 71.26, 'unit': 'M', 'net_profit': -37.63}]","[{'period': ""Q4 '24"", 'revenue': 14.13, 'unit': 'M', 'net_profit': -2.81}, {'period': ""Q3 '24"", 'revenue': 12.6, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q2 '24"", 'revenue': 12.39, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q1 '24"", 'revenue': 12.0, 'unit': 'M', 'net_profit': -5.04}, {'period': ""Q4 '23"", 'revenue': 14.78, 'unit': 'M', 'net_profit': -4.66}, {'period': ""Q3 '23"", 'revenue': 15.63, 'unit': 'M', 'net_profit': -26.57}]",-0.24,-0.24,86182000,39518000,7826000,28334000,6103000,7463000,23863000,7826000,8151000,-5.349047619047619,0.7353362238219895,0.7391304347826088,"[0.04, 0.025]","['2025-03-14', '2024-04-11']",__nan__,0.32876934858787216
303,CURIW,CuriosityStream Inc. Warrant,"CuriosityStream, Inc. is a media and entertainment company. It offers video and audio programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The company was founded by John S. Hendricks on June 06, 2008 and is headquartered in Silver Spring, MD.",Mr. Clint  Stinchcomb,Broadcasting,0.021,USD,1210146,https://images.financialmodelingprep.com/symbol/CURIW.png,13355.9799,,0.001,20704,-13333000,-12941000,"[{'period': '2024', 'revenue': 51.13, 'unit': 'M', 'net_profit': -12.94}, {'period': '2023', 'revenue': 56.89, 'unit': 'M', 'net_profit': -48.9}, {'period': '2022', 'revenue': 78.04, 'unit': 'M', 'net_profit': -50.92}, {'period': '2021', 'revenue': 71.26, 'unit': 'M', 'net_profit': -37.63}]","[{'period': ""Q4 '24"", 'revenue': 14.13, 'unit': 'M', 'net_profit': -2.81}, {'period': ""Q3 '24"", 'revenue': 12.6, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q2 '24"", 'revenue': 12.39, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q1 '24"", 'revenue': 12.0, 'unit': 'M', 'net_profit': -5.04}, {'period': ""Q4 '23"", 'revenue': 14.78, 'unit': 'M', 'net_profit': -4.66}, {'period': ""Q3 '23"", 'revenue': 15.63, 'unit': 'M', 'net_profit': -26.57}]",-0.24,-0.24,86182000,39518000,7826000,28334000,6103000,7463000,23863000,7826000,8151000,-5.349047619047619,0.7353362238219895,0.7391304347826088,__nan__,__nan__,__nan__,0.32876934858787216
304,CUTR,Cutera Inc. Common Stock,"Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.",Mr. Taylor C. Harris,Medical - Devices,0.0969,USD,1956014,https://images.financialmodelingprep.com/symbol/CUTR.png,7632352,-0.013495821727019498,0,17512935,-140944000,-162833000,"[{'period': '2023', 'revenue': 212.37, 'unit': 'M', 'net_profit': -162.83}, {'period': '2022', 'revenue': 252.4, 'unit': 'M', 'net_profit': -82.34}, {'period': '2021', 'revenue': 231.27, 'unit': 'M', 'net_profit': 2.06}, {'period': '2020', 'revenue': 147.68, 'unit': 'M', 'net_profit': -23.88}]","[{'period': ""Q3 '24"", 'revenue': 32.5, 'unit': 'M', 'net_profit': -39.02}, {'period': ""Q2 '24"", 'revenue': 34.38, 'unit': 'M', 'net_profit': -24.68}, {'period': ""Q1 '24"", 'revenue': 38.79, 'unit': 'M', 'net_profit': -22.78}, {'period': ""Q4 '23"", 'revenue': 49.54, 'unit': 'M', 'net_profit': -45.23}, {'period': ""Q3 '23"", 'revenue': 46.48, 'unit': 'M', 'net_profit': -44.27}, {'period': ""Q2 '23"", 'revenue': 61.22, 'unit': 'M', 'net_profit': -31.64}]",-8.19,-8.19,346291000,269185000,143612000,518121000,49428000,0,87747000,143612000,-170880000,-1.1612205780878633,-0.9775686179256741,-0.8656036446469249,__nan__,__nan__,__nan__,1.4962011718467993
305,CVAC,CureVac N.V. Ordinary Shares,"CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.","Dr. Alexander  Zehnder M.B.A., M.D.",Biotechnology,3.21,USD,722750343,https://images.financialmodelingprep.com/symbol/CVAC.png,640945,3.91,0.09,438979,209690000,162186000,"[{'period': '2024', 'revenue': 535.18, 'unit': 'M', 'net_profit': 162.19}, {'period': '2023', 'revenue': 53.76, 'unit': 'M', 'net_profit': -260.17}, {'period': '2022', 'revenue': 67.42, 'unit': 'M', 'net_profit': -249.03}, {'period': '2021', 'revenue': 102.99, 'unit': 'M', 'net_profit': -411.72}]","[{'period': ""Q4 '24"", 'revenue': 14.47, 'unit': 'M', 'net_profit': -32.76}, {'period': ""Q3 '24"", 'revenue': 493.9, 'unit': 'M', 'net_profit': 338.04}, {'period': ""Q2 '24"", 'revenue': 14.44, 'unit': 'M', 'net_profit': -72.54}, {'period': ""Q1 '24"", 'revenue': 12.37, 'unit': 'M', 'net_profit': -70.55}, {'period': ""Q4 '23"", 'revenue': 21.99, 'unit': 'M', 'net_profit': -84.43}, {'period': ""Q3 '23"", 'revenue': 16.48, 'unit': 'M', 'net_profit': -48.68}]",0.7,0.7,802827000,526414000,485370000,106219000,32902000,0,72348000,481748000,83407000,1.8957665855013028,1.6233918982807196,1.5932203389830508,__nan__,__nan__,__nan__,0.13230621292009362
306,CVBF,CVB Financial Corporation Common Stock,"CVB Financial Corp. operates as a bank holding company for Citizens Business Bank, a state-chartered bank that provides banking and financial services to small to mid-sized businesses and individuals. It offers checking, savings, money market, and time certificates of deposit products for business and personal accounts; and serves as a federal tax depository for business customers. The company also provides commercial lending products comprising lines of credit and other working capital financing, accounts receivable lending, and letters of credit; agriculture loans to finance the operating needs of wholesale dairy farm operations, cattle feeders, livestock raisers, and farmers; lease financing services for municipal governments; commercial real estate and construction loans; and consumer financing products, including automobile leasing and financing, lines of credit, credit cards, home mortgages, and home equity loans and lines of credit. In addition, it offers various specialized services, such as treasury management systems for monitoring cash flow, merchant card processing program, armored pick-up and delivery, payroll services, remote deposit capture, electronic funds transfers, wires and automated clearinghouse, and online account access. Further, the company provides trust services through its CitizensTrust Division, such as fiduciary services, mutual funds, annuities, 401(k) plans, and individual investment accounts. As of December 31, 2021, it operated 58 banking centers located in the Inland Empire, Los Angeles County, Orange County, San Diego County, Ventura County, Santa Barbara County, and the Central Valley area of California; and three trust offices located in Ontario, Newport Beach, and Pasadena, as well as two loan production offices in California's Central Valley and the Sacramento area. The company was founded in 1974 and is headquartered in Ontario, California.",Mr. David A. Brager,Banks - Regional,17.72,USD,2464710240,https://images.financialmodelingprep.com/symbol/CVBF.png,823198,12.31,0.02,657536,0,200716000,"[{'period': '2024', 'revenue': 134.04, 'unit': 'M', 'net_profit': 200.72}, {'period': '2023', 'revenue': 547.32, 'unit': 'M', 'net_profit': 221.44}, {'period': '2022', 'revenue': 555.5, 'unit': 'M', 'net_profit': 235.43}, {'period': '2021', 'revenue': 461.94, 'unit': 'M', 'net_profit': 212.52}]","[{'period': ""Q4 '24"", 'revenue': 31.06, 'unit': 'M', 'net_profit': 50.86}, {'period': ""Q3 '24"", 'revenue': 117.28, 'unit': 'M', 'net_profit': 51.22}, {'period': ""Q2 '24"", 'revenue': 173.5, 'unit': 'M', 'net_profit': 50.03}, {'period': ""Q1 '24"", 'revenue': 171.8, 'unit': 'M', 'net_profit': 48.6}, {'period': ""Q4 '23"", 'revenue': 177.24, 'unit': 'M', 'net_profit': 48.51}, {'period': ""Q3 '23"", 'revenue': 137.68, 'unit': 'M', 'net_profit': 57.89}]",1.46,1.46,15153655000,2741706000,2695990000,12967339000,282803000,0,5047000,153875000,249765000,-1,-0.09356696095919796,-0.08176100628930824,"[0.2, 0.088]","['2025-04-02', '1992-03-31']",__nan__,0.8557235201672467
307,CVCO,Cavco Industries Inc. Common Stock When Issued,"Cavco Industries, Inc. designs, produces, and retails manufactured homes primarily in the United States. It operates in two segments, Factory-Built Housing and Financial Services. The company markets its manufactured homes under the Cavco, Fleetwood, Palm Harbor, Nationwide, Fairmont, Friendship, Chariot Eagle, Destiny, Commodore, Colony, Pennwest, R-Anell, Manorwood, and MidCountry brands. It also builds park model RVs; vacation cabins; and factory-built commercial structures, including apartment buildings, condominiums, hotels, workforce housing, schools, and housing for the United States military troops. In addition, the company produces various modular homes, which include single and multi-section ranch, split-level, and Cape Cod style homes, as well as two- and three-story homes, and multi-family units. Further, it provides conforming and non-conforming mortgages and home-only loans to purchasers of various brands of factory-built homes sold by company-owned retail stores, as well as various independent distributors, builders, communities, and developers. Additionally, the company offers property and casualty insurance to owners of manufactured homes. As of April 3, 2022, it operated 45 company-owned retail stores in Oregon, Arizona, Nevada, New Mexico, Texas, Indiana, Oklahoma, Florida, and New York. The company also distributes its homes through a network of independent distribution points in 48 states and Canada; and through planned community operators and residential developers. Cavco Industries, Inc. was founded in 1965 and is headquartered in Phoenix, Arizona.",Mr. William C. Boor C.F.A.,Residential Construction,461.47,USD,3697826946,https://images.financialmodelingprep.com/symbol/CVCO.png,65947,22.78,-16.28,41618,219354000,157817000,"[{'period': '2024', 'revenue': 1790.0, 'unit': 'M', 'net_profit': 157.82}, {'period': '2023', 'revenue': 2140.0, 'unit': 'M', 'net_profit': 240.55}, {'period': '2022', 'revenue': 1630.0, 'unit': 'M', 'net_profit': 197.7}, {'period': '2021', 'revenue': 1110.0, 'unit': 'M', 'net_profit': 76.65}]","[{'period': ""Q3 '25"", 'revenue': 522.04, 'unit': 'M', 'net_profit': 56.46}, {'period': ""Q2 '25"", 'revenue': 507.46, 'unit': 'M', 'net_profit': 43.81}, {'period': ""Q1 '25"", 'revenue': 477.6, 'unit': 'M', 'net_profit': 34.43}, {'period': ""Q4 '24"", 'revenue': 419.22, 'unit': 'M', 'net_profit': 33.93}, {'period': ""Q3 '24"", 'revenue': 446.77, 'unit': 'M', 'net_profit': 35.99}, {'period': ""Q2 '24"", 'revenue': 452.03, 'unit': 'M', 'net_profit': 41.54}]",18.55,18.37,1354160000,851799000,370957000,320749000,141152000,17316000,273267000,352687000,207261000,-0.30364251655545044,-0.34394356360733974,-0.3180147058823529,__nan__,__nan__,__nan__,0.23686196608967922
308,CVCY,Central Valley Community Bancorp Common Stock,"Central Valley Community Bancorp operates as the bank holding company for the Central Valley Community Bank that provides various commercial banking services to small and middle-market businesses and individuals in the central valley area of California. The company accepts demand, savings, and time deposits; certificates of deposit; and non-interest-bearing demand deposits, as well as provides NOW and money market accounts. Its loan products include commercial and industrial loans, as well as loans secured by crop production and livestock; owner occupied and investor commercial real estate, real estate construction and other land, agricultural real estate, and other real estate loans; and equity loans and lines of credit, and installment and other consumer loans. The company also offers domestic and international wire transfer, safe deposit box, Internet banking, and other customary banking services. As of December 31, 2021, the company operated through a network of 20 full-service banking offices in Cameron Park, Clovis, Exeter, Folsom, Fresno, Gold River, Kerman, Lodi, Madera, Merced, Modesto, Oakhurst, Prather, Roseville, Sacramento, Stockton, and Visalia. Central Valley Community Bancorp was founded in 1979 and is based in Fresno, California.",Mr. James J. Kim,Banks - Regional,19.89,USD,235332513,https://images.financialmodelingprep.com/symbol/CVCY.png,26440,9.165898617511521,0.44,34540,68000,25536000,"[{'period': '2023', 'revenue': 109.04, 'unit': 'M', 'net_profit': 25.54}, {'period': '2022', 'revenue': 83.34, 'unit': 'M', 'net_profit': 26.64}, {'period': '2021', 'revenue': 80.42, 'unit': 'M', 'net_profit': 28.4}, {'period': '2020', 'revenue': 76.75, 'unit': 'M', 'net_profit': 20.35}]","[{'period': ""Q1 '24"", 'revenue': 20.13, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q4 '23"", 'revenue': 27.72, 'unit': 'M', 'net_profit': 5.89}, {'period': ""Q3 '23"", 'revenue': 21.81, 'unit': 'M', 'net_profit': 6.39}, {'period': ""Q2 '23"", 'revenue': 21.55, 'unit': 'M', 'net_profit': 6.28}, {'period': ""Q1 '23"", 'revenue': 22.56, 'unit': 'M', 'net_profit': 6.97}, {'period': ""Q4 '22"", 'revenue': 22.66, 'unit': 'M', 'net_profit': 7.63}]",2.18,2.17,2437865000,64626000,-30017000,2230801000,0,30847000,1910945000,53728000,18046000,-0.9986116782360147,-0.04162131732032276,-0.039647577092510954,"[0.12, 0.1]","['2024-05-02', '2002-03-01']",__nan__,0.9150633853802405
309,CVET,Covetrus Inc. Common Stock,"Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.",Mr. Benjamin Wolin,Medical - Distribution,20.99,USD,0,https://images.financialmodelingprep.com/symbol/CVET.png,1216992,-69.96666666666667,0,5300387,178000000,-86000000,"[{'period': '2021', 'revenue': 4580.0, 'unit': 'M', 'net_profit': -86.0}, {'period': '2020', 'revenue': 4340.0, 'unit': 'M', 'net_profit': -19.0}, {'period': '2019', 'revenue': 3.98, 'unit': 'B', 'net_profit': -1.02}, {'period': '2018', 'revenue': 3780.0, 'unit': 'M', 'net_profit': 100.86}]","[{'period': ""Q2 '22"", 'revenue': 1220.0, 'unit': 'M', 'net_profit': -4.0}, {'period': ""Q1 '22"", 'revenue': 1150.0, 'unit': 'M', 'net_profit': -2.0}, {'period': ""Q4 '21"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q3 '21"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': -4.0}, {'period': ""Q2 '21"", 'revenue': 1190.0, 'unit': 'M', 'net_profit': -31.0}, {'period': ""Q1 '21"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': -16.0}]",-0.63,-0.63,3410000000,1351000000,183000000,1899000000,555000000,49000000,698000000,183000000,42000000,-0.15639810426540285,-3.526315789473684,-2.9374999999999996,__nan__,__nan__,__nan__,0.556891495601173
310,CVGI,Commercial Vehicle Group Inc. Common Stock,"Commercial Vehicle Group, Inc., together with its subsidiaries, designs, manufactures, produces, and sells components and assemblies in North America, Europe, and the Asia-Pacific regions. It operates in four segments: Vehicle Solutions, Warehouse Automation, Electrical Systems, and Aftermarket & Accessories. The company offers electrical wire harness assemblies that function as current carrying devices in providing electrical interconnections for gauges, lights, control functions, power circuits, powertrain and transmission sensors, emissions systems, and other electronic applications on commercial and other vehicles; and panel assemblies. It also offers electro-mechanical assemblies, such as box builds, complex automated and robotic assemblies, and large multi-cabinet control cabinets with power distribution and cabling; vinyl or cloth-covered appliqués, armrests, map pocket compartments, and sound-reducing insulations; instrument panels; and plastics decorating and finishing products. In addition, it provides cab structures; design products, including armrests, grab handles, storage systems, floor coverings, floor mats, sleeper bunks, headliners, wall panels, and privacy curtains; and mirrors, wipers, and controls used in commercial, military and specialty recreational vehicles. Further, it offers seats and seating systems, such as mechanical and air suspension, static and military seats, and bus, as well as seats for medium-and heavy-duty trucks (MD/HD trucks); office seating products; and seats, parts, and components for the aftermarket. The company supplies its products and systems for the commercial vehicle market comprising the MD/HD truck market; and MD/HD truck, bus, construction, mining, agricultural, military, industrial, municipal, off-road recreational, and specialty vehicle markets. Commercial Vehicle Group, Inc. was incorporated in 2000 and is headquartered in New Albany, Ohio.",Mr. James R. Ray Jr.,Auto - Parts,0.8333,USD,28747683,https://images.financialmodelingprep.com/symbol/CVGI.png,379206,-0.78,-0.0667,375024,18317000,-27867000,"[{'period': '2024', 'revenue': 723.36, 'unit': 'M', 'net_profit': -27.87}, {'period': '2023', 'revenue': 994.68, 'unit': 'M', 'net_profit': 49.41}, {'period': '2022', 'revenue': 981.55, 'unit': 'M', 'net_profit': -21.97}, {'period': '2021', 'revenue': 971.58, 'unit': 'M', 'net_profit': 23.73}]","[{'period': ""Q4 '24"", 'revenue': 163.29, 'unit': 'M', 'net_profit': -38.72}, {'period': ""Q3 '24"", 'revenue': 171.77, 'unit': 'M', 'net_profit': 9.51}, {'period': ""Q2 '24"", 'revenue': 229.91, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q1 '24"", 'revenue': 232.07, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q4 '23"", 'revenue': 223.09, 'unit': 'M', 'net_profit': 23.28}, {'period': ""Q3 '23"", 'revenue': 246.69, 'unit': 'M', 'net_profit': 7.29}]",-0.83,-0.83,424573000,303300000,26630000,288981000,118683000,0,125798000,26630000,-51972000,-0.7159934878672766,-1.563983728319605,-1.5533333333333335,__nan__,__nan__,__nan__,0.6806391362616088
311,CVGW,Calavo Growers Inc. Common Stock,"Calavo Growers, Inc. markets and distributes avocados, prepared avocados, and other perishable foods to retail grocery and foodservice customers, club stores, mass merchandisers, food distributors, and wholesale customers worldwide. It operates in three segments: Fresh Products, Calavo Foods, and Renaissance Food Group (RFG). The Fresh products segment distributes avocados and other fresh produce products comprising tomatoes and papayas; and procures avocados grown in California, Mexico, Peru, and Colombia. The Calavo Foods segment is involved in purchasing, processing, packaging, and distributing prepared avocado products, including guacamole and salsa. The RFG segment manufactures, markets, and distributes fresh-cut fruits and vegetables, fresh prepared entrée salads, wraps, sandwiches, and fresh snacking products, as well as ready-to-heat entrees, other hot bar and various deli items, meals kits and related components, and salad kits. The company offers its products under the Calavo and RFG brands, and related logos; and Avo Fresco, Bueno, Calavo Gold, Calavo Salsa Lisa, Salsa Lisa, Celebrate the Taste, El Dorado, Fresh Ripe, Select, Taste of Paradise, The First Name in Avocados, Tico, Mfresh, Maui Fresh International, Triggered Avocados, ProRipeVIP, RIPE NOW!, Garden Highway Fresh Cut, Garden Highway, and Garden Highway Chef Essentials trademarks. Calavo Growers, Inc. was founded in 1924 and is headquartered in Santa Paula, California.",Mr. Lecil E. Cole,Food Distribution,26.66,USD,475521303,https://images.financialmodelingprep.com/symbol/CVGW.png,192521,34.18,0.49,579322,23147000,-1076000,"[{'period': '2024', 'revenue': 661.54, 'unit': 'M', 'net_profit': -1.08}, {'period': '2023', 'revenue': 971.95, 'unit': 'M', 'net_profit': -8.34}, {'period': '2022', 'revenue': 1190.0, 'unit': 'M', 'net_profit': -6.04}, {'period': '2021', 'revenue': 1060.0, 'unit': 'M', 'net_profit': -10.2}]","[{'period': ""Q1 '25"", 'revenue': 154.38, 'unit': 'M', 'net_profit': 4.42}, {'period': ""Q4 '24"", 'revenue': 169960.0, 'unit': 'K', 'net_profit': -139.0}, {'period': ""Q3 '24"", 'revenue': 179600.0, 'unit': 'K', 'net_profit': -732.0}, {'period': ""Q2 '24"", 'revenue': 184.38, 'unit': 'M', 'net_profit': 6.06}, {'period': ""Q1 '24"", 'revenue': 127.61, 'unit': 'M', 'net_profit': -6.27}, {'period': ""Q4 '23"", 'revenue': 241.18, 'unit': 'M', 'net_profit': -7.91}]",-0.06,-0.06,301119000,158579000,57031000,99343000,41909000,2424000,73205000,57031000,21529000,0.2398628742835717,0.8710450623202302,0.8723404255319149,"[0.2, 0.2]","['2025-04-01', '2002-11-13']",__nan__,0.3299127587432211
312,CVLG,Covenant Logistics Group Inc. Class A Common Stock,"Covenant Logistics Group, Inc., together with its subsidiaries, provides transportation and logistics services in the United States. It operates through four segments: Expedited, Dedicated, Managed Freight, and Warehousing. The Expedited segment primarily provides truckload services with high service freight and delivery standards, such as 1,000 miles in 22 hours or 15-minute delivery windows. The Dedicated segment provides customers with committed truckload capacity over contracted periods using equipment either owned or leased by the company. The Managed Freight segment offers brokerage services, including logistics capacity by outsourcing the carriage of customers' freight to third parties; and transport management services, such as logistics services on a contractual basis to customers who prefer to outsource their logistics needs. The Warehousing segment provides day-to-day warehouse management services to customers. The segment also provides shuttle and switching services to shuttling containers and trailers. The company also engages in used equipment sales and leasing business. It serves transportation companies, such as parcel freight forwarders, less-than-truckload carriers, and third-party logistics providers; and traditional truckload customers, including manufacturers, retailers, and food and beverage shippers. As of December 31, 2021, it operated 2,291 tractors and 5,331 trailers. The company was formerly known as Covenant Transportation Group, Inc. and changed its name to Covenant Logistics Group, Inc. in July 2020. Covenant Logistics Group, Inc. was founded in 1986 and is based in Chattanooga, Tennessee.",Mr. David Ray Parker,Trucking,18.34,USD,489424926,https://images.financialmodelingprep.com/symbol/CVLG.png,112955,14.33,-0.09,223619,146002000,35921000,"[{'period': '2024', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 35.92}, {'period': '2023', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 55.23}, {'period': '2022', 'revenue': 1220.0, 'unit': 'M', 'net_profit': 108.68}, {'period': '2021', 'revenue': 1050.0, 'unit': 'M', 'net_profit': 60.73}]","[{'period': ""Q4 '24"", 'revenue': 277.33, 'unit': 'M', 'net_profit': 6.72}, {'period': ""Q3 '24"", 'revenue': 287.88, 'unit': 'M', 'net_profit': 13.03}, {'period': ""Q2 '24"", 'revenue': 287.5, 'unit': 'M', 'net_profit': 12.19}, {'period': ""Q1 '24"", 'revenue': 278.76, 'unit': 'M', 'net_profit': 3.97}, {'period': ""Q4 '23"", 'revenue': 273.99, 'unit': 'M', 'net_profit': 12.79}, {'period': ""Q3 '23"", 'revenue': 288.72, 'unit': 'M', 'net_profit': 13.51}]",1.37,1.3,997568000,213850000,35619000,559228000,152133000,0,131137000,35619000,122893000,-0.027625707625707627,-0.34959894258451174,-0.6761229314420804,"[0.07, 0.063]","['2025-03-07', '2022-03-03']",__nan__,0.5605913581831014
313,CVLT,Commvault Systems Inc. Common Stock,"Commvault Systems, Inc. provides data protection and information management software applications and related services in the United States and internationally. The company offers Commvault Backup and Recovery, a backup and recovery solution; Commvault Disaster Recovery, a replication and disaster recovery solution; and Commvault Complete Data Protection, a data protection solution. It also provides Commvault HyperScale X, an easy-to-deploy scale-out solution; Commvault Distributed Storage Platform that offers software-defined storage built on a hyperscale architecture; Metallic Cloud Storage service, which is the easy button to adopt secure and scalable cloud storage; and Metallic Software-as-a-Service. In addition, the company provides technology and business consulting, education, and remote managed services. Further, it sells appliances that integrate the software with hardware for use in a range of business needs and use cases; and offers professional and customer support services that include data management-as-a-service under the Metallic brand. The company sells its products and services directly through its sales force, and indirectly through its network of distributors, value-added resellers, systems integrators, corporate resellers, and original equipment manufacturers to large enterprises, small and medium sized businesses, and government agencies. It supports customers in a range of industries, including banking, insurance and financial services, government, healthcare, pharmaceuticals and medical services, technology, legal, manufacturing, utilities, and energy. Commvault Systems, Inc. was founded in 1988 and is headquartered in Tinton Falls, New Jersey.",Mr. Sanjay  Mirchandani,Software - Application,143.05,USD,6293857252,https://images.financialmodelingprep.com/symbol/CVLT.png,516570,37.64,-6.69,491131,90443000,168906000,"[{'period': '2024', 'revenue': 839.25, 'unit': 'M', 'net_profit': 168.91}, {'period': '2023', 'revenue': 784.59, 'unit': 'M', 'net_profit': -35.77}, {'period': '2022', 'revenue': 769.59, 'unit': 'M', 'net_profit': 33.62}, {'period': '2021', 'revenue': 723.47, 'unit': 'M', 'net_profit': -30.95}]","[{'period': ""Q3 '25"", 'revenue': 262.63, 'unit': 'M', 'net_profit': 11.02}, {'period': ""Q2 '25"", 'revenue': 233.28, 'unit': 'M', 'net_profit': 15.56}, {'period': ""Q1 '25"", 'revenue': 224.67, 'unit': 'M', 'net_profit': 18.53}, {'period': ""Q4 '24"", 'revenue': 223.29, 'unit': 'M', 'net_profit': 126.12}, {'period': ""Q3 '24"", 'revenue': 216.81, 'unit': 'M', 'net_profit': 17.14}, {'period': ""Q2 '24"", 'revenue': 201.0, 'unit': 'M', 'net_profit': 13.02}]",3.85,3.75,943913000,595126000,312754000,665828000,222683000,21789000,484928000,312754000,199712000,20.31717214865442,5.721473695980321,5.8125,__nan__,__nan__,__nan__,0.705391280764223
314,CVLY,Codorus Valley Bancorp Inc Common Stock,"Codorus Valley Bancorp, Inc. operates as the bank holding company for the PeoplesBank that provides community banking services. The company accepts demand, money market, time, and savings deposits, as well as certificates of deposit. It also offers commercial loans, such as builder and developer, commercial and residential real estate investor, hotel/motel, wholesale and retail, agriculture, manufacturing, and other loans; consume loans, including residential mortgage, home equity, and others. In addition, the company provides mortgage and wealth management services; and sells non-deposit investment products. It operates through twenty-five full service financial centers located in South Central Pennsylvania and Central Maryland. The company was founded in 1864 and is headquartered in York, Pennsylvania.",Mr. Craig L. Kauffman,Banks - Regional,24.04,USD,232283615,https://images.financialmodelingprep.com/symbol/CVLY.png,40614,10.452173913043477,1.14,565905,-3576000,24973000,"[{'period': '2023', 'revenue': 129.7, 'unit': 'M', 'net_profit': 24.97}, {'period': '2022', 'revenue': 1.64, 'unit': 'M', 'net_profit': 20.09}, {'period': '2021', 'revenue': 78.47, 'unit': 'M', 'net_profit': 14.66}, {'period': '2020', 'revenue': 76.35, 'unit': 'M', 'net_profit': 8.44}]","[{'period': ""Q1 '24"", 'revenue': 34.02, 'unit': 'M', 'net_profit': 4.25}, {'period': ""Q4 '23"", 'revenue': 34.18, 'unit': 'M', 'net_profit': 5.45}, {'period': ""Q3 '23"", 'revenue': 23.02, 'unit': 'M', 'net_profit': 5.92}, {'period': ""Q2 '23"", 'revenue': 23.52, 'unit': 'M', 'net_profit': 6.61}, {'period': ""Q1 '23"", 'revenue': 24.06, 'unit': 'M', 'net_profit': 6.99}, {'period': ""Q4 '22"", 'revenue': 0.519, 'unit': 'M', 'net_profit': 7.93}]",2.6,2.59,2197241000,42071000,-10882000,1997636000,0,15501000,1350206000,33691000,15562000,-1.0934413378625556,0.24293251045192116,0.2322274881516589,"[0.17, 0.13]","['2024-05-06', '1994-07-20']",__nan__,0.9091565285737887
315,CVV,CVD Equipment Corporation Common Stock,"CVD Equipment Corporation, together with its subsidiaries, designs, develops, manufactures, and sells process equipment and solutions that are used to develop and manufacture materials and coatings for research and industrial applications in the United States. It operates through three segments: CVD, SDC, and CVD Materials. The company offers chemical vapor deposition systems for use in the research, development, and manufacture of aerospace, medical components, semiconductors, LEDs, carbon nanotubes, nanowires, solar cells, and other industrial applications; and rapid thermal processing systems for use in implant activation, oxidation, silicide formation, and other processes. It also provides annealing, diffusion, and low pressure chemical vapor deposition furnaces for use in diffusion, oxidation, implant anneal, solder reflow, solar cell manufacturing, and other processes; and gas and liquid control systems, such as gas cylinder storage cabinets, custom gas and chemical delivery systems, gas and liquid valve manifold boxes, and gas isolation boxes for semiconductor fabrication processes, solar cells, LEDs, carbon nanotubes, nanowires, and industrial applications. In addition, the company offers standard and custom fabricated quartz-ware used in its equipment and other customer tools, as well as repair and replacement services for existing quartz-ware. Further, it provides MesoPlasma direct write printing, a materials deposition process that provides instrumentation, fine feature patterns, and coatings onto conformal components; and Tantaline corrosion resistant coating for valves, fittings, fasteners, vessels, bellows, and custom designed items, as well as offers carbon composites and electronic materials. The company sells its products primarily to aerospace/defense, medical, electronic component manufacturers, universities, and government and industrial laboratories. The company was incorporated in 1982 and is headquartered in Central Islip, New York.",Mr. Emmanuel N. Lakios,Industrial - Machinery,2.96,USD,20370240,https://images.financialmodelingprep.com/symbol/CVV.png,21362,-10.57,-0.11,17790,-1171000,-1898000,"[{'period': '2024', 'revenue': 26.88, 'unit': 'M', 'net_profit': -1.9}, {'period': '2023', 'revenue': 24.11, 'unit': 'M', 'net_profit': -4.18}, {'period': '2022', 'revenue': 25810.0, 'unit': 'K', 'net_profit': -224.0}, {'period': '2021', 'revenue': 16.45, 'unit': 'M', 'net_profit': 4.75}]","[{'period': ""Q4 '24"", 'revenue': 7410.0, 'unit': 'K', 'net_profit': 132.0}, {'period': ""Q3 '24"", 'revenue': 8189.999999999999, 'unit': 'K', 'net_profit': 203.0}, {'period': ""Q2 '24"", 'revenue': 6340.0, 'unit': 'K', 'net_profit': -761.0}, {'period': ""Q1 '24"", 'revenue': 4.92, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q4 '23"", 'revenue': 4.11, 'unit': 'M', 'net_profit': -2.27}, {'period': ""Q3 '23"", 'revenue': 6230.0, 'unit': 'K', 'net_profit': -753.0}]",-0.28,-0.28,31686000,19986000,12598000,0,4375000,0,6137000,12598000,-1595000,0.6534477656111276,0.5459329057255755,0.5483870967741935,__nan__,__nan__,__nan__,0.0
316,CWBC,Community West Bancshares Common Stock,"Community West Bancshares operates as the bank holding company for Community West Bank, N.A. that provides various financial products and services in California. The company offers deposit products, such as checking accounts, savings accounts, money market accounts, and fixed rate and fixed maturity certificates of deposit; and cash management products. It also provides commercial, commercial real estate, consumer, manufactured housing, and small business administration loans, as well as agricultural loans for real estate and operating lines; home equity lines of credit collateralized by residential real estate; single family real estate loans; and installment loans consisting of automobile and general-purpose loans. The company serves small to medium-sized businesses and their owners, professionals, high-net worth individuals, and non-profit organizations. It operates through a network of seven branch banking offices in Goleta, Santa Barbara, Santa Maria, Ventura, San Luis Obispo, Oxnard, and Paso Robles. Community West Bancshares was founded in 1989 and is headquartered in Goleta, California.",Mr. James J. Kim,Banks - Regional,15.98,USD,304594780,https://images.financialmodelingprep.com/symbol/CWBC.png,49359,35.51,-0.05,33921,0,7666000,"[{'period': '2024', 'revenue': 114.17, 'unit': 'M', 'net_profit': 7.67}, {'period': '2023', 'revenue': 57.52, 'unit': 'M', 'net_profit': 25.54}, {'period': '2022', 'revenue': 49.79, 'unit': 'M', 'net_profit': 13.45}, {'period': '2021', 'revenue': 46.13, 'unit': 'M', 'net_profit': 13.1}]","[{'period': ""Q4 '24"", 'revenue': 33.35, 'unit': 'M', 'net_profit': 6.89}, {'period': ""Q3 '24"", 'revenue': 30.51, 'unit': 'M', 'net_profit': 3.38}, {'period': ""Q2 '24"", 'revenue': 45.4, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q1 '24"", 'revenue': 27.26, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q4 '23"", 'revenue': 15550.0, 'unit': 'K', 'net_profit': 479.0}, {'period': ""Q3 '23"", 'revenue': 11.6, 'unit': 'M', 'net_profit': 2.25}]",0.41,0.41,3521771000,423813000,423813000,3159086000,0,785058000,0,120398000,17163000,0,-0.699796365914787,-0.8119266055045872,"[0.12, 0.176]","['2025-02-07', '1998-12-31']",__nan__,0.8970163023092643
317,CWBR,CohBar Inc. Common Stock,"CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.","Dr. Pinchas  Cohen Dean, M.D., Ph.D.",Biotechnology,0.41,USD,1191841,https://images.financialmodelingprep.com/symbol/CWBR.png,3044,-0.09382151029748284,0,172,-12289050,-11962119,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.96}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.41}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.63}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.65}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.33}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.8}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.39}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.72}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.26}]",-4.13,-4.12,16365667,16218503,15737322,1033638,27500,0,1033638,5930731,-10446492,0.20214325174287393,0.22364540223458357,0.40489913544668593,__nan__,__nan__,__nan__,0.06315892899446139
318,CWCO,Consolidated Water Co. Ltd. Ordinary Shares,"Consolidated Water Co. Ltd., together with its subsidiaries, designs, constructs, manages, and operates water production and water treatment plants primarily in the Cayman Islands, the Bahamas, and the United States. The company operates through four segments: Retail, Bulk, Services, and Manufacturing. It uses reverse osmosis technology to produce potable water from seawater. The company produces and supplies water to end-users, including residential, commercial, and government customers, as well as government-owned distributors. It also provides design, engineering, construction, procurement, and management services for desalination projects and water treatment plants, as well as management and engineering services relating to municipal water distribution and treatment. In addition, the company manufactures and services a range of water-related products, including reverse osmosis desalination equipment, membrane separation equipment, filtration equipment, piping systems, vessels, and custom fabricated components; and provides design, engineering, consulting, management, inspection, training, and equipment maintenance services for commercial, municipal, and industrial water production, supply, and treatment, as well as desalination and wastewater treatment. Consolidated Water Co. Ltd. was incorporated in 1973 and is headquartered in Grand Cayman, the Cayman Islands.",Mr. Frederick W. McTaggart,Regulated Water,23.69,USD,376074012,https://images.financialmodelingprep.com/symbol/CWCO.png,136072,21.15,-0.54,97037,18284798000000,28237554,"[{'period': '2024', 'revenue': 133970000.0, 'unit': 'M', 'net_profit': 28.24}, {'period': '2023', 'revenue': 180.21, 'unit': 'M', 'net_profit': 29.59}, {'period': '2022', 'revenue': 94.1, 'unit': 'M', 'net_profit': 9.34}, {'period': '2021', 'revenue': 66.86, 'unit': 'M', 'net_profit': 4.08}]","[{'period': ""Q4 '24"", 'revenue': 133.97, 'unit': 'T', 'net_profit': 28.24}, {'period': ""Q3 '24"", 'revenue': 33.39, 'unit': 'M', 'net_profit': 4.45}, {'period': ""Q2 '24"", 'revenue': 32.48, 'unit': 'M', 'net_profit': 15.85}, {'period': ""Q1 '24"", 'revenue': 39.69, 'unit': 'M', 'net_profit': 6.47}, {'period': ""Q4 '23"", 'revenue': 53.25, 'unit': 'M', 'net_profit': 9.84}, {'period': ""Q3 '23"", 'revenue': 49.85, 'unit': 'M', 'net_profit': 8.61}]",1.78,1.77,243313181000000,157788165000000,99350121000000,28003534000000,44051225,0,24938509000000,99350121,31475456000000,408893.1646546548,-0.04555751857394753,-0.05319148936170206,"[0.11, 0.06]","['2025-04-01', '1996-09-26']",__nan__,0.11509254815093639
319,CWST,Casella Waste Systems Inc. Class A Common Stock,"Casella Waste Systems, Inc., together with its subsidiaries, operates as a vertically integrated solid waste services company in the northeastern United States. It offers resource management services primarily in the areas of solid waste collection and disposal, transfer, recycling, and organics services to residential, commercial, municipal, institutional, and industrial customers. The company provides a range of non-hazardous solid waste services, including collections, transfer stations, and disposal facilities. It also markets recyclable metals, aluminum, plastics, and paper and corrugated cardboard that are processed at its facilities, as well as recyclables purchased from third parties. In addition, the company is involved in commodity brokerage operations. As of January 31, 2022, it owned and/or operated 50 solid waste collection operations, 65 transfer stations, 23 recycling facilities, 8 Subtitle D landfills, 3 landfill gas-to-energy facilities, and 1 landfill permitted to accept construction and demolition materials. Casella Waste Systems, Inc. was founded in 1975 and is headquartered in Rutland, Vermont.",Mr. Jeffrey A. Stein,Waste Management,114.675,USD,7152311171,https://images.financialmodelingprep.com/symbol/CWST.png,472981,521.25,-3.625,384672,318366000,13536000,"[{'period': '2024', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 13.54}, {'period': '2023', 'revenue': 1260.0, 'unit': 'M', 'net_profit': 25.4}, {'period': '2022', 'revenue': 1090.0, 'unit': 'M', 'net_profit': 53.08}, {'period': '2021', 'revenue': 889.21, 'unit': 'M', 'net_profit': 41.1}]","[{'period': ""Q4 '24"", 'revenue': 427.49, 'unit': 'M', 'net_profit': 4.88}, {'period': ""Q3 '24"", 'revenue': 411.63, 'unit': 'M', 'net_profit': 5.77}, {'period': ""Q2 '24"", 'revenue': 377.16, 'unit': 'M', 'net_profit': 7.01}, {'period': ""Q1 '24"", 'revenue': 341.01, 'unit': 'M', 'net_profit': -4.12}, {'period': ""Q4 '23"", 'revenue': 359.57, 'unit': 'M', 'net_profit': -1.81}, {'period': ""Q3 '23"", 'revenue': 352.74, 'unit': 'M', 'net_profit': 18.17}]",0.23,0.23,3230068000,393516000,383303000,1679229000,0,10967000,307317000000,383303000,77848000,0.16119925593609805,-0.46706563250521677,-0.5,__nan__,__nan__,__nan__,0.5198741945989992
320,CXDC,China XD Plastics Company Limited Common Stock,"China XD Plastics Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of modified plastics primarily for automotive applications in the People's Republic of China, and Dubai, the United Arab Emirates. Its modified plastics are used to fabricate various auto components, including exteriors consisting of automobile bumpers, rearview and sideview mirrors, and license plate parts; interiors, such as door panels, steering wheels, dashboards, glove compartments, and safety belt components; and functional components comprising air conditioner casings, heating and ventilation casings, engine covers, and air ducts. The company also offers engineered plastics and environment-friendly plastics for use in oilfield equipment, mining equipment, vessel propulsion systems, and power station equipment; and polymer composite materials. Its products are also used in high-speed railways, airplanes, ships, and electronic appliances. The company sells its products through distributors, as well as directly to end customers. China XD Plastics Company Limited was founded in 1985 and is headquartered in Harbin, the People's Republic of China.",Mr. Jie  Han,Chemicals - Specialty,0.0024,USD,0,https://images.financialmodelingprep.com/symbol/CXDC.png,5791,0,0,60,-196101414,-181700885,"[{'period': '2020', 'revenue': 1310.0, 'unit': 'M', 'net_profit': -181.7}, {'period': '2019', 'revenue': 1450.0, 'unit': 'M', 'net_profit': 3.06}, {'period': '2018', 'revenue': 1270.0, 'unit': 'M', 'net_profit': 68.31}, {'period': '2017', 'revenue': 1290.0, 'unit': 'M', 'net_profit': 31.62}]","[{'period': ""Q4 '20"", 'revenue': 593.79, 'unit': 'M', 'net_profit': -150.01}, {'period': ""Q3 '20"", 'revenue': 290.05, 'unit': 'M', 'net_profit': -38.23}, {'period': ""Q2 '20"", 'revenue': 283.22, 'unit': 'M', 'net_profit': 17.58}, {'period': ""Q1 '20"", 'revenue': 144.84, 'unit': 'M', 'net_profit': -11.04}, {'period': ""Q4 '19"", 'revenue': 310.51, 'unit': 'M', 'net_profit': -65.0}, {'period': ""Q3 '19"", 'revenue': 373.16, 'unit': 'M', 'net_profit': 16.97}]",-2.68,-2.68,2923926000,1344760833,78261679,2156711763,423946875,0,1230282394,78261679,-3031485,-2.35244266556872,-60.467253568836036,-54.599999999999994,__nan__,__nan__,__nan__,0.7376081894685433
321,CXDO,Crexendo Inc. Common Stock,"Crexendo, Inc. provides cloud communication, unified communications as a service, call center, collaboration, and other cloud business services for businesses in the United States, Canada, and internationally. It operates through two segments, Cloud Telecommunications and Web Services. The Cloud Telecommunications segment provides telecommunications services that transmit calls using Internet protocol (IP) or cloud technology, which converts voice signals into digital data packets for transmission over the Internet or cloud; and resells broadband Internet services. This segment is also involved in the sale and lease of cloud telecommunications equipment. In addition, it offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over high-speed internet connection through various devices and user interfaces, such as desktop phones and/or mobile, and desktop applications under the Crexendo brand name. The Web Services segment provides website hosting and other professional services. The company was formerly known as iMergent, Inc. and changed its name to Crexendo, Inc. in May 2011. Crexendo, Inc. was incorporated in 1995 and is headquartered in Tempe, Arizona.",Mr. Jeffrey G. Korn,Telecommunications Services,4.17,USD,116347470,https://images.financialmodelingprep.com/symbol/CXDO.png,194667,69.5,-0.28,110914,1824000,1677000,"[{'period': '2024', 'revenue': 60.84, 'unit': 'M', 'net_profit': 1.68}, {'period': '2023', 'revenue': 53200.0, 'unit': 'K', 'net_profit': -362.0}, {'period': '2022', 'revenue': 37.55, 'unit': 'M', 'net_profit': -35.41}, {'period': '2021', 'revenue': 28.09, 'unit': 'M', 'net_profit': -2.44}]","[{'period': ""Q4 '24"", 'revenue': 16239.999999999998, 'unit': 'K', 'net_profit': 507.0}, {'period': ""Q3 '24"", 'revenue': 15630.0, 'unit': 'K', 'net_profit': 148.0}, {'period': ""Q2 '24"", 'revenue': 14690.0, 'unit': 'K', 'net_profit': 588.0}, {'period': ""Q1 '24"", 'revenue': 14290.0, 'unit': 'K', 'net_profit': 434.0}, {'period': ""Q4 '23"", 'revenue': 14160.0, 'unit': 'K', 'net_profit': 61.0}, {'period': ""Q3 '23"", 'revenue': 13.87, 'unit': 'M', 'net_profit': 1.7}]",0.0627,0.0559,64938000,26882000,18193000,13525000,5476000,0,12094000,18193000,6257000,-0.4668225665010231,5.632596685082873,5.478571428571429,"[0.005, 0.005]","['2023-03-30', '2022-02-17']",__nan__,0.20827558594351536
322,CYAD,Celyad Oncology SA American Depositary Shares,"Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. The company's preclinical candidate includes CYAD-203, a non-gene edited allogeneic CAR-T candidate to co-express the cytokine interleukin-18 with natural killer group 2D ligands (NKG2D) for the treatment of solid tumors. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA technology to generate second non-gene-edited allogeneic platform. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.",Dr. Georges  Rawadi,Biotechnology,0.47,USD,14238462,https://images.financialmodelingprep.com/symbol/CYAD.png,18057,-0.3197278911564626,-0.07,48998,-7763000,-8448000,"[{'period': '2023', 'revenue': 0.10200000000000001, 'unit': 'M', 'net_profit': -8.45}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.94}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.51}, {'period': '2020', 'revenue': 0.005, 'unit': 'M', 'net_profit': -17.5}]","[{'period': ""Q2 '24"", 'revenue': 0.014, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q4 '23"", 'revenue': 0.058, 'unit': 'M', 'net_profit': -4.71}, {'period': ""Q2 '23"", 'revenue': 0.044, 'unit': 'M', 'net_profit': -3.74}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.88}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.37}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.53}]",-0.33,-0.33,16282000,11121000,7004000,9978000,380000,0,2932000,7004000,-16101000,0.26456329658300104,-0.5440178032589016,-0.06470588235294124,__nan__,__nan__,__nan__,0.612823977398354
323,CYAN,Cyanotech Corporation Common Stock,"Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.",Mr. Matthew Keith Custer,Packaged Foods,0.29,USD,2075199,https://images.financialmodelingprep.com/symbol/CYAN.png,5704,-0.43,-0.002,302,-2511000,-5267000,"[{'period': '2023', 'revenue': 23.07, 'unit': 'M', 'net_profit': -5.27}, {'period': '2022', 'revenue': 23.18, 'unit': 'M', 'net_profit': -3.44}, {'period': '2021', 'revenue': 35.97, 'unit': 'M', 'net_profit': 2.15}, {'period': '2020', 'revenue': 32340.000000000004, 'unit': 'K', 'net_profit': 920.0}]","[{'period': ""Q3 '24"", 'revenue': 6170.0, 'unit': 'K', 'net_profit': -224.0}, {'period': ""Q2 '24"", 'revenue': 5.84, 'unit': 'M', 'net_profit': -1.15}, {'period': ""Q1 '24"", 'revenue': 5.9, 'unit': 'M', 'net_profit': -1.2}, {'period': ""Q4 '23"", 'revenue': 5.97, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q3 '23"", 'revenue': 5.58, 'unit': 'M', 'net_profit': -1.02}, {'period': ""Q2 '23"", 'revenue': 6370.0, 'unit': 'K', 'net_profit': -797.0}]",-0.81,-0.81,25112000,10591000,707000,13298000,2102000,0,8554000,707000,-836000,-2.0436363636363635,-0.5311046511627907,-0.4727272727272727,__nan__,__nan__,__nan__,0.5295476266326856
324,CYBE,CyberOptics Corporation Common Stock,"CyberOptics Corporation designs, develops, manufactures, and markets high precision sensing technology solutions and system products for inspection and metrology worldwide. It offers products based on multi-reflection suppression (MRS) technology, including multi-function systems for inspection and metrology; MX3000 memory module inspection system; 3D NanoResolution MRS sensor and WX3000 inspection and metrology system for semiconductor wafer and advanced packaging inspection and metrology; high precision 3D and 2D sensors; 3D MRS sensors; SMT electronic assembly alignment sensors; and inspection and metrology systems. The company also provides automated optical inspection (AOI) products; SQ3000 multi-function systems; QX Series 2D AOI products; MX products for inspection of memory modules; SPI Products; and semiconductor wafer and advanced packaging products. In addition, it offers general industrial metrology products and services, such as CyberGage360, a near-line or off-line metrology tool; and 3D scanning and metrology equipment, as well as semiconductor, automatic leveling, automatic gapping, automatic teaching, automatic vibration, WaferSense airborne particle, in-line particle, WaferSense auto multi, WaferSense 300mm auto resistance, and WaferSense auto vibration and leveling sensors. The company sells its products to SMT electronic assembly circuit board manufacturers, end-user customers manufacturing their own circuit boards, semiconductor manufacturers, and outsourced semiconductor assembly and test companies through independent sales representatives and distributors. CyberOptics Corporation was founded in 1984 and is headquartered in Minneapolis, Minnesota.",Dr. Subodh Kulkarni,Semiconductors,54,USD,0,https://images.financialmodelingprep.com/symbol/CYBE.png,155275,25.352112676056336,0,260186,14495000,12751000,"[{'period': '2021', 'revenue': 92.77, 'unit': 'M', 'net_profit': 12.75}, {'period': '2020', 'revenue': 70.12, 'unit': 'M', 'net_profit': 5.74}, {'period': '2019', 'revenue': 59260.0, 'unit': 'K', 'net_profit': 774.0}, {'period': '2018', 'revenue': 64.72, 'unit': 'M', 'net_profit': 2.83}]","[{'period': ""Q2 '22"", 'revenue': 27.57, 'unit': 'M', 'net_profit': 4.39}, {'period': ""Q1 '22"", 'revenue': 24.25, 'unit': 'M', 'net_profit': 3.59}, {'period': ""Q4 '21"", 'revenue': 22.08, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q3 '21"", 'revenue': 27.76, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q2 '21"", 'revenue': 25.2, 'unit': 'M', 'net_profit': 3.11}, {'period': ""Q1 '21"", 'revenue': 17.73, 'unit': 'M', 'net_profit': 1.44}]",1.69,1.69,98022000,70106000,21011000,18916000,19821000,17281000,16156000,13684000,10089000,1.4170418542604635,1.2206548241031,1.1948051948051948,__nan__,__nan__,__nan__,0.19297708677643793
325,CYBR,CyberArk Software Ltd. Ordinary Shares,"CyberArk Software Ltd., together with its subsidiaries, develops, markets, and sales software-based security solutions and services in the United States, Europe, the Middle East, Africa, and internationally. Its solutions include Privileged Access Manager that offers risk-based credential security and session management to protect against attacks involving privileged access; Vendor Privileged Access Manager combines Privileged Access Manager and Remote Access to provide fast, easy, and secure privileged access to third-party vendors; Endpoint Privilege Manager, a SaaS solution that secures privileges on the endpoint; and Cloud Entitlements Manager, a SaaS solution, which reduces risk that arises from excessive privileges by implementing least privilege across cloud environments. The company also offers robust Identity and Access Management as a Services, such as workforce identity, which offers adaptive multi-factor authentication (MFA), single sign-on, secure Web sessions, application gateway, identity lifecycle management, and directory services; and customer identity services that provides authentication and authorization services, MFA, directory, and user management to enable organizations to provide their customers with easy and secure access to websites and applications. In addition, it offers Secrets Manager Credential Providers to provide and manage the credentials used by third-party solutions; and Secrets Manager Conjur for cloud-native applications. The company provides its products to financial services, manufacturing, insurance, healthcare, energy and utilities, transportation, retail, technology, and telecommunications industries; and government agencies through direct sales force, as well as distributors, systems integrators, value-added resellers, and managed security service providers. CyberArk Software Ltd. was founded in 1999 and is headquartered in Petah Tikva, Israel.",Mr. Matthew Lessner Cohen,Software - Infrastructure,312.9,USD,15475631611,https://images.financialmodelingprep.com/symbol/CYBR.png,688427,-147.59,-12.94,376586,26017000,-93461000,"[{'period': '2024', 'revenue': 1000.0, 'unit': 'M', 'net_profit': -93.46}, {'period': '2023', 'revenue': 751.89, 'unit': 'M', 'net_profit': -66.5}, {'period': '2022', 'revenue': 591.71, 'unit': 'M', 'net_profit': -130.37}, {'period': '2021', 'revenue': 502.92, 'unit': 'M', 'net_profit': -83.95}]","[{'period': ""Q4 '24"", 'revenue': 314.38, 'unit': 'M', 'net_profit': -97.12}, {'period': ""Q3 '24"", 'revenue': 240.1, 'unit': 'M', 'net_profit': 11.11}, {'period': ""Q2 '24"", 'revenue': 224.71, 'unit': 'M', 'net_profit': -12.92}, {'period': ""Q1 '24"", 'revenue': 221.55, 'unit': 'M', 'net_profit': 5.47}, {'period': ""Q4 '23"", 'revenue': 223.1, 'unit': 'M', 'net_profit': 8.91}, {'period': ""Q3 '23"", 'revenue': 191.24, 'unit': 'M', 'net_profit': -14.61}]",-2.12,-2.12,3348395000,1193533000,819776000,978591000,328465000,21345000,807431000,526467000,220828000,1.5943889790043637,-0.4053440394562733,-0.325,__nan__,__nan__,__nan__,0.29225673792966483
326,CYCC,Cyclacel Pharmaceuticals Inc. Common Stock,"Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. Its development programs also comprise Sapacitabine, a novel nucleoside analog that is orally available prodrug of CNDAC, which is in Phase 1/2 clinical trials to treat acute myeloid leukemia and myelodysplastic syndrome; and seliciclib, a CDK inhibitor that is in Phase 2 investigator-sponsored trials (IST) for Cushing's disease, as well as in Phase 1/2 IST for the treatment for advanced rheumatoid arthritis. The company has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey.",Dr. Sing Ee Wong,Biotechnology,0.2111,USD,2376163,https://images.financialmodelingprep.com/symbol/CYCC.png,309840,-0.1,-0.015,113623,-11998000,-11212000,"[{'period': '2024', 'revenue': 0.043000000000000003, 'unit': 'M', 'net_profit': -11.21}, {'period': '2023', 'revenue': 0.42, 'unit': 'M', 'net_profit': -22.55}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.2}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.89}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.05}, {'period': ""Q3 '24"", 'revenue': 10.0, 'unit': 'K', 'net_profit': -1.96}, {'period': ""Q2 '24"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -3.26}, {'period': ""Q1 '24"", 'revenue': 0.029, 'unit': 'M', 'net_profit': -2.95}, {'period': ""Q4 '23"", 'revenue': 0.031, 'unit': 'M', 'net_profit': -5.27}, {'period': ""Q3 '23"", 'revenue': 0.016, 'unit': 'M', 'net_profit': -6.1}]",-5.21,-5.21,4094000,3674000,3137000,6268000,237000,0,6268000,3137000,-7990000,0.5280465738336874,0.5029040124140989,0.8052336448598131,"[0.0005, 0.0005]","['2016-07-13', '2016-07-13']",__nan__,1.5310210063507572
327,CYCCP,Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock,"Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. Its development programs also comprise Sapacitabine, a novel nucleoside analog that is orally available prodrug of CNDAC, which is in Phase 1/2 clinical trials to treat acute myeloid leukemia and myelodysplastic syndrome; and seliciclib, a CDK inhibitor that is in Phase 2 investigator-sponsored trials (IST) for Cushing's disease, as well as in Phase 1/2 IST for the treatment for advanced rheumatoid arthritis. The company has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey.",Dr. Sing Ee Wong,Biotechnology,4.88,USD,46878759,https://images.financialmodelingprep.com/symbol/CYCCP.png,5731,-2.38,0.33,1511,-11998000,-11212000,"[{'period': '2024', 'revenue': 0.043000000000000003, 'unit': 'M', 'net_profit': -11.21}, {'period': '2023', 'revenue': 0.42, 'unit': 'M', 'net_profit': -22.55}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.2}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.89}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.05}, {'period': ""Q3 '24"", 'revenue': 10.0, 'unit': 'K', 'net_profit': -1.96}, {'period': ""Q2 '24"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -3.26}, {'period': ""Q1 '24"", 'revenue': 0.029, 'unit': 'M', 'net_profit': -2.95}, {'period': ""Q4 '23"", 'revenue': 0.031, 'unit': 'M', 'net_profit': -5.27}, {'period': ""Q3 '23"", 'revenue': 0.016, 'unit': 'M', 'net_profit': -6.1}]",-5.21,-5.21,4094000,3674000,3137000,6268000,237000,0,6268000,3137000,-7990000,0.5280465738336874,0.5029040124140989,0.8052336448598131,"[0.15, 0.0125]","['2024-01-19', '2006-01-18']",__nan__,1.5310210063507572
328,CYCN,Cyclerion Therapeutics Inc. Common Stock,"Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's disease with vascular pathology; and Phase 1 trials diagnosed with schizophrenia in adults. It is also developing Praliciguat, an orally administered systemic sGC stimulator, which is in Phase II studies to treat resistant hypertension and diabetic nephropathy; Olinciguat, an orally administered vascular sGC stimulator that is in Phase II studies for the sickle cell disease; and CY3018 for the treatment of disorders of the CNS. It has license agreement with Akebia Therapeutics, Inc. for the development, manufacture, medical affairs, and commercialization of pharmaceutical products, including pharmaceutical compound, and other related products and forms. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.",Dr. Regina  Graul Ph.D.,Biotechnology,2.7,USD,7317259,https://images.financialmodelingprep.com/symbol/CYCN.png,1930055,-2.23,-0.05,2499,-3628000,-3057000,"[{'period': '2024', 'revenue': 2.0, 'unit': 'M', 'net_profit': -3.06}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.02}, {'period': '2022', 'revenue': 0.297, 'unit': 'M', 'net_profit': -43.78}, {'period': '2021', 'revenue': 3.32, 'unit': 'M', 'net_profit': -51.66}]","[{'period': ""Q4 '24"", 'revenue': 1810.0, 'unit': 'K', 'net_profit': 530.0}, {'period': ""Q3 '24"", 'revenue': 194.0, 'unit': 'K', 'net_profit': -723.0}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.32}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.54}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.69}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.57}]",-1.21,-1.21,9575000,4225000,3232000,725000,556000,5350000,725000,3232000,-4333000,0.7119034384181688,0.8545324768022841,0.8654060066740823,__nan__,__nan__,__nan__,0.07571801566579635
329,CYRN,CYREN Ltd. Ordinary Shares,"Cyren Ltd., together with its subsidiaries, provides cloud delivered Software-as-a-Service (SaaS) cybersecurity solutions that protect businesses, their employees, and customers against threats from email, files, and the web. It provides Cyren threat detection services, which include email security engine that offers anti-spam inbound and outbound, IP reputation, and virus outbreak detection services; malware detection engine that is used to protect email applications; Web security engine, which is used by customers to provide URL classification for web browser filtering and safe search capabilities; and threat analysis services to detect advanced cyber threats. The company also provides Cyren threat intelligence data products, which include real-time phishing intelligence, malware file intelligence, IP reputation intelligence, malware URL intelligence, and Zombie host intelligence for threat detection, threat hunting, and incident response. In addition, it offers Cyren enterprise email security products, including Cyren Email Security, a cloud-based secure email gateway; and Cyren Inbox Security, an anti-phishing and remediation product for Microsoft 365. The company sells its products through direct and indirect channels, including distributors, value added resellers, and managed service providers to enterprise customers and original equipment manufacturers. It has operations in the United States, Germany, other European countries, the Asia Pacific, Israel, and internationally. The company was formerly known as Commtouch Software Ltd. and changed its name to Cyren Ltd. in January 2014. Cyren Ltd. was incorporated in 1991 and is based in Herzliya, Israel.",Mr. Brett M. Jackson,Software - Infrastructure,0.2182,USD,1745559,https://images.financialmodelingprep.com/symbol/CYRN.png,1035629,-0.02936742934051144,0,1013508,-16737000,-23039000,"[{'period': '2021', 'revenue': 31.19, 'unit': 'M', 'net_profit': -23.04}, {'period': '2020', 'revenue': 36.39, 'unit': 'M', 'net_profit': -17.26}, {'period': '2019', 'revenue': 38.39, 'unit': 'M', 'net_profit': -18.02}, {'period': '2018', 'revenue': 35.9, 'unit': 'M', 'net_profit': -19.41}]","[{'period': ""Q3 '22"", 'revenue': 5.62, 'unit': 'M', 'net_profit': -6.12}, {'period': ""Q2 '22"", 'revenue': 5.75, 'unit': 'M', 'net_profit': -5.77}, {'period': ""Q1 '22"", 'revenue': 7.26, 'unit': 'M', 'net_profit': -6.48}, {'period': ""Q4 '21"", 'revenue': 7.36, 'unit': 'M', 'net_profit': -7.49}, {'period': ""Q3 '21"", 'revenue': 7.46, 'unit': 'M', 'net_profit': -5.79}, {'period': ""Q2 '21"", 'revenue': 7.61, 'unit': 'M', 'net_profit': -5.59}]",-5.9,-5.9,46128000,7324000,4302000,32300000,799000,0,12706000,4302000,-16799000,-0.990604186489058,-0.33458842611365347,-0.031468531468531576,__nan__,__nan__,__nan__,0.7002254595907041
330,CYRX,CryoPort Inc. Common Stock,"Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.",Mr. Jerrell W. Shelton,Integrated Freight & Logistics,5.52,USD,275505369,https://images.financialmodelingprep.com/symbol/CYRX.png,460272,-2.22,-0.025,351944,-78615000,-122756000,"[{'period': '2023', 'revenue': 228.38, 'unit': 'M', 'net_profit': -122.76}, {'period': '2022', 'revenue': 233.25, 'unit': 'M', 'net_profit': -99.59}, {'period': '2021', 'revenue': 237.28, 'unit': 'M', 'net_profit': -37.33}, {'period': '2020', 'revenue': 222.61, 'unit': 'M', 'net_profit': -275.53}]","[{'period': ""Q4 '23"", 'revenue': 59.53, 'unit': 'M', 'net_profit': -20.68}, {'period': ""Q3 '23"", 'revenue': 56660.0, 'unit': 'K', 'net_profit': 805.0}, {'period': ""Q2 '23"", 'revenue': 57.6, 'unit': 'M', 'net_profit': -77.99}, {'period': ""Q1 '23"", 'revenue': 54.59, 'unit': 'M', 'net_profit': -18.89}, {'period': ""Q4 '22"", 'revenue': 57.26, 'unit': 'M', 'net_profit': -62.39}, {'period': ""Q3 '22"", 'revenue': 56.16, 'unit': 'M', 'net_profit': -13.27}]",-2.49,-2.49,703492000,341571000,261749000,301594000,45778000,0,64563000,45289000,-33577000,-0.18471020826426354,-0.23265084800224928,-0.12669683257918563,__nan__,__nan__,__nan__,0.42870992136371133
331,CYTH,Cyclo Therapeutics Inc. Common Stock,"Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.",Mr. N. Scott Fine,Drug Manufacturers - Specialty & Generic,0.7206,USD,23589778,https://images.financialmodelingprep.com/symbol/CYTH.png,1761627,-0.8,0,186806,-20030781,-20057302,"[{'period': '2023', 'revenue': 1.08, 'unit': 'M', 'net_profit': -20.06}, {'period': '2022', 'revenue': 1.38, 'unit': 'M', 'net_profit': -15.28}, {'period': '2021', 'revenue': 1.59, 'unit': 'M', 'net_profit': -14.31}, {'period': '2020', 'revenue': 0.90338, 'unit': 'M', 'net_profit': -8.92}]","[{'period': ""Q3 '24"", 'revenue': 0.23377, 'unit': 'M', 'net_profit': -8.83}, {'period': ""Q2 '24"", 'revenue': 0.1231, 'unit': 'M', 'net_profit': -5.98}, {'period': ""Q1 '24"", 'revenue': 0.20245, 'unit': 'M', 'net_profit': -4.34}, {'period': ""Q4 '23"", 'revenue': 0.3114, 'unit': 'M', 'net_profit': -5.64}, {'period': ""Q3 '23"", 'revenue': 0.49548000000000003, 'unit': 'M', 'net_profit': -4.77}, {'period': ""Q2 '23"", 'revenue': 0.11712, 'unit': 'M', 'net_profit': -4.64}]",-1.23,-1.23,13247538,12318257,9246592,8490531,122379,0,8468047,9246592,-16187446,-0.28382649982486674,-0.31266010422849905,0.32044198895027626,__nan__,__nan__,__nan__,0.6409138815076432
332,CYTHW,Cyclo Therapeutics Inc. Warrant,"Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.",Mr. N. Scott Fine,Drug Manufacturers - Specialty & Generic,0.032,USD,899367,https://images.financialmodelingprep.com/symbol/CYTHW.png,12317,,0,28412,-20030781,-20057302,"[{'period': '2023', 'revenue': 1.08, 'unit': 'M', 'net_profit': -20.06}, {'period': '2022', 'revenue': 1.38, 'unit': 'M', 'net_profit': -15.28}, {'period': '2021', 'revenue': 1.59, 'unit': 'M', 'net_profit': -14.31}, {'period': '2020', 'revenue': 0.90338, 'unit': 'M', 'net_profit': -8.92}]","[{'period': ""Q3 '24"", 'revenue': 0.23377, 'unit': 'M', 'net_profit': -8.83}, {'period': ""Q2 '24"", 'revenue': 0.1231, 'unit': 'M', 'net_profit': -5.98}, {'period': ""Q1 '24"", 'revenue': 0.20245, 'unit': 'M', 'net_profit': -4.34}, {'period': ""Q4 '23"", 'revenue': 0.3114, 'unit': 'M', 'net_profit': -5.64}, {'period': ""Q3 '23"", 'revenue': 0.49548000000000003, 'unit': 'M', 'net_profit': -4.77}, {'period': ""Q2 '23"", 'revenue': 0.11712, 'unit': 'M', 'net_profit': -4.64}]",-1.23,-1.23,13247538,12318257,9246592,8490531,122379,0,8468047,9246592,-16187446,-0.28382649982486674,-0.31266010422849905,0.32044198895027626,__nan__,__nan__,__nan__,0.6409138815076432
333,CYTK,Cytokinetics Incorporated Common Stock,"Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.",Mr. Robert I. Blum,Biotechnology,37.93,USD,4520789082,https://images.financialmodelingprep.com/symbol/CYTK.png,1989178,-7.21,-1.55,1850572,-493483000,-589526000,"[{'period': '2024', 'revenue': 18.47, 'unit': 'M', 'net_profit': -589.53}, {'period': '2023', 'revenue': 7.53, 'unit': 'M', 'net_profit': -526.24}, {'period': '2022', 'revenue': 94.59, 'unit': 'M', 'net_profit': -402.55}, {'period': '2021', 'revenue': 70.43, 'unit': 'M', 'net_profit': -242.37}]","[{'period': ""Q4 '24"", 'revenue': 16.93, 'unit': 'M', 'net_profit': -150.02}, {'period': ""Q3 '24"", 'revenue': 0.463, 'unit': 'M', 'net_profit': -160.54}, {'period': ""Q2 '24"", 'revenue': 0.249, 'unit': 'M', 'net_profit': -143.32}, {'period': ""Q1 '24"", 'revenue': 0.835, 'unit': 'M', 'net_profit': -135.64}, {'period': ""Q4 '23"", 'revenue': 1.67, 'unit': 'M', 'net_profit': -136.9}, {'period': ""Q3 '23"", 'revenue': 0.378, 'unit': 'M', 'net_profit': -129.42}]",-5.26,-5.26,1401673000,1107940000,1076014000,1537045000,16650000,145055000,179674000,94857000,-399796000,-0.08057869336346357,-0.12025220240040742,0.03486238532110099,__nan__,__nan__,__nan__,1.0965788739599036
334,CZNC,Citizens & Northern Corp Common Stock,"Citizens & Northern Corporation operates as the bank holding company for Citizens & Northern Bank that provides a range of banking and mortgage services to individual and corporate customers. The company offers lending products include commercial, mortgage, and consumer loans, as well as specialized instruments, such as commercial letters-of-credit; and deposit products, including various types of checking accounts, passbook and statement savings accounts, money market accounts, interest checking accounts, individual retirement accounts, and certificates of deposits. It also offers wealth management services, including administration of trusts and estates, retirement plans, and other employee benefit plans, and investment management services; and a range of personal and commercial insurance products; mutual funds, annuities, educational savings accounts, and other investment products through registered agents. In addition, the company reinsures credit and mortgage, life and accident, and health insurance products. As of December 31, 2021, it had 31 branch offices, including 23 in the Northern tier/Northcentral region of Pennsylvania, 2 in the Southern tier of New York State, 4 in Southeastern Pennsylvania, and 2 in Southcentral Pennsylvania, as well as a lending office in Elmira, New York. The company was founded in 1864 and is based in Wellsboro, Pennsylvania.",Mr. J. Bradley Scovill,Banks - Regional,19.05,USD,294628595,https://images.financialmodelingprep.com/symbol/CZNC.png,33831,11.27,0.21,27765,0,25958000,"[{'period': '2024', 'revenue': 128.08, 'unit': 'M', 'net_profit': 25.96}, {'period': '2023', 'revenue': 104.63, 'unit': 'M', 'net_profit': 24.15}, {'period': '2022', 'revenue': 105.96, 'unit': 'M', 'net_profit': 26.62}, {'period': '2021', 'revenue': 103.82, 'unit': 'M', 'net_profit': 30.55}]","[{'period': ""Q4 '24"", 'revenue': 27.67, 'unit': 'M', 'net_profit': 8.17}, {'period': ""Q3 '24"", 'revenue': 26.08, 'unit': 'M', 'net_profit': 6.37}, {'period': ""Q2 '24"", 'revenue': 39.19, 'unit': 'M', 'net_profit': 6.11}, {'period': ""Q1 '24"", 'revenue': 37.02, 'unit': 'M', 'net_profit': 5.31}, {'period': ""Q4 '23"", 'revenue': 35.91, 'unit': 'M', 'net_profit': 4.26}, {'period': ""Q3 '23"", 'revenue': 25.65, 'unit': 'M', 'net_profit': 7.59}]",1.71,1.71,2610653000,475669000,475669000,2335369000,8735000,0,0,22209000,33035000,0,0.074954447573298,0.08917197452229293,"[0.28, 0.4822]","['2025-02-03', '1994-06-24']",__nan__,0.8945535848693794
335,CZR,Caesars Entertainment Inc. Common Stock,"Caesars Entertainment, Inc. operates as a gaming and hospitality company in the United States. The company operates casinos comprising poker, keno, and race and online sportsbooks; dining venues, bars, nightclubs, and lounges; hotels; and entertainment venues. It also provides staffing and management services; accessories, souvenirs, and decorative items through retail stores; and online sports betting and iGaming services. As of December 31,2021, the company owned, leased, and managed 52 domestic properties in 16 states, consisting of approximately 55,700 slot machines, video lottery terminals, and e-tables; 2,900 table games; and 47,700 hotel rooms. Caesars Entertainment, Inc. was founded in 1937 and is based in Reno, Nevada.",Mr. Thomas Robert Reeg CFA,"Gambling, Resorts & Casinos",25,USD,5300325000,https://images.financialmodelingprep.com/symbol/CZR.png,5559922,-19.38,-0.51,5573440,3577000000,-278000000,"[{'period': '2024', 'revenue': 11240.0, 'unit': 'M', 'net_profit': -278.0}, {'period': '2023', 'revenue': 11530.0, 'unit': 'M', 'net_profit': 786.0}, {'period': '2022', 'revenue': 10820.0, 'unit': 'M', 'net_profit': -524.0}, {'period': '2021', 'revenue': 9570.0, 'unit': 'M', 'net_profit': -986.0}]","[{'period': ""Q4 '24"", 'revenue': 2800.0, 'unit': 'M', 'net_profit': 11.0}, {'period': ""Q3 '24"", 'revenue': 2870.0, 'unit': 'M', 'net_profit': -9.0}, {'period': ""Q2 '24"", 'revenue': 2830.0, 'unit': 'M', 'net_profit': -122.0}, {'period': ""Q1 '24"", 'revenue': 2740.0, 'unit': 'M', 'net_profit': -158.0}, {'period': ""Q4 '23"", 'revenue': 2830.0, 'unit': 'M', 'net_profit': -72.0}, {'period': ""Q3 '23"", 'revenue': 2990.0, 'unit': 'M', 'net_profit': 74.0}]",-1.29,-1.29,32590000000,1747000000,866000000,28214000000,470000000,131000000,2272000000,866000000,-221000000,0.006188466947960619,-1.3536895674300256,-1.3524590163934427,__nan__,__nan__,__nan__,0.8657256827247622
336,CZWI,Citizens Community Bancorp Inc. Common Stock,"Citizens Community Bancorp, Inc. operates as a bank holding company for Citizens Community Federal N.A. that provides various traditional community banking services to businesses, agricultural operators, and consumers. The company accepts various deposit products, including demand deposits, savings and money market accounts, and certificates of deposit. It also offers various loan products comprising commercial real estate, commercial and industrial, agricultural real estate, agricultural operating, and consumer loans; and one-to-four family residential mortgages and home equity lines-of-credit. In addition, the company provides a portfolio of investments, such as mortgage-backed, corporate asset-backed, U.S. Government sponsored agency, corporate debt, and trust preferred securities. It operates through a network of 25 full-service branch in Wisconsin and Minnesota. Citizens Community Bancorp, Inc. was founded in 1938 and is based in Eau Claire, Wisconsin.",Mr. Stephen M. Bianchi,Banks - Regional,13.74,USD,137256225,https://images.financialmodelingprep.com/symbol/CZWI.png,24037,10.25,0.15,10093,0,2702000,"[{'period': '2024', 'revenue': 56.29, 'unit': 'M', 'net_profit': 2.7}, {'period': '2023', 'revenue': 58.54, 'unit': 'M', 'net_profit': 13.06}, {'period': '2022', 'revenue': 67.19, 'unit': 'M', 'net_profit': 17.76}, {'period': '2021', 'revenue': 69.69, 'unit': 'M', 'net_profit': 21.27}]","[{'period': ""Q4 '24"", 'revenue': 13.47, 'unit': 'M', 'net_profit': 2.7}, {'period': ""Q3 '24"", 'revenue': 14.14, 'unit': 'M', 'net_profit': 3.29}, {'period': ""Q2 '24"", 'revenue': 24.28, 'unit': 'M', 'net_profit': 3.67}, {'period': ""Q1 '24"", 'revenue': 25.8, 'unit': 'M', 'net_profit': 4.09}, {'period': ""Q4 '23"", 'revenue': 24.35, 'unit': 'M', 'net_profit': 3.69}, {'period': ""Q3 '23"", 'revenue': 14.59, 'unit': 'M', 'net_profit': 2.5}]",0.26,0.26,1748519000,1547108000,193023000,1569435000,1354085000,0,0,50172000,20176000,-1,-0.7930928861321694,-0.792,"[0.36, 0.0262]","['2025-02-07', '2004-07-30']",__nan__,0.8975796088003619
337,DADA,Dada Nexus Limited American Depositary Shares,"Dada Nexus Limited operates a platform of local on-demand retail and delivery in the People's Republic of China. It operates Dada Now, a local on-demand delivery platform that provides intra-city delivery and last-mile delivery services on an on-demand basis to chain merchants, small- and medium-sized enterprise merchants, and individual senders; and JDDJ, a local on-demand retail platform for consumers, retailers, and brand owner. The company was incorporated in 2014 and is headquartered in Shanghai, the People's Republic of China.",Mr. Jun  Mao,Specialty Retail,1.85,USD,119863700,https://images.financialmodelingprep.com/symbol/DADA.png,2541796,-1.75,0,3443813,-585042000,-2038536000,"[{'period': '2024', 'revenue': 9.66, 'unit': 'B', 'net_profit': -2.04}, {'period': '2023', 'revenue': 10.51, 'unit': 'B', 'net_profit': -1.96}, {'period': '2022', 'revenue': 9.37, 'unit': 'B', 'net_profit': -2.01}, {'period': '2021', 'revenue': 6.87, 'unit': 'B', 'net_profit': -2.47}]","[{'period': ""Q4 '24"", 'revenue': 2.43, 'unit': 'B', 'net_profit': -1.23}, {'period': ""Q3 '24"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': -197.33}, {'period': ""Q2 '24"", 'revenue': 2350.0, 'unit': 'M', 'net_profit': -286.23}, {'period': ""Q1 '24"", 'revenue': 2450.0, 'unit': 'M', 'net_profit': -327.97}, {'period': ""Q4 '23"", 'revenue': 2.25, 'unit': 'B', 'net_profit': -1.28}, {'period': ""Q3 '23"", 'revenue': 2870.0, 'unit': 'M', 'net_profit': -165.98}]",-7.8,-7.8,5212669000,5164187000,3003242000,1606216000,1163451000,0,1577767000,3003242000,-1062445000,0.595413354135201,-0.04137482548276079,-3.148936170212766,__nan__,__nan__,__nan__,0.30813696400059165
338,DAIO,Data I/O Corporation Common Stock,"Data I/O Corporation engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. The company's programming system products are used to program integrated circuits (ICs) with the specific data necessary for the ICs. It offers PSV handlers offline automated programming systems; SentriX, a security deployment system; RoadRunner and RoadRunner3 series handlers, an in-line automated programming systems; LumenX Programmer; and non-automated FlashPAK III programming systems. The company also provides hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, Internet of Things and their programming center partners, and electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.",Mr. William O. Wentworth,"Hardware, Equipment & Parts",1.99,USD,18387065,https://images.financialmodelingprep.com/symbol/DAIO.png,21873,-5.85,0.005,28752,-2436667,-3093000,"[{'period': '2024', 'revenue': 21.77, 'unit': 'M', 'net_profit': -3.09}, {'period': '2023', 'revenue': 28060.0, 'unit': 'K', 'net_profit': 486.0}, {'period': '2022', 'revenue': 24.22, 'unit': 'M', 'net_profit': -1.12}, {'period': '2021', 'revenue': 25840.0, 'unit': 'K', 'net_profit': -555.0}]","[{'period': ""Q4 '24"", 'revenue': 5.18, 'unit': 'M', 'net_profit': -1.18}, {'period': ""Q3 '24"", 'revenue': 5420.0, 'unit': 'K', 'net_profit': -307.0}, {'period': ""Q2 '24"", 'revenue': 5060.0, 'unit': 'K', 'net_profit': -797.0}, {'period': ""Q1 '24"", 'revenue': 6100.0, 'unit': 'K', 'net_profit': -807.0}, {'period': ""Q4 '23"", 'revenue': 6870.0, 'unit': 'K', 'net_profit': 144.0}, {'period': ""Q3 '23"", 'revenue': 6560.0, 'unit': 'K', 'net_profit': -53.0}]",-0.34,-0.34,24970000,21157000,10326000,7344000,3960000,0,5072000,10326000,-1462000,-3.3074498106060606,-7.364197530864198,-7.250000000000001,"[4.15, 4.15]","['1989-03-09', '1989-03-09']",__nan__,0.29411293552262713
339,DAKT,Daktronics Inc. Common Stock,"Daktronics, Inc. designs, manufactures, markets, and sells electronic display systems and related products worldwide. It operates through five segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company offers video display systems, such as displays to show various levels of video, graphics, and animation; indoor and outdoor light emitting diodes (LED) video displays, including centerhung, landmark, ribbon board, and corporate office entrance displays, as well as video walls and hanging banners; mobile and modular display systems; architectural lighting and display products; indoor and outdoor scoreboards for various sports, digit displays, scoring and timing controllers, statistics software, and other related products; and timing systems for sports events primarily aquatics and track competitions, as well as swimming touchpads, race start systems, and relay take-off platforms. It also provides control components for video displays in live event applications; message displays; ITS dynamic message signs, including LED displays for road management; mass transit displays; and sound systems for indoor and outdoor sports venues. In addition, the company offers out-of-home advertising displays comprising digital billboards and street furniture displays; DataTime product line that consists of outdoor time and temperature displays; and Fuelight digit displays designed for the petroleum industry. Further, it provides ADFLOW DMS systems that include indoor networked solutions for retailers, convenience stores, and other businesses; and Venus Control Suite, Show Control, Vanguard, and others, as well as maintenance and professional services related to its products. The company sells its products through direct sales and resellers. Daktronics, Inc. was founded in 1968 and is headquartered in Brookings, South Dakota.",Mr. Bradley T. Wiemann,"Hardware, Equipment & Parts",12.07,USD,602212131,https://images.financialmodelingprep.com/symbol/DAKT.png,465121,301.75,-0.34,204451,104855000,34621000,"[{'period': '2024', 'revenue': 818.08, 'unit': 'M', 'net_profit': 34.62}, {'period': '2023', 'revenue': 754.2, 'unit': 'M', 'net_profit': 6.8}, {'period': '2022', 'revenue': 610970.0, 'unit': 'K', 'net_profit': 592.0}, {'period': '2021', 'revenue': 482.03, 'unit': 'M', 'net_profit': 10.93}]","[{'period': ""Q3 '25"", 'revenue': 149.51, 'unit': 'M', 'net_profit': -17.16}, {'period': ""Q2 '25"", 'revenue': 208.33, 'unit': 'M', 'net_profit': 21.41}, {'period': ""Q1 '25"", 'revenue': 226.09, 'unit': 'M', 'net_profit': -4.95}, {'period': ""Q4 '24"", 'revenue': 215.88, 'unit': 'M', 'net_profit': 2.52}, {'period': ""Q3 '24"", 'revenue': 170.3, 'unit': 'M', 'net_profit': 10.74}, {'period': ""Q2 '24"", 'revenue': 199.37, 'unit': 'M', 'net_profit': 2.17}]",0.75,0.74,527884000,401949000,81299000,289092000,173732000,2375000,192296000,81299000,46261000,1.4409293013944178,4.089826521611291,4,"[0.05, 0.1]","['2020-03-06', '2005-06-10']",__nan__,0.5476430427897038
340,DARE,Dare Bioscience Inc. Common Stock,"Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.",Ms. Sabrina Martucci Johnson,Biotechnology,2.97,USD,25840158,https://images.financialmodelingprep.com/symbol/DARE.png,23260,-6.19,0.07,13343,-23409160,-4053599,"[{'period': '2024', 'revenue': 0.009779999999999999, 'unit': 'M', 'net_profit': -4.05}, {'period': '2023', 'revenue': 2.81, 'unit': 'M', 'net_profit': -30.16}, {'period': '2022', 'revenue': 10.0, 'unit': 'M', 'net_profit': -30.95}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.33}]","[{'period': ""Q4 '24"", 'revenue': -0.06365, 'unit': 'M', 'net_profit': -5.51}, {'period': ""Q3 '24"", 'revenue': 0.04169, 'unit': 'M', 'net_profit': -4.7}, {'period': ""Q2 '24"", 'revenue': 0.02244, 'unit': 'M', 'net_profit': 12.91}, {'period': ""Q1 '24"", 'revenue': 0.009300000000000001, 'unit': 'M', 'net_profit': -6.76}, {'period': ""Q4 '23"", 'revenue': 1.81, 'unit': 'M', 'net_profit': -5.06}, {'period': ""Q3 '23"", 'revenue': 1.0, 'unit': 'M', 'net_profit': -8.3}]",-0.48,-0.48,22101131000,18447863000,15698174000,28113220000,229982,0,21609013000,15698174,4821201000,0.24245919706789798,0.8656030486127115,0.8843373493975903,__nan__,__nan__,__nan__,1.272026304898152
341,DBDR,Roman DBDR Tech Acquisition Corp. Class A Common Stock,"As of December 27, 2021, Roman DBDR Tech Acquisition Corp. was acquired by CompoSecure, L.L.C., in a reverse merger transaction. Roman DBDR Tech Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or business combination with one or more businesses in the technology, media, and telecom industries. The company was incorporated in 2020 and is based in Las Vegas, Nevada.",,Shell Companies,9.95,USD,771491180,https://images.financialmodelingprep.com/symbol/DBDR.png,218082,0,-0.13000011,34862,-165106,-165106,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -165.11}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 176.91}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.66}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -165.11}]",-0.0057,-0.0057,237253,1038.304,236818,8202.712,0,0,98.112,603.615,,0,0,0,__nan__,__nan__,__nan__,0.03457369137587301
342,DBDRU,Roman DBDR Tech Acquisition Corp. Unit,"As of December 27, 2021, Roman DBDR Tech Acquisition Corp. was acquired by CompoSecure, L.L.C., in a reverse merger transaction. Roman DBDR Tech Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or business combination with one or more businesses in the technology, media, and telecom industries. The company was incorporated in 2020 and is based in Las Vegas, Nevada.",Dr. Donald G. Basile Ph.D.,Shell Companies,0,USD,0,https://images.financialmodelingprep.com/symbol/DBDRU.png,935,0,0,1822,-165106,-165106,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -165.11}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 176.91}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.66}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -165.11}]",-0.0057,-0.0057,237253,1038.304,236818,8202.712,0,0,98.112,603.615,,0,0,0,__nan__,__nan__,__nan__,0.03457369137587301
343,DBDRW,Roman DBDR Tech Acquisition Corp. Warrant,,,,,,,,,,,,-165106,-165106,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -165.11}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 176.91}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.66}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.93}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -165.11}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-0.03,-0.03,237.25339300000002,1.0383040000000001,236.818704,8.202712,0,236.215089,0.09811199999999999,0.603615,-525572,0,0,0,__nan__,__nan__,__nan__,0.03457363410604627
344,DBGI,Digital Brands Group Inc. Common Stock,"Digital Brands Group, Inc. provides apparel under various brands on direct-to-consumer and wholesale basis. The company offers denims under the DSTLD brand; and luxury men's suiting under the ACE Studios brand. It also designs, manufactures, and sells women's apparel, such as dresses, tops, jumpsuits, bottoms, sets, jackets, and rompers under the Bailey brand. It offers luxury custom and made-to- measure suiting and sportwear, as well as shirts, jackets, pants, shorts, polos, and other products that are made-to-measure under the Harper & Jones brand. The company also offers luxury T-shirts, tops, and bottoms under the Stateside brand. Digital Brands Group, Inc. sells directly to the consumer through its websites, as well as through its wholesale channel in specialty stores, select department stores, and own showrooms. The company was formerly known as Denim.LA, Inc. Digital Brands Group, Inc. was incorporated in 2012 and is headquartered in Austin, Texas.",Mr. John Hilburn Davis IV,Apparel - Retail,8.9,USD,36903761,https://images.financialmodelingprep.com/symbol/DBGI.png,74470,-0.12,0,800,-10200782,-13106589,"[{'period': '2024', 'revenue': 11.56, 'unit': 'M', 'net_profit': -13.11}, {'period': '2023', 'revenue': 14.92, 'unit': 'M', 'net_profit': -10.25}, {'period': '2022', 'revenue': 13.97, 'unit': 'M', 'net_profit': -54.15}, {'period': '2021', 'revenue': 7.58, 'unit': 'M', 'net_profit': -32.36}]","[{'period': ""Q4 '24"", 'revenue': 2.14, 'unit': 'M', 'net_profit': -5.37}, {'period': ""Q3 '24"", 'revenue': 2.44, 'unit': 'M', 'net_profit': -3.54}, {'period': ""Q2 '24"", 'revenue': 3.4, 'unit': 'M', 'net_profit': -3.51}, {'period': ""Q1 '24"", 'revenue': 3580.0, 'unit': 'K', 'net_profit': -683.74}, {'period': ""Q4 '23"", 'revenue': 2.79, 'unit': 'M', 'net_profit': -3.72}, {'period': ""Q3 '23"", 'revenue': 3.26, 'unit': 'M', 'net_profit': -5.44}]",-76.71,-76.71,19890327,4697267,164431,21218868,434253,0,20819878,164431,-6152338,-12.510343229121828,-0.2790493692235672,-2.177713338856669,__nan__,__nan__,__nan__,1.0667933211957752
345,DBGIW,Digital Brands Group Inc. Warrant,"Digital Brands Group, Inc. provides apparel under various brands on direct-to-consumer and wholesale basis. It operates as a digitally native vertical brand that sources products from third-party manufacturers and sells directly to the end consumer through its websites, as well as through its wholesale channel in specialty stores, select department stores, and own showrooms. The company offers denims under the DSTLD brand; and luxury men's suiting under the ACE Studios brand. It also designs, manufactures, and sells women's apparel, including dresses, tops, jumpsuits, bottoms, sets, jackets, and rompers under the Bailey brand. The company was formerly known as Denim.LA, Inc. Digital Brands Group, Inc. was founded in 2012 and is headquartered in Austin, Texas.",Mr. John Hilburn Davis IV,Apparel - Retail,16,USD,30472320,https://images.financialmodelingprep.com/symbol/DBGIW.png,0,0,3.39,818,-10200782,-13106589,"[{'period': '2024', 'revenue': 11.56, 'unit': 'M', 'net_profit': -13.11}, {'period': '2023', 'revenue': 14.92, 'unit': 'M', 'net_profit': -10.25}, {'period': '2022', 'revenue': 13.97, 'unit': 'M', 'net_profit': -54.15}, {'period': '2021', 'revenue': 7.58, 'unit': 'M', 'net_profit': -32.36}]","[{'period': ""Q4 '24"", 'revenue': 2.14, 'unit': 'M', 'net_profit': -5.37}, {'period': ""Q3 '24"", 'revenue': 2.44, 'unit': 'M', 'net_profit': -3.54}, {'period': ""Q2 '24"", 'revenue': 3.4, 'unit': 'M', 'net_profit': -3.51}, {'period': ""Q1 '24"", 'revenue': 3580.0, 'unit': 'K', 'net_profit': -683.74}, {'period': ""Q4 '23"", 'revenue': 2.79, 'unit': 'M', 'net_profit': -3.72}, {'period': ""Q3 '23"", 'revenue': 3.26, 'unit': 'M', 'net_profit': -5.44}]",-76.71,-76.71,19890327,4697267,164431,21218868,434253,0,20819878,164431,-6152338,-12.510343229121828,-0.2790493692235672,-2.177713338856669,__nan__,__nan__,__nan__,1.0667933211957752
346,DBTX,Decibel Therapeutics Inc. Common Stock,"Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO and AAV.201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV.103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.104 to restore hearing in individuals with stereocilin (STRC) deficiency; and cochlear hair cell regeneration program, an AAV-based gene therapy that utilizes cell-selective expression of reprogramming factors to convert supporting cells into outer hair cells. Decibel Therapeutics, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop gene therapies for monogenic forms of congenital hearing loss. The company was formerly known as Hearing Inc. and changed its name to Decibel Therapeutics, Inc. in April 2014. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts.",Dr. Laurence E. Reid Ph.D.,Biotechnology,4.91,USD,123373079,https://images.financialmodelingprep.com/symbol/DBTX.png,214738,-1.9330708661417324,-0.04,1055379,-62495000,-63005000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -63.01}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.82}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.64}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.26}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.14}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.3}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.94}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.05}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.02}]",-2.52,-2.52,123373000,108030000,104561000,41580000,0,0,22442000,34607000,-57361000,-0.28016305461100416,-0.21577291936012968,-0.05882352941176476,__nan__,__nan__,__nan__,0.3370267400484709
347,DBVT,DBV Technologies S.A. American Depositary Shares,"DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.",Mr. Daniel  Tassé,Biotechnology,8.91,USD,243567306,https://images.financialmodelingprep.com/symbol/DBVT.png,412054,-1.52,0.93,124678,-87464694,-72726000,"[{'period': '2023', 'revenue': 15.73, 'unit': 'M', 'net_profit': -72.73}, {'period': '2022', 'revenue': 4.8, 'unit': 'M', 'net_profit': -96.3}, {'period': '2021', 'revenue': 5.71, 'unit': 'M', 'net_profit': -97.81}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -195.68}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.02}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.44}, {'period': ""Q2 '24"", 'revenue': 1.16, 'unit': 'M', 'net_profit': -33.12}, {'period': ""Q1 '24"", 'revenue': 1.41, 'unit': 'M', 'net_profit': -27.34}, {'period': ""Q4 '23"", 'revenue': 8.88, 'unit': 'M', 'net_profit': -11.19}, {'period': ""Q3 '23"", 'revenue': 2.4, 'unit': 'M', 'net_profit': -16.7}]",-0.71,-0.71,65658000,44388000,32456000,38271000,10391000,4312000,31136000,32456000,-106815000,-0.1406555175160386,0.244797507788162,0.4274193548387097,__nan__,__nan__,__nan__,0.5828840354564562
348,DBX,Dropbox Inc. Class A Common Stock,"Dropbox, Inc. provides a content collaboration platform worldwide. Its platform allows individuals, families, teams, and organizations to collaborate and sign up for free through its website or app, as well as upgrade to a paid subscription plan for premium features. As of December 31, 2021, the company had approximately 700 million registered users. It serves customers in professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.",Mr. Andrew W. Houston,Software - Infrastructure,26.67,USD,7678673234,https://images.financialmodelingprep.com/symbol/DBX.png,4373885,19.05,-0.44,3293471,623600000,452300000,"[{'period': '2024', 'revenue': 2550.0, 'unit': 'M', 'net_profit': 452.3}, {'period': '2023', 'revenue': 2500.0, 'unit': 'M', 'net_profit': 453.6}, {'period': '2022', 'revenue': 2320.0, 'unit': 'M', 'net_profit': 553.2}, {'period': '2021', 'revenue': 2160.0, 'unit': 'M', 'net_profit': 335.8}]","[{'period': ""Q4 '24"", 'revenue': 643.6, 'unit': 'M', 'net_profit': 102.8}, {'period': ""Q3 '24"", 'revenue': 638.8, 'unit': 'M', 'net_profit': 106.7}, {'period': ""Q2 '24"", 'revenue': 634.5, 'unit': 'M', 'net_profit': 110.5}, {'period': ""Q1 '24"", 'revenue': 631.3, 'unit': 'M', 'net_profit': 132.3}, {'period': ""Q4 '23"", 'revenue': 635.0, 'unit': 'M', 'net_profit': 227.3}, {'period': ""Q3 '23"", 'revenue': 633.0, 'unit': 'M', 'net_profit': 114.1}]",1.42,1.4,3325200000,1738400000,1594200000,4077600000,70400000,0,1210800000,1328300000,871600000,0.12664859981933152,-0.0028659611992945325,0.06766917293233071,__nan__,__nan__,__nan__,1.226272103933598
349,DCBO,Docebo Inc. Common Shares,"Docebo Inc. provides a cloud-based learning management system to train internal and external workforces, partners, and customers in North America, Europe, and the Asia-Pacific region. Its platform helps customers to centralize learning materials from peer enterprises and learners into one learning management system (LMS) to expedite and enrich the learning process, increase productivity, and grow teams uniformly. The company's learning platform includes Docebo Learn LMS, a cloud-based learning platform; Docebo Shape, an AI-based learning content creation tool; Docebo Content that allows to unlock the industry's best-learning content; Docebo Learning Impact, a learning measurement tool; Docebo Learning Analytics that allows learning administrators to prove their learning programs are powering their business, as well as connecting learning data to business results; Docebo Connect that connects Docebo to custom tech stack and making integrations; and Docebo Flow that allows businesses to directly inject learning into the flow of work. It also provides Docebo for Salesforce, a native integration that leverages Salesforce's application programming interface and technology architecture to produce a learning experience; and Docebo Embed (OEM) that allows original equipment manufacturers to embed and re-sell Docebo as a part of their software. In addition, the company offers Docebo Mobile App Publisher product that allows companies to create and publish own branded version of Docebo Go.Learn mobile learning applications; Docebo Extended Enterprise that breeds customer education, partner enablement, and retention; and Docebo Discover, Coach & Share that enhances the learning experience to create a culture of social learning. It serves customers in the technology, media, manufacturing, consulting and professional services, and retail industries. The company was formerly known as Docebo Canada, Inc. Docebo Inc. founded in 2005 and is based in Toronto, Canada.",Mr. Alessio  Artuffo,Software - Application,28.63,USD,866227992,https://images.financialmodelingprep.com/symbol/DCBO.png,89578,33.29,-0.55,38603,27282000,26736000,"[{'period': '2024', 'revenue': 216.93, 'unit': 'M', 'net_profit': 26.74}, {'period': '2023', 'revenue': 180.84, 'unit': 'M', 'net_profit': 2.84}, {'period': '2022', 'revenue': 142.91, 'unit': 'M', 'net_profit': 7.02}, {'period': '2021', 'revenue': 104.24, 'unit': 'M', 'net_profit': -13.6}]","[{'period': ""Q4 '24"", 'revenue': 57.04, 'unit': 'M', 'net_profit': 11.91}, {'period': ""Q3 '24"", 'revenue': 55.43, 'unit': 'M', 'net_profit': 4.96}, {'period': ""Q2 '24"", 'revenue': 53.05, 'unit': 'M', 'net_profit': 4.7}, {'period': ""Q1 '24"", 'revenue': 51.17, 'unit': 'M', 'net_profit': 5.17}, {'period': ""Q4 '23"", 'revenue': 49.28, 'unit': 'M', 'net_profit': 3.22}, {'period': ""Q3 '23"", 'revenue': 46.51, 'unit': 'M', 'net_profit': 4.05}]",0.88,0.86,190713000,154241000,92583000,132952000,45602000,0,128602000,92540000,28004000,2.2359818599031698,8.414084507042254,9.080183276059564,__nan__,__nan__,__nan__,0.6971312915218155
350,DCOM,Dime Community Bancshares Inc. Common Stock,"Dime Community Bancshares, Inc. operates as the holding company for Dime Community Bank that provides various commercial banking and financial services. It accepts time, savings, and demand deposits from the businesses, consumers, and local municipalities. The company also offers commercial real estate loans; multi-family mortgage loans; residential mortgage loans; secured and unsecured commercial and consumer loans; home equity loans; and construction and land loans. In addition, it invests in Federal Home Loan Bank, Federal National Mortgage Association, Government National Mortgage Association, and Federal Home Loan Mortgage Corporation mortgage-backed securities, collateralized mortgage obligations, and other asset backed securities; U.S. Treasury securities; New York state and local municipal obligations; U.S. government-sponsored enterprise securities; and corporate bonds. Further, the company offers certificate of deposit account registry services and insured cash sweep programs; merchant credit and debit card processing, automated teller machines, cash management services, lockbox processing, online banking services, remote deposit capture, safe deposit boxes, and individual retirement accounts; investment products and services through a third-party broker dealer; and title insurance broker services. As of December 31, 2021, it operated 60 branch locations throughout Long Island and the New York City boroughs of Brooklyn, Queens, Manhattan, and the Bronx. Dime Community Bancshares, Inc. was founded in 1910 and is headquartered in Hauppauge, New York.",Mr. Stuart H. Lubow,Banks - Regional,25.12,USD,1096667231,https://images.financialmodelingprep.com/symbol/DCOM.png,310480,45.67,-0.09,235192,0,29084000,"[{'period': '2024', 'revenue': 650.15, 'unit': 'M', 'net_profit': 29.08}, {'period': '2023', 'revenue': 352.78, 'unit': 'M', 'net_profit': 96.09}, {'period': '2022', 'revenue': 418.02, 'unit': 'M', 'net_profit': 152.56}, {'period': '2021', 'revenue': 399.68, 'unit': 'M', 'net_profit': 104.0}]","[{'period': ""Q4 '24"", 'revenue': 57.24, 'unit': 'M', 'net_profit': -20.41}, {'period': ""Q3 '24"", 'revenue': 87.56, 'unit': 'M', 'net_profit': 13.33}, {'period': ""Q2 '24"", 'revenue': 170.14, 'unit': 'M', 'net_profit': 18.48}, {'period': ""Q1 '24"", 'revenue': 171.07, 'unit': 'M', 'net_profit': 17.69}, {'period': ""Q4 '23"", 'revenue': 82.99, 'unit': 'M', 'net_profit': 16.31}, {'period': ""Q3 '23"", 'revenue': 84.41, 'unit': 'M', 'net_profit': 14.98}]",0.8,0.8,14353258000,2030234000,1974264000,12956741000,55970000,0,50000000,1283571000,92798000,0,-0.6973380231856308,-0.6506550218340611,"[0.25, 0.21]","['2025-04-17', '1999-01-27']",__nan__,0.902703832119509
351,DCOMP,Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A,"Dime Community Bancshares, Inc. operates as the holding company for Dime Community Bank that provides various commercial banking and financial services. It accepts time, savings, and demand deposits from the businesses, consumers, and local municipalities. The company also offers commercial real estate loans; multi-family mortgage loans; residential mortgage loans; secured and unsecured commercial and consumer loans; home equity loans; and construction and land loans. In addition, it invests in Federal Home Loan Bank, Federal National Mortgage Association, Government National Mortgage Association, and Federal Home Loan Mortgage Corporation mortgage-backed securities, collateralized mortgage obligations, and other asset backed securities; U.S. Treasury securities; New York state and local municipal obligations; U.S. government-sponsored enterprise securities; and corporate bonds. Further, the company offers certificate of deposit account registry services and insured cash sweep programs; merchant credit and debit card processing, automated teller machines, cash management services, lockbox processing, online banking services, remote deposit capture, safe deposit boxes, and individual retirement accounts; investment products and services through a third-party broker dealer; and title insurance broker services. As of December 31, 2021, it operated 60 branch locations throughout Long Island and the New York City boroughs of Brooklyn, Queens, Manhattan, and the Bronx. Dime Community Bancshares, Inc. was founded in 1910 and is headquartered in Hauppauge, New York.",Mr. Stuart H. Lubow,Banks - Regional,18.41,USD,1270313086,https://images.financialmodelingprep.com/symbol/DCOMP.png,6519,4.92,-0.3,1800,0,29084000,"[{'period': '2024', 'revenue': 650.15, 'unit': 'M', 'net_profit': 29.08}, {'period': '2023', 'revenue': 352.78, 'unit': 'M', 'net_profit': 96.09}, {'period': '2022', 'revenue': 418.02, 'unit': 'M', 'net_profit': 152.56}, {'period': '2021', 'revenue': 399.68, 'unit': 'M', 'net_profit': 104.0}]","[{'period': ""Q4 '24"", 'revenue': 57.24, 'unit': 'M', 'net_profit': -20.41}, {'period': ""Q3 '24"", 'revenue': 87.56, 'unit': 'M', 'net_profit': 13.33}, {'period': ""Q2 '24"", 'revenue': 170.14, 'unit': 'M', 'net_profit': 18.48}, {'period': ""Q1 '24"", 'revenue': 171.07, 'unit': 'M', 'net_profit': 17.69}, {'period': ""Q4 '23"", 'revenue': 82.99, 'unit': 'M', 'net_profit': 16.31}, {'period': ""Q3 '23"", 'revenue': 84.41, 'unit': 'M', 'net_profit': 14.98}]",0.8,0.8,14353258000,2030234000,1974264000,12956741000,55970000,0,50000000,1283571000,92798000,0,-0.6973380231856308,-0.6506550218340611,"[0.34375, 0.38]","['2025-02-06', '2020-05-05']",__nan__,0.902703832119509
352,DCPH,Deciphera Pharmaceuticals Inc. Common Stock,"Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.",Mr. Steven L. Hoerter,Drug Manufacturers - Specialty & Generic,25.59,USD,2212920840,https://images.financialmodelingprep.com/symbol/DCPH.png,1855995,-11.57918552036199,0.02,1572857,-208858000,-194942000,"[{'period': '2023', 'revenue': 163.36, 'unit': 'M', 'net_profit': -194.94}, {'period': '2022', 'revenue': 134.04, 'unit': 'M', 'net_profit': -178.93}, {'period': '2021', 'revenue': 96.15, 'unit': 'M', 'net_profit': -296.84}, {'period': '2020', 'revenue': 42.09, 'unit': 'M', 'net_profit': -266.49}]","[{'period': ""Q1 '24"", 'revenue': 45.0, 'unit': 'M', 'net_profit': -45.08}, {'period': ""Q4 '23"", 'revenue': 48.29, 'unit': 'M', 'net_profit': -47.19}, {'period': ""Q3 '23"", 'revenue': 43.31, 'unit': 'M', 'net_profit': -49.58}, {'period': ""Q2 '23"", 'revenue': 38.3, 'unit': 'M', 'net_profit': -48.56}, {'period': ""Q1 '23"", 'revenue': 33.45, 'unit': 'M', 'net_profit': -49.61}, {'period': ""Q4 '22"", 'revenue': 36.34, 'unit': 'M', 'net_profit': -45.94}]",-2.29,-2.29,473566000,381096000,306216000,122650000,31952000,46699000,100275000,83507000,-147475000,-0.14303696325565612,-0.08948142021226059,0.03375527426160341,__nan__,__nan__,__nan__,0.25899241077273283
353,DCRB,Decarbonization Plus Acquisition Corporation Class A Common Stock,,,,,,,,,,,,-5476998,-5476998,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.48}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': -216.96}, {'period': '2018', 'revenue': 0.0, 'unit': '', 'net_profit': -462.0}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.18}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.48}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -2.58}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -214.12}]",-0.19,-0.19,17972571,225727721,225727721,12972568,0,0,5072192,0,-1644507,-24.244275442477875,-24.244275442477875,-23.675324675324674,__nan__,__nan__,__nan__,0.7217981222608607
